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ABSTRACT 
1. The literature has been reviewed with respect to the dietary intake and 
subsequent metabolism of polyunsaturated fatty acids (PUFA), of both the n-6 and 
n-3 series, in teleost fish. Particular emphasis has been made to the physiological 
roles of PUFA with respect to cell membrane function and eicosanoid production. 
2. Atlantic salmon post-smolts were fed practical-type diets, based on fish meal, in 
three separate dietary experiments of 10-16 weeks duration. The first trial compared 
dietary lipid supplied either as fish oil (FO) or as sunflower oil (SO) with the diets 
having an n-3/n-6 PUFA ratio of 9.4 and 0.2 respectively. The second trial used diets 
formulated with blends of FO, SO, grape seed oil and safflower oil to provide linoleic 
acid at 10, 25 and 45% of total dietary fatty acids. The third trial was similar to the 
first but with an additional diet in which the'lipid component was supplied by linseed 
oil (LO). All diets satisfied the nutritional requirements of salmonid fish for n-3 PUFA. 
There were no statisticallly significant differences in final weights between dietary 
treatments in the third trial. However, in the second trial fish fed the intermediate 
level of linoleic acid (25%) attained a significantly higher final weight compared to 
both other treatments while fish fed the highest level of linoleic acid (45%) had 
significantly lower final weights compared to both other treatments. In the first trial 
the effect of diet on growth (weight gain) could not be ascertained as the initial 
weights of the fish were significantly different. 
3. A number of fish fed SO developed severe cardiac lesions which caused thinning 
of the ventricular wall and heart muscle necrosis. In addition the fish fed diets 
containing SO were susceptible to a transportation-induced shock syndrome that 
resulted in 30% mortality. 
4. Incorporation of linoleic acid (18:2n-6) into membrane phospholipids increased in 
response to dietary intake with fish fed SO having increased levels of 18:2n-6 (up to 
15-fold), 20:2n-6 (up to 12-fold), 20:3n-6 (up to 25-fold) and arachidonic acid (AA; 
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20:4n-6) (up to 3-fold), and decreased levels of eicosapentaenoic acid (EPA; 20:5n-
3) (up to 3-fold). The ratio of n-3/n-6 PUFA was decreased (up to 4-fold) and the 
20:4n-6/20:5n-3 ratio increased (up to 9-fold) in membrane phospholipids from fish 
fed SO compared to those fed fish oil. While the tissue phospholipids from fish fed 
La had increased levels of 18:2n-6, 20:2n-6 and 20:3n-6, the levels of AA, 22:4n-6 
and 22:5n-6 were similar to or significantly reduced compared to fish fed Fa. 
Membrane phospholipids from fish fed La also had increased 18:3n-3 and 20:4n-3 
compared to both other treatments while in some tissues and phospholipid classes 
EPA was increased compared to fish fed Fa. 
5. These dietary induced changes in phospholipid eicosanoid precursor ratio were 
reflected in altered eicosanoid production. In gill cells, stimulated with the calcium 
ionophore A23187, 12-hydroxy-8, 10, 14, 17-eicosapentaenoic acid (12-HEPE) was 
the major 12-lipoxygenase product in fish fed Fa. In stimulated gill cells from fish fed 
SO and La, 12-HEPE, 12-hydroxy-5, 8, 10, 14-eicosatetraenoic acid (12-HETE), 14-
hydroxy-4, 7, 10, 13, 16, 19-docosahexaenoic acid (14-HDHE) and thromboxane 
B2 (TXB2) were all decreased compared to fish fed Fa. However, the ratio of 12-
HETE/12-HEPE was significantly elevated in stimulated gill cells from SO-fed fish 
compared to both other treatments. In stimulated blood leucocytes leukotriene B4 
(LTB4)' 12-HETE and TXB2 were significantly increased while LTB5 and 12-HEPE 
were significantly decreased in fish fed SO compared to those fed Fa. Blood 
leucocytes from fish fed La produced less TXB2 compared to fish fed SO and 
prostaglandin E2 was reduced compared to both other treatments. In isolated 
cardiac myocytes stimulated with A23187, TXB2 production was increased in SO-
fed fish compared to those fed FO. 
6. The activity of cardiac sarcoplasmic reticulum Ca2+-Mg2+ATPase was not 
affected by dietary treatment. 
7. An established cell line derived from chum salmon heart (CHH-1) was utilised to 
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study PUFA metabolism. The CHH-1 cells exhibited considerable A6 desaturase 
activity but showed no preference towards n-3 over n-6 PUFA. CHH-1 cells did 
exhibit significant A5 desaturase activity which showed a preference towards n-3 
PUFA. No A4 desaturation activity was observed. Elongation of C20 PUFA was 
especially active in CHH-1 cells with C22 PUFA being specifically incorporated into 
phosphatidylethanolamine (PE) and phosphatidylserine (PS). CHH-1 cells 
supplemented with 20:3n-6 showed reduced growth rate, cell death and unusual 
pycnotic appearance, compared to those supplemented with other PUFA. 
8. The lipid compositions of hearts and livers from wild and farmed parr and pre-
smolts were analysed and compared. The fatty acid compositions of triacylglycerols 
(TAG) and phospholipids from both farmed parr and pre-smolts contained greater 
amounts of monoenoic fatty acids compared to their wild counterparts. TAG, 
phosphatidylcholine (PC) and PE from heart and liver of wild fish contained more 
18:2n-6 and AA compared to farmed fish. Linolenic acid, EPA and 22:Sn-3 were 
increased in hearts and livers of wild fish compared to farmed. Docosahexaenoic 
acid (DHA; 22:6n-3) levels were higher in heart and liver of farmed fish, particularly 
in heart PC, PS and TAG. The n-3/n-6 PUFA ratio was generally lower in wild 
compared to farmed fish, largely due to higher n-6 PUFA, in particular AA, in wild 
fish. 
9. The results are discussed with respect to the competitive interactions between 
PUFA of the n-6 and n-3 series which determine the fatty acid compositions of 
membrane phospholipids in salmon. The ratio of n-3/n-6 PUFA in membrane 
phospholipids, and in particular the ratio of AAIEPA, appears important in terms of 
membrane physiology and biochemistry, eicosanoid production and the 
development of cardiac histopathological lesions. 
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ABBREVIATIONS 
The following abbreviations were used throughout the text: 
AA, arachidonic acid 
SHT, butylated hydroxy toluene 
SSA, bovine serum .album in 
Cl, cardiolipin 
DHA, docosahexaenoic acid 
EFA, essential fatty acid 
EPA, eicosapentaenoic acid 
FCS, fetal calf serum 
FO, fish oil 
FSH, follicle stimulating hormone 
GRH, gonadotrophin-releasing hormone 
HDHE, hydroxy-4, 7, 10, 13, 16, 19-docosahexaenoic acid 
HEPE, hydroxy-5, 8, 10, 14, 17-eicosapentaenoic acid 
HEPES, N-(2-hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid) 
HETE, hydroxy-5, 8, 10, 14-eicosatetraenoic acid 
HPlC, high-performance liquid chromatography 
HPTlC, high-performance thin-layer chromatography 
HUFA, highly unsaturated fatty acid 
lA, linoleic acid 
lH, lutein ising hormone 
lO, linseed oil 
lTB4. leukotriene B4 
lTB5' leukotriene B5 
Nl, neutral lipid 
PA, phosphatidic acid 
PC, phosphatidylcholine 
PD, pancreas disease 
PE, phosphatidylethanolam ine 
PG, prostaglandin 
PGA, prostaglandin A 
PGD, prostaglandin D 
PGE2, prostaglandin E2 
PGF 1 a' 6-keto-prostaglandin F 1 a 
PGF2a' prostaglandin F2a 
PGI2' prostacyclin 
PI, phosphatidylinositol 
PL, polar lipid 
PLA, phospholipase A 
PLC, phospholipase C 
PS, phosphatidylserine 
PUFA, polyunsaturated fatty acid 
SD, standard deviation 
SM, sphingomyelin 
SR, sarcoplasmic reticulum 
SO, sunflower oil 
TAG, triacylglycerol 
TXA2, thromboxane 
TX82' thromboxane 82 
TLC, thin-layer chromatography 
UV, ultraviolet 
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Section 1: Introduction 
1 : 1 Lipid classes 
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The term 'lipid' generally describes a group of biological substances distinct from 
proteins, carbohydrates and nucleic acids, which are not water soluble but are 
soluble in organic solvents such as chloroform, hexane, diethylether etc. More 
specifically the term describes compounds fulfilling the aforementioned solubility 
characteristics and which contain esterified fatty acids. Lipids so defined can be 
divided into a) neutral lipids, including triacylglycerols (TAG), partial acyl glycerols, 
alkyldiacylglycerols, wax esters and sterol esters, and b) polar lipids, including 
glycerophospholipids, sphingolipids and glyceroglycolipids. The neutral lipids are 
generally involved in lipid storage whereas the polar lipids provide the structural 
components of cell membranes. Among these structural lipids the 
glycerophospholipids are quantitatively the most important in animal cell 
membranes and upon hydrolysis yield fatty acids, glycerol and a polar head group. 
The head group contains phosphate simultaneously esterified to a small molecule 
e.g. an amine, an amino acid or an alcohol esterified to the sn-3 position of glycerol, 
while the fatty acids are esterified at the sn-1 and sn-2 positions of glycerol (Gurr 
and Harwood, 1991). The major glycerophospholipid components of animal cell 
membranes are phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylserine (PS), phosphatidylinositol (PI) and cardiolipin (CL). 
1:2 Fatty acid structure and nomenclature 
The area of fatty acid nomenclature can be something of a minefield for the 
uninitiated in that a variety of trivial, systematic and shorthand forms are all 
commonly used. For example, palmitic acid is a saturated fatty acid containing 16 
carbon atoms in a straight chain (Fig. 1.2.1) and is given the shorthand 
nomenclature 16:0. The number before the colon gives the carbon number while 
Fig. 1 :2:1 FATTY ACID CLASSES AND NOMENCLATURE 
SATURATED 
e.g. 16:0; hexadecanoic acid; palmitic acid 
MONOUNSATURATED 
e.g. 18:1 n-9; cis-9-octadecenoic acid; oleic acid 
POLYUNSATURATED 
e.g. 18:2n-6; ~ 9, 12-octadecadienoic acid; linoleic acid 
e.g. 20:5n-3; ~ 5,8,11, 14,17-eicosapentaenoic acid 
e.g. 22:6n-3; ~ 4,7,10,13,16,19-docosahexaenoic acid 
OOH 
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the number after the colon signifies the number of double bonds. In the present 
study double bonds have the cis nomenclature and where two or more double 
bonds are present they are methylene interrupted, unless otherwise stated (Christie, 
1982). The monounsaturated fatty acid, oleic acid, is given in shorthand form as 
18:1n-9 where 9 is the position of the double bond in the chain while n (or 
sometimes ro) shows that numbering is from the methyl end. The polyunsaturated 
fatty acid (PUFA) linoleic acid is given the shorthand form 18:2n-6 where the n-6 
identifies the position of the first double bond from the methyl end. An alternative 
nomenclature using the ~ notation identifies the position of the first double bond 
counting from the carboxyl end. Thus oleic acid is 18:1~9 and linoleic acid is 18:2 ~ 
9, 12. The long-chain highly unsaturated fatty acids (HUFA) eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (OHA) are shown in Fig. 1.2.1. Throughout this 
study the n-x shorthand nomenclature has been used when describing fatty acids. 
In general, PUFA of the n-3 series tend to predominate in the marine environment 
whereas PUFA of the n-6 series are the dominant species in terrestrial organisms 
(Sargent and Henderson, 1986; Wood, 1988). 
1:3 Biosynthesis and metabolism of PUFA 
1 :3:1 Introduction 
Lipids are probably the most intensively studied of the biochemical components in 
aquatic organisms. Much interest has been generated by the high levels and wide 
ranges of lipids in many aquatic organisms and also by them containing, by 
comparison to most terrestrial organisms, high levels and a wide range of the n-3 
series polyunsaturated fatty acids (PUFA). Fish lipids in particular are 
characteristically rich in n-3 PUFA (Henderson and Tocher, 1987; Ackman, 1980), 
although considerable differences exist between freshwater and marine species. 
For example, in fish from northern latitudes, freshwater species generally have 
higher levels of C18 PUFA and lower levels of C20 and C22 PUFA compared to 
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marine species (Sargent et al. 1989) . 
1 :3:2 Fatty acid synthetase 
Although the fatty acid synthetase enzyme complex has not been fully 
characterised in fish, it is generally agreed that fatty acid synthesis in fish proceeds 
using pathways broadly similar to those which occur in mammals (Wakil et al. 
1983). Thus 2C acetyl-CoA units derived from the tricarboxylic acid cycle are 
carboxylated to malonyl-CoA which is subsequently converted to fatty acids by the 
fatty acid synthetase complex via a series of condensation and reduction reactions 
utilizing NADPH (Wakil et al., 1983). Fish possess a similar cytosolic fatty acid 
synthetase complex to that found in other vertebrates (fatty acid synthetase type I) 
(Sargent et al. 1989) although the chain lengths of the saturated fatty acid products 
(mainly palmitiC and stearic acids in fish) may differ in range and proportion to those 
found in mammals. A detailed description of the enzyme pathways involved in de 
novo fatty acid synthesis is given in a number of general biochemistry textbooks 
(Lehninger, 1975; Zubay, 1988) or textbooks devoted to lipid metabolism (Harwood 
and Russell, 1984; Gurr and Harwood,1991). A recent review of lipid biosynthesis in 
fish can be found in Sargent et al. (1989). 
1 :3:3 Fatty acid elongation 
By comparison to the de novo synthesis of fatty acids by the fatty synthetase type I 
enzyme, the lengthening of preformed or dietary-derived fatty acids is performed by 
type III synthetases or elongases. While this system has been little studied in fish, it 
is presumed to operate by similar mechanisms to those found in other vertebrates. 
These elongation reactions occur in the membrane fraction of the endoplasmic 
reticulum and which can be isolated as the microsomal fraction by differential 
ultracentifugation. The reaction involves fatty acyl-CoAs as primers with malonyl-
CoA being the donor of 2C units and requires NADPH as reducing co-enzyme. 
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Details of these reactions can be found in Gurr and Harwood (1991). In general, the 
elongases are not all that well characterised in mammals and could be very 
complex. There appear to be four component reactions, which require fatty acid 
CoA derivatives, and can utilise both NADH and NADPH, involving both cytochrome 
b5 and cytochrome P450. The enzyme complex resides on the cytoplasmic surface 
of the endoplasmic reticulum and appears to function in concert with desaturases. 
The complex was identified in all mammalian tissues investigated, except heart 
(Cinti et al. 1992). 
1 :3:4 Fatty acid desaturation 
The utilisation of acetyl units for both elongation reactions and de novo fatty acid 
synthesis has been demonstrated in carp and eels injected with 14C-acetate 
(Farkas and Csenger, 1976; Henderson, 1995). These studies also observed the 
presence of radioactivity in 16: 1 and 18: 1 n-9 indicating that endogenously 
synthesised fatty acids had undergone /1 9 desaturation reactions. However, as with 
other vertebrates, fish do not possess the /112 and /1 15 desaturase enzymes which 
are required for the synthesis of 18:2n-6 and 18:3n-3, and consequently these fatty 
acids or their longer chain metabolites must be obtained from dietary sources. Thus, 
18:2n-6 and 18:3n-3, linoleic and a-linolenic acids respectively, are regarded as 
essential fatty acids (EFA) and must be supplied by the diet. The ultimate source 
material for both n-3 and n-6 PUFA in both mammals and fish are photosynthetic 
organisms, i.e. higher plants in the terrestrial environment and phytoplankton in the 
marine environment (Harwood, 1988). In photosynthetic organisms the synthesis of 
both n-3 and n-6 PUFA occurs initially by conversion of biosynthesised 18:0 to 
18:1n-9 (or similarly 16:0 to 16:1n-7) utilising /19 desaturase (Harwood, 1988). 
Plants can further desaturate 18: 1 n-9 to 18:2n-6 utilising a A 12 desaturase and 
finally produce 18:3n-3 by /1 15 desaturation. These enzymatic processes which 
insert double bonds into a monounsaturated fatty acid between the existing double 
1 1 
bond and the methyl end of the molecule are the source of all n-3 and n-6 PUFA. 
The reactions occur within the thylakoid membranes of eukaryotic chloroplasts. 
Animals, unlike plants, are not able to insert double bonds between existing 
double bonds and the methyl terminus of any fatty acid i.e. animals do not possess 
either A12 or A15 desaturase. However, the desaturase enzymes present in 
animals and some plants can insert additional double bonds between existing 
double bonds and the carboxyl end of the molecule. These latter reactions can 
occur with both 18:2n-6 and 18:3n-3, both before and after chain elongation, and 
utilise A 6, A 5 and A 4 desaturases (Fig. 1 :3:1). The A4 desaturation reaction is now 
believed to occur, in rats, by elongation of 20:5n-3 to 24:5n-3 followed by A6 
desaturation to give 24:6n-3 which is converted to 22:6n-3 following peroxisomal b 
oxidation (Voss et al. 1991) (See Figure 1 :3:2, page 15). Thus, animals can convert 
18:2n-6 to 22:5n-6 and 18:3n-3 to 22:6n-3, although different species may contain 
varying complements of desaturase enzymes and therefore different end products. 
In plants the A12 and A15 desaturases mainly occur in the glycolipids of the 
thylakoid membranes, for the production of 18:2n-6 (A12) and 18:3n-3 (A12 and 
t:..15), whereas in animals the further conversion of these fatty acids to 22:5n-S, 
22:5n-3 and 22:Sn-3 are associated with the phospholipids of the endoplasmic 
reticulum where the AS and A5 desaturation reactions occur. Plants also possess 
AS desaturase since many produce oils rich in 18:3n-S and 18:4n-3 (Cook, 1985). 
Members of the phytoplankton produce 20:5n-3 and 22:6n-3 and therefore have A6, 
A5 and A4 desaturase activities. However, whether the species concerned are true 
plants is very debatable. Most of the species concerned are phototrophic but many 
can be simultaneously heterotrophic, especially those species rich in 22:6n-3 which 
are generally flagellates and include the dinoflagellates. The distinction between 
'plants' and 'animals' in single celled eukaryotes is confused and tends to be 
avoided in modern classifications based on non-symbiotic functions of protists 
Figure 1 :3:1 PATHWAYS OF DESATURATION AND ELONGATION 
(Horizontal lines represent elongation by addition of acetyl units. Vertical lines 
represent desaturation steps). 
Desaturase Fatty acid Diet Diet 
rhetT 18:2n-6 18:3n-3 
16:0 18:0 
a9 I I 
16: 1--> 18: 1-->20: 1-->22: 1 18:2-->20:2-->22:2 18:3-->20:3-->22:3 
a6 I I I 
18:2-->20:2-->22:2 18:3-->20:3-->22:3 18:4-->20:4-->22:4 
a5 I I I 
20:3-->22:3 20:4-->22:4 20:5-->22:5 
a~ \ \ I 
22:4 22:5 22:6 
n-9 n-6 n-3 
*The recent work of Voss et al. (1991) has established that il4 desaturation actually 
proceeds via elongation to 24:5n-3 (or 24:4n-6) and subsequent £\6 desaturation 
producing 24:6n-3 (or 24:5n-6) which is then converted to 22:6n-3 (or 22:5n-6) via 
peroxisomal ~ - oxidation. 
12 
(Margulis, 1993). In line with this the precise amounts of 16, 18, 20 and 22C in 
phytoplankton and algae are dependent on both the species and the 
developmental cycle of the cell (Wood, 1988). 
Although relatively few fish species have been studied in detail there are general 
trends regarding desaturation and elongation of fatty acids which have traditionally 
been related to whether the fish inhabit either the freshwater or marine environment. 
Experiments involving administration of 14C-18:3n-3 by injection or feeding, and 
nutritional studies feeding 18:2n-6 and 18:3n-3, have confirmed that various 
freshwater fish including rainbow trout, ayu and eel are able to elongate and 
desaturate 18:3n-3 to 22:6n-3 (reviewed by Henderson and Tocher, 1987). 
However, a considerable variation in the conversion rate of 18:3n-3 to 22:6n-3 
between different freshwater species has been observed (Kanazawa, 1985). Marine 
species, including the turbot (Scophthalmus maxim us) , appear unable to 
synthesise long-chain HUFA from 18C precursors supplied in the diet (Owen et al. 
1975) although recent work with turbot cells in culture has suggested they actively 
convert 18:2n-6 to 18:3n-6 and 18:3n-3 to 18:4n-3 via /). 6 desaturase (Tocher et al. 
1989). It appears that marine fish, including turbot, striped jack, gilthead bream and 
grey mullet, are deficient in or have a very low /). 5 desaturase activity and 
consequently require a dietary supply of 20:5n-3, 22:6n-3 and probably also 20:4n-
6 (Bell et al. 1985; Takeuchi et al. 1992; Kalogeropoulos et al. 1992; Argyropoulou 
et al. 1992). (The ability of marine fish to convert 20:5n-3 to 22:6n-3 at a rate 
sufficient to satisfy their requirement for the latter PUFA is discussed in detail on 
pages 13 & 14). In studies with an anadromous fish, the Atlantic salmon, the parr 
stage appears to possess similar desaturation and elongation capability to 
freshwater species but while undergoing smoltification the ability to elongate and 
desaturate 18:2n-6 may be reduced or even absent (Ackman and Takeuchi, 1986). 
This effect during smoltification may reflect less of an inherent inability to metabolise 
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18:2n-6 but more a strong preference to metabolise 18:3n-3 to 22:6n-3 because the 
latter HUFA is known to increase in anadromous fish undergoing the transition to 
sea water. This phenomenon in salmon will be returned to in the discussion of this 
thesis. 
1:4 Competitive interactions between PUFA 
When undertaking dietary studies utilising oils of varying PUFA composition, it is 
important to bear in mind that the presence of one type of fatty acid can influence 
the metabolism of others (Garcia and Holman, 1965). In mammals it is generally 
accepted that the substrate preference for the A 6 desaturase is 18:3n-3 > 18:2n-6 > 
18: 1 n-9 and that competitive interactions exist between these three substrates 
(Sprecher, 1989). The same substrate affinity pattern exists in fish and, although an 
excess of dietary 18:2n-6 may inhibit metabolism of 18:3n-3, it is generally accepted 
that 18:3n-3 is more effective in inhibiting the metabolism of 18:2n-6 than vice versa 
(Yu and Sinhuber, 1976, 1979). In addition, the A 6 desaturase can be subjected to 
feedback inhibition by long-chain HUFA such as 20:5n-3 and 22:6n-3 which 
therefore prevent desaturation of both 18:2n-6 and 18:3n-3 (Leger et al. 1981). As a 
consequence of these competitive interactions, 18: 1 n-9 is only utilised as a 
substrate for A 6 desaturase when both 18:2n-6 and 18:3n-3 are absent. Thus, 
trout given diets lacking both 18:2n-6 and 18:3n-3 tend to accumulate 20:3n-9, 
originating from the A 6 desaturation of 18: 1 n-9, in their tissue phospholipids 
(Castell et al. 1972) (See Fig. 1.3.1). Moreover, recent studies have established that 
A 4 desaturation can occur, in rats, as a result of A 6 desaturase acting on 24:Sn-3 
which results in 22:6n-3 after chain shortening of 24:6n-3 (Voss et al. 1991; see Fig. 
1 :3:2). If A 4 desaturation proceeds extensively by this mechanism, as now seems 
likely, a further consequence of the competitive inhibitions between dietary PUFA 
concerns whether 20:5n-3 can be elongated and desaturated to 22:6n-3, at a rate 
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sufficient to satisfy requirements. This may be especially important in marine fish 
consuming diets which are rich in 20:5n-3 but relatively poor in 22:6n-3. Evidence 
suggests that the conversion 20:5n-3 to 22:6n-3 is slow (Sargent et al. 1989) and 
may be influenced by the presence of additional A6 desaturase substrates in the 
diet. Recent studies utilising cultured cells from the turbot have confirmed that this 
marine fish can convert 20:5n-3 to 22:6n-3, but at a relatively slow rate (Tocher and 
McKinlay, 1990; Tocher and Sargent, 1990). Whether this reaction rate is 
quantitatively sufficient to satisfy 22:6n-3 requirement or if additional dietary 22:6n-3 
is required has been difficult to establish. 
A recent study using isolated hepatocytes from trout and rats established that A 6 
desaturase activities were similar in both species at 120 and 370 C respectively, and 
that 18:3n-3 was preferred as substrate compared to 18:2n-6 in both species 
(Hagve et al. 1986). However, A 5 desaturase, measured with 20:3n-6 as substrate, 
was four times greater in rat than in trout hepatocytes although the difference 
between species was less marked when 18:2n-6 and 18:3n-3 were initial substrates 
for A 5 desaturation. In contrast, A 5 desaturase activity measured with 20:4n-3 as 
substrate was almost twice as great in trout hepatocytes compared to rats. 
Moreover, considerably more of the radioactive substrate fatty acids were 
incorporated into 20:2n-6, 20:3n-3 and 22:3n-3 in trout hepatocytes compared to rat. 
These fatty acids are considered 'dead end' products not normally subject to further 
metabolism and are generally stored in triglycerides until they are subsequently 
released and retroconverted to be utilised as substates for more conventional 
pathways of desaturation and elongation (Sellner and Hazel, 1982). However, while 
retroconversion of 22:6n-3 to 20:5n-3 occurs in rats, (Schlenk et al. 1969) there is 
some evidence that rainbow trout are not capable of performing the same reaction 
(Yu and Sinnhuber, 1972). The balance between chain shortening activity and 
chain elongating activity is a very important factor in ultimately determining the 
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PUFA composition of membrane lipids. There is evidence from mammalian 
experiments which suggests that the balance between elongation and shortening of 
n-6 PUFA is such that 20:4n-6 rather than 22:5n-6 is the end product in membrane 
lipids. However, for n-3 PUFA, 22:6n-3 is the prefered end product incorporated in 
membranes in preference to 20:5n-3 (Rosenthal et al. 1991). The way in which this 
balance operates in fish is of obvious importance in fish nutrition. However, because 
of the complexities of predicting the competitive interactions involved in 
desaturation and elongation, it has proved extremely difficult to envisage which 
PUFA will be incorporated into tissues of fish, and other animals, from PUFA 
compositions given in the diet (Lands, 1991). The recent confirmation that A 4 
desaturase may actually be a A 6 desaturase which operates on 24:5n-3 (following 
elongation of 22:5n-3) producing 24:6n-3 which is then converted to 22:6n-3 after 
undergoing peroxisomal ~ - oxidation (Voss et al. 1991), would consolidate the 
preferential conversion of 18:3n-3 rather than 18:2n-6 by the A 6 desaturase (See 
Fig. 1 :3:2). Thus, the apparent inability to metabolise 18:2n-6 during smoltification of 
salmon parr may reflect the increased requirement for 22:6n-3 and the consequent 
increased competition for the A 6 desaturase. 
Figure 1:3:2 PATHWAY FOR CONVERSION OF 20:5n-3 TO 22:6n-3 (Voss et al. 
1991) 
1 1 2 3 
20:5n-3 ----->22:5n-3 ----->24:5n-3 ----->24:6n-3 ----->22:6n-3 
Where 1 represents a microsomal fatty acid elongase, 2 is the microsomal A 6 
desaturase and 3 is the peroxisomal ~-oxidation chain shortening system. The 
same pathway will also operate to convert 20:4n-6 to 22:5n-6. 
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1:5 Functional roles of PUFA 
1 :S: 1 Membrane Structure and Function 
1 :S: 1: 1 Homeoviscous adaptation to environmental temperature 
PUFA are an integral component of phospholipids which are in turn the building 
blocks which form the bilayer structure of cellular membranes in all animal cells, 
including fish. Since fish are poikilothermic organisms, the ability to undergo 
homeoviscous adaptation to environmental temperature changes is a particularly 
important role for membrane lipids. To function correctly the fluid state of cell 
membranes must be controlled and this is governed largely by the fatty acid 
compositions of the membrane phospholipids (Hazel and Williams, 1990). The 
phase transition temperatures (melting points) of fatty acids are determined by the 
number and position of double bonds in the carbon chain and all PUFA commonly 
found in fish membranes have transition temperatures far below OOC. (18:2n-6, -
80 C; 18:3n-3, -100 C; 20:4n-6, -49.SoC; 20:Sn-3, -S4.40 C; 22:6n-3, -44.SoC; 
Fasman, 1975). The' balance of PUFA with saturated and monounsaturated fatty 
acids maintains the biomembrane in a fluid state (Hazel, 1984). During cold 
adaptation the amount of total phospholipid does not alter but the relative 
proportions of phospholipids, the fatty acid composition of phospholipids and the 
distribution of fatty acids within phospholipids are all altered. Thus, in trout 
transferred from 200 to SoC PE increases and PC decreases in both liver and gills 
(Hazel, 1979). Similar changes in the PE:PC ratio have been observed during cold 
acclimation in goldfish intestine and carp muscle (Miller et al. 1976; Wodke, 1981). 
During cold adaptation, the proportions of PUFA and especially the n-3 PUFA 
increase in the phospholipids of trout liver, while saturated fatty acids decrease 
(Hazel, 1979). Such changes in PUFA composition of phospholipids are brought 
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about by a combination of increased desaturase activity and increased 
incorporation of long-chain PUFA into phospholipids (Ninno et al. 1974). However, 
studies by Cossins (1977) suggest that the major fatty acid compositional alterations 
in membrane phospholipids involve the monounsaturated fatty acids with much 
smaller changes occuring in saturated and polyunsaturated fatty acids. This result 
suggests that the activity of the ~9-fatty acid desaturase may be of major importance 
in determining the adaptive changes in phospholipid fatty acid compositions which 
occur as a result of temperature acclimation. 
1 :5: 1:2 Neural tissues 
Fish cell membranes are characteristically rich in n-3 PUFA, particularly 20:5n-3 
and 22:6n-3. The brain, retina and reproductive tissue in mammals are all markedly 
rich in n-3 PUFA relative to other body tissues and, likewise, the brain and retina of 
fish are particularly rich in these PUFA, especially DHA (Sastry, 1985; Bell and Dick, 
1991). It has now been established that DHA is essential for proper development of 
neural including visual membranes in mammals and that deficiency during 
embryonic development in primates and Homo sapiens leads to visual and mental 
subnormalities (Neuringer et al. 1988; Bazan, 1990; Hoffman et al. 1993). Until 
recently, no direct evidence of neural or visual impairment has been observed in 
fish but a study by Bell et al. (1995) has shown that a dietary deficiency of DHA, in 
larval herring (Clupea harengus) , results in impaired vision at low light intensities. 
Recent studies involving larval turbot have established that DHA is initially deficient 
in intensively reared fish but is rapidly taken up and incorporated into brain 
phospholipids when larvae are weaned onto particulate feeds (Mourente et al. 
1991; Mourente and Tocher, 1992). The larval turbot were fed a diet of brine shrimp 
(Artemia) , which had been enriched using fish oil, for the first 51 days after 
hatching. After 51 days the larvae were weaned onto a dry pelleted diet which 
contained 13 times more DHA than the enriched Artemia. Upon weaning DHA was 
18 
rapidly and specifically incorporated into brain phospholipids. Clearly DHA levels in 
developing larvae are extremely important and the low levels of DHA in the brains 
of Artemia -fed larvae may be one factor underlying the high mortalities 
encountered in larvae during first feeding. 
Clearly the accumulation of DHA into neural tissues must have an important 
functional significance possibly related to the physical properties of the DHA 
molecule. Increasing the number of double bonds in a long-chain fatty acid 
molecule results in an increasingly compact conformation. In DHA this results in the 
minimum energy conformation of a compact helix or angle iron having a length 
shorter than that of 18:0 (Applegate and Glomset, 1986). In fish neural tissues DHA 
is largely found in PE and PS where a very large percentage (ca. 70%) is in the 
form of the di-22:6n-3 molecular species (Bell and Tocher, 1989; Bell and Dick, 
1991). It has been suggested from physico-chemical studies with mammalian rod 
outer segment membranes that the abundance of di-22:6n-3 PE maintains the 
required membrane balance between fluidity and rigidity which is necessary to 
allow the rapid conformational changes undergone by the retinal chromophore of 
rhodopsin (Dratz and Deese, 1986). A model for rhodopsin function describing the 
conformational transition between metarhodopsin I (MI) and metarhodopsin II (Mil) 
as the fundemental triggering event in the visual process has been described by 
Brown (1994). This study details the use of flash photolysis to determine the 
(MII)/(MI) ratio for rhodopsin in various recombinant membranes and allows 
investigation of the role of phospholipid head groups and fatty acid composition on 
rhodopsin function. To achieve normal photochemical function the membrane must 
comprise PC, PE and PS in combination with DHA and the MI-MII transition appears 
favoured by relatively small head groups, e.g. PE, which produce a condensed 
bilayer surface together with bulky acyl chains like DHA which have a large cross-
sectional area. The result is a force imbalance across the bilayer giving a curvature 
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stress at the lipid/water interface and the relatively unstable membrane composition 
required for rhodopsin transition and triggering of the visual process (Brown, 1994). 
1 :5: 1:3 Membrane-bound proteins 
Cell membranes are not only composed of a phospholipid bilayer but also contain 
proteins which perform various critical physiological functions including signal 
reception, transport of ions and molecules, and enzymic reactions. The fatty acid 
composition of the membrane phospholipids, which can be influenced by dietary 
lipid input, can directly affect the function of membrane-associated proteins (Spector 
and Yorek, 1985). The effects of changes in membrane fatty acid composition may 
be extremely complex in that different tissues or cell types may respond very 
differently, in terms of protein functionality, to the same dietary induced 
compositional changes. For example, Nalbone et a/. (1990) observed that 
cardiomyocytes supplemented with a high n-6/n-3 PUFA ratio had higher 
phospholipase A activity compared to those supplemented with a low n-6/n-3 PUFA 
ratio. In contrast, rats given a fish oil diet, rich in n-3 PUFA, had an increased gastric 
phospholipase A activity compared to rats given a corn oil diet rich in n-6 PUFA 
(Grataroli et a/. 1988). Functional modifications of this type may be attributed to 
changes in membrane fluidity such that the lipid micro-environment adjacent to the 
enzyme active site influences substrate access, and thus enzymic activity (Stubbs 
and Smith. 1984). It would appear that the composition of both acyl chains and 
phospholipid head group are fundamental in the control of overall membrane 
bilayer energetics and that the mechanism described for rhodopsin (Brown, 1994) 
may be a marked example of a general phenomenon related to protein 
conformational change. 
1 :5:2 Eicosanoid production 
The term eicosanoid was first used by Corey et a/. (1980) to describe a group of 
biologically active compounds derived from eicosapolyenoic acids, particularly 
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arachidonic acid (AA), but also 20:3n-6 (di-homo y- linolenic acid) and 20:5n-3. The 
two major di-oxygenase enzymes involved in eicosanoid production are 
cyclooxygenase and Iipoxygenase. Cyclooxygenase converts AA into prostaglandin 
H (PGH) which can be further metabolised by isomerases to produce a range of 
compounds collectively known as prostanoids, including prostaglandins (PG), 
prostacyclins (PGI) and thromboxanes (TX). The lipoxygenases initially produce 
hydroperoxy fatty acids which are further metabolised into a number of derivatives 
including hydroxy fatty acids, leukotrienes (LT) and lipoxins. A summary of the 
pathways involved in eicosanoid production and the various classes of eicosanoids 
produced is presented in Figure 1 :5: 1. The eicosanoid precursors 20:3n-6, 20:4n-6 
and 20:5n-3 can be converted, after reaction with cyclooxygenese, to 
prostaglandins of the 1-, 2- and 3-series respectively. Alternatively 20:3n-6, 20:4n-6 
and 20:5n-3 can be metabolised by a number of Iipoxygenase enzymes to yield 
hydroxyeicosatrienoic, hydroxytetraenoic and hydroxypentaenoic acids (HETES 
and HEPES) respectively. Initial reaction with a 5-lipoxygenase can be followed by 
further hydroxylation to produce di-HETE/HEPE products, some of which are known 
as leukotrienes, and are designated 3-, 4- and 5-series when derived from 20:3n-6, 
20:4n-6 and 20:5n-3 respectively. 
Eicosanoids are synthesised and released locally in response to stimuli which can 
be physiological, pharmacological or pathological in origin. The processes involved 
in eicosanoid production in response to an extracellular stimulus are often 
described as "the arachidonic acid cascade", largely because AA is the major 
precursor for eicosanoid production in mammals. The precursor fatty acids for 
eicosanoid production are obtained from membrane phospholipids, although 
specifically which ones is still a matter of some controversy, which are hydrolysed 
after activation of cell surface receptors. These cellular receptors are linked to G 
proteins (guanine nucleotide regulatory proteins) which are activated upon binding 
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of ligand. The activated G proteins then act directly on other membrane proteins e.g. 
adenylate cyclase, ion channels, protein kinases etc, which ultimately leads to 
activation of phospholipase A2 (PLA2) (Blackwell et al. 1978; Smith, 1989). The 
activated phospholipase A2 enzyme then acts to release AA and other eicosanoid 
precursors from the sn -2 position of membrane phospholipids (Wolfe, 1982). The 
phospholipase A enzymes are ubiquitous in eukaryotic cells and may be cytosolic 
but migrate to the membrane on activation. They may be associated with plasma, 
Golgi and mitochondrial membranes and are often stimulated by calcium ions (van 
den Bosch, 1980; Dennis et al. 1995). An alternative supply of eicosanoid 
precursors may arise from the sequential action of phospholipase C and 
diacylglycerol lipase (Irvine, 1982), which form part of the phosphoinositide cycle, or 
from the combined action of both PLC and PLA (Rittenhouse-Simmons, 1979). 
Eicosanoids synthesised by the above mechanisms can themselves activate other 
receptors and G proteins to generate, inter alia, other and more eicosanoids (Smith, 
1989). 
1 :5:3 Eicosanoids in fish 
Prostanoids have been identified in a large range of freshwater fish, including 
carp, tilapia, Asian catfish (Bandyopadhyay et al. 1982), eel, (Srivastava and 
Mustafa, 1984) and rainbow trout (Kayama et al. 1986), and in marine fish such as 
plaice (Anderson et a/. 1981), turbot (Henderson et a/. 1985), flounder and black 
and red sea breams (Matsumoto et al. 1989). Cyclooxygenase activity has been 
demonstrated in virtually all fish tissues studied to date, in general following 
addition of exogenous precursors. However synthesis of prostanoids from 
endogenous fatty acids has been established in a number of tissues including gills 
(Christ and van Dorp, 1972), leucocytes (Pettitt et al. 1989), ovarian tissues (Ogata 
et al. 1979) and heart, liver, intestine, brain, testes, kidney and air sac (Nomura and 
Ogata, 1976). Production of lipoxygenase metabolites has also been established in 
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both freshwater and marine fish (Tocher, 1995). Tissues identified as having 
significant lipoxygenase activity include gills, skin, blood and brain (German et al. 
1986; German et al. 1985; Pettitt and Rowley, 1991; Tocher et al. 1991). 
The prostaglandins PGE2, PGF2a and PGD2 have been identified in numerous 
fish tissues (Rowley etal. 1987; Henderson and Tocher, 1987) and TXB2, the stable 
metabolite of thromboxane, is produced by thrombocytes from rainbow trout 
(Kayama et al. 1985) and by dogfish leucocytes (Rowley et al. 1987). 12-
Lipoxygenase has been identified in gills and skin from fourteen species of fish 
(Tocher, 1995) and has also been measured in rainbow trout head kidney 
macrophages and brain (Pettitt et al. 1991; Tocher et al. 1991). The 15- and 5-
lipoxygenase enzymes have also been identified in a number of fish species and 
tissues including, gills, brain, neutrophils and head kidney macrophages (German 
and Creveling, 1990; Tocher et al. 1991; Tocher and Sargent, 1987; Pettitt et al. 
1991). Leukotriene B (LTB) appears the most commonly occuring leukotriene in fish 
having been reported in trout macrophages and peripheral blood leucocytes (Pettitt 
et al. 1991; Pettitt and Rowley, 1990) as well as plaice neutroph i1s and rainbow trout 
brain cells (Tocher and Sargent, 1987; Tocher et al. 1991). The peptido-
leukotrienes LTC, LTD and LTE have been identified in American eel gills (Piomelli, 
1985). In general fish appear capable of synthesising a similar varied range of 
eicosanoids to those occuring in mammals. 
1 :5:4 Functions of eicosanoids 
It is currently accepted that mammalian tissues can synthesise up to thirty different 
eicosanoids each possessing a different biological activity. Individual tissues can 
synthesise a wide range of eicosanoids which may have complementary or 
opposing physiological activities in the same tissue. Since tissue and speCies 
variations exist in mammalian systems it is difficult, if not impossible, to extrapolate 
the roles of cyclooxygenase and Iipoxygenase metabolites from mammalian 
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studies, to their roles in fish. Prostaglandins in mammals are involved in a range of 
physiological functions including contraction of smooth muscle, control of blood 
pressure, nerve transmission, development of inflammatory response, electrolyte 
balance, blood clotting, thermoregulation and reproductive mechanisms. The 
leukotrienes and hydroxy acids also have a role in smooth muscle contraction as 
well as vascular permeability, chemotaxis and chemokinesis towards leucocytes 
and enzyme secretion. Although eicosanoid function has been less well studied in 
fish their involvement in a number of physiological processes have been 
established. 
1 :5:4:1 Control of fluid and electrolyte fluxes 
In humans and other mammals, the prostaglandins PGE, PGA and PGI have 
natriuretic activity i.e. they increase urine volume and urinary output of Na+ and CI-
ions (Bolger et al. 1978; Smith, 1989). In fish also, prostaglandins appear to 
regulate fluid and electrolyte balance, either directly, or in conjunction with 
catecholamines, cortisol, prolactin, growth hormone or vasopressin. In rainbow trout 
PGE2 injection resulted in antiduiresis resulting from decreased glomerular filtration 
rate and increased renal tubule water reabsorption (Brown and Bucknall, 1986). 
The antiduiretic action of PGE2 may reflect a direct effect on renal tubule adenylate 
cyclase resulting in increased water permeability. Rainbow trout injected with 
increasing amounts of PGE1 showed a dose-dependent increase in circulating 
cortisol which was diminished on administration of indomethacin, an inhibitor of 
prostaglandin production (Gupta et al. 1985). This suggests that electrolyte balance 
in fish could be regulated jointly by the mineralcorticoid cortisol and prostaglandins. 
The hormone prolactin is also involved in osmoregulation by reducing influx of 
water and efflux of Na+ and CI - at the gill and the studies of Horseman and Meier 
(1978) indicate that the osmoregulatory actions of prolactin also operate in 
conjunction with prostaglandins. 
Figure 1 :5:1 Major Pathways of Eicosanoid Synthesis 
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The eicosanoid precursors 20:3n-6, 20:4n-6 and 20:5n-3 can be converted, after 
reaction with cyclooxygenase, to prostaglandins of the 1-, 2- and 3-series 
respectively. Alternatively 20:3n-6, 20:4n-6 and 20:5n-3 can be metabolised by a 
number of lipoxygenase enzymes to yield hydroxyeicosatrienoic, hydroxytetraenoic 
and hydroxypentaenoic acids (HETES and HEPES), respectively. Initial reaction with 
a 5-lipoxygenase can be followed by further hydroxylation to produce di-HETE/HEPE 
products, which are known as leukotrienes, and are designated 3-, 4- and 5-series 
when derived from 20:3n-6, 20:4n-6 and 20:5n-3 respectively. 
24 
1 :5:4:2 Eicosanoids and the cardiovascular system 
In mammals the role of prostaglandins and leukotrienes in the cardiovascular 
system has been extensively studied. In general PGE2 and PGI2 exhibit 
vasodilatory activity while PGF2a ' TXA2 and the leukotrienes normally have 
vasoconstrictor activity (Wolfe, 1982). The role of eicosanoids in the cardiovascular 
system of non-mammalian animals has been little studied. However, 
cyclooxygenase activity has been identified in hearts from goldfish, eel and 
flounder, (Cagen et al. 1983; Herman et al. 1984; Srivastava and Mustafa, 1984) 
and in blood cells of toadfish, rainbow trout and dogfish (Cagen et al. 1983; Kayama 
et al. 1986; Rowley et al. 1987). In all cardiovascular tissues studied, PGE2 was 
formed and, as in mammals, this prostaglandin was found to have hypotensive 
activity in rainbow trout (Brown and Bucknall, 1986). In carp, intravenous injections 
of PGE2 caused bradycardia as a result of vagal inhibition and tachycardia, which 
also occurs after PGE2 injection in mammals (Peyraud-Waitzenegger et al. 1976). 
1 :5:4:3 Reproductive functions of eicosanoids 
Arachidonic acid-derived prostaglandins are involved in all aspects of the 
mammalian female reproductive system from release of gonadotrophic hormones to 
parturition and lactation. The order of importance of the cyclooxygenase metabolites 
in reproductive function is as follows; PGE2 > PGF1 > PGF2 > PGI2 > PGD2 
(Mustafa and Srivastava, 1989). These prostaglandins may act directly on the 
reproductive organs or in conjunction with reproductive hormones and cAMP. Most 
studies on the function of prostaglandins in teleost fish reproduction are concerned 
with females, although fish testes and sperm also produce considerable amounts of 
prostaglandins (Nomura et al. 1973). 
In mammals the gonadotrophic hormones luteinizing hormone (LH) and follicle 
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stimulating hormone (FSH) are released from the anterior pituitary following 
stimulation by the peptide gonadotrophin-releasing hormone (GRH). In rats PGE2 or 
PGE1 can trigger FSH and LH release from the pituitary, (Spies and Norman, 1973) 
while treatment with indomethacin can decrease plasma levels of gonadotrophic 
hormones (Sato et al. 1975). In carp (Cyprinus carpio) a single injection of 
indomethacin blocked ovulation for up to 12 days whereas controls ovulated 
spontaneously in 24 hours (Kapoor and Toor, 1979). Injection of clomiphene citrate, 
which stimulates GRH release in carp (Breton et al. 1975), restored ovulation in 
indomethacin treated carp and suggested that the cyclooxygenase inhibitor was 
blocking GRH release (Stacey and Goetz, 1982). Similar effects of PGE2 and 
PGF2a on GRH release have also been described in goldfish and catfish 
(Heteropneustes tossilis) (Peter and Billard, 1976; Singh and Singh, 1976). 
Inhibition of cyclooxygenase can prevent the pre-ovulatory surge of GRH release 
from the pituitary in both rats and fish. However, in both rats and goldfish, ovulation 
is not restored by LH injection, suggesting that indomethacin also blocks the action 
of gonadotrophic hormones on the ovary (Armstrong and Grimwich, 1972; Stacey 
et al. 1979). Thus, in rats it appears that prostaglandins synthesised in the ovary, as 
a response to LH stimulus, cause contraction of smooth muscle in follicle cells 
resulting in rupture of the follicle and release of the ovum. In rainbow trout mature 
follicles could be induced to ovulate in response to PGF2a acting directly on the 
smooth muscle cells of the theca (Jalabert and Szollosi, 1975). PGF2a also induced 
ovulation in brook trout (Salvelinus tontinalis) , whereas PGE inhibited ovulation 
(Goetz et al. 1982). In contrast PGE2' PGE1 and PGD2 were all equally effective in 
inducing ovulation in goldfish. In a further study utilising postpartum follicles and 
vitellogenic oocytes from guppy (Poecilia reticulata) I the synthesis of PGE and PGF 
was demonstrated in vitro utilising both endogenous and exogenous precursors 
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(Tan et a/. 1987). This confirms the ability of locally synthesised prostaglandins to 
participate in ovulation. 
1 :5:4:4 Eicosanoids in the nervous system 
In mammals eicosanoids have been implicated in many physiological processes 
which are controlled by the nervous system (Horrobin, 1978). In teleost fish 
prostaglandins, and in particular PGF2w have been shown to induce spawning 
behaviour in goldfish (Stacey and Liley, 1974). Non-ovulating goldfish developed 
spawning behavior when injected with ovulated oocytes, although this could be 
inhibited by simultaneous injection of indomethacin, and restored by injection of 
PGF2a (Stacey, 1976). Injection of PGF2a directly into goldfish brain was the most 
effective site of injection for stimulation of spawning behavior and thus it seems 
likely that PGF2a released from the ovary acts on the central nervous system to 
induce spawning behaviour (Stacey, 1981). Stimulation of spawning behaviour by 
prostaglandins has also been demonstrated in a number of other fish species 
including Pacific herring (C/upea hallengus pallasi), rainbow trout (Sa/rno 
gairdneri) and three-spined stickleback (Gasterosteus acu/eaus) (Stacey and 
Goetz, 1982). In some fish species sexually active males are thought to secrete a 
pheromone-like substance which induces ovulation and spawning behavior in 
females. Similarly females may secrete a substance which induces spermiation in 
males. Although not positively identified the pheromone-like substance was thought 
to be a prostanoid (Crow and Liley, 1979). However, more recent evidence suggests 
the pheromone may be a hydroxylated progesterone derivative (Stacey et a/. 1994). 
Although prostaglandins produced in the brain do not regulate normal body 
temperature in mammals, there is evidence that prostaglandins regulate the 
increase in body temperature arising from bacterial infection (Milton, 1982). The 
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crawfish (Camborus bartoni), a poikilothermic crustacean, injected with a 
suspension of killed bacteria (Aeromonas hydrophila) showed a 20 C increase in 
body temperature, while crawfish injected with doses of PGE1 from 50-500 
mg/animal showed increases in body temperature from 10 to 3.50C (Casterlin and 
Reynolds, 1978). Similar results were recorded in blue gill sunfish (Lepomis 
machrochirus) and largemouth bass (Micropterus salmonoides) (Reynolds et al., 
1976). 
1:6 Dietary n-3/n-6 PUFA ratio 
There is now a wealth of evidence arising from epidemiological studies and 
clinical trials that many of the pathophysiological conditions which are widespread 
in Western society are associated with a low dietary n-3/n-6 PUFA ratio which is in 
turn due to an excessive intake of vegetable oil-derived n-6 PUFA (Lands,1986). In 
human populations consuming a "Western"-type diet, arachidonic acid (AA) is by far 
the most abundant precursor fatty acid available for eicosanoid production 
(Horrobin, 1983). In the preceding pages I have described many of the 
physiological processes which are controlled by eicosanoids. If these latter are 
"switched on" excessively then many of the disease conditions arising from an over-
active arachidonic acid cascade can result. These disorders include 
atherothrombotic conditions including coronary heart disease, stroke and 
hypertension, and auto-immune and inflammatory conditions such as asthma, 
psoriasis, rheumatism and arthritis (Weber, 1990). Eskimo and other populations 
consuming large quantities of fish have a relatively high dietary ratio of n-3/n-6 
PUFA and suffer a much lower incidence of coronary heart disease than most 
western populations (Lands, 1986). At present considerable research effort is 
directed towards identifying the optimal ratio of n-3/n-6 PUFA in human diets and 
likely estimates between 1:4 and 1:1 would seem to be beneficial, depending on 
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developmental age (Crawford, 1987; Anon., 1992). Although fish and fish oils are 
considered the best way to bring about a desirable alteration in dietary n-3/n-6 
PUFA ratio (Simopoulos et a/. 1991) the importance of green vegetables and some 
plant oils rich in 18:3n-3 should not be overlooked (Okuyama, 1992), but this, of 
course, depends on the rate or extent of conversion of C18 PUFA to C20 and C22 
PUFA. 
The mechanisms by which increased dietary intake of n-3 PUFA act to overcome 
the undesirable results of excessive n-6 PUFA intake can probably be attributed to 
two separate, although related, biochemical effects. First, there is the direct effect 
which increased n-3 PUFA in membrane phospholipids can have on membrane-
bound enzymes. Second, there is the ability of n-3 PUFA to modify the arachidonic 
acid cascade. 
The increased incorporation of n-3 PUFA, especially DHA, into membrane 
phospholipids may be particularly important in the physiological function of cardiac 
tissue (Kinsella, 1990). Fish oil consumption protects heart muscle against ischemic 
damage in dogs and can reduce isoprenaline-induced arrhythmias in rats (Culp et 
a/. 1980; Charnock et a/. 1985). The beneficial effects may have resulted from 
increased uptake of calcium by the sarcoplasmic reticulum (SR). The uptake and 
release of Ca2+ from the SR requires an ATP-dependent calcium pump which is 
situated in the SR membrane bilayer. The activity of this pump controls cytosolic 
calcium concentration in cardiac myocytes and is thus important in the regulation of 
the contraction and relaxation cycle of heart muscle. Since the Ca2+-Mg2+ ATPase 
is located within the membrane, the fatty acid composition of the surrounding 
phospholipids may regulate its activity. In mice fed menhaden oil, the cardiac Ca2+-
Mg2+ ATPase had a specific activity in vitro over six times less than in mice 
consuming corn oil. The reduction in activity following menhaden oil intake was 
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related not to fatty acid unsaturation index but to DHA levels in SR phospholipids, 
especially PC and PE (Swanson et al. 1989). The effect of DHA may reflect changes 
in membrane fluidity or thickness causing altered accessibility of enzyme substrates 
(Froud et al. 1986). Other membrane-associated enzymes whose activities can be 
altered by dietary n-3/n-6 PUFA ratio include adenyl cyclase, which generates the 
important second messenger cAMP, and 5' nucleotidase which produces 
adenosine, a blood vessel dilator and attenuator of b-adrenergic responses 
(Gudbjarsson et al. 1978; Alam et al. 1988). 
There are essentially three main mechanisms identified in mammals by which an 
increased dietary n-3/n-6 PUFA ratio can 'down regulate' the arachidonic acid 
cascade: first, by intake of n-3 PUFA decreasing tissue levels of M; second, by EPA 
and DHA competitively inhibiting cyclooxygenase and lipoxygenase activity; third, 
by EPA-derived eicosanoids competing with AA-derived homologues for receptor 
binding sites (Kinsella, 1990). Ingestion of dietary fish oil results in enhanced 
incorporation of EPA and DHA into cellular lipids causing a replacement and 
redistribution of AA in membrane phospholipids (Garg et al. 1990). In addition, 
competitive effects of n-3 PUFA from both fish oil and linseed oil can reduce activity 
of microsomal 66 and 65 desaturases resulting in depressed production of cellular 
M (Garg et al. 1988a, 1988b). In both cases the result is a reduction in the 
phospholipid pool of AA which is available for eicosanoid production. Once 
incorporated in cell membranes, both AA and EPA can subsequently be released 
by phospholipase A2 and are available as substrates for cyclooxygenase and 
lipoxygenase. However, mammalian studies indicate that EPA-derived eicosanoids 
tend to be of lower biological efficacy compared to their AA-derived homologues 
{Terano et al. 1986; Bruckner et al. 1984). Thus, thromboxane A3 (TXA3) formed in 
small concentrations by n-3 PUFA- enriched platelets has only negligible 
vasoconstrictor and aggregatory activity compared to TXA2 which is also reduced 
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considerably by increasing the dietary n-3/n-6 PUFA ratio (Weber, 1990). The EPA-
derived leukotriene B5 produced by rat neutrophils and macrophages has around 
30 times less chemotactic activity than LTB4 which is in turn reduced by prolonged 
intake of n-3PUFA (Strasser et a/. 1985). However, EPA-derived PGI3, which can 
account for 50% of total prostacyclin production in n-3 PUFA-supplemented 
individuals, is as biologically active as AA-derived PGI2 in inhibiting platelet 
aggregation and reducing vascular tone (von Shacky ef al. 1985). 
Although phospholipids in wild fish tend to have an excess of EPA over AA 
(Henderson and Tocher, 1987; Ackman, 1980), fish tissues still produce 
considerable amounts of AA-derived eicosanoids (Mustafa and Srivastava, 1989). 
Indeed AA appears to be the preferred substrate for cyclooxygenase in plaice skin 
and neutrophils and in turbot gills (Anderson ef a/. 1981; Tocher and Sargent, 1987; 
Henderson et a/. 1985). As with humans and farmed mammals, intensively reared 
fish like Atlantic salmon are susceptible to a wide range of disease conditions, many 
of which can be induced or exacerbated by periods of stress. Commercial salmon 
feeds often contain some plant-derived lipids, either as a result of using 
components such as brewing by-products or soybean meals, or by addition of 
vegetable oils. The result is that farmed salmon generally contain around five times 
the amount of n-6 PUFA compared to their wild counterparts. The alteration in 
cellular fatty acid composition which would arise from consuming diets with a 
reduced n-3/n-6 PUFA ratio could potentially upset the normal spectrum of 
eicosanoids produced by the fish. It is possible therefore that increased production 
of AA-derived eicosanoids in farmed Atlantic salmon could increase occurrence and 
severity of some pathophYSiological conditions occurring in this species. 
1:7 Aims of this study 
In the relatively few fish species studied to date it is generally accepted that while 
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freshwater fish can elongate and desaturate 18C PUFA to 22C HUFA, marine fish 
require 20C and probably 22C HUFA to be provided in the diet. In anadromous fish 
like Atlantic salmon, which start their life cycle in freshwater before migrating to 
seawater after undergoing smoltification, the situation is less clear. While 
freshwater parr are thought to express the full complement of desaturase enzymes 
there has been evidence suggesting a loss of some desaturating capacity during 
smoltification (Ackman and Takeuchi, 1986). In addition, lipid metabolism in post-
smolt Atlantic salmon has been little studied. The aim of this study was to utilise the 
Atlantic salmon as an n-3 PUFA-rich model system in which to study PUFA 
metabolism and to advance basic knowledge of PUFA interactions and eicosanoid 
metabolism in an n-3 PUFA-rich organism. PUFA metabolism would be followed by 
measuring the fatty acid composition of membrane phospholipids in a range of 
tissues after feeding diets with varying n-3/n-6 PUFA ratios. In addition, by feeding 
these diets it was predicted that membrane fatty acid compositions would be altered 
so as to affect eicosanoid precursor supply and elicit changes in the spectrum of 
both cyclooxygenase and lipoxygenase products. Gill and white blood cells were 
chosen to study eicosanoid production because of their established activity in this 
respect. During the course of the study the development of any gross or histological 
pathologies arising from feeding diets with varying n-3/n-6 PUFA ratio was routinely 
recorded. 
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Section 2. Materials and methods 
2:1 Materials 
TLC plates (20 x 20 cm) and HPTLC plates (10 x 10 cm), pre-coated with silica gel 
60 (0.2Smm), were obtained from Merck (Darmstadt, Germany). 
All solvents were of HPLC grade and were obtained from Rathburn Chemicals 
(Walkerburn, U.K.). 
Leukotriene BS (LTBS)' 12-hydroxyeicosatetraenoic acid (12(R,S)-HETE) and 12-
hydroxyeicosapentaenoic acid (12(S)-HEPE were purchased from Cascade 
Biochemicals Ltd. (Reading, U.K.). 
Leukotriene B4 (LTB4)' calcium ionophore A23187 (free acid), disodium ATP, 
collagenase (type IV), all PUFA (approx. 99% pure), fatty acid-free bovine serum 
albumin (BSA), 'Trizma' and 'Sigmacote' were from Sigma Chemical Co. Ltd. 
(Poole, U.K.). 
1S-Hydroxyeicosatetraenoic acid (1S(S)-HETE) and S-hydroxyeicosatetraenoic 
acid (5(R,S)-HETE) were purchased from Novabiochem Ltd. (Nottingham, U.K.). 
[1_14C]-DHA was obtained from Du Pont (U.K.) Ltd., Stevenage. 
Lymphocyte separation medium, Hanks balanced salt solution, tryptose 
phosphate broth, 10 x concentrated non-essential amino acids, sodium 
bicarbonate, antibiotics, HCI and phosphate buffered saline were obtained from 
Flow Ltd. (Rickmansworth, U.K.). 
Eagles' Minimum Essential Medium (EMEM), Dulbeccos modification of Eagles 
medium (DMEM), trypsin-EDTA and foetal calf serum (FCS) were obtained from 
Northumbria Biologicals Ltd. (Cramlington, U.K.). 
ODS 'Sep-Pak' mini-columns were purchased from Millipore (U.K.) Ltd., (Watford). 
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2:2:1 Experimental animals and husbandry 
Atlantic salmon S1 smolts (salmon undergoing transition to seawater in one year) 
were obtained from the S.O.A.E.F.D. Fish Cultivation Unit (Aultbea, Wester Ross, 
Scotland) or from Seafarm Kerry Ltd. (Gairloch, Scotland) and were used in three 
dietary trials in successive years. The fish weighed between 36 and 85g, depending 
on length of time in seawater after smoltification. In all three experiments fish were 
less than two months post-seawater transfer. In trials Band C, fish were distributed 
randomly into circular tanks of 1 m diameter containing 500 L of seawater (100 fish 
per tank) which were supplied with seawater, subjected to sub-sand filtration, at a 
rate of 10 Umin. In trial A fish were placed into larger tanks of 2000 L capacity 
which were supplied with seawater at a rate of 26 Umin. In trial C fish were 
transferred to the 2000 L tanks after 8 weeks in the smaller (500 L) tanks. (See 
following "Results" section for details of each dietary trial). In all three dietary trials 
one tank of fish only was allotted to each dietary treatment. The tanks were 
subjected to natural photoperiod and the water temperature over the experimental 
periods (May-November) varied from 9-150 C. The diets were supplied by automatic 
feeders which were activated for a few seconds every 15 min during daylight hours 
and were adjusted to provide between 20 and 28g/kg biomass each day. Fish were 
weighed individually at the start and finish of each trial and were bulk weighed 
every 28 days during the intervening period and the ration adjusted accordingly. 
During bulk weighing batches of 50 fish were placed in a tared dustbin containing 
approximately 50 litres of water and the final weight recorded. After weighing fish 
were returned to the same tank from which they came. The experiment was 
conducted in accordance with British Home Office guidelines regarding research on 
experimental animals. 
2:2:2 Wild Atlantic salmon 
Samples of wild Atlantic salmon parr were obtained by electrofishing in the river 
34 
Gairn, a tributary of the river Dee in Grampian, Scotland. Samples of smolts were 
obtained from smolt traps placed in the Dinnet burn, another tributary of the river 
Dee. Fish were transported alive to the S.O.A.E.F.D. Marine Laboratory, Aberdeen 
where the fish were killed, tissues dissected and stored at -800 C until analysed. 
2.3 Diet formulation and preparation 
The practical-type diets, utilising fish meal as protein source, were formulated to 
meet the nutritional requirements of salmonid fish (U.S. National Research Council, 
1981). Diets containing 47% crude protein and 17% lipid were prepared in 5 kg 
batches. The composition of the basal diet is shown in Table 2:3:1. All diets satisfied 
the nutritional requirements of salmonid fish for n-3 PUFA, which were supplied by 
the dietary fish meal. The fatty acid composition of the LT 94 fish meal, which 
contained 11 % lipid by weight, is shown in Table 2:3:2. The dry dietary components 
were mixed in 5 kg batches using a IHobart' commercial food mixer for at least 5 
minutes. The appropriate oil containing added antioxidant mix (see page 35) was 
then added slowly, with continual mixing for a further 2 minutes, to the dry 
ingredients. Immediately before pelleting water (1 Oml/1 DOg diet) and choline 
chloride (40% w/v) were added and the diet mixed thoroughly for five minutes. The 
diet was pelleted using a ICalifornia Pellet Mill' producing pellets of 2 or 3 mm 
diameter. The pellets were then spread on ventilated trays and placed in a drying 
cabinet supplied with a continual flow of warm air (approx. 250 C) for a period of 12-
16 h after which the diets were sealed in dark plastic bags. The fatty acid 
compositions of the diets were determined immediately after drying and again QS!.. 6 
weeks after pelleting. There were no significant differences in the fatty acid 
compositions after this storage period. 
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TABLE 2:3: 1. Composition of basal, diet 
Ingredient g/kg 
LT-94 Fishmeal1 650 
Starch2 150 
Oil 100 
Vitamin mix3 10 
Mineral mix4 24 
a-cellulose 61.6 
Antioxidant mix5 0.4 
Choline chloride 4 
1 L T-94 Norwegian low temperature herring meal, Ewos Ltd., Bathgate, Scotland. 
2Passelli WA4 pre-cooked potato starch, Avebe (U.K.) Ltd., Ulceby, England. 
3Supplied (mg/kg diet): all-rae -a-tocopheryl acetate, 40; menadione, 10; ascorbic 
acid, 1000; thiamin hydrochloride, 10; riboflavin, 20; pyridoxine hydrochloride, 12; 
calcium pantothenate, 44; nicotinic acid, 150; biotin, 1; folic acid,S; 
cyanocobalamin, 0.02; myo-inositol, 400; retinyl acetate 7.3; cholecalciferol, 0.06. 
4Supplied (per kg diet): KH2P04, 22g; FeS04.7H20, 1.0g; ZnS04.7H20, 0.13g; 
MnS04.4H20, 52.8mg; CuS04.5H20, 12mg; CoS04.7H20, 2mg; KI, 2mg. 
50issolved in propylene glycol and contained (giL): butylated hydroxyanisole, 60; 
propyl gallate, 60; citric acid, 40. 
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Table 2:3:2. Fatty acid composition of LT 94 fishmeal. Values are weight % of total 
fatty acids. 
Fatty acid 
14:0 
16:0 
18:0 
Total saturates 1 
16:1n-7 
18:1n-9 
18:1n-7 
20:1n-9 
22:1n-11 
22:1n-9 
24:1 
Total monoenes2 
18:2n-6 
18:3n-6 
20:2n-6 
20:4n-6 
22:5n-6 
Total n-6 
18:3n-3 
18:4n-3 
20:3n-3 
20:4n-3 
20:5n-3 
22:5n-3 
22:6n-3 
Total n-3 
Total PUFA 
n-3/n-6 
1 Includes 15:0 and 17:0. 21ncludes 20:1n-7. 
L T 94 fish meal 
4.8 
14.8 
1.6 
21.8 
7.6 
10.7 
3.0 
13.0 
10.4 
1.2 
1.3 
47.6 
1.3 
0.1 
0.2 
0.5 
0.2 
2.3 
0.7 
2.1 
0.1 
0.4 
7.9 
0.8 
11.9 
23.9 
26.2 
10.4 
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2:4 Lipid extraction and analysis 
2:4:1 Extraction of diets and tissues 
Samples of diets were collected after pelleting and drying, and again 
approximately 6 weeks later, and stored at -200 C until extracted. Tissue samples 
were dissected, after fish had been killed by a blow to the head or decapitation, and 
immediately placed in liquid nitrogen. Samples were stored at -800 C until extracted. 
Total lipid was extracted from tissues and diets by the method of Folch et al. {1957}. 
Samples were homogenised in 10 volumes of ice-cold chloroform:methanol {2:1, 
v/v} using either a glass-teflon homogeniser for soft tissues e.g. liver, kidney, brain, 
leucocytes and retina or a 'Polytron' tissue disrupter for tougher material e.g. heart, 
muscle, gill and diets. Homogenates were filtered through filter paper pre-washed 
with choroform:methanol (2:1 v/v) and the filtrate mixed with 0.2 volumes of 0.88% 
KC\. The extract was then mixed vigourously in a stoppered test-tube using a vortex 
mixer. After the layers had separated the lower chloroform layer was removed using 
a pasteur pipette, placed in a pre-weighed tube and dried under a stream of 
nitrogen. The lipid extract was then dried for at least one hour in a vacuum 
dessicator containing KOH before re-weighing. The lipid extracts were dissolved in 
chloroform:methanol (2:1, vlv) containing 0.05% butylated hydroxy toluene at a 
concentration of 10 mg/ml and stored at -200 C. 
2:4:2 Analysis of lipid class composition 
Total lipid (10-20 Ilg) was applied as a 2 mm streak to a 10 x 10 cm high-
performance thin-layer chromatography (HPTLC) plate which had been pre-run in 
hexane:diethyl ether (1 :1, v/v) and activated in an oven at 11 OOC for 30 min. The 
plates were developed to 6 cm in methyl 
acetate:isopropanol:chloroform:methanol:0.25% aqueous KCI {25:25:25: 10:9 by 
volume} to separate polar lipid classes with neutral lipids running at the solvent front 
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(Vitiello and Zanetta, 1978). After drying the plates were then developed fully in 
hexane:diethyl ether:acetic acid (85: 15: 1.5, v/v/v) to separate neutral lipids and 
cholesterol. Lipid classes were visualised by charring at 1600 C for 15 min after 
spraying with 3% copper acetate (w/v) in 8% phosphoric acid (v/v) and identified by 
comparison with commercially available standards (Sigma Chemical Co. Ltd., 
Poole, U.K.) . Lipid classes were quantified by scanning densitometry using a 
Shimadzu CS-930 dual wavelength TLC scanner and a DR-2 recording integrator. 
2:4:3 Lipid class separation and fatty acid transmethylation 
Total lipid extracts were separated into phosphatidylcholine (PC). 
phosphatidylethanolamine (PE), phosphatidylserine (PS) and phosphatidylinositol 
(PI) fractions by TLC. Samples were loaded onto 20 x 20 cm TLC plates (1 mg/cm) 
and the plate developed with methyl 
acetate:isopropanol:chloroform:methanol:0.25% aqueous KCI (25:25:25: 1 0:9 by 
volume). When amounts of total lipid available were less than 2 mg the 
phospholipid fractions were separated on 10 x 10 cm HPTLC plates loaded at 0.75 
mg/cm and developed using the solvents described above. The phospholipid bands 
were visualised by spraying the plate lightly with 0.1 % 2', 7' ,-dichlorofluorescein in 
97% methanol containing 0.05% BHT and viewing under UV light. The 
phospholipid bands were marked in pencil and the areas of silica scraped into 
stoppered test tubes containing 2 ml of 1 % H2S04 in methanol. The tubes were 
flushed with nitrogen. stoppered and placed in a heated hot block at 500 C. Acid-
catalysed transmethylation was carried out for 16 h as described by Christie (1982). 
Triacylglycerol fraction (TAG) was separated from the total lipid extract by TLC using 
the solvent system hexane:diethyl ether:acetic acid (70:30: 1 v/v/v). Loading and 
identification of lipid classes were carried in the same way as for phospholipid 
classes. Acid-catalysed transmethylation of TAG samples were carried out in 2 ml of 
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1% H2S04 in methanol and 1 ml of toluene at 500 C for 16h. After transmethylation, 
the fatty acid methyl esters (FAME) from phospholipids and TAG were extracted after 
first neutralising the acid with 2 ml of 2% KHC03 (w/v) followed by succesive 
extractions with 5 ml of hexane followed by 5 ml of hexane:diethyl ether (1:1, v/v). 
The two solvent extracts were combined and dried under a stream of nitrogen. The 
dry FAME were dissolved in hexane containing 0.02% BHT at a concentration of 2 
mg/ml and stored at -200C prior to analysis. 
2:4:4 Separation and identification of fatty acid methyl esters 
The fatty acid methyl esters were separated and quantified by gas-liquid 
chromatography performed with a Carlo Erba Vega series 2 model 6180 gas 
chromatograph (Fisons Ltd., Crawley, U.K.). The capillary columns utilised were 
coated with the moderately polar phases, CP-Wax 51 (Chrompak (U.K.) Ltd., 
London) or FFAP (free fatty acid phase, S.G.E. Ltd., Milton Keynes, U.K.). Both 
columns were SOm long and 0.32mm and 0.22mm internal diameter respectively. 
Injection of samples was 'on-column' and hydrogen was used as carrier gas. 
Separation of fatty acid methyl esters was achieved using a two-stage thermal 
gradient from 500 C to 22SoC. Fatty acids were separated in terms of carbon 
number with the most saturated eluted first followed by the monounsaturated and 
then the di-unsaturated etc in the same series. Individual methyl esters were 
identified by comparison with known standards and by reference to published data 
(Ackman, 1980; Bell et al. 1983). 
2:5 Isolation of leucocytes 
Blood was collected, from the caudal vessel, into heparinised syringes from six 
fish per dietary treatment and was diluted with 3 volumes of Hanks balanced salt 
solution containing 20 Lu.lml of heparin. Four ml of diluted blood was layered onto 5 
40 
mlof lymphocyte separation medium and centrifuged at 400 x g for 45 min at 40 C. 
The leucocytes located around the interface of the separation medium and the salt 
solution were harvested and washed twice in phosphate buffered saline. If 
erythrocyte contamination was greater than 2% the gradient separation was 
repeated. The leucocytes obtained from six fish per dietary treatment were pooled 
and the lipids extracted by the method of Folch et af. (1957). 
2:6:1 Preparation of isolated gill cells (1) 
Fish were killed by a blow to the head, the pericardium opened and the bulbus 
arteriosus was perfused with 20 ml of ice-cold 0.9% NaCI (w/v) to remove blood 
from the gills. The gill arches were then removed and placed in ice-cold calcium 
free modified Hanks medium. This is a medium specially formulated for use with 
salmonid fish (Moon et af. 1985). The composition was: 10.29 gIL NaCI, 0.4 gIL 
KCI, 0.2 gIL MgS04·7H20, 0.06 gIL KH2P04, 0.13 gIL Na2HP04.12H20, 0.5 giL 
NaHC03, and 2.38 gIL (N-[2-Hydroxyethyl]piperazine-N'-[2-ethanesulphonic acid 
(HEPES). The medium was adjusted to pH 7.4 with KOH. The gill arches were then 
blotted on tissue and the epithelial layer scraped with a blunt scalpel blade to 
remove cells. The cells were then suspended in ice-cold calcium-free Hanks 
medium, gently separated by stirring with a magnetic stirrer and filtered through a 
1 00 ~m nylon gauze. The cells were collected by centrifugation at 1000 x g for 5 
min. 
2:6:2 Preparation of isolated gill cells (2) 
Fish were killed and the gills perfused as described above. The intact gill arches 
were dissected out and placed in ice-cold medium. The gill filaments were 
dissected from the arches and chopped finely with scissors before addition of 25 ml 
of medium containing 0.1 % (w/v) collagenase (type IV). This suspension was 
incubated for 45 min at room temperature and was stirred constantly using a 
magnetic stirrer. The suspension was finally filtered through two grades of nylon 
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gauze (190 and 1 00 ~m) and the filtered cells collected by centrifugation at 1000 x g 
for 5 min. The cells were washed twice in Hanks medium and finally resuspended in 
1 ml of the same medium containing 1 mM CaCI2' 50 ~I was retained for protein 
determination. 
2:7 Challenge of whole blood and isolated gill cells with calcium 
ionophore 
Glass test tubes used in the incubations were pre-coated with the silanizing 
reagent, 'Sigmacote', prior to use to prevent cell adhesion. One ml of whole blood 
was mixed with an equal volume of modified Hanks medium containing 1 mM 
CaCI2 and both blood and gill cells were incubated in a shaking water bath at 1SoC 
for 10 min. Calcium ionophore A23187 was added in up to 5 ~I of dimethyl 
sulphoxide at a final concentration of 20 11M and the incubation continued for a 
further 20 min. The cells were removed by centrifugation (12000 x g, 2 min) and the 
supernatant removed for eicosanoid extraction. 
2:8 Eicosanoid extraction 
Eicosanoids were extracted from incubation media using ODS reverse-phase 
'Sep-Pak' mini-columns largely using the methods described by Powell (1982). 
Samples were loaded onto 'Sep-Pak' columns which had been pre-washed with 5 
ml methanol and 10 ml distilled water. The sample was then washed with 5 ml of 
15% (v/v) ethanol, 10 ml of distilled water, 5 ml of hexane:chloroform (65:35 v/v) 
before prostaglandins were eluted with 10 ml ethyl acetate. When measuring 
Iipoxgenase metabolites e.g. leukotrienes and hydroxyfatty acids the wash with 
hexane:chloroform was omitted. 
2:9 HPLC separation of lipoxygenase products 
The profiles of Iipoxygenase products extracted from gill and blood supernatants 
were determined using reverse phase high-performance liquid chromatography 
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(HPLC) using a 'Spherisorb' 5 llm octadecylsilane (00S2) column (25 cm x 4.6 
mm) supplied by Scotlab Ltd., Bellshill, Scotland. The chromatographic system was 
equipped with Waters Model M-45 pumps and 680 Automated Gradient Controller 
and the effluent was monitored at 280 nm and 235 nm to detect leukotrienes and 
hydroxy fatty acids, respectively, using a Pye-Unicam LC-UV detector. Two isocratic 
solvent systems were utilised at a flow rate of 1 mllmin. To separate the 
monohydroxy fatty acids a solvent system containing methanol/water/acetic acid 
(80:20:0.05 vlv/v) (Solvent 1) was used. To separate leukotrienes and monohydroxy 
fatty acids a solvent system containing acetonitrile/methanol/water/acetic 
acid/phosphoric acid/ammonia (40:29:30:0.5:0.3:0.2 by vol.) (Solvent 2) was used. 
Quantitations were based on external standards of 12-HEPE, 12-HETE, LTB5 and 
LTB4' Chromatograms representing separation of leukotriene and hydroxy fatty acid 
standards and lipoxygenase products obtained after stimulation of whole blood with 
A23187, are shown in Figure 2:9:1. 
2:10 Preparation and chromatography of hydroxy fatty acid methyl 
esters 
The peak eluting at a retention time similar to that of standard 12-HEPE on HPLC 
separation of gill lipoxygenase products was collected and concentrated. Methyl 
esters of standard 12-HEPE and the concentrate were prepared using 
diazomethane as described by Schwartz and Bright (1974). The methyl esters were 
purified using HPLC (Solvent 1) and analysed by gas-liquid chromatography 
(Philipis PU 4500 chromatograph) using a CP-Sil 5 column (50 m x 0.32 mm Ld.; 
Chrompak, Middleberg, The Netherlands). Hydrogen was used as carrier gas and 
the temperature was programmed from 500 C to 2600 C at 40C/min. 
2:11 Labelling of gill cells with [1-14C]-22:6n-3 
Isolated gill cells produced as described previously were resuspended in 2 ml 
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Fig. 2:9:1 A typical HPLC chromatogram of leukotriene and 
hydroxy acid standards separated using solvent system described 
in Materials and Methods (A). A typical HPLC chromatogram of 
lipoxygenase products obtained after stimulation of whole blood with 
A23187 (20 J.1.M) (8). 
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Dulbeccos modification of Eagles medium (DMEM). After 10 min at 180 C in a 
shaking water bath, 0.5 Ilei radiolabelled DHA (in 5 III ethanol) was added and the 
incubation continued for 5 h. The cells were sedimented by centrifugation (400 x g, 
5 min) and washed in 5 ml PBS containing 1% (w/v) bovine serum albumin (fatty 
acid free) to remove non-incorporated radiolabel. The cells were resuspended in 2 
ml of fresh DMEM and incubated in a shaking water bath for 10 min, before addition 
of A23187, as described previously. Eicosanoids were extracted from the cell 
supernatant after centrifugation as described above. The eicosanoid extract was 
dissolved finally in 0.2 ml HPLC solvent Band 0.1 ml was injected onto the HPLC 
column and eluted as described previously. Fractions of 1 ml were collected and 
counted in a scintillation counter after addition of 5 ml 'Ecoscint A' (BS and S Ltd., 
Edinburgh, Scotland). 
2:12 Determination of 6-keto prostaglandin F1 ex and thromboxane 82 
6-keto PGF1 ex and TXB2, the stable metabolites of prostacyclin (PGI2) and TXA2 
respectively, were measured by radioimmunoassay using the tritium isotope kits 
supplied by Amersham (U.K.) Ltd. The assay is based on the competition between 
unlabelled prostaglandin and a fixed quantity of the tritium labelled compound for 
binding to a protein with high specificity and affinity for the prostaglandin. The 
amounts of antibody and radioactive prostaglandin remain constant and the amount 
of radioactivity bound by the antibody is inversely proportional to the concentration 
of added non-radioactive prostaglandin. Measuring the amount of antibody-bound 
radioactivity enables the amount of unlabelled prostaglandin in the sample to be 
calculated. The unbound prostaglandin is separated from the antibody-bound 
prostaglandin by absorption of the free prostaglandin on to dextran-coated 
charcoal, followed by centrifugation. By measuring the amount of radioactivity in the 
supernatant the amount of labelled prostaglandin bound by the antibody can be 
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calculated. The concentration of unlabelled prostaglandin in the sample is then 
determined from the linear standard curve. 
2:13 Isolation of cardiac sarcoplasmic reticulum 
The procedure used was largely that described by Swanson et al. (1989). Hearts 
from two fish were pooled (300-500 mg wet weight) and homogenised in 20 
volumes of ice-cold 20 mM Tris-HCI (pH 7.4) buffer containing 30 mM l-histidine 
and 250 mM sucrose using a 'Polytron' tissue homogeniser. The homogenate was 
centrifuged at 1600 x g for 10 min at 40 C to remove nuclei and cell debris. The 
supernatant was retained and the pellet re-homogenised and centrifuged as 
described above. The combined supernatants were then centrifuged at 14000 x g 
for 15 min at 40 C to remove mitochondria and Iysosomes. The pellet was discarded 
and the supernatant centrifuged at 45000 x g for 50 min at 40 C. The pellet was 
resuspended in 20 ml homogenisation buffer and re-centrifuged at 48000 x g for 50 
min at 40 C. The final sarcoplasmic reticulum pellet was resuspended in 0.25 ml of 
homogenisation buffer prior to assaying Ca2+-Mg2+ ATPase activity. 
2:14 Ca2 +-Mg2+ ATPase assay 
The assay was performed largely as described by Bonis et al. (1985). 
Sarcoplasmic reticulum vesicles, containing between 25-50 ~g protein, were 
incubated in a 2.0 ml reaction medium compriSing 50 mM Tris-HCI (pH 7.1), 5 mM 
potassium oxalate, 60 ~M CaCI2, 30 mM KCI and 5 mM MgCI2 for 5 min at 180 C. 
The reaction was initiated by addition of 2 mM disodium-ATP and the incubation 
was continued for a further 45 min before the reaction was terminated by addition of 
1.0 ml of 5% (w/v) trichloroacetic acid. Total ATPase activity was determined by 
measurement of inorganic phosphorus released from ATP by the method of Stanton 
(1968), using a diagnostic kit (Sigma Chemical Co., Poole, U.K.). Calcium-
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dependent ATPase activity was determined by subtracting the basal value obtained 
in the presence of 0.1 mM [ethylenebis (oxyethylene nitrilo)] tetra acetic acid and in 
the absence of calcium from values obtained with 60 11M CaCI2· 
2:15 Isolation of cardiac myocytes and Ca2 +·ionophore stimulation 
The procedure for enzymatic isolation of cardiac myocytes is based on the method 
of Powell et al. (1980). Hearts from two salmon were cannulated via the bulbus 
arteriosus and perfused with modified Hank's medium (Moon et al. 1985) which was 
gassed continuously with 95% 02, 5% C02. After 15 min, the system was switched 
to recirculation and the medium changed to modified Hanks containing 0.6% (w/v) 
collagenase. The perfusion was continued for a further 45 min, after which the 
partially digested hearts were removed and chopped finely in perfusion medium. 
This material was filtered through two grades of nylon mesh (190 and 100 11m) and 
the myocytes collected by centrifugation (1000 x g, 2 min). The myocytes were 
washed twice in Hank's medium (without collagenase) and finally resuspended in 
1.0 ml of the same medium containing 1 mM CaCI2. The suspensions routinely 
contained 60-85% of the total cells present as rod-shaped, cardiac myocytes. Fifty 
microlitres of the suspension were retained for protein determination. The myocyte 
suspensions were incubated in a shaking water bath at 180 C for 10 min before 
addition of calcium ionophore (A23187, final concentration 20 IlM in 5 III dimethyl 
sulphoxide). The incubation was continued for 20 min, after which the cells were 
sedimented by centrifugation and the prostanoids extracted from the supernatant as 
described previously. 
2:16 Chum salmon heart cells and medium 
The chum salmon (Oncorhynchus keta) established heart (CHH-1) cell line was 
obtained from Dr. D. Smail, S.O.A.E.F.D. Marine Laboratory, Aberdeen, U.K. and 
had been derived from primary cultures of heart cells prepared by Lannan et al. 
(1984), using the technique described by Wolf and Quimby (1976). The cells were 
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maintained in Eagles minimum essential medium (EMEM; with Earles salts) 
containing 1% tryptose phosphate broth, 4 mM Tris-HCI buffer (Trizma pH 7.4, 
Sigma Chemical Co. Ltd., Poole, U.K.), 1% non-essential amino acids, 0.275% 
sodium bicarbonate, 2 mM HCI, antibiotics (50 I.U. mr1 penicillin and 50 Jlg.mr1 
streptomycin) and either 10% or 1 % fetal calf serum (FCS). 
2:17 Preparation of PUFA supplements 
PUFA supplements were added to the CHH-1 cultures as BSA complexes which 
were prepared according to the method of Spector and Hoak (1969). To minimise 
oxidation all procedures were carried out at room temperature under a stream of 
nitrogen. Twenty five mg of each PUFA were dissolved in 7.5 ml of hexane in a 10 
ml test-tube (some PUFA required the addition of a small amount of 
chloroform/methanol (2:1 v/v) to allow full solubilisation). The dissolved PUFA were 
added to SOO mg of 'Celite' in a 50 ml conical flask (covered in aluminium foil) and 
the slurry mixed on a magnetic stirrer. The slurry was dried under a stream of 
nitrogen until all solvent was evaporated.The top of the flask was then covered with 
fine wire mesh and the dry slurry vacuum desiccated for 30 min. Twenty five ml of 
BSA solution (0.25 mM BSA in 16 mM phosphate buffer, 116 mM NaCI, 4.9 mM KCI 
and 1.2 mM MgS04 pH 7.4) was added and the slurry stirred for 30 min with 
constant nitrogen gassing. The mixture was transferred to a 30 ml centrifuge tube 
and centrifuged (2000 x g, 5 min) to sediment the 'Celite'. The PUFA:BSA 
complexes in the supernatant were then filter-sterilized through 0.2 Jlm filters 
(Flowpore, Flow Laboratories) prior to use. The fatty acid concentrations were 
assayed after addition of an internal standard (17:0) to an aliquot of the complex. 
The lipids were then extracted, transmethylated and quantified by gas-liquid 
chromatography. PUFA concentrations were in the range 1.5-2.0 mM (BSA 0.25 
mM) giving a PUFA:BSA ratio of 6-S. The PUFA:BSA mixtures were stored under 
nitrogen at -200 C in darkened vials. 
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2:18 Culture of CHH-1 cells 
CHH-1 cells were routinely cultured in sealed 75 cm2 flasks with 15 ml medium 
containing 10% FCS as described previously. Cells were harvested for analysis or 
subculture within 24 h of achieving confluence (usually after 5-7 days). Cells 
incubated with PUFA were subcultured into 225 cm2 flasks with 50 ml medium 
containing 1 % FCS and an appropriate volume of PUFA:BSA complex to give a 
final fatty acid concentration of 25 11M. FCS contains around 0.37% (w/v) lipid of 
which around 50% is esterified fatty acid. Previous studies with cultured fish cells 
indicated that a fatty acid concentration of 25 ~M resulted in considerable 
incorporation and metabolism into phospholipids without causing increased 
deposition of neutral lipid (Tocher et al. 1988, 1989). Control flasks received the 
same volume of fatty acid free-BSA solution. All incubations were performed at 
220 C. 
2:19 Cell harvesting and lipid extraction 
Cells were harvested within 24 h of reaching confluence. The media were 
removed by aspiration and the cells were washed with 20 ml phosphate-buffered 
saline before addition of 3 ml trypsin-EDTA (0.05% and 0.02% (w/v) respectively). 
Once the cells became dissociated 6 ml of basal EMEM were added to inhibit 
trypsin activity. Cells from two 225 cm2 flasks were pooled and centrifuged at 600 x 
g for 10 min at 40 C, the supernatant poured off and the cell pellet washed twice with 
25 ml of phosphate-buffered saline to ensure removal of serum. Total lipid was 
extracted from the cells by homogenisation in 5 ml of ice-cold chloroform:methanol 
(2:1, v/v) followed by addition of 1 ml 0.88% (w/v) KCI and mixing on a vortex mixer. 
The phases were separated by centrifugation, the chloroform layer removed and 
dried under nitrogen and the residue dissolved in chloroform/methanol (2: 1, v/v) 
48 
containing 0.05% BHT at a final concentration of 10 mg/ml. 
2:20 Protein estimation 
Protein in tissue homogenates and intracellular fractions was quantified by the 
method of Lowry et al. (1951). Protein in intact cell preparations was measured 
using an adaptation of the above method. Standards containing 0-1 00 ~g of protein, 
prepared from a standard 1 mg/ml solution of BSA, were placed in 5 ml 
polypropylene tubes and the volume adjusted to 0.1 ml with distilled water. Samples 
of cell suspensions, containing up to 0.1 ml, were placed in similar tubes. 0.25 ml of 
a solution containing 1 M NaOH and 0.25% (w/v) sodium dodecyl sulphate (SOS) 
was added to standard and sample tubes which were incubated for 45 min at 600 C 
in a water bath. After cooling 2.5 ml of a solution containing 1 ml 1 % (w/v) 
CUS04.5H20, 1 m12% (w/v) sodium potassium tartrate and 100 ml 2% (w/v) 
NaC03 was added, the contents mixed, and incubated for 15 min. at room 
temperature. 0.25 ml of Folin-Ciocalteu phenol reagent, diluted 1:1 (v/v) with 
distilled water, was added to all tubes. After mixing and incubating for a further 30-
60 min the absorbance of samples and standards were recorded at 660 nm in a 
spectrophotometer. 
2:21 Enzyme immunoassay of prostaglandins 
These assays were performed using commerially available enzyme immunoassay 
kits. The assay principle is based on the competition between free prostaglandin 
(e.g. PGE2) and a PGE2 tracer (PGE2 linked to an acetylcholinesterase molecule) 
for a limited number of PGE2-specific rabbit antiserum binding sites. The 
concentration of the PGE2 tracer remains constant while the concentration of free' 
PGE2' either standard or sample, is varied. Therefore, the amount of PGE2 tracer 
that is able to bind to the rabbit antiserum will be inversely proportional to the 
concentration of free PGE2 in the well. The rabbit antiserum-PGE2 (either free or 
tracer) binds to the mouse monoclonal antibody which has been previously 
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attached to the well. The plate is then washed to remove any unbound reagents and 
then Ellmans reagent, which contains the substrate for the acetylcholinesterase, is 
added to the well. The chromophore produced by this enzyme reaction is yellow in 
colour and absorbs strongly at 412 nm. The absorption is determined 
spectrophotometrically and is proportional to the amount of PG E2 tracer bound to 
the well, which is in turn inversely proportional to the amount of free PGE2 present 
in the well during the incubation. A standard graph of %B/Bo (% bound/maximum 
bound) versus log PGE2 concentration is shown in Figure 2:21 :1. While the kits 
purport to measure PGE2, which will be the major PGE analogue in mammals, the 
antibody also cross-reacts with PGE analogues derived from both EPA and 20:3n-6. 
The cross-reactivity of the PGE2 antibody with PGE3 and PGE1 was 100% and 
6.2% respectively. 
2:22 Assay of phospholipase A activity 
Cardiac phospholipase A activity was assayed using endogenous substrate 
largely as described by Szymanska et al. (1991). One heart was homogenised in 2 
ml of 50 mM Tris-HCI (pH 8.5) containing 200 mM KCI and 5 mM CaCI2' One ml of 
homogenate was immediately extracted by the method of Folch et al. (1957), 100 III 
was removed for protein determination and the remaining 1 ml was placed in a 
shaking water bath at 180 C. After 2 h the reaction was terminated by addition of 5 
ml of chloroform:methanol (2:1 v/v) containing 0.05% BHT (w/v) and the lipids 
extracted as above. Free fatty acids, PC and PE were separated in 0 and 2 h 
samples by HPTLC and quantified as described in section 2:4:2. Phospholipase A 
activities are expressed either as nmol fatty acid liberated or nmol PC and PE 
hydrolysed/h per mg protein. The composition of released free fatty acid was 
determined after separating the free fatty acids using TLC. Lipid extracts were 
separated on 20 x 20 cm TLC plates using hexane:diethyl ether:acetic acid (70:30: 1 
Figure 2.21.1 
Standard graph of log PGE2 concentration vs. %B/Bo (% bound/maximum bound) 
for PGE2 enzyme immunoassay (EIA). 
The assay is based on competition between free PGE2 and PGE2 tracer (PGE2 
linked to acetylcholinesterase) for a limited number of PGE2-specific antiserum 
binding sites. The concentration of the tracer remains constant while the 
concentration of free PGE2' either standard or sample, is varied. Therefore, the 
amount of PGE2 tracer that is able to bind to the antiserum is inversely proportional 
to the concentration of free PGE2 in the well. 
Figure 2:21: 1 
60~---------------------------------, 
y = -26.241LOG(x) + 30.359 
50 
40 
--0- PGE2 standards 
30 
20 
104-----------------~----------~--~ 
0.1 10 
pg PGE2 
50 
v/v/v), the free fatty acid band scraped off and transmethylated, and the fatty acids 
identified and quantified by gas-liquid chromatography. The average molecular 
weight of released fatty acid was calculated as 291. The composition of cardiac PC 
and PE was analysed similarly and average molecular weights for PC and PE of 
852 and 804 respectively, were used in calculating phospholipase A activity. 
2:23 Histology 
Samples of heart, liver, kidney, pancreas, spleen and gills were fixed in 20% 
buffered formol saline (Na2HP04' 32.1 g; NaH2P04.2H20, 22.8g; NaCI, 22.5g; 
formalin, SOOml; distilled water, 2L) at the time of sampling. Gills were decalcified in 
a solution containing 40 ml of 20% nitric acid, 30 ml of 1% chromic acid and 30 ml of 
absolute ethanol. All tissues were dehydrated by immersion in increasing 
concentrations of absolute ethanol, from 70-100%, fOllowed by a mixture of absolute 
ethanol and "Histoclear" (B.S. & S. Ltd, Edinburgh, Scotland) (1:1 v/v) before final 
clearing in "Histoclear". Tissues were then embedded in paraffin wax and 5 Jlm 
sections were cut. Samples were then stained with Harris's haematoxylin and 1 % 
(w/v) aqueous eosin before mounting with "Histomount" (B.S. & S. Ltd., Edinburgh, 
Scotland) and a coverslip. Pathological assessment was carried out on coded, 
randomised slides to eliminate bias in interpretation. All slides were randomised, 
existing identification numbers covered by autoclave tape and the slides 
renumbered. In all histological examinations 12-24 slides per dietary treatment 
(one slide per fish) were examined. This allowed estimation of inter-population 
variability rather than intra-organ variation which would necessitate serial 
sectioning. Pathological examination was carried out on a Wild M20 compound 
microscope at an objective magnification of x20 or x40. Each heart ventricle section 
(and auricle if present) was scanned, in its entirety, at low power (x 20) followed by a 
second scan focussing on specific areas of interest, at high power (x 40). All 
histopatho.logical assessments were performed by Dr Alasdair McVicar, 
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S.O.A.E.F.D. Marine Laboratrory, Aberdeen. 
2:24 Statistical analysis 
Significance of difference (P < 0.05) between treatments was determined either by 
Student's t test or by analysis of variance (ANOVA). Analyses were performed using 
a Statgraphics (system 3.0) computer package. Data which were identified as non-
homogeneous (using Bartlett's test, Bartlett, 1937) were subjected to either arcsine 
square root or log transformation before analysis. Data which were non-
homogeneous after transformation were analysed by the non-parametric Kruskal-
Wallis test (Kruskal and Wallis, 1952). 
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Section 3. Dietary study A; Effects of feeding diets with high and low n-3/n-6 
PUFA ratio on tissue phospholipid fatty acid compositions and eicosanoid 
production in Atlantic salmon post-smolts. 
3:1 Introduction 
Most mammals, with the exception of strict carnivores, can metabolise linoleic acid 
(18:2n-6) by A 6-desaturation to gamma-linolenic acid (18:3n-6) which after 
elongation to dihomogamma-linolenic acid (20:3n-6) can undergo further 
desaturation by a A 5-desaturase to produce arachidonic acid (AA; 20:4n-6) 
(Crawford et a/. 1976). The same enzymes are also active in converting a-linolenic 
acid (18:3n-3) to eicosapentaenoic acid (EPA; 20:5n-3). While most freshwater fish 
possess the same pathway (Henderson and Tocher, 1987), marine fish such as 
turbot are apparently deficient in A 5-desaturase activity and thus require the long-
chain PU FA, EPA, docosahexaenoic acid (DHA; 22:6n-3) and probably AA to be 
supplied by the diet (Owen et a/. 1975; Bell et a/. 1985). In an anadromous fish such 
as Atlantic salmon (Sa/mo salary the ability to elongate and desaturate C18 PUFA 
may be diminished during smoltification (Ackman and Takeuchi, 1986) but appears 
to be present in post-smolting juveniles (Bell et al. 1989). 
In humans consuming 'Western-type' diets with a high n-6/n-3 PUFA ratio AA is 
the major precursor available for eicosanoid production, and these diets are 
possibly responsible for the high incidence of atherothrombotic and inflammatory 
conditions prevalent in Western populations (Nordoy and Goodnight, 1990; Miller 
et a/. 1990). Considerable evidence now exists that many of these conditions can 
be attenuated by reducing the tissue n-6/n-3 PUFA ratio using dietary fish oil 
supplements which are rich in EPA and DHA (Lands, 1986). As with humans, 
intensively farmed Atlantic salmon are susceptible to stress-induced disease 
conditions. Due to the inclusion of some plant-derived lipids in their dietary regime, 
farmed salmon contain around five times as much n-6 PUFA compared to their wild 
.. 
53 
counterparts (Bell, J.G. unpublished data) and it is possible that the subsequent 
increase in n-6/n-3 PUFA ratio is responsible for increased AA-derived eicosanoid 
production in farmed salmon. In this experiment two groups of Atlantic salmon post-
smolts were fed diets with the same total lipid content, but in which the lipid was 
supplied either as fish oil, (Fosol, white fish body oil; FO, obtained from Seven Seas 
Ltd., Hull, U.K.) or sunflower oil (SO; Tesco Ltd., Cheshunt, U.K.), with the latter diet 
containing adequate levels of n-3 PUFA derived from fishmeal (U.S. National 
Research Council, 1981). The fatty acid compositions of the experimental diets are 
shown in Table 3: 1: 1. The objective was to alter the n-3/n-6 PUFA ratio in salmon 
and specifically to investigate the incorporation of 18:2n-6 and its metabolites into 
the individual phospholipids of heart, liver, brain and retina. The former two tissues 
were chosen because they are tissues of high metabolic activity while the two 
neural tissues are especially rich in 22:6n-3 (Tocher and Harvie, 1988) which is 
thought to perform specific functional roles in both brain and retina (Connor et al. 
1992). Reduction of 22:6n-3 in neural tissues results in impaired physiological 
function in primates (Neuringer et al. 1988) and impaired visual function in herring 
(Bell et al. 1995). The fatty acid compositions of individual phospholipids from both 
gill and blood leucocytes were also measured since these tissues are particularly 
active in eicosanoid production (German and Kinsella, 1986; Henderson et al. 
1985; Pettitt et al. 1989). Lipoxygenase products derived from endogenous 
precursors were measured in isolated gill cells and whole blood challenged with 
the calcium ionophore A23187. 
3:2 Experimental details, growth and mortality 
Three hundred Atlantic salmon S1 smolts were obtained from the S.O.A.E.F.D. 
Fish Cultivation Unit, (Aultbea, Wester Ross) and transferred to seawater at the 
same facility. The smolts were distributed randomly into two tanks of 2 m x 2 m 
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Table 3:1:1 Fatty acid composition of diets (Values are weight % of total fatty 
acids) 
--------------------------------------------------------
Fatty acid Fish oil diet Sunflower oil diet 
14:0 5.7 2.0 
16:0 13.8 9.7 
18:0 2.5 3.4 
16:1n-7 5.2 2.2 
18:1n-9 12.0 14.7 
18:1n-7 2.3 2.3 
20:1n-9 8.9 3.2 
22:1n-11 13.8 4.0 
24:1 1.4 0.4 
18:2n-6 1.4 42.1 
18:3n-6 0.2 1.1 
20:2n-6 0.2 t 
20:3n-6 0.2 0.1 
20:4n-6 0.6 0.4 
18:3n-3 1.3 0.4 
18:4n-3 2.9 0.7 
20:5n-3 7.2 3.4 
22:5n-3 1.2 0.5 
22:6n-3 10.4 4.6 
Total n-6 2.5 43.6 
Total n-3 23.8 9.9 
n-3/n-6 9.4 0.2 
Unsaturation index 173.5 168.3 
t = trace value < 0.05%. Unsaturation index = weight % x number of double bonds. 
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square containing 2000 L of seawater which were supplied with non-recirculated at 
26 Umin. The tanks were subjected to natural photoperiod and the temperature 
over the experimental period (June-October) was 9-130 C. The fish meal-based 
diets contained 46% protein and 17% lipid (see section 2; Materials and Methods). 
The diets were supplied by automatic feeders, which were activated for a few 
seconds every 15 min during daylight hours and adjusted to provide 20 g/kg 
biomass each day. Fish were weighed individually at the start and finish of the 
experiment and were weighed in bulk every 28 days, and the ration adjusted 
accordingly. Both dietary treatments achieved satisfactory growth during the 16-
week experimental period (See Table 3.2.1). Final weights after 16 weeks were not 
significantly different although fish fed the FO diet were Significantly lighter at the 
outset of the trial. Mortalities with both diets were low « 10%) over the experimental 
period. However, when 30 fish from each treatment were simultaneously 
transported to the aquarium at the University of Stirling, from the experimental 
station at Aultbea (a 4 h journey), 30% of SO-fed fish died, while no mortalities 
occurred in the FO-fed group. The fish were transported in sealed, double, black 
polythene bags. Each bag contained approximately 15 L of seawater and 2 kg 
biomass and were sealed after inflation with approximately 30 L of oxygen. The 
initial water temperature was 130 C and the temperature at the end of the journey 
was 150 C. Although no fish were dead on arrival, several of the SO-fed fish 
appeared in a stressed condition, i.e. lying upside down and showing rapid gill 
movement. The tank was immediately bubbled with oxygen, for a period of 30 min, 
but within 24 h 30% were dead. These symptoms are similar to the shock syndrome 
described by Castell et al. (1972); Castell (1993, personal communication) in 
essential fatty acid-deficient rainbow trout. 
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Table 3.2.1. Growth parameters and mortalities during the 16 weeks experimental 
period. 
Parameter FOdiet SO diet 
Number of fish 152 152 
* Mean initial weight 46.4 ± 14.1 55.3 ± 14.9 
Mean final weight 243.2 ± 40.7 241.4 ± 43.6 
Mortalities (number) 10 12 
Specific growth rate (%/d) 1.5 1.3 
Feed efficiency ratio 48.6 49.9 
* Values for initial and final weights are mean ± SO. Values are significantly different 
(P < 0.05). Specific growth rate calculated as %weight gain/day = (eGw-1) x 100, 
where Gw (daily growth rate) = InW1-lnWOff. (W1 = final weight, Wo = initial weight, 
T = time in days). Feed efficiency ratio = gain/feed x 100. 
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3.3 Tissue histopathology 
No significant histopathology was observed in the pancreas, kidney, spleen, heart 
and gills of the salmon fed the Fa diet. One fish fed the SO diet showed areas of 
focal degenerative necrosis in the liver, while another fish had a similar lesion in the 
spleen and kidney. These organs were normal in all other fish in the SO group, and 
therefore, little significance can probably be attributed to these observations. 
However, a high proportion of fish fed the SO diet showed heart ventricle lesions 
ranging from mild to severe (Table 3.3.1). At low magnifications 45% of all hearts 
from the SO-fed group showed a pronounced depletion in the amount of muscle 
present in both the spongy and compact layers, with (in extreme cases) the heart 
wall becoming extremely thin (Fig. 3.3.1) compared to the normal organ (Fig. 3.3.2). 
Closer histological examination of affected hearts, as well as some not showing 
obvious muscle depletion, generally showed active focal myodegeneration, 
particularly in the spongy tissue (Fig 3.3.3). The foci of degeneration ranged from 
single small lesions to multiple extensive areas. Similar lesions were also apparent 
in atrial muscle. The cardiac myodegenerative lesions found in this study are similar 
to those described by Roberts and Bullock (1989). 
Figure 3.3.1 Light micrograph of heart tissue from Atlantic salmon fed sunflower oil-
containing diet for 16 weeks. Micrograph indicates depletion in the amount of 
muscle present in both spongy (0) and compact layers (~) , resulting in thinning of 
the heart wall (Scale = 300 ~m) . 
Figure 3.3.2 Light micrograph of heart tissue from Atlantic salmon fed fish oil-
containing diet for 16 weeks showing normal appearance of spongy (0) and 
compact (.) muscle layers (Scale = 200 flm) 
Figure 3.3.3 Light micrograph of heart atrium from Atlantic salmon fed sunflower oil-
containing diet for 16 weeks. Micrograph indicates areas of apparent focal 
myodegeneration and necrosis (arrows) beneath the extensive accumulation and 
infiltration of leucocytes (L) . (Scale = 20 /lm). 
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Table 3.3.1 Prevalence of heart muscle necrosis in salmon post-smolts fed diets 
containing fish oil or sunflower oil. 
Sampling time 
(weeks) 
16 
18 
20 
Total 
Total 
Sample 
5 
6 
10 
21 
Fish oil diet 
Normal 
Hearts 
5 
6 
9 
20 
Necrotic 
Hearts 
o 
o 
1 
1 
Sunflower oil diet 
Total Normal 
Sample Hearts 
5 
10 
9 
24 
1 
1 
5 
7 
Necrotic 
Hearts 
4 
9 
4 
17 
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3.4 Fatty a.cid compositions of salmon heart 
The fatty acid compositions of heart phospholipid classes are shown in Tables 
3.4.1 and 3.4.2. In PC from SO-fed fish there were significant increases in 18:2n-6, 
18:3n-6, 20:2n-6, 20:3n-6 and 20:4n-6 compared to FO-fed fish. In addition, the SO-
fed fish had significantly reduced 20:5n-3 and total monoenes. In PE the same 
pattern of changes was observed, and in both classes the n-3/n-6 ratio was 
significantly reduced in SO-fed fish. A significant decrease in total saturates was 
also seen in PE. In PS of SO-fed fish the n-6 PUFA described above were all 
significantly increased, with the exception of 20:4n-6, which was unchanged. The 
levels of 18:3n-3, 20:5n-3 and 22:5n-3 were significantly reduced as were total 
monoenes. Total saturates were significantly increased in the hearts of SO-fed fish 
compared with those fed FO. In PI of hearts from SO-fed fish, 18:2n-6, 20:2n-6, 
20:3n-6 and 20:4n-6 were significantly increased, while 20:5n-3 and 22:6n-3 were 
significantly reduced compared to FO-fed fish. The AAiEPA ratio was significantly 
increased in all phospholipid classes of fish fed SO. The n-3/n-6 PUFA ratio was 
significantly reduced in both PS and PI of SO-fed fish. 
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Table 3.4.1 Fatty acid compositions of phosphatidylcholine and phosphatidyl 
ethanolamine from hearts of salmon fed diets containing fish oil (FO) or sunflower 
oil (SO) 
Phosphatidylcholine Phosphatidylethanolam ine 
Fatty acid FO diet SO diet FO diet SO diet 
weight % 
Total saturates 40.8 ±2.3 40.6 ± 1.3 • 24.0±0.S 20.8 ± 0.7 
• • • Total monoenes 18.3 ± 1.1 14.8 ± 1.0 10.S ± 0.6 8.3± 0.7 
• • 18:2n-6 0.4 ± 0.1 6.6±0.5 0.7±0.2 6.7 ± 0.4 
• • 18:3n-6 0.1 ±O.O 0.3±0.1 0.2±0.0 0.1 ± 0.0 
• • 20:2n-6 0.1 ±O.O 0.6±0.1 0.1 ±O.O 0.7 ± 0.1 
• • 20:3n-6 0.1 ± 0.0 0.9±0.2 0.1 ±O.O 0.8 ±0.2 
• • 20:4n-6 1.6 ± 0.1 2.6±0.4 1.S ± 0.2 2.9 ± O.S 
Total n-61 • • 2.8 ± 0.2 11.3 ± 0.2 3.6±0.1 12.1 ± 0.4 
18:3n-3 0.2 ± 0.1 0.1 ±O.O 0.2 ± 0.1 0.1 ± 0.0 
• • 20:Sn-3 6.4± 0.2 4.2±0.3 3.9 ± 0.4 2.5 ± 0.1 
22:5n-3 0.9±0.1 0.9±0.0 2.7±0.0 2.5±0.2 
22:6n-3 24.2 ± 1.9 22.6±2.1 42.1 ± 1.4 43.5 ± 1.6 
Total n-32 32.1 ± 1.6 28.0±2.0 49.4 ± 1.6 48.8 ± 1.6 
Total PUFA 34.9 ± 1.8 39.3± 1.9 • 53.0 ± 1.6 61.0 ± 1.8 
• • 
n-3/n-6 11.S ± 0.4 2.5 ±0.2 13.S ± 0.5 4.0± 0.2 
• •• 20:4/20:5 0.2 ± 0.1 0.6±0.2 0.4 ± 0.0 1.1 ± 0.3 
Values are means ± SD from three salmon. • Values are significantly different (P < 
0.05) as determined by Student's t test. ··Values are significantly different (P < 
O.OS) as determined by Kruskal-Wallis analysis. SD < 0.05 are tabulated as 0.0. 
1 Includes 22:4n-6 and 22:5n-6. 
21ncludes 18:4n-3 and 20:4n-3. 
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Table 3.4.2 Fatty acid compositions of phosphatidylserine and phosphatidylinositol 
from hearts of salmon fed diets containing fish oil (FO) or sunflower oil (SO) 
Phosphatidylserine Phosphatidylinositol 
Fatty acid Fa diet SO diet Fa diet SO diet 
Weight % 
* Total saturates 30.6 ± 1.4 34.9± 1.7 31.2 ± 0.6 34.6±3.0 
* Total monoenes 13.3 ± 0.7 8.0 ± 0.1 9.4±0.1 7.8 ± 1.2 
* * 18:2n-6 0.9± 0.1 8.0±0.1 0.6±0.1 4.2 ± 0.4 
* * 18:3n-6 0.7±0.1 0.4 ± 0.1 0.3±0.0 0.2 ±O.O 
* * 20:2n-6 0.2±0.0 0.9±0.2 t 0.3 ± 0.1 
* * 20:3n-6 0.1 ±O.O 1.0±0.1 0.1 ± 0.1 0.8 ±0.2 
20:4n-6 1.8 ±0.8 1.9 ± 0.3 13.5 ± 0.1 ** 16.1 ± 2.1 
Total n-61 4.4±0.8 * 12.8 ± 0.4 15.0±0.3 * 22.0 ± 1.9 
* * 18:3n-3 0.6±0.1 0.1 ± 0.1 0.3±0.0 t 
* * 20:5n-3 1.8±0.3 0.9±0.2 7.6±0.8 3.6±0.3 
* 22:5n-3 3.2±0.3 2.1 ± 0.4 1.1 ± 0.2 1.4 ± 0.5 
22:6n-3 37.3±0.7 35.4 ± 2.1 28.9± 0.8 * 22.6 ± 2.5 
Total n-32 * * 43.4 ± 0.8 36.9± 1.5 38.3± 0.2 28.0 ± 2.8 
Total PUFA 47.8 ± 1.0 49.8 ± 1.9 53.3±0.3 * 50.0 ± 4.7 
** * n-3/n-6 10.1 ± 2.0 2.9±0.1 2.6± 0.1 1.3 ± 0.0 
* * 20:4/20:5 1.0 ± 0.4 2.1 ±0.3 1.8 ± 0.2 4.5 ±0.9 
* Values are means ± SO from three salmon. Values are significantly different (P < 
0.05) as determined by Student's t test. **Values are significantly different (P < 
0.05) as determined by Kruskal-Wallis analysis. SO < 0.05 are tabulated as 0.0. 
1 Includes 22:4n-6 and 22:5n-6. 
21ncludes 18:4n-3 and 20:4n-3. 
t = trace value < 0.05%. 
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3.5 Fatty acid compositions of salmon liver, brain and retina 
The fatty acid compositions of the major liver phospholipid classes are shown in 
Tables 3.5.1 and 3.5.2. Liver PC from SO-fed fish showed significantly increased 
18:2n-6, 18:3n-6, 20:2n-6 and 20:3n-6, the latter being some 25 times that in FO-fed 
fish. Significant decreases in 20:5n-3 and 22:5n-3 were observed in liver PC of fish 
fed SO. Similar changes also occurred in liver PE, but, in addition, 20:4n-6 and total 
PUFA were significantly increased while 18:3n-3 and total monoenes were 
significantly decreased in SO-fed fish. In liver PS, 18:2n-6 and 20:3n-6 were 
significantly elevated while 18:3n-3 was significantly reduced in SO-fed fish. In liver 
PI, values for 18:2n-6, 20:2n-6 and 20:3n-6 were significantly increased in fish fed 
SO. The n-3/n-6 PUFA ratio was significantly reduced in all liver phospholipid 
classes of SO-fed fish, except in PI. The 20:4n-6/20:5n-3 ratio was generally 
increased in fish fed SO, although this was only significant in PE. 
The fatty acid compositions of the phospholipid classes from brain and retina were 
much less affected by dietary lipid compOSition tt'lan those of heart and liver. The 
major changes were generally in PC and PE whose fatty acid compositions in retina 
and brain are shown in Tables 3.5.3 and 3.5.4. In retinal PC and PE, significant 
increases were observed in 18:2n-6, 20:2n-6 and 20:3n-6 in SO-fed fish. 20:4n-6 
was significantly increased in PC but not PE. In both PC and PE 20:5n-3 was 
significantly decreased and 22:6n-3 was significantly reduced in PC of SO-fed fish. 
In retinal PI of SO-fed fish, 22:6n-3 was also significantly decreased (from 23.0% ± 
1.6 to 15.2% ± 0.9). A similar pattern was observed in brain PC and PE where 
18:2n-6, 20:2n-6 and 20:3n-6 were increased in SO-fed fish but 20:5n-3 was 
significantly decreased only in PC. 
. 
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Table 3.5.1 Fatty acid compositions of phosphatidylcholine and 
phosphatidylethanolamine from liver of salmon fed diets containing fish oil (FO) or 
sunflower oil (SO) 
Phosphatidylcholine Phosphatidylethanolam ine 
Fatty acid FOdiet SO diet FO diet SO diet 
Weight % 
Total saturates 41.1 ± 4.3 38.2 ±2.9 25.6±2.7 22.9±2.6 
Total monoenes 18.3 ± 2.7 16.5 ± 3.5 23.2 ± 0.7 * 15.1±1.9 
* ** 18:2n-6 0.6±0.1 11.9 ± 2.9 0.8 ± 0.1 12.1 ±2.1 
* 18:3n-6 t 0.6 ± 0.4 t t 
* * 20:2n-6 0.3±0.2 2.1 ± 1.1 0.3 ± 0.1 2.8 ±0.9 
* * 20:3n-6 0.2 ± 0.1 5.1 ± 1.2 0.2±0.1 4.3 ±0.2 
20:4n-6 1.3 ± 1.0 2.7± 1.6 * 1.8 ± 0.2 4.2 ±0.2 
Total n-61 * * 2.9± 1.5 22.8 ± 1.6 4.0±0.5 24.1 ± 2.4 
18:3n-3 0.1 ±O.O t 0.2±0.1 * t 
* * 20:5n-3 4.8 ±0.4 1.9 ± 0.2 5.2 ± 0.4 2.7 ± 0.4 
* 22:5n-3 1.3 ± 0.1 0.9± 0.1 1.6 ± 0.3 1.0±0.3 
22:6n-3 21.2 ± 3.3 15.0±3.1 32.0± 1.6 30.1 ± 2.0 
Total n-32 * * 27.6 ± 3.6 17.8 ± 2.9 39.8 ± 1.7 33.8 ± 1.7 
Total PUFA 30.5±4.7 40.6± 4.1 43.7± 1.5 * 57.9 ± 3.4 
** * n-3/n-6 10.7 ± 3.8 0.8 ± 0.1 10.1 ± 1.5 1.4 ± 0.1 
20:4/20:5 0.3±0.2 1.5 ± 0.9 * 0.4±0.1 1.6 ± 0.2 
* Values are means ± SO from three salmon. Values are significantly different (P < 
0.05) as determined by Student's t test. **Values are significantly different (P < 
0.05) as determined by Kruskal-Wallis analysis. SO < 0.05 are tabulated as 0.0. 
1 Includes 22:4n-6 and 22:5n-6. 
21ncludes 18:4n-3 and 20:4n-3. 
t = trace value < 0.05%. 
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Table 3.5.2 Fatty acid compositions of phosphatidylserine and phosphatidylinositol 
from liver of salmon fed diets containing fish oil (FO) or sunflower oil (SO). 
Phosphatidylserine Phosphatidylinositol 
Fatty acid FO diet SO diet FO diet SO diet 
Weight % 
Total saturates 34.9± 1.0 34.8 ±3.8 36.5±3.9 35.1 ± 3.2 
Total monoenes 25.9± 4.5 24.3±9.2 13.3±1.1 10.4 ± 2.8 
* ** 18:2n-6 1.2±0.3 9.2±3.9 0.5±0.0 3.4 ± 1.2 
18:3n-6 0.9±0.3 0.4±0.2 * 0.6 ±0.1 0.2 ± 0.1 
20:2n-6 0.3±0.2 1.1 ± 0.5 * 0.2 ±0.1 1.1 ± 0.3 
* * 20:3n-6 0.1 ±0.1 2.0±0.3 0.7±0.2 3.9 ± 1.2 
20:4n-6 0.4±0.1 1.0±0.5 19.5±1.7 20.6±4.2 
Total n-61 * * 2.7±0.2 13.9 ± 3.9 21.8±1.6 29.5 ± 2.9 
* * 18:3n-3 0.3±0.1 t 0.2 ± 0.1 t 
20:5n-3 1.4 ± 0.6 0.7±0.1 3.2±0.3 2.6±0.7 
22:5n-3 1.1 ± 0.2 1.5 ± 0.5 1.5 ± 0.5 0.9±0.2 
22:6n-3 20.5±3.8 13.1 ±2.9 14.2± 1.2 13.1 ± 3.7 
Total n-32 24.0±4.6 14.7±3.3 19.4 ± 2.0 16.6 ± 4.2 
Total PUFA 26.7± 4.7 28.5 ± 5.4 41.2± 0.4 46.2 ±3.0 
* n-3/n-6 8.7 ± 1.4 1.1 ± 0.4 0.9±0.2 0.6±0.2 
20:4/20:5 0.3±0.1 1.4 ± 0.7 6.2 ± 1.2 8.3±3.0 
* Values are means ± SO from three salmon. Values are significantly different (P < 
0.05) as determined by Student's t test. **Values are significantly different (P < 
0.05) as determined by Kruskal-Wallis analysis. SO < 0.05 are tabulated as 0.0. 
1 Includes 22:4n-6 and 22:5n-6. 
21ncludes 18:4n-3 and 20:4n-3. 
t = trace value < 0.05%. 
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Table 3.4.3 Fatty acid compositions of phosphatidylcholine and 
phosphatidylethanolamine from retina of salmon fed diets containing fish oil (FO) or 
sunflower oil (SO) 
Phosphatidylcholine Phosphatidylethanolam ine 
Fatty acid FO diet SO diet FO diet SO diet 
Weight % 
Total saturates 35.4 ± 1.1 33.3 ± 0.4 14.7 ± 0.9 14.6 ± 1.7 
Total monoenes 20.3±0.2 20.8 ±0.4 18.8 ± 2.9 22.1 ±3.4 
* ** 18:2n-6 0.4±0.1 5.6± 0.1 0.5 ± 0.1 2.8 ± 0.9 
18:3n-S t 0.1 ±o.o 0.1 ±0.1 t 
* * 20:2n-6 t 0.8 ±0.1 t 0.5 ± 0.1 
20:3n-6 t * 0.9± 0.1 0.2 ± 0.1 * 0.6 i 0.1 
* 20:4n-6 0.9±0.0 1.1 ± 0.0 1.7iO.0 2.3iO.6 
Total n-61 * * 1.6 ± 0.1 8.7±0.2 2.7±0.3 6.5 ± 0.6 
18:3n-3 0.1 ±O.O t 0.2±0.1 0.2 ± 0.1 
* * 20:5n-3 4.4±0.1 3.9±0.2 3.0iO.3 2.4 i 0.1 
22:5n-3 0.8±0.1 0.8 ± 0.1 1.9 ± 0.7 1.4± 0.1 
** 22:6n-3 31.2 ±2.6 2S.2±0.6 43.6±0.8 39.9±5.5 
Total n-32 ** 36.6 ± 2.2 31.2 ± 0.5 48.5 ±0.9 41.8 i 5.6 
Total PUFA 38.4± 1.7 39.6±0.3 SO.8±0.9 48.3±S.9 
n-3/n-6 23.4 ± 1.8 * 3.6iO.2 18.1 ± 1.S * 6.S i 0.8 
* 20:4/20:5 0.2±0.0 0.3±0.0 0.6±0.1 1.0iO.3 
* Values are means ± SD from three salmon. Values are significantly different (P < 
0.05) as determined by Student's t test. *·Values are significantly different (P < 
0.05) as determined by Kruskal-Wallis analysis. SD < 0.05 are tabulated as 0.0. 
1 Includes 22:4n-6 and 22:5n-6. 
21ncludes 18:4n-3 and 20:4n-3. 
t = trace value < 0.05%. 
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Table 3.S.4 Fatty acid compositions of phosphatidylcholine and 
phosphatidylethanolamine from brain of salmon fed diets containing fish oil (FO) or 
sunflower oil (SO) 
Phosphatidylcholine Phosphatidylethanolam ine 
Fatty acid FO diet SO diet FO diet SO diet 
Weight % 
Total saturates 33.2 ±2.6 31.3± 1.1 16.9 ± 0.2 17.1±0.2 
Total monoenes 47.6±2.0 46.S ±0.4 30.9±0.3 31.1 ± 0.4 
* * 18:2n-6 0.3±0.0 1.2 ± 0.3 0.3±0.0 1.1 ± 0.2 
18:3n-6 t t 0.1 ±0.1 t 
* * 20:2n-6 t 0.3±0.1 t 0.4 ± 0.1 
* * 20:3n-6 t 0.3±0.0 t 0.3 ± 0.1 
20:4n-6 0.4 ± 0.1 0.6±0.1 0.7±0.1 1.1 ± 0.2 
Total n-61 * * 0.9 ± 0.0 2.7±0.3 1.2 ± 0.2 3.0 ± 0.1 
18:3n-3 t t t t 
* 20:Sn-3 2.9±0.1 2.S±0.1 4.8 ±0.2 4.4 ± 0.1 
22:Sn-3 0.9 ±0.1 1.0±0.4 1.8±0.2 1.6 ± 0.1 
22:6n-3 11.S ± 1.3 12.7±0.7 20.9 ± 1.8 21.S ± 0.8 
Total n-32 1S.4 ± 1.S 16.3 ± 0.4 27.8 ±2.0 27.7±0.8 
Total PUFA 16.3 ± 1.S 18.9 ± 0.1 29.0± 1.9 30.6±0.8 
* * n-3/n-6 17.2 ± 1.6 6.2 ± 1.0 22.9± 4.3 9.3 ± 0.1 
20:4/20:S 0.1 ±0.1 0.2 ±0.1 0.2 ± 0.1 0.2 ± 0.1 
* Values are means ± SO from three salmon. Values are significantly different (P < 
0.05) as determined by Student's t test. **Values are significantly different (P < 
O.OS) as determined by Kruskal-Wallis analysis. SD < O.OS are tabulated as 0.0. 
1 Includes 22:4n-6 and 22:Sn-6. 
21ncludes 18:4n-3 and 20:4n-3. 
t = trace value < O.OS%. 
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3.6 Fatty acid compositions of blood leucocyte and gill phospholipids 
The fatty acid compositons of blood leucocyte phospholipid classes are shown in 
Tables 3.6.1 and 3.6.2. In PC of SO fed fish there were increased levels of 18:2n-6, 
18:3n-6, 20:2n-6 and 20:3n-6 compared to fish fed Fa. The SO fed fish also had 
decreased 20:5n-3, 22:6n-3, total saturates and total monoenes. Similar changes 
were apparent in PE although 20:4n-6 was also increased in fish fed SO. In both 
lipid classes the n-3/n-6 ratio was reduced in fish fed SO. In PS of fish fed SO the n-
6 PUFA were increased and EPA and DHA reduced compared to fish fed Fa. In PI 
20:3n-6 and 20:4n-6 were increased in SO fed fish, but EPA and DHA were also 
increased. In general, PI was the least affected by dietary lipid and the n-3/n-6 ratio 
and 20:4n-6/20:5n-3 ratio was relatively unaffected. In PS, as with PC and PE, the 
n-3/n-6 ratio was decreased and the AAlEPA ratio was increased in fish fed SO 
compared to those fed Fa. 
The fatty acid compositions of gill phospholipid classes are shown in Tables 3.6.3 
and 3.S.4. PC from SO fed fish had significantly increased 18:2n-6, 20:2n-6, 20:3n-S 
and total PUFA but decreased EPA and total n-3 PUFA compared to Fa fed fish. 
Similar changes were also apparent in gill PE. In gill PS, 18:2n-6, 20:2n-6 and 
20:3n-6 were significantly elevated in SO fed fish, while EPA and 22:5n-3 were 
significantly decreased. Similar changes were observed in gill PI. The n-3/n-6 PUFA 
ratio was significantly increased in all phosphOlipid classes of fish fed SO. While the 
mean value of the AAiEPA ratio was increased in all phospholipid classes this was 
only significant for PS. 
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Table 3.6.1 Fatty acid compositions of phosphatidylcholine and 
phosphatidylethanolamine from blood leucocytes of salmon fed diets containing fish 
oil (FO) of sunflower oil (SO). 
PC PE 
Fatty acid FO diet SO diet FO diet SO diet 
Weight % 
Total saturates 34.8 32.6 22.5 18.2 
Total monoenes 25.0 20.6 25.4 14.2 
18:2n-6 1.0 8.8 2.4 12.2 
18:3n-6 0.2 0.5 0.1 0.6 
20:2n-6 0.2 1.6 0.3 2.0 
20:3n-6 0.2 1.6 0.2 1.5 
20:4n-6 2.8 2.8 2.8 4.2 
Total n-61 4.9 15.5 6.5 20.9 
18:3n-3 0.2 0.2 0.3 0.2 
20:5n-3 8.8 5.1 4.1 2.8 
22:5n-3 1.1 0.9 1.0 1.8 
22:6n-3 18.6 14.6 29.1 31.1 
Total n-32 29.3 20.9 35.5 36.2 
Total PUFA 34.2 36.4 42.0 57.0 
n-3/n-6 6.0 1.4 5.4 1.7 
20:4n-6/20:5n-3 0.3 0.7 0.6 1.5 
Results are from pooled leucocyte samples from six salmon. 
1 Includes 22:4n-6 and 22:5n-6. 
21ncludes 18:4n-3 and 20:4n-3. 
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Table 3.6.2 Fatty acid compositions of phosphatidylserine and phosphatidylinositol 
of blood leucocytes form salmon fed diets containing fish oil (FO) or sunflower oil 
(SO). 
PS 
Fatty acid FO diet SO diet FO diet 
Weight % 
Total saturates 31.9 34.9 26.7 
Total monoenes 11.4 7.1 12.5 
18:2n-6 1.0 3.8 1.2 
18:3n-6 t 0.2 0.3 
20:2n-S t 1.0 0.2 
20:3n-6 t 0.9 0.4 
20:4n-6 1.S 2.7 13.0 
Total n-61 2.8 9.1 15.2 
18:3n-3 0.2 0.3 0.3 
20:5n-3 2.1 1.7 2.4 
22:5n-3 1.7 1.9 1.8 
22:6n-3 41.8 38.4 25.3 
Total n-32 46.0 42.4 31.7 
Total PUFA 48.7 51.4 47.4 
n-3/n-S 16.7 4.7 2.1 
20:4/20:5 0.8 1.S 5.4 
Results are from pooled leucocyte samples from six salmon. 
1 Includes 22:4n-6 and 22:5n-6. 
21ncludes 18:4n-3 and 20:4n-3. 
t = trace value < 0.05%. 
PI 
SO diet 
22.9 
S.S 
1.4 
0.2 
0.3 
0.8 
17.8 
21.1 
t 
2.7 
1.8 
30.4 
34.9 
56.0 
1.7 
6.S 
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Table 3.6.3 Fatty acid compositions of phosphatidylcholine and 
phosphatidylethanolamine from gills of salmon fed diets containing fish oil (FO) or 
sunflower oil (SO). 
PC PE 
Fatty acid FO diet SO diet FO diet SO diet 
Weight % 
Total saturates 40.6±2.3 40.S ± 1.1 19.1 ± 0.7 21.S±4.1 
Total monoenes 24.9 ± 1.S 22.3±0.9 14.8 ± 1.3 16.2 ± 4.1 
* * 18:2n-6 0.6±0.1 7.9± 1.0 0.9±0.2 4.8 ± 0.8 
18:3n-6 0.2 ±0.1 0.2±0.2 0.4±0.2 0.2 ± 0.1 
* * 20:2n-6 0.1 ± 0.0 1.2±0.2 0.2 ± 0.1 0.9 ± 0.1 
* * 20:3n-6 0.1 ±O.O 1.6±0.3 0.1 ±O.O 0.7± 0.3 
20:4n-6 1.4± 0.2 2.2±0.9 2.8 ± 0.4 4.2±2.3 
Total n-61 * • 2.6 ± 0.4 13.4 ± 0.6 S.0±0.6 11.4 ± 2.6 
18:3n-3 t t 0.1 ± 0.0 t 
* * 20:Sn-3 4.9±0.6 2.6± 0.2 4.3±0.S 2.2 ±0.2 
22:Sn-3 0.8±0.3 O.S ± 0.1 1.2 ± 0.2 0.8±0.3 
22:6n-3 15.3 ± 1.3 13.8 ± 0.6 33.7 ± 0.6 26.9±S.2 
Total n-32 * 21.3 ± 2.0 16.9 ± 0.7 39.4±0.6 30.4 ± 5.2 
* Total PUFA 23.9 ± 2.4 30.3 ± 1.3 44.S±0.4 41.8±7.7 
* * n-3/n-6 8.1 ± O.S 1.3 ± 0.0 8.0±0.9 2.7 ±0.3 
20:4n-6/20:Sn-3 0.3 ± 0.1 0.9±0.4 0.7±0.2 1.9 ± 0.9 
1 Includes 22:4n-6 and 22:Sn-6. 21ncludes 18:4n-3 and 20:4n-3. t = trace value < 
O.OS%. Results are means ± SO form three fish per dietary treatment. ·Values are 
significantly different (P < O.OS). t = trace value < O.OS%. SO less than O.OS are 
tabulated as 0.0. 
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Table 3.6.4. Fatty acid compositions of phosphatidylserine and phosphatidylinositol 
from gills of salmon fed diets containing fish oil (FO) or sunflower oil (SO). 
PS PI 
Fatty acid FO diet SO diet FO diet SO diet 
Weight % 
* Total saturates 36.1 ± 0.5 45.8 ± 1.5 36.0±4.8 40.3±4.5 
* Total monoenes 15.0 ± 0.7 10.7 ± 1.2 14.6 ± 0.6 14.6 ± 0.3 
* * 18:2n-6 0.8±0.3 2.8±0.5 1.6 ± 0.1 3.9 ± 0.4 
18:3n-6 0.8±0.1 0.6±0.2 1.0±0.5 0.6±0.2 
* * 20:2n-6 0.1 ± 0.1 0.9±0.1 t 0.5 ± 0.0 
* * 20:3n-6 t 0.9± 0.1 0.4±0.2 1.2 ± 0.1 
20:4n-6 0.8 ± 0.1 1.1 ± 0.2 9.1 ± 0.8 8.7±2.1 
Total n-61 * 3.3 ±0.4 6.9±0.3 12.1 ±O.S 1S.4± 1.9 
18:3n-3 0.1 ± 0.0 t 0.S±0.2 0.2±0.1 
* * 20:Sn-3 1.3 ± 0.3 0.4± 0.1 2.S±0.3 1.3 ± 0.1 
* 22:Sn-3 1.7 ±0.1 1.2±0.2 1.0 ± 0.2 0.6±0.1 
22:6n-3 27.6± 1.0 2S.2 ± 1.4 21.S ± 2.9 17.6 ± 0.8 
Total n-32 30.8 ± 1.2 26.9± 1.7 2S.4 ± 3.3 19.7 ± 0.7 
Total PUFA 34.2± 1.0 33.8 ± 1.7 37.S ± 3.8 3S.1 ±2.S 
* * n-3/n-6 9.3 ± 1.4 3.9±0.4 2.1 ±0.3 1.3 ± 0.2 
* 20:4n-6/20:Sn-3 0.7 ± 0.2 2.S±0.7 3.7±0.3 6.9± 1.9 
1 Includes 22:4n-6 and 22:Sn-6. 21ncludes 18:4n-3 and 20:4n-3. t = trace value < 
O.OS%. Results are means ± SO form three fish per dietary treatment. *Values are 
significantly different (P < O.OS). t = trace value < O.OS%. SO less than O.OS are 
tabulated as 0.0. 
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3.7 Lipoxygenase products from gill and blood stimulated with 
Ca2 +ionophore A23187. 
The major lipoxygenase products from gill and blood are shown in Tables 3.7.1 
and 3.7.2. Peaks were identified by co-elution with commercial standards, and in 
the case of 12-HEPE, by GC resolution of methyl esters prepared from both 
commercial standard and from hydroxy fatty acids recovered from the HPLC 
separation. Gill cells from both dietary treatments produced large amounts of both 
12-HEPE (from EPA) and 12-HETE (from AA). The amount of 12-HETE produced 
was similar for both dietary treatments whereas the amount of 12-HEPE was 
significantly reduced in fish fed SO. No leukotriene 84 (LT84) or leukotriene 85 
were detected in gill cell extracts. In whole blood stimulated with A23187, LT84 
production was unaffected by dietary treatment but LT8S' derived from EPA, was 
significantly reduced in fish fed SO. Feeding SO significantly reduced formation of 
both 12-HETE and 12-HEPE by blood leucocytes, compared to fish fed FO. 
Table 3.7.1. Upoxygenase products from isolated salmon gill cells stimulated using 
the Ca2+-ionophore A23187. 
Eicosanoid 
12-HEPE 
12-HETE 
12-HETEl12-HEPE 
FOdiet 
(nglmg protein) 
108.3 ± 7.2 • 
54.8 ± 10.9 
• 0.5 ± 0.1 
Values are mean ± SD for five fish per dietary treatment. 
·Values are significantly different (P < 0.05). 
SO diet 
(ng/mg protein) 
43.1 ± 1.7 
S2.7±7.4 
1.3 ± 0.2 
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Table 3.7.2. Lipoxgenase products from whole blood of salmon stimulated using the 
Ca2+-ionophore A23187. 
Eicosanoid 
LTB4 
LTBS 
LTB4/LTBs 
12-HEPE 
12-HETE 
12-HETEl12-HEPE 
FO diet 
(nglml blood) 
23.2 ±2.2 
3S.2 ± 10.2 
• 0.7 ± 0.2 
• 
• 109.0 ± 2S.5 
• 18S.0± 17.3 
2.1 ±0.3 
Values are mean ± SD for five fish per dietary treatment. 
·Values are significantly different (P < O.OS). 
SO diet 
(nglml blood) 
18.1 ± 7.4 
9.6 ± 1.6 
1.9 ± 0.6 
38.1 ± 4.5 
97.2 ± 14.8 
2.7±0.2 
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3.8 Summary 
1. Practical-type diets containing either fish oil (FO) or sunflower oil (SO) were fed to 
Atlantic salmon post-smolts for a period of 16 weeks. Both diets contained adequate 
levels of n-3 PUFA. The effect of diet on growth (weight gain) could not be 
ascertained as the initial weights of the fish were significantly different. However, 
the specific growth rate was slightly higher in fish fed FO. 
2. A number of fish fed SO developed severe heart lesions causing thinning of the 
ventricular wall and muscle necrosis. In addition the fish fed SO were susceptible to 
a transportation-induced shock syndrome that caused 30% mortality. 
3. The phospholipid classes of heart, liver, gill and leucocytes in fish fed SO had 
increased levels of 18:2n-6 (2-15 fold), 20:2n-6 (4.5 -12 fold) and 20:3n-6 (2-25 
fold). In some tissues, 20:4n-6 was also increased (up to 2 fold), particularly in PC 
and PE. There was a general decrease in phospholipid 20:Sn-3 (up to 3 fold) which 
was reflected in an increased 20:4n-6/20:Sn-3 ratio of up to 6 fold. The fatty acid 
compositions of brain and retina while showing similar changes to the above 
tissues were generally much less affected by altered dietary n-3/n-6 PUFA ratio. 
4. When isolated gill cells were stimulated with the Ca2+-ionophore A23187, 12-
hydroxy-8,1 0, 14,17-eicosapentaenoic acid (12-HEPE) was the major lipoxygenase 
product in fish fed FO. 12-HEPE was significantly reduced in fish fed SO. The 
lipoxygenase products derived from whole blood stimulated with A23187 showed 
decreased levels of LTB5' 12-HEPE and 12-hydroxy-5,8,1 O,14-eicosatetraenoic 
acid (12-HETE) in fish fed SO compared to those fed FO. 
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Section 4. Dietary study B: Effects of increasing levels of dietary linoleic acid on 
tissue phospholipid fatty acid composition and eicosanoid production, with 
particular emphasis on cardiac tissue, in Atlantic salmon. 
4.1 Introduction 
A number of experiments with mammals have demonstrated that the PUFA 
composition of heart membrane lipids can be influenced by dietary fat intake 
(Swanson and Kinsella, 1986; Leonardi et al. 1987). The availability of PUFA for 
eicosanoid production is dictated by phospholipid fatty acid composition and 
therefore by dietary PUFA intake (Lands, 1989). Prostaglandins are important 
mediators of cardiac physiology and function (Karmazyn, 1985) and are also 
involved in muscle protein synthesis and degradation (Palmer, 1990). 
Alterations in cell membrane phospholipid fatty acid composition can also have 
direct effects on the activities of membrane bound enzymes and the control of ion 
permeability (Stubbs and Smith, 1984). In particular, the activity of the cardiac 
sarcoplasmic reticulum (SR) Ca2+-Mg2+ATPase (EC 3.6.1.4) can be influenced by 
the membrane n-3 and n-6 PUFA composition (Swanson ef al. 1989). In mice fed 
diets containing either menhaden or corn oil the Ca2+-Mg2+ ATPase activity was 
increased 6.5 fold by the latter dietary treatment. The SR regulates intracellular 
calcium concentrations during the contraction-relaxation cycle of the myocardium 
and the calcium-dependent ATPase in the SR membrane is fundamental in this 
regulatory process. Thus, dietary lipid modifications which influence this enzyme 
and thereby alter intracellular calcium concentrations can affect the severity of 
cardiac necrosis resulting from ischemia and reperfusion (Dhalla et al. 1978). 
In the previous dietary experiment it was established that the fatty acid 
composition of heart pho.spholipids could be markedly altered by feeding either fish 
oil or sunflower oil and that the fish fed the latter developed a severe 
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cardiomyopathy. In this experiment three diets were prepared containing the same 
protein and total lipid level (46 and 16% respectively) but with linoleic acid (LA) 
provided at 10, 25 and 45% of total dietary fatty acids. These percentages of LA 
were achieved using blends of fish oil, sunflower oil, safflower oil and grapeseed 
oil. The diet formulations are shown in Table 4.1.1. The fish oil and sunflower oil 
were as described in trial A and the blend of sunflower, safflower and grapeseed oil 
("Vitelma") was supplied by Vandermoortele (UK) Ltd., Hounslow, Middlesex. The 
fatty acid compositions of the diets are shown in Table 4.1.2. The main objectives 
were to investigate the effects of increasing levels of LA on the fatty acid 
compositions of the individual phospholipids of salmon hearts, to measure the 
activity of Ca2+-Mg2+ ATPase in cardiac SR and production of eicosanoids by 
isolated cardiac myocytes. In addition, the phospholipid fatty acid compositions of 
the active eicosanoid synthesising cells in blood and gills were measured. Products 
of cyclooxygenase (6-keto-PGF1 ex and TXB2) and lipoxygenases (LTB4' LTB5' 12-
HETE and 12-HEPE) were measured after stimulating the above cells with A23187, 
and in plasma. 
4.2 Experimental details, growth, mortality and histopathology 
Three hundred and thirty Atlantic salmon 81 smolts were obtained from Seafarm 
Kerry Ltd., Gairloch, Scotland and transferred to tanks at the 8.0.A.E.F.D. Fish 
Cultivation Unit, Aultbea, Wester Ross, Scotland. Fish were distributed randomly 
into three circular tanks of 1 m diameter containing 500 L of seawater which was 
supplied at a rate of 10 Umin. The tanks were subjected to natural photoperiod and 
the water temperature over the experimental period (May-October) varied from 9-
140C. Diets were supplied by automatic feeders, as described in trial A, and were 
adjusted initially to provide 20 g/kg biomass per day. After 8 weeks the ration was 
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increased to provide 25 g/kg biomass per day. Fish were weighed individually at the 
start and finish of the experiment and were weighed in bulk every 28 days as 
described in trial A. All three groups of fish increased in weight more than 3 fold 
over the 16 week experimental period (Table 4.2.1). The fish fed the intermediate 
. 
level of linoleic acid (25%) had significantly increased final weights compared to 
fish fed the two other dietary treatments and the fish fed the highest level of LA 
(50%) had the lowest final weights of all the dietary treatments. Mortalities were 
greater in fish fed the two highest levels of LA (16 and 17% respectively) than those 
fed 10% LA (10% mortality). The heart histopathological lesion involving thinning of 
the ventricular wall and active muscle necrosis was apparent in a small number 
(around 10%) of fish from each dietary treatment. The lack of myodegeneration in 
the highest LA group might be explained by the slower growth rate achieved by 
these fish compared to the fish used in the first experiment. The reason for the lower 
growth rate may have been that this experiment was performed in smaller tanks (1 m 
diameter instead of 2m) so that overcrowding may have retarded growth. However, 
it may be also be due to the fish being of different genetic stock compared to those 
used in trial A. 
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Table 4.1.1. Composition of diets (g/kg) 
Ingredient Diet 1 Diet 2 Diet 3 
(10% LA) (25% LA) (45% LA) 
Fishmeal1 650 650 650 
Starch2 150 150 150 
Fish oil3 78 40 
Sunflower oil4 22 60 
'Vitelma oil'S 100 
Vitamin mix6 10 10 10 
Mineral mix7 24 24 24 
a-cellulose 61.6 61.6 61.6 
Antioxidant mix8 0.4 0.4 0.4 
Choline chloride 4 4 4 
1 LT-94 Norwegian low temperature herring meal, Ewos Ltd., Bathgate, Scotland. 
2Passelli WA4 pre-cooked potato starch, Avebe (U.K.) Ltd., Ulceby, England. 
3FosoI, Seven Seas Ltd., Hull, U.K. 4Tesco Ltd., Cheshunt, U.K. 
5Vandermoortele (UK) Ltd., Hounslow, U.K. 
6Supplied (mg/kg diet): all-rae -a-tocopheryl acetate, 40; menadione, 10; ascorbic 
acid, 1000; thiamin hydrochloride, 10; riboflavin, 20; pyridoxine hydrochloride, 12; 
calcium pantothenate, 44; nicotinic acid, 150; biotin, 1; folic acid, 5; 
cyanocobalamin, 0.02; myo-inositol, 400; retinyl acetate 7.3; cholecalciferol, 0.06. 
7 Supplied (per kg diet): KH2P04, 22g; FeS04.7H20, 1.0g; ZnS04.7H20, 0.13g; 
MnS04.4H20, 52.8mg; CuS04.5H20, 12mg; CoS04.7H20, 2mg; KI, 2mg. 
80issolved in propylene glycol and contained (gIL): butylated hydroxyanisole, 60; 
propyl gallate, 60; citric acid, 40. 
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Table 4.1.2 Fatty acid composition of experimental diets 
Fatty acid Diet 1 Diet 2 Diet 3 
(10% LA) (25% LA) (45% LA) 
(Weight %) 
14:0 4.9 3.7 2.1 
16:0 12.6 11.9 9.8 
18:0 2.6 3.3 3.5 
16:1 n-7 4.0 3.3 2.4 
18:1 n-9 12.1 15.0 14.1 
18:1 n-7 2.1 1.8 1.5 
20:1n-9 7.2 5.5 2.8 
22:1n-11 9.9 6.7 3.0 
24:1 0.9 0.7 0.4 
18:2n-6 10.4 25.3 46.3 
20:2n-6 0.2 0.2 t 
20:3n-6 t t t 
20:4n-6 0.7 0.6 0.5 
18:3n-3 1.0 0.8 0.5 
18:4n-3 2.8 2.1 1.1 
20:5n-3 6.4 5.1 3.5 
22:5n-3 1.3 0.8 0.5 
22:6n-3 9.4 6.5 4.7 
Total n-6 11.9 26.4 46.8 
Total n-3 21.8 15.8 10.6 
n-3/n-6 1.8 0.6 0.2 
t = trace value < 0.05%. 
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Table 4.2.1. Growth parameters and mortalities during the 16 weeks experimental 
period. 
Parameter Diet 1 Diet 2 Diet 3 
(10% LA) (25% LA) (45% LA) 
Number of fish 110 110 110 
Mean initial weight 36.2 ± 8.1 36.4 ± 7.4 37.1 ±B.2 
Mean final weight 127.3 ± 20.5a 137.0 ± 22.7b 120.9 ± 19.2c 
Mortalities (number) 11 18 19 
Specific growth rate (%/d) 1.1 1.2 1.1 
Feed efficiency ratio 46.5 50.0 42.4 
Values for initial and final weights are mean ± SD. Values in the same row having 
different superscript letters are significantly different (P < 0.05). Specific growth rate 
calculated as %weight gain/day = (eGw-1) x 100, where Gw (daily growth rate) = 
InW1-lnWOff. (W1 = final weight, Wo = initial weight, T = time in days). Feed 
efficiency ratio = gain/feed x 100. 
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4.3 Cardiac sarcoplasmic reticulum Ca2 +. M 92 + ATPase activity 
The activity of the SR Ca2+-Mg2+ ATPase was not significantly affected by dietary 
treatment. There was no significant difference in total heart lipid content between 
different dietary treatments. Both these measurements are shown in Table 4.3.1. 
Table 4.3.1 Heart total lipid and sarcoplasmic reticulum Ca2+-Mg2+ ATPase activity 
in salmon fed diets containing increasing levels of linoleic acid. 
Diet 1 
(10% LA) 
Heart totallipid1 1.97±0.28 
Ca2+ -Mg2+ ATPase2 650.7 ± 161.3 
Diet 2 
(25% LA) 
2.07 ±0.11 
366.8 ± 100.7 
Diet 3 
(45% LA) 
2.16 ± 0.08 
488.9 ± 173.1 
1 Values are mean % Weight ± SD for four fish per dietary treatment. 
2nmol Pi released/min per mg protein. Values are mean ± SD for four sarcoplasmic 
reticula samples per dietary treatment. 
4.4 Fatty acid compositions of individual phospholipids from heart. 
The fatty acid compositions of heart phospholipids are shown in Tables 4.4.1-
4.4.4. In PC (Table 4.4.1), 18:2n-6, 20:2n-6, 20:3n-6 and total n-6 PUFA all 
increased significantly with increasing dietary intake of LA. Arachidonic acid was 
significantly increased in fish fed the highest dietary LA (45%), compared to those 
fed the lowest LA (10%). The fish fed the highest LA also had significantly reduced 
EPA, 22:5n-3 and total n-3 PUFA compared to those fed the lowest and intermediate 
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(25%) dietary LA. Total PUFA were significantly increased in fish fed the highest and 
intermediate level of LA compared to those fed the lowest LA. The n-3/n-6 PUFA 
ratio decreased significantly with increasing dietary LA and the 20:4/20:5 ratio was 
significantly increased in fish fed the highest dietary LA. 
The fatty acid compositions of heart PE are shown in Table 4.4.2. Total monoenes 
were significantly reduced in fish fed the highest dietary LA compared to those fed 
the lowest LA. The changes in n-6 PUFA were similar to those observed in PC but 
EPA was significantly reduced with each increase in dietary LA. 22:5n-3 was 
significantly reduced in fish fed the highest LA compared to those fed the lowest 
dietary LA. The n-3/n-6 ratio decreased significantly with increasing dietary LA, but 
the 20:4/20:5 ratio was significantly increased only in fish given the highest dietary 
LA. 
The fatty acid compositions of heart PS are shown in Table 4.4.3. Total saturates 
and 18:2n-6 were significantly increased in fish fed the intermediate and highest 
dietary LA compared with those fed the lowest LA. 20:2n-6, 20:3n-6 and total n-6 
PUFA were all significantly increased, while EPA was significantly decreased with 
increasing dietary LA. 22:5n-3 was significantly decreased in fish fed the 
intermediate and highest dietary LA and 22:6n-3 was significantly decreased in fish 
fed the the highest LA compared to those fed the lowest LA.The n-3/n-6 PUFA ratio 
was significantly decreased in fish fed the intermediate and highest dietary LA, but 
the 20:4/20:5 ratio was only increased in those fed the highest dietary LA. 
The fatty acid compositions of heart PI are shown in Table 4.4.4. LA, 20:3n-6 and 
total n-6 PUFA were all significantly increased and EPA and n-3/n-6 ratio were both 
significantly decreased with increasing dietary LA. 20:2n-6 was significantly 
increased in fish fed the intermediate and highest dietary LA compared to those fed 
the lowest LA. Total n-3 PUFA were significantly decreased and both AA and the 
20:4/20:5 ratio significantly increased in fish given the highest dietary LA. 
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Table 4.4.1. Fatty acid compositions of heart phosphatidylcholine from salmon fed 
increasing levels of dietary linoleic acid. 
Fatty acid 
Total saturates 
Total monoenes 
18:2n-6 
20:2n-6 
20:3n-6 
20:4n-6 
Total n-61 
20:5n-3 
22:5n-3 
22:6n-3 
Total n-32 
Total PUFA 
n-3/n-6 
20:4/20:5 
Diet 1 
(10% LA) 
45.9±4.8 
17.2 ± 2.0 
1.7± 0.2a 
0.2± 0.1a 
0.2±0.Oa 
1.3± 0.2a 
3.8 ± 0.6a 
4.4± 1.1a 
0.6± 0.1a 
20.9± 1.1 
25.5 ± 1.8a 
29.1 ±2.0a 
7.5± 1.2a 
0.3± 0.1a 
Diet 2 
(25% LA) 
(Weight %) 
43.2±2.9 
16.2±0.9 
4.0± 0.3b 
0.4 ± 0.1 b 
0.5 ± 0.1 b 
1.6±0.1ab 
7.2 ± 0.2b 
3.9 ± 0.4a 
0.5 ± 0.1 ab 
22.6±3.1 
27.2 ± 3.5a 
34.5 ± 3.4b 
4.0 ± 0.7b 
0.4 ± O.Oa 
Results are mean ± SO for 4 fish per treatment. 
1 Includes 18:3n-6, 22:4n-6 and 22:5n-6. 
21ncludes 18:3n-3, 18:4n-3 and 20:4n-3. 
Diet 3 
(45% LA) 
47.3 ±2.3 
14.7 ± 1.3 
7.2 ± 0.6C 
0.6 ± 0.1c 
1.1 ± 0.1c 
2.0 ± O.4b 
11.6 ± O.4c 
2.2 ± 0.3b 
0.4 ± 0.1 b 
17.8 ± 0.7 
20.8 ± 0.6b 
33.1 ± 1.0b 
1.7 ± 0.2c 
0.9 ± 0.3b 
Values in the same row with different superscript letters are significantly different 
(P < 0.05). 
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Table 4.4.2 Fatty acid compositions of heart phosphatidylethanolamine from salmon 
fed increasing levels of linoleic acid 
Diet 1 Diet 2 Diet 3 
Fatty acid (10% LA) (25% LA) (45% LA) 
(Weight %) 
Total saturates 30.3 ± 1.9 31.7±3.0 30.5± 1.1 
Total monoenes 10.2 ± O.4a 9.1 ± 1.7ab 7.8 ± 0.2b 
18:2n-6 2.5±0.1a 5.3± 0.9b 7.9 ± 0.9c 
20:2n-6 0.2±0.1a 0.4 ± O.Ob 0.7±0.1c 
20:3n-6 0.2±0.1a 0.5±0.1 b 1.1 ± 0.3C 
20:4n-6 1.6 ± 0.2a 1.7 ± 0.2a 2.5 ± 0.3b 
Total n-61 5.1 ± O.4a 8.7 ± 1.0b 13.5 ± 1.4c 
20:5n-3 3.4 ± 0.1a 2.9 ± 0.2b 2.0 ± 0.3c 
22:5n-3 2.2±0.1a 2.0 ± O.4ab 1.6 ± 0.3b 
22:6n-3 41.8± 1.1 36.9±3.9 37.4± 1.3 
Total n-32 47.8 ± 1.2 41.9± 4.3 42.2 ± 1.6 
Total PUFA 52.9± 1.0 51.0 ± 3.8 55.6± 1.3 
n-3/n-6 9.5±0.8a 4.6 ± O.7b 3.2 ± O.4c 
20:4/20:5 0.5±0.1 a 0.6 ± 0.1a 1.3 ± 0.3b 
Results are mean ± SD for 4 fish per treatment. 1 Includes 18:3n-6, 22:4n-6 and 
22:5n-6. 21ncludes 18:3n-3, 18:4n-3 and 20:4n-3. 
Values in the same row with different superscript letters are significantly different 
(P < 0.05). 
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Table 4.4.3. Fatty acid compositions of heart phosphatidylserine from salmon fed 
increasing levels of linoleic acid. 
Fatty acid 
Total saturates 
Total monoenes 
18:2n-6 
20:2n-6 
20:3n-6 
20:4n-6 
Total n-61 
20:4n-3 
20:5n-3 
22:5n-3 
22:6n-3 
Total n-32 
Total PUFA 
n-3/n-6 
20:4/20:5 
Diet 1 
(10% LA) 
38.1 ±4.5a 
10.2 ± 0.7a 
3.0±0.6a 
0.3±0.1 a 
0.3± 0.1a 
0.4± 0.1 
5.3±0.8a 
0.5±0.1 a 
1.2 ± 0.1a 
2.2±0.3a 
34.8±3.9 
38.9 ± 4.1a 
44.2±3.5 
7.6 ± 1.8a 
0.4 ± 0.1a 
Diet 2 
(25% LA) 
(Weight %) 
46.5 ± 3.5b 
8.5 ± 0.9b 
5.0 ± 0.7b 
0.5 ± 0.1 b 
0.6 ± 0.2b 
0.4 ± 0.1 
7.6 ± 0.9b 
tb 
0.9 ± 0.1 b 
1.6 ± 0.2b 
31.7±2.4 
34.3 ± 2.2ab 
41.9±2.6 
4.6 ± 0.6b 
0.4 ± 0.1a 
Diet 3 
(45% LA) 
46.6 ± 1.8b 
5.7 ±0.5c 
6.4 ± 1.1 c 
0.8 ± 0.1c 
1.2 ± 0.2c 
0.5 ± 0.1 
9.8 ± 1.2c 
tb 
0.5 ± 0.1c 
1.4 ± 0.2b 
29.9 ± 1.5 
31.8±1.7b 
41.6± 1.7 
3.3 ± 0.5c 
1.2 ± 0.5b 
Results are mean ± SD for 4 fish per treatment. 1 Includes 18:3n-6, 22:4n-6 and 
22:5n-6. 21ncludes 18:3n-3, 18:4n-3 and 20:4n-3. 
Values in the same row with different superscript letters are significantly different 
(P < 0.05). t = trace value < 0.05%. 
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Table 4.4.4. Fatty acid compositions of heart phosphatidylinositol from salmon fed 
increasing levels of dietary linoleic acid. 
Diet 1 
Fatty acid (10% LA) 
Total saturates 35.9 ± 4.5 
Total monoenes 9.6 ± 0.6a 
18:2n-6 2.6±0.2a 
20:2n-6 ta 
20:3n-6 0.5±0.1a 
20:4n-6 12.2±0.9a 
Total n-61 16.5 ± 1.9a 
20:4n-3 0.5±0.1a 
20:5n-3 6.6±0.7a 
22:5n-3 1.0 ± 0.4 
22:6n-3 25.9±5.0 
Total n-32 34.2 ± 5.Sa 
Total PUFA 50.7±5.6 
n-3/n-6 2.1 ± O.4a 
20:4/20:5 1.9 ± 0.3a 
Diet 2 
(25% LA) 
Weight % 
37.2± 1.2 
7.9 ± O.4b 
5.3 ± 0.5b 
0.3 ± 0.1 b 
0.9 ± 0.1 b 
13.3 ± 0.6a 
20.9± 1.2b 
0.4 ± 0.1a 
5.3 ± 0.3b 
0.7± 0.1 
25.7±1.7 
32.2 ± 2.0a 
53.0±2.9 
1.6 ± 0.1 b 
2.6 ± 0.1 a 
Diet 3 
(45% LA) 
40.3± 1.6 
5.9 ± 0.3c 
6.1 ± 0.6c 
0.3 ± 0.1 b 
1.3 ± 0.1c 
14.9 ± 0.8b 
23.4 ± 0.5c 
tb 
3.0 ± 0.6c 
0.6±0.2 
21.8 ± 0.6 
25.4 ± 0.5b 
48.8 ±0.3 
1.1 ± O.1c 
5.1 ± 1.2b 
Results are mean ± SD for 4 fish per treatment. 1 Includes 18:3n-6, 22:4n-6 and 
22:5n-6. 21ncludes 18:3n-3, 18:4n-3 and 20:4n-3. 
Values in the same row with different superscript letters are significantly different 
(P < 0.05). 
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4.5 Production of eicosanoids by isolated cardiac myocytes 
The amounts of 6-ketoPGF1 a and TXB2 produced by isolated cardiac myocytes 
stimulated with A23187 are given in Table 4:5:1. 6-KetoPGF1a concentration was 
not significantly affected in isolated cardiac myocytes as a result of increasing 
dietary LA. TXB2 production was increased with increasing dietary LA, but was only 
significant at the highest level of dietary LA. 
Table 4:5: 1. Production of eicosanoids by isolated cardiac myocytes from salmon 
fed increasing levels of linoleic acid. 
Eicosanoid 
6-ketoPGF1 a 
Diet 1 
(10% LA) 
363.3 ± 76.5 
194.8 ± 35.6a 
Diet 2 Diet 3 
(25% LA) (45% LA) 
(pg/mg protein) 
531.7 ± 71.5 533.9 ± 290.1 
238.0 ± 42.0a 439.4 ± 71.9b 
Values are mean ± SD for three cardiac myocyte preparations per treatment. Values 
in the same row with different superscript letters are significantly different (P < 0.05). 
4:6 Fatty acid compositions of blood leucocyte phospholipids 
The fatty acid compositions of leucocyte phospholipids are summarised in Tables 
4:6: 1 - 4:6:4. In PC (Table 4:6: 1) 18:2n-6, 20:2n-6, 20:3n-6, 20:4n-6 and total n-6 
PUFA all increased with increasing dietary intake of LA. 80th EPA and total n-3 
PUFA decreased with increasing LA intake. Consequently, the n-3/n-6 PUFA ratio 
decreased and the 20:4/20:5 ratio increased with increasing dietary LA. 
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Table 4:6: 1 Fatty acid compositions of leucocyte phosphatidylcholine from salmon 
given increasing levels of dietary linoleic acid 
Diet 1 Diet 2 Diet 3 
Fatty acid (10% LA) (25% LA) (45% LA) 
Weight % 
Total saturates 38.9 36.6 38.3 
Total monoenes 26.6 23.4 23.6 
18:2n-6 3.1 5.5 8.4 
20:2n-6 0.4 1.1 1.3 
20:3n-6 0.4 1.1 1.8 
20:4n-6 2.7 4.2 4.9 
Total n-61 7.4 12.8 17.4 
20:5n-3 8.1 5.3 4.7 
22:5n-3 0.9 0.7 0.7 
22:6n-3 11.7 10.6 11.5 
Total n-32 21.6 17.3 17.3 
Total PUFA 29.0 30.1 34.7 
n-31n-6 2.9 1.4 1.0 
20:4/20:5 0.3 0.8 1.0 
Results were obtained from pooled leucocyte samples from 6 fish per dietary 
treatment (see Materials and Methods for details). 
1 Includes 18:3n-6, 22:4n-6 and 22:Sn-6. 21ncludes 18:3n-3, 18:4n-3 and 20:4n-3. 
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Table 4:6:2. Fatty acid compositions of leucocyte phosphatidylethanolamine from 
salmon given increasing levels of dietary linoleic acid. 
Diet 1 Diet 2 Diet 3 
Fatty acid (10% LA) (25% LA) (45% LA) 
(Weight %) 
Total saturates 21.2 20.3 20.6 
Total monoenes 22.9 17.6 14.0 
18:2n-6 5.6 9.5 12.0 
20:2n-6 0.5 1.0 1.2 
20:3n-6 0.3 0.9 1.2 
20:4n-6 3.4 5.6 6.5 
Total n-61 10.2 17.6 21.6 
20:5n-3 3.3 2.6 2.0 
22:5n-3 0.9 1.0 0.8 
22:6n-3 29.2 29.1 29.0 
Total n-32 34.3 33.4 32.0 
Total PUFA 44.5 51.0 53.6 
n-3/n-6 3.4 1.9 1.5 
20:4/20:5 1.0 2.2 3.3 
Results were obtained from pooled leucocyte samples from 6 fish per dietary 
treatment (see Materials and Methods for details). 
1 Includes 18:3n-6, 22:4n-6 and 22:5n-6. 21ncludes 18:3n-3, 18:4n-3 and 20:4n-3. 
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Broadly similar changes occurred in the fatty acid compositions of leucocyte PE and 
PS (Tables 4:6:2 and 4:6:3). The fatty acid compositon of leucocyte PI was less 
affected by dietary LA intake but AA content was increased with increasing LA 
(Table 4:6:4). In general, the saturated and monoenoic fatty acids in leucocyte 
phospholipids reflected dietary intake. 
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Table 4:6:3. Fatty acid compositions of leucocyte phosphatidylserine from salmon 
given increasing levels of dietary linoleic acid. 
Diet 1 Diet 2 Diet 3 
Fatty acid (10% LA) (25% LA) (45% LA) 
Weight % 
Total saturates 44.7 50.9 41.8 
Total monoenes 19.3 13.0 17.6 
18:2n-6 1.5 1.7 4.7 
20:2n-6 0.3 0.4 0.7 
20:3n-6 0.2 0.5 0.6 
20:4n-6 0.8 1.7 4.7 
Total n-61 3.5 5.2 9.4 
20:5n-3 1.0 0.7 0.4 
22:5n-3 1.3 1.8 1.0 
22:6n-3 21.8 23.7 21.9 
Total n-32 24.4 26.3 23.3 
Total PUFA 27.9 31.5 32.7 
n-31n-6 7.0 6.1 2.5 
20:4/20:5 0.8 2.4 6.8 
Results were obtained from pooled leucocyte samples from 6 fish per dietary 
treatment (see Materials and Methods for details). 
1 Includes 18:3n-6, 22:4n-6 and 22:5n-6. 21ncludes 18:3n-3, 18:4n-3 and 20:4n-3. 
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Table 4:6:4. Fatty acid composition of leucocyte phosphatidylinositol from salmon 
given increasing levels of dietary linoleic acid 
Diet 1 Diet 2 Diet 3 
Fatty acid (10% LA) (25% LA) (45% LA) 
Weight % 
Total saturates 40.3 46.3 47.1 
Total monoenes 22.4 10.7 6.S 
1S:2n-6 2.0 1.6 2.7 
20:2n-6 0.2 0.5 0.5 
20:3n-6 0.2 0.4 0.6 
20:4n-6 22.S 32.0 36.9 
Total n-61 25.5 34.5 40.7 
20:5n-3 0.5 0.5 0.4 
22:5n-3 0.3 t t 
22:6n-3 2.1 3.3 2.9 
Total n-32 3.5 3.S 3.3 
Total PUFA 29.0 38.3 44.0 
n-3/n-6 0.14 0.11 O.OS 
20:4/20:5 45.6 64.0 92.3 
Results were obtained from pooled leucocyte samples from 6 fish per dietary 
treatment (see Materials and Methods for details). 
1 Includes 1S:3n-6, 22:4n-6 and 22:5n-6. 21ncludes 1S:3n-3, 1S:4n-3 and 20:4n-3 
t = trace value < 0.05%. 
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4:7 Fatty acid compositions of gill phospholipids 
The fatty acid compositions of gill phospholipids are shown in Table 4:7: 1 - 4:7:4. In 
PC (Table 4:7: 1) 18:2n-6, 20:2n-6, 20:3n-6 and total n-6 PU FA were all increased 
significantly with increasing dietary LA, but AA and the 20:4/20:5 ratio were only 
increased significantly in the fish given the highest dietary LA. EPA, total n-3 PUFA 
and n-3/n-6 PUFA ratio were significantly reduced with increasing dietary LA while 
DHA was significantly reduced in fish given 25 and 45% LA. A very similar pattern of 
changes was observed in gill PE (Table 4:7:2) but EPA and total n-3 PUFA were 
significantly reduced only in fish given the highest dietary LA, while DHA was 
unaffected. Gill PS fatty acid composition (Table 4:7:3) showed changes similar to 
those in PE except that 18:2n-6, 20:2n-6 and 20:3n-6 were only significantly 
increased in fish given the highest dietary level of LA. The n-3/n-6 PUFA ratio was 
significantly decreased only in fish given the highest dietary LA. In gill PI (Table 
4:7:4) 18:2n-6, 20:2n-6, 20:3n-6, total n-6 PUFA and the 20:4/20:5 ratio were all 
increased significantly with increasing dietary LA, while total PUFA were 
significantly increased only in fish fed the highest dietary LA. EPA, total n-3 PUFA 
and n-3/n-6 PUFA ratio were all significantly reduced with increasing dietary LA, 
while 22:5n-3 and DHA were significantly reduced in fish given 25 and 45% LA. 
94 
Table 4:7: 1 Fatty acid compositions of gill phosphatidylcholine from salmon fed 
increasing levels of dietary linoleic acid. 
Diet 1 Diet 2 Diet 3 
Fatty acid (10% LA) (2S% LA) (4S% LA) 
(Weight %) 
Total saturates 41.8 ±2.6 43.1 ± 0.9 44.1 ±2.2 
Total monoenes 26.1 ± 1.7a 26.6 ± 1.5a 23.7 ± 1.0b . 
18:2n-6 2.4±0.2a 5.0±0.3b 8.9 ± 0.8b 
20:2n-6 0.3±0.1a 0.7 ±0.1 b 1.2 ± 0.2c 
20:3n-6 0.2 ± 0.1a 0.6 ± 0.1 b 1.S ± 0.3c 
20:4n-6 1.3 ± 0.2a 1.5 ± 0.3a 2.5 ± 0.7b 
Total n-61 4.8 ± 0.6a 8.3 ± 0.6b 14.4 ± 1.Sc 
20:Sn-3 3.7±0.3a 2.9 ± 0.7a 1.7 ± 0.2b 
22:5n-3 0.5±0.0 0.4 ± 0.1 0.4 ± 0.1 
22:6n-3 15.7± 1.7a 13.6 ± 0.6b 12.1 ± 0.5b 
Total n-32 20.1 ± 1.7a 17.1 ± 1.2a 14.2 ± 0.6b 
Total PUFA 24.9± 1.8 25.4 ± 1.8 28.6±2.2 
n-3/n-6 4.3±0.6a 2.1 ± O.Ob '1.0±0.1c 
20:4/20:5 0.4 ± 0.1 a O.S ± 0.1a 1.S ± o.sb 
Values are means ± SO for 4 fish per dietary treatment. 
1 Includes 18:3n-6, 22:4n-6 and 22:Sn-6. 21ncludes 18:3n-3, 18:4n-3 and 20:4n-3. 
Values in the same row having different superscript letters are significantly different. 
SD of < O.OS is tabulated as 0.0. 
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Table 4:7:2. Fatty acid compositions of gill phosphatidylethanolamine from salmon 
given increasing levels of dietary linoleic acid. 
Fatty acid 
Total saturates 
Total monoenes 
18:2n-6 
20:2n-6 
20:3n-6 
20:4n-6 
Total n-61 
20:5n-3 
22:5n-3 
22:6n-3 
Total n-32 
Total PUFA 
n-3/n-6 
20:4/20:5 
Diet 1 
(10% LA) 
25.7±0.8 
14.2 ± 0.9a 
2.8 ±0.3a 
0.4 ± 0.1a 
0.2 ± 0.1 a 
2.6 ±0.5a 
6.6 ± 1.0a 
3.2±0.6a 
0.8 ±0.1 
36.2± 1.5 
40.4 ± 1.2a 
47.0±1.3 
6.2 ± 1.1a 
0.8±0.Oa 
Diet 2 
(25% LA) 
25.4 ± 1.9 
13.2 ± 0.8a 
5.9±0.6b 
0.8 ± 0.2b 
0.6 ± 0.1 b 
2.9 ± 0.4a 
10.9±1.1b 
2.9 ± O.4a 
0.8 ±0.1 
32.6±2.9 
36.3 ± 2.7ab 
47.2±2.3 
3.4 ± 0.5b 
1.0 ± 0.2a 
Values are means ± SD for 4 fish per dietary treatment. 
Diet 3 
(45% LA) 
27.3±2.0 
10.8 ± 0.6b 
8.4 ± 0.6c 
1.2 ± 0.2c 
1.2 ± 0.2c 
5.1 ± 1.3b 
16.7 ± 1.7c 
2.0 ± 0.3b 
0.6 ± 0.1 
31.6±2.7 
34.2 ± 3.1 b 
51.5 ± 3.3 
2.0 ± 0.2c 
2.7 ± 1.0b 
1 Includes 18:3n-6, 22:4n-6 and 22:5n-6. 21ncludes 18:3n-3, 18:4n-3 and 20:4n-3. 
Values in the same row having different superscript letters are significantly different. 
SD of < 0.05 is tabulated as 0.0. 
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Table 2:7:3. Fatty acid compositions of gill phosphatidylserine from salmon given 
increasing levels of dietary linoleic acid . 
Fatty acid 
Total saturates 
Total monoenes 
18:2n-6 
20:2n-6 
20:3n-6 
20:4n-6 
Total n-61 
20:5n-3 
22:5n-3 
22:6n-3 
Total n-32 
Total PUFA 
n-31n-6 
20:4/20:5 
. Diet 1 
(10% LA) 
32.8 ± 1.5a 
14.2 ± 1.5a 
1.9 ± 0.2a 
0.4 ± 0.1a 
0.5 ± 0.1a 
0.9±0.1a 
5.4 ± 0.2a 
0.9 i 0.1 a 
1.3 ± 0.1 
33.5 ± 1.1 
36.6 ± 1.3 
42.0 i 1.5 
6.7iO.2a 
0.7 i 0.2a 
Oiet2 
(25% LA) 
33.6 ± 2.8ab 
11.7 ± 1.0b 
2.3 ± 0.3ab 
0.7 ± 0.2a 
0.7 ± 0.2ab 
1.5 ± 0.6ab 
6.3 i 0.7a 
0.9 i 0.1 a 
1.3iO.2 
35.0i3.3 
37.6±3.5 
43.9i3.8 
6.0 i 0.6a 
1.6 ± O.Sa 
Values are means ± SO for 4 fish per dietary treatment. 
Diet 3 
(45% LA) 
36.2 ± 0.8b 
9.0 ± 0.4c 
2.9 ± O.4b 
1.1 i 0.1 b 
1.1 ± 0.2b 
1.6±0.2b 
8.1 i 0.6b 
0.6 i 0.1 b 
1.1 ± 0.1 
32.1 iO.3 
33.8 ± 0.1 
41.9 i 0.6 
4.2 i 0.4 
2.8 ± O.4b 
1 Includes 18:3n-6, 22:4n-6 and 22:Sn-6. 21ncludes 18:3n-3, 18:4n-3 and 20:4n-3. 
Values in the same row having different superscript letters are significantly different. 
SD of < 0.05 is tabulated as 0.0. 
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Table 4.7.4. Fatty acid compositions of gill phosphatidylinositol from salmon given 
increasing levels of dietary linoleic acid. 
Fatty acid 
Total saturates 
Total monoenes 
18:2n-6 
20:2n-6 
20:3n-6 
20:4n-6 
Total n-61 
20:Sn-3 
22:Sn-3 
22:6n-3 
Total n-32 
Total PUFA 
n-3/n-6 
20:4/20:S 
Diet 1 
(10% LA) 
3S.6± 1.0 
16.0 ± 0.7a 
2.2±0.2a 
0.3 ±0.1a 
O.S ±0.1a 
8.2±0.3 
12.S ± 0.3a 
2.7±0.2a 
1.2 ±0.2a 
17.2±0.4a 
22.2 ± 0.1a 
34.7±O.2a 
1.8 ± 0.1a 
3.0±0.2a 
Diet 2 
(2S% LA) 
Weight % 
38.S ±2.4 
19.7 ± 1.2b 
4.7 ± 0.5b 
O.S ± 0.1a 
1.1 ± 0.1 b 
8.0±0.8 
17.S ± 0.8b 
2.0 ± 0.2b 
0.7 ± 0.1 b 
14.S ± 0.6b 
18.2 ± 0.4b 
3S.7 ± O.4a 
1.0 ± 0.1 b 
4.1 ± 0.3b 
Values are means ± SD for 4 fish per dietary treatment. 
Diet 3 
(4S% LA) 
36.4±0.7 
18.8 ± 0.2 
6.8 ± 0.3c 
1.0 ± 0.1 b 
1.S ± 0.1 c 
9.0±0.3 
20.3 ± 0.7c 
1.2 ± 0.2c 
O.S ± 0.1 b 
14.6 ± 0.3b 
17.2 ± 0.4c 
37.S ± 0.9b 
0.8 ± 0.1 b 
7.9±1.1c 
1 Includes 18:3n-6, 22:4n-6 and 22:Sn-6. 21ncludes 18:3n-3, 18:4n-3 and 20:4n-3. 
Values in the same row having different superscript letters are significantly different. 
SO of < O.OS is tabulated as 0.0. 
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4.8 Plasma eicosanoid concentrations and production of eicosanoids 
following stimulation with A23187 in whole blood and gill cells. 
The concentrations of plasma 6-keto-PGF 1 ex and TXB2 are shown in Table 4.8.1. 
Both cyclooxygenase products were significantly increased in plasma of salmon fed 
the highest dietary level of LA. However, while 6-keto-PGF 1 ex was increased around 
1.5-fold, TXB2 was increased over 3.5-fold. The production of eicosanoids by whole 
blood stimulated with the calcium ionophore A23187 is shown in Table 4.8.2. LTB4, 
12-HETE, TXB2 and the 12-HETE/12-HEPE ratio were all significantly increased, 
whereas 12-HEPE was significantly reduced in fish fed the highest dietary LA. While 
LTB5 was not significantly affected, the ratio of LTB4/LTB5 was significantly 
increased in fish given the highest dietary LA. 
The production of eicosanoids by isolated gill cells stimulated with A23187 is 
shown in Table 4.8.3. The production of both 12-HEPE and 12-HETE was 
significantly reduced with increasing dietary linoleic acid although the ratio 12-
HETEl12-HEPE indicated that the EPA-derived species was more affected. The 
production of a DHA-derived 12-lipoxygenase product, eluting immediately before 
12-HETE on HPLC, was confirmed by labeling gill cells with [1_14C]-DHA. The peak 
detected by absorbance at 235 nm co-eluted with the maximum radioactive peak 
when eicosanoids derived from gill cells labeled with [1_14C]-DHA were analysed 
by HPLC. This was presumed to be the 12-lipoxygenase product of DHA, 14-
hydroxy-4, 7, 10, 13, 16, 19-docosahexaenoic acid (14-HDHE). Production of the 
putative 14-HDHE was also decreased with increasing dietary LA. Production of 
TXB2 by isolated gill cells was not affected by increasing dietary LA but the amount 
of 6-keto-PGF1ex was significantly reduced. 
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Table 4.8.1. Plasma 6-keto-PGF1 a and TXB2 concentrations in salmon given 
increasing dietary levels of linoleic acid. 
Eicosanoid 
6-keto-PGF 1 a 
Diet 1 
(10% LA) 
1103 ± 84a 
402 ± 130a 
Diet 2 
(25% LA) 
pg/ml plasma 
100S ± 177a 
293 ± S4a 
Values are mean ± SD for 4 fish per treatment. 
Diet 3 
(45% LA) 
1664 ± 323b 
1418 ± 1083b 
Values in the same row with different superscript letters are significantly different (P 
< O.OS). 
Table 4.8.2. Eicosanoid production by whole blood of salmon fed increasing dietary 
linoleic acid, after stimulation with calcium ionophore A23187. 
Eicosanoid 
LTB4 
LTBS 
LTB4/LTBS 
12-HETE 
12-HEPE 
12-HETEl12-HEPE 
TXB2 
Diet 1 
(10% LA) 
54.8 ± 21.8a 
38.3 ± 10.2 
1.44 ± 0.60a 
SS.6±7.1a 
40.5± 6.8a 
1.69 ± 0.39a 
36.4 ± 8.7a 
Footnotes as described in Table 4.8.1. 
Diet 2 
(25% LA) 
(ng/ml blood) 
75.3 ± 15.0ab 
28.7±8.3 
2.85 ± 0.99ab 
53.3 ± 14.1a 
24.7 ± 3.9b 
2.20 ± 0.60ab 
53.1 ± 19.9a 
Diet 3 
(45% LA) 
101.4 ± 27.3b 
29.2±2.2 
3.53 ± 1.17b 
92.7 ± 8.8b 
20.8 ± 3.4b 
3.81 ± 1.51b 
136.5 ± 41.1 b 
100 
Table 4.8.3. Eicosanoid production by isolated gill cells from salmon given diets with 
increasing linoleic acid, after stimulation with calcium ionophore A23187. 
Diet 1 Diet 2 
Eicosanoid (10% LA) (25% LA) 
nglmg protein 
12-HEPE 48.8± 11.3a 22.1 ± 5.9b 
12-HETE 17.7 ± 4.9a 13.1 ± 2.5ab 
12-HETEl12-HEPE 0.33 ± 0.04a 0.64 ± 0.16b 
14-HDHE 43.1 ± 15.4a 19.7 ± 4.4b 
6-keto-PGF 1 a 0.23 ± 0.06a NO 
TXB2 0.30 ± 0.14 NO 
Values are mean ± SO for 4 fish per treatment. 
Diet 3 
(45% LA) 
5.9 ± 2.1c 
6.9 ± 3.Sb 
0.98 ± 0.15c 
10.8 ± 4.4c 
0.14 ± 0.06b 
0.30±0.12 
Values in the same row with different superscript letters are significantly different (P 
< 0.05). ND = not determined. 
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4.9. Summary. 
1. Diets containing linoleic acid at 10, 25 and 45% of total dietary fatty acids were 
fed to three groups of post-smolt Atlantic salmon (Sa/mo safar) for 16 weeks. 
Cardiac lesions, similar to those described in the previous experiment, were 
recorded in a small number of individuals from all dietary treatments although 
number of fish and lesion severity was lower than in the first study. While the reason 
for this is not clear it may be due to the fish being of different genetic stock 
compared to those used in trial A. The fish fed the intermediate level of linoleic acid 
(25%) had significantly increased final weights compared to fish fed the two other 
dietary treatments and the fish fed the highest level of LA (50%) had the lowest final 
weights of all the dietary treatments. 
2. Incorporation of linoleic acid into membrane phospholipids of heart, gill and 
blood leucocytes increased in response to dietary intake. In addition to linoleic acid 
individual phospholipids from the above tissues showed increased 20:2n-6 (2 to 4-
fold), 20:3n-6 (2 t07-fold) and 20:4n-6 (1 t03-fold) and decreased 20:5n-3 (up to 2.3 
fold) in response to increasing dietary linoleic acid. The ratio of n-3/n-6 PUFA 
decreased (up to 4.3-fold) in heart, gill and blood leucocyte phospholipids and the 
20:4n-6/20:5n-3 ratio increased (up to 8.5-fold) in response to increasing dietary 
linoleic acid. 
3. These changes in eicosanoid precursors were reflected in significantly increased 
plasma concentrations of 6-keto-PGF1 (l and TXB2 in salmon fed the highest dietary 
level of linoleic acid. In isolated cardiac myocytes, stimulated with A23187, TXB2 
production was increased in salmon fed the highest dietary level of linoleic acid. In 
whole blood stimulated with A23187, LTB4' 12-HETE and TXB2 were significantly 
increased and 12-HEPE significantly decreased in response to increasing dietary 
linoleic acid. In isolated gill cells stimulated with A23187, 12-HEPE, 12-HETE, 14-
HDHE and TXB2 were all decreased in response to increasing dietary linoleic 
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acid, although the ratio of 12-HETEl12-HEPE was increased. The activity of heart 
sarcoplasmic reticulum Ca2+ -Mg2+ ATPase was not affected by dietary linoleic 
acid. 
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Section 5. Dietary study C: Effects of diets rich in linoleic acid or a-linolenic 
acid on phospholipid fatty acid compositions, development of cardiac lesions, 
phospholipase activity and eicosanoid production in Atlantic salmon (Sa/mo salar). 
5.1 Introduction 
The essential fatty acids, linoleic acid and linolenic acid (18:3n-3), are the 
precursors of the long-chain n-6 and n-3 species which are important components 
of the phospholipid bilayer of cell membranes. It is generally accepted that both the 
n-6 and n-3 fatty acids are metabolised by the same enzyme systems of sequential 
desaturation and elongation to yield their long-chain products (Sprecher, 1981). In 
these pathways the desaturation steps are generally rate-limiting while elongation 
is rapid (Horrobin, 1991), and thus competition between substrate fatty acids at 
desaturase binding sites will determine the nature of the resulting PUFA and 
ultimately the composition of cellular membranes. While an excess of n-6 PUFA may 
inhibit metabolism of 18:3n-3, in competitive terms, the n-3 PUFA are much more 
potent inhibitors of n-6 PUFA metabolism than vice versa although the relative 
concentrations of the two substrates will also determine the resulting products 
(Garcia and Holman, 1965). 
Evidence suggests that M is the preferred eicosanoid substrate in fish (Tocher 
and Sargent, 1987; Anderson et al. 1981) although the presence of EPA can reduce 
production of AA-derived eicosanoids in fish cells in culture (Bell et al. 1994b). EPA, 
DHA and 18:3n-3 can act directly to inhibit cyclooxygenase activity in mammals, 
thereby reducing production of AA-derived prostaglandins and thromboxanes 
(Lands et al. 1973; Garg et a/. 1990). A number of recent studies have suggested 
that feeding oils rich in 18:3n-3 can reduce production of AA-derived eicosanoids by 
increasing levels of EPA in membrane phospholipids (Hwang et al. 1988; Olomu 
and Baracos, 1991). 
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In the first study (trial A), salmon fed diets rich in 18:2n-6 developed a severe 
cardiomyopathy which caused extensive thinning of the ventricular muscle and 
active necrosis in both the atrium and ventricle. Salmon fed high dietary levels of 
18:2n-6 also showed increased levels of AA-derived eicosanoids in plasma and 
from stimulated cell preparations from heart, gill and whole blood. In the present 
study the objective was to investigate the metabolism of 18:2n-6 and 18:3n-3 in 
salmon fed diets containing either sunflower oil (SO), linseed oil (LO) or fish oil (FO) 
by measuring phospholipid fatty acid compositions in heart, liver, gill and blood 
leucocytes. The fatty acid compositions of diets are shown in Table 5.1.1. 
Eicosanoids, derived from both cyclooxygenase and lipoxygenase, would be 
measured in plasma and stimulated gill cells, cardiac myocytes and blood 
leucocytes. The occurrence of cardiac pathology is also be recorded as well as the 
measurement of cardiac phospholipase A activity. 
5.2 Experimental details, growth, mortality and cardiac pathology. 
Three hundred and thirty Atlantic salmon S 1 smolts were obtained from 
theS.O.A.E.F.D. Fish Cultivation Unit, Aultbea, Wester Ross. Fish were distributed 
randomly into three circular tanks of 1 m diameter containing 500 L of seawater 
supplied at a rate of 10 Umin. After 5 weeks the fish were transferred to 2 m x 2 m 
square tanks containing 2000 L of seawater supplied at a rate of 26 Umin. The 
tanks were subjected to natural photoperiod and the water temperature over the 
experimental period (August-November) varied from 10-150 C. The diets were 
supplied by automatic feeders as described in the previous experiments and were 
adjusted to supply 28 gll<g biomass initially and were adjusted to provide 20 g/kg 
biomass after 4 weeks. Fish were weighed individually at the start and finish of the 
experiment and were bulk weighed every 28 days as described in the previous 
trials. The diets contained 47% protein and 16% lipid with the latter being supplied 
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Table 5.1.1. Fatty acid composition of experimental diets. Values are weight % 
Fatty acid FO diet SO diet LOdiet 
14:0 6.6 1.8 1.8 
16:0 14.8 9.5 9.1 
18:0 2.4 4.3 3.5 
Total saturates 1 24.6 15.9 14.9 
16:1n-7 5.1 2.0 2.0 
18:1n-9 9.7 17.8 17.4 
18:1n-7 2.0 1.0 1.0 
20:1n-9 10.5 3.1 3.1 
22:1n-11 16.6 4.8 4.4 
24:1 1.0 0.6 0.5 
Total monoenes2 45.2 29.5 28.7 
18:2n-6 1.4 40.3 12.2 
18:3n-6 0.2 0.1 t 
20:2n-6 0.3 0.1 0.1 
20:3n-6 0.1 t t 
20:4n-6 0.6 0.5 0.5 
Total n-63 2.8 41.1 12.9 
18:3n-3 1.3 0.5 31.8 
18:4n-3 3.1 1.0 0.9 
20:4n-3 0.7 0.2 0.2 
20:5n-3 6.5 3.6 3.4 
22:5n-3 0.9 0.5 0.5 
22:6n-3 8.8 4.9 4.5 
Total n-3 21.3 10.7 41.3 
Total PUFA 25.0 51.8 54.2 
n-3/n-6 7.6 0.3 3.4 
1 Includes 15:0,17:0,20:0 and 22:0. 21ncludes 20:1n-11, 20:1n-7 and 22:1n-9. 
31ncludes 22:4n-6 and 22:5n-6. t = trace value < 0.05%. 
106 
as Fa, so (suppliers as described previously) or La (ICN Biomedicals Ltd., High 
Wycombe, U.K.). Cardiosomatic index was calculated as heart weight in mg/ body 
weight in g. Satisfactory growth was observed in all dietary treatments over the 10 
week experimental period and no differences were apparent between treatments 
(Table 5.2.1). Mortalities were low in all dietary treatments « 5%). There was no 
significant effect of dietary treatment on cardiosomatic index (1.35 ± 0.21, 1.30 ± 
0.18 and 1.32 ± 0.19 for Fa, So and La diets respectively) or heart total lipid 
content and no gross pathologies were evident. The only cardiac histopathological 
lesion evident was focal degeneration of the myocardium of the spongy layer of the 
ventricle with associated leucocyte accumulation (see Fig. 5.2.1). For assessment 
purposes the ventricle muscle tissue of each fish was categorised into one of five 
groups ranging from no detectable degeneration through to severe lesion (Table 
5.2.2). Similar lesions were also evident in the muscle of the auricle. The greatest 
incidence and severity of lesion was in the SO-fed fish although some evidence of 
tissue damage was also apparent in Fa-fed fish. Feeding La appeared to suppress 
lesion occurrence to a greater extent than Fa. 
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Table 5.2.1. Growth parameters and mortalities during the 10 week experimental 
period. 
Parameter Fa diet SO diet La diet 
Number of fish 110 110 110 
Mean initial weight 82.9 ± 15.7 84.9 ± 15.6 85.6 ± 14.5 
Mean final weight 190.5±43.2 191.0 ± 45.6 200.0 ± 53.7 
Mortalities (number) 3 10 5 
Specific growth rate (%/d) 1.2 1.2 1.2 
Feed efficiency ratio 54.5 54.8 58.1 
Values for initial and final weights are mean ± SO. Specific growth rate calculated 
as %weight gain/day = (eGw-1) x 100, where Gw (daily growth rate) = InW1-lnWOff. 
(W1 = final weight, Wo = initial weight, T = time in days). Feed efficiency ratio = 
gain/feed x 100. 
Figure 5.2.1 
Areas of focal myotomal degeneration (arrowed) in the heart ventricle of a salmon 
fed diet containing sunflower oil. The leucocytic accumulation overlies each of 
these areas. Scale bar = 20 11m. 
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Table 5.2.2. Severity of heart histopathology in salmon fed diets containing fish 
(FO), sunflower (SO), or linseed oils (LO). 
Lesion severitya FOdiet SO diet LOdiet 
Number of fish 
0 7 6 11 
1 2 0 0 
2 2 3 1 
3 0 2 0 
4 0 0 0 
Total sample 11 11 12 
aLesion severity categories; 0 = no changes evident. 1 = focal increase of 
endocardial cellularity without evidence of myocardial damage. 2 = focal 
lymphocyte accumulation with myocardial degeneration, 1-3 lesions per ventrical 
section. 3 = as 2 but with 4-10 lesions. 4 = as 2 with 10 + lesions. 
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5.3 Activity of cardiac phospholipase A 
The activities of cardiac phospholipase A, measured with endogenous substrate, 
are shown in Table 5.3.1. Results are calculated as both accumulation of free fatty 
acid or hydrolysis of PC and PElh per mg protein. In both cases the phospholipase 
activity in fish given dietary SO was significantly increased compared to those fed 
either FO or LO. 
Table 5.3.1. Phospholipase A activities in hearts of salmon fed diets containing fish, 
sunflower or linseed oils 
Phospholipase A activity FO diet SO diet LOdiet 
nmol fatty acid liberatedl 53.1 ± 4.9a 96.4 ± 6.9b 59.9 ± 13.4a 
h per mg protein 
nmol PC and PE 11.2 ± 1.4a 26.3 ± 7.0b 13.9 ± 3.4a 
hydrolysed/h per mg protein 
Values are means ± SO for 4 fish per treatment. 
Values in the same row with different superscript letters are significantly different (P 
< 0.05). 
5.4 Cardiac lipid class compositions 
The lipid class composition of heart is shown in Table 5.4.1. The amount of PI was 
significantly reduced in fish fed SO compared to those fed FO and LO and PC was 
significantly reduced in fish fed LO compared to both other dietary treatments. The 
latter observation significantly reduced the ratio PC:PE in LO-fed fish compared to 
both other dietary treatments so that in LO-fed fish PE was the major polar lipid 
class. 
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Table 5.4.1. Lipid class compositions of hearts from salmon fed diets containing 
either fish, sunflower or linseed oils 
Lipid class FO diet SO diet lO diet 
weight % 
Total phospholipids 60.1 ±B.6 54.5± B.3 53.5± 3.5 
Total neutral lipids 39.B± B.6 45.3±B.3 46.3 ± 3.7 
SM 3.0±0.5 2.4± 0.4 2.6±0.2 
• 22.1 ± 3.1a 20.4 ± 3.1a 16.1 ± 0.9b PC 
PS 3.3±0.6 2.7±0.4 3.1 ±0.2 
PI 3.5±0.6a 3.0±0.5b 3.7 ± 0.3a 
PAtCl B.7±1.4 7.9± 1.5 B.B±O.B 
PE 19.4±2.7 1B.1 ±2.7 19.3 ±2.6 
PC:PE ratio+ 1.14 ± 0.03a 1.13 ± O.OBa 0.B4 ± 0.04b 
Triacylglycerol 27.8±9.B 32.B±B.8 33.6±5.1 
Free fatty acids 0.4 ± 0.1 0.5 ± 0.1 0.B±0.6 
Cholesterol 11.0 ± 1.B 12.3±1.7 12.0 ± 1.6 
Values are means ± SD for 12 fish per dietary treatment. 
Values in the same row with different superscript letters are significantly different (P 
<0.05. 
·Values subjected to arc sine square root transformation before ANOVA. 
+Values subjected to log transformation before ANOVA. 
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5.5. Fatty acid compositions of phospholipids from heart and blood 
leucocytes and eicosanoid production in blood and cardiac myocytes 
The fatty acid compositions of heart PC are shown in Table 5.5.1. Fish fed SO had 
significantly reduced total saturates compared to FO-fed fish. SO-fed fish had 
significantly increased 18:2n-6, 18:3n-6, 20:2n-6, 20:3n-6, AA and total n-6 PUFA 
compared to both other dietary treatments. Fish fed LO had significantly increased 
18:2n-6, 20:2n-6, 20:3n-6 and total n-6 PUFA compared to fish fed FO but had 
significantly reduced AA compared to both other treatments. The 20:4/20:5 ratio was 
also significantly increased in fish fed SO compared to both other treatments while 
total PUFA were significantly increased compared to FO-fed fish. Fish fed LO had 
significantly increased 18:3n-3 and 20:4n-3 but decreased EPA, DHA and n-3/n-6 
PUFA ratio compared to FO-fed fish. 
The fatty acid compositions of heart PE are shown in Table 5.5.2. Total monoenes 
were significantly different for each dietary treatment with the highest levels in FO-
fed fish and the lowest in SO-fed fish. SO-fed fish had significantly increased 18:2n-
6, 20:2n-6, 20:3n-6, AA and total n-6 PUFA compared to the other two dietary 
treatments. Fish fed LO had significantly greater 18:2n-6, 20:2n-6, 20:3n-6 and total 
n-6 PUFA compared to FO-fed fish. 18:3n-3, 20:3n-3, 20:4n-3 and total n-3 PUFA 
were significantly increased in LO-fed fish and significantly reduced in SO-fed fish 
compared to fish fed FO. EPA was significantly reduced in fish fed SO compared to 
both other treatments. 22:5n-3 and the n-3/n-6 PUFA ratio were significantly different 
in all dietary treatments with the highest level in FO-fed fish and the lowest in SO-
fed fish. Total n-3 PUFA were also significantly different in each dietary treatment 
with the highest level in LO-fed fish and the lowest in SO-fed fish. The 20:4/20:5 
eicosanoid precursor ratio was significantly increased in SO-fed fish. Total PUFA 
were significantly increased in SO and LO-fed fish compared to those given fish oil. 
Total dimethyl acetals derived from plasmalogens were significantly reduced in SO-
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fed fish compared to FO-fed fish. 
Table 5.5.1 Fatty acid compositions of phosphatidylcholine from hearts of salmon 
fed diets containing either fish, sunflower or linseed oils 
Fatty acid FO diet SO diet LO diet 
Weight % 
Total saturates 32.9±0.8a 31.3±0.1b 32.4 ± 0.3ab 
Total monoenes 14.2 ± 0.8 12.9 ± 0.9 13.7 ± 0.5 
18:2n-6 0.5±0.1a 8.0 ± 0.1b 2.5 ± 0.1c 
18:3n-6 ta 0.2 ± 0.1 b ta 
20:2n-6 0.1 ±O.Oa 0.8 ± O.Ob 0.2 ± O.Oc 
20:3n-6 0.1 ±O.Oa 1.5 ± 0.1a 0.4± 0.1c 
20:4n-6 2.1 ±0.2a 3.0 ± 0.2b 1.6 ± 0.1c 
Total n-61 3.3± 0.3a 13.9 ± O.4b 4.9 ± 0.1 c 
18:3n-3 0.5±0.2a 0.2 ± O.Oa 5.7 ± 0.3b 
18:4n-3 0.3±0.1a 0.1 ± O.Ob 0.4 ± 0.1a 
20:4n-3 0.5±0.1 a 0.3 ± 0.1a 1.0 ± O.Ob 
20:5n-3 12.2 ±0.1a 7.7 ± 0.1 b 10.3 ± 0.6c 
22:5n-3 1.4± 0.1 1.2 ± 0.1 1.4±0.2 
22:6n-3 32.6 ± 1.Sa 30.4 ± 0.3ab 28.9 ± 1.2b 
Total n-3 47.5 ± 1.4a 39.9 ± 0.2b 48.8 ± 0.9a 
Total PUFA 50.8 ± 1.2a 53.8 ± 0.5b 52.9 ± 0.9ab 
* 14.5 ± 1.Sa 2.8 ± 0.1 b 9.8 ± 0.3c n-3/n-6 
20:4/20:5 0.2±0.Oa 0.4 ± o.ob 0.2 ± O.Oa 
Values are mean ± SO for 3 fish per treatment. Values in the same row with different 
superscript letters are significantly different. 1 Includes 22:4n-6 and 22:5n-6. ·Values 
were subjected to log transformation before ANOVA. 
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Table 5.5.2. Fatty acid compositions of heart phosphatidylethanolamine from 
salmon fed diets containing either fish, sunflower or linseed oils. 
Fatty acid FO diet SO diet LO diet 
Weight % 
Total saturates 15.7 ± 0.2 15.4±0.4 15.4 ± 0.6 
Total monoenes 12.4 ± O.4a 7.6 ± 0.2b 9.1 ±0.2c 
1B:2n-6 1.1 ± O.,a B.2 ± 0.3b 3.1 ± 0.1c 
20:2n-6 0.2±0.Oa 1.0 ± O.Ob 0.3 ± O.Oc 
20:3n-6 0.' ±O.Oa 1.1 ± 0.1 b 0.3 ± 0.1c 
20:4n-6 2.2±0.3a 3.0 ± 0.2b 1.7±0.1a 
Total n-61 4.5 ± 0.2a 14.4 ± O.4b 6.3 ± 0.2c 
1B:3n-3 1.0 ± 0.1 a 0.4 t o.,b 5.2 ± O.,c 
20:3n-3 0.1 t 0.1a tb 0.7 ± O.,c 
20:4n-3 0.7tO.1 a 0.4 t O.Ob 1.2 t O.Oc 
20:5n-3 6.1 t O.,a 4.7 t 0.2b 6.5 ± O.4a 
22:5n-3 4.0tO.1 a 3.3 t 0.1 b 3.6 t 0.1c 
22:6n-3 47.9tO.6 46.5 t 0.4 45.7 ± 1.6 
Total n-3 59.BtO.5a 55.3 t O.4b 63.0 ± 1.3c 
Total PUFA 64.3tO.3a 69.7 t 0.3b 69.3 ± 1.4b 
n-3/n-6 13.4tO.7a 3.9 t 0.1 b 10.0 ± 0.2c 
20:4/20:5 0.4 t 0.1a 0.7tO.1 b 0.3 ±O.Oa 
Total dimethyl aceta Is 5.4 ± O.Sa 4.6 t 0.1 b 4.7 ± 0.2ab 
Values are mean ± SO for 3 fish per treatment. Values in the same row with different 
superscript letters are significantly different. 1 Includes 22:4n-6 and 22:5n-6. 
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Heart phosphatidylserine (PS) fatty acid composition was less affected by dietary 
lipid than PC and PE. Linoleic acid and 18:3n-3 levels reflected dietary intake and 
20:2n-6, 20:3n-6 and total n-6 PUFA levels were significantly increased in SO-fed 
fish (data not shown). The fatty acid compositions of heart PI are shown in Table 
5.5.3. Total monoenes were significantly reduced in fish fed SO and LO compared 
to those fed FO. Linoleic acid was significantly different in each dietary treatment 
with highest levels in SO and lowest levels in FO-fed fish. 20:2n-6, 20:3n-6, AA and 
total n-6 PUFA were significantly increased in SO-fed fish compared to the other two 
treatments. Linolenic acid was significantly increased in fish fed the LO containing 
diet. EPA, 22:5n-3, total n-3 PUFA and n-3/n-6 PUFA ratio were all significantly 
reduced in SO-fed fish compared to fish fed the other two dietary treatments. The 
20:4/20:5 ratio was significantly increased in fish fed SO. 
The fatty acid compositions of leucocyte PC and PE are shown in Table 5.5.4. The 
dietary induced changes in fatty acid compositions are largely similar for both 
phospholipid classes. In general, feeding SO increased 18:2n-6 and all C20 n-6 
PUFA while reducing all n-3 PUFA compared to FO-fed fish. This resulted in a 
decreased n-3/n-6 PUFA ratio and an increased 20:4/20:5 eicosanoid precursor 
ratio compared to FO-fed fish. Feeding LO also increased 18:2n-6, 20:2n-6 and 
20:3n-6 but decreased AA compareq to FO-fed fish. EPA was increased in LO-fed 
fish compared to FO-fed fish and the resulting n-3/n-6 PUFA ratio and 20:4/20:5 ratio 
were similar. The fatty acid compositions of leucocyte PS and PI are shown in Table 
5.5.5. Dietary induced changes in PS were minimal although 18:2n-6 and C20 n-6 
PUFA were increased in SO-fed fish compared to the other two treatments. In LO-
fed fish all n-3 PUFA were increased compared to the other two treatments. In PI, 
feeding LO did not reduce AA but did increase EPA such that the resulting 20:4/20:5 
ratio was similar to that in FO-fed fish but was considerably less than SO-fed fish. 
The levels of plasma PGE2 and TXB2' and production of the same prostanoids by 
I' 
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whole blood and cardiac myocytes stimulated with A23187, are shown in Table 
5.5.6. There were no significant dietary-induced changes in concentration of either 
eicosanoid in plasma. In stimulated blood cells TXB2 was significantly increased in 
fish fed SO compared to those fed LO, whereas PGE2 was significantly decreased 
in fish fed LO compared to those fed either SO or FO. In stimulated cardiac 
myocytes TXB2 production was not affected by dietary treatment whereas PGE2 
was significantly increased in fish given both SO and LO compared to those given 
FO. 
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Table S.S.3. Fatty acid compositions of heart phosphatidylinositol from salmon fed 
diets containing either fish, sunflower or linseed oils. 
Fatty acid FOdiet SO diet LO diet 
Weight % 
Total saturates 32.9±2.0 3S.8±0.9 3S.1 ± 2.7 
Total monoenes 11.0 ± 0.9a 8.8 ± 0.2b 8.S ± 0.2b 
18:2n-B 0.4±0.Oa 3.S ± 0.2b 1.1 ± 0.1c 
18:3n-S 0.4±0.2 0.2±0.1 0.4±0.3 
20:2n-6 0.2 ± 0.1a 0.4 ± O.Ob 0.1 ± 0.1a 
20:3n-S 0.2±0.Oa 1.2 ± 0.1 b 1.0 ± 0.2b 
20:4n-S 19.5 ± 2.1 a 23.1 ± O.Bb 18.7 ± 0.9a 
Total n-61 20.8 ± 1.8a 28.S ± 0.7b 21.2 ± 0.7a 
18:3n-3 0.4±0.2a 0.2 ± O.Oa 3.0 ± 0.2b 
20:3n-3 ta ta 0.2 ± O.Ob 
20:4n-3 0.4± 0.1 0.3±0.1 0.S±0.1 
20:Sn-3 10.3±0.Sa S.S±O.Sb 10.3 ± 0.8a 
22:Sn-3 1.2 ± 0.1a 0.9 ± 0.1 b 1.0 ± 0.1 ab 
22:Bn-3 1B.9±2.8 13.4 ± 0.7 13.2 ± O.S 
Total n-3 29.3± 2.7a 21.S ± 0.4b 28.2 ± 1.Sa 
Total PUFA SO.1 ± 1.3 SO.0±0.3 49.4±2.0 
n-3/n-S 1.4± 0.2a 0.8 ± 0.1 b 1.3 ± 0.1a 
20:4/20:S 1.9 ± 0.2a 3.S ± 0.2b 1.8 ± 0.1a 
Values are mean ± SD for 3 fish per treatment. Values in the same row with different 
superscript letters are significantly different. 1 Includes 22:4n-S and 22:Sn-6. 
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Table 5.5.4. Fatty acid compositions of blood leucocyte phosphatidylcholine and 
phosphatidylethanolamine from salmon fed diets containing either fish, sunflower or 
linseed oil. 
PC PE 
Fatty acid FOdiet SO diet LOdiet FOdiet SO diet LOdiet 
T otaJ saturates 33.0 36.3 352 22.4 16.6 15.1 
Total monoenes 30.1 25.4 27.7 16.0 10.3 15.1 
18:2n-6 1.7 9.6 2.6 2.0 11.3 4.4 
18:3n-6 0.4 0.2 0.2 0.2 0.2 0.3 
2O:2n-6 0.2 1.7 0.4 0.3 1.5 0.5 
2O:3n-6 0.3 1.7 0.5 0.2 1.0 0.3 
2O:4n-O 2.1 3.0 1.7 2.9 4.7 2.6 
Total n-61 4.7 16.2 5.6 5.6 18.9 8.1 
18:30-3 0.5 0.2 3.0 0.3 0.3 3.2 
20:30-3 t 0.7 0.5 
20:4n-3 0.5 02 0.7 t t 0.4 
2O:5n-3 8.9 6.1 9.3 4.0 3.2 4.9 
22:5n-3 1.5 0.7 0.9 1.1 1.0 1.2 
22:6n-3 16.4 13.4 15.2 36.2 36.2 39.0 
Total n-3 28.0 20.6 29.8 41.6 40.7 49.2 
Total PUFA 32.7 36.8 35.4 472 59.6 57.3 
n-3'n-6 6.0 1.3 5.3 7.4 22 6.1 
20:4120:5 0.2 0.5 0.2 0.7 1.5 0.5 
Total dimett-ryl 10.1 8.8 10.4 
acetals 
Results were obtained from pooled leucocyte samples from 6 fish per dietary 
treatment. t = trace value < 0.05%. - = not determined. 1 Includes 22:4n-6 and 22:5n-
6. 
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Table 5.5.5. Fatty acid compositions of blood leucocyte phosphatidylserine and 
phosphatidylinositol from salmon fed diets containing either fish oil, sunflower oil or 
linseed oil. 
PS PI 
Fatty acid FOdiet SO diet LOdiet FOdiet SO diet LOdiet 
Total saturates 39.2 45.3 43.0 40.4 43.7 43.9 
Total rnonoenes 19.6 11.0 9.5 24.3 7.9 6.0 
18:2rH> 1.7 2.6 1.0 12 1.5 0.6 
18:3rK> 0.3 0.4 0.2 2.0 0.5 0.2 
2O:2n-6 t 0.8 0.3 t 0.4 0.1 
20:3n-6 t 0.6 02 t 0.9 0.7 
2O:4n-6 0.6 1.1 0.7 19.4 32.5 35.6 
Total n-61 2.6 5.7 2.4 22.6 35.8 37.2 
18:~3 0.5 0.2 1.0 0.6 t 0.5 
20:50-3 1.5 1.3 2.0 12 0.9 1.8 
22:50-3 1.7 1.6 2.1 0.6 1.1 1.3 
22:611-3 30.9 31.5 37.9 8.2 6.7 6.1 
Total n-32 35.3 34.6 43.6 10.6 9.2 10.1 
Total PUFA 39.5 40.3 46.0 33.2 45.0 47.3 
n-3'n-6 13.6 6.1 18.2 0.5 0.3 0.3 
20:4120:5 0.4 0.9 0.4 16.2 36.1 19.8 
Results were obtained from pooled leucocyte samples from 6 fish per dietary 
treatment. t = trace value < 0.05%. - = not determined. 1 Includes 22:4n-6 and 22:5n-
6. 21ncludes 18:4n-3, 20:3n-3 and 20:4n-3. 
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Table 5.5.6. PGE2 and TXB2 concentrations in plasma and extracts from blood and 
cardiac myocytes stimulated with calcium-ionophore A23187 in salmon fed diets 
containing Fa, so or La. 
Eicosanoid Fa diet so diet La diet 
Plasma TXB2 (r19'm~ 124±0.35 o.n±O.55 1.02 ± 0.67 
Plasma PGE2 (pgImO 109.0± 15.5 125.3±46.1 165.7±75.3 
Stimulated blood TXB2 2.54 ± 2.00
ab 12.27 ± 6.20a 2.20 ± 2.17 
(nglml) 
Stimulated blood PGE2 1.39 ± 0.33
a 2.93 ± 0.88a 0.58 ± 0.21 
• (nglml) 
b 
b 
Stimulated cardiac 112.2 ± 48.4 10B.7±27.1 9B.0±56.B 
myocytes TXB2 (pglmg protein) 
Stimulated cardiac 268.0± 141.9 b 857.0 ± 141.9a 706.3 ± 157.9a 
myocytes PGE2 (pg/mg protein) 
Values are mean ± SO for 4 fish per treatment. 
Values in the same row with different superscript letters are significantly different (P < 0.05). 
·Values were subjected to log transformation before ANOVA. 
120 
5.6 Fatty acid compositions of salmon liver and gills and eicosanoid 
production by isolated gill cells 
The fatty acid compositions of liver PC are shown in Table 5.6.1. Total monoenoic 
fatty acids were significantly reduced in SO-fed fish compared to fish fed FO. In SO-
fed fish 18:2n-6, 18:3n-6, 20:2n-6, 20:3n-6, 20:4n-6, 22:4n-6 and 22:5n-6 were all 
significantly increased compared to both other dietary treatments. Fish fed LO had 
significantly increased 18:2n-6, 18:3n-6, 20:2n-6, 20:3n-6 and total n-6 PUFA but 
reduced 22:5n-6 compared to fish fed FO. LO-fed fish had significantly increased 
18:3n-3, 18:4n-3, 20:3n-3 and 20:4n-3 compared to both other dietary treatments 
but had significantly reduced DHA compared to FO-fed fish. In fish fed SO 18:3n-3, 
20:4n-3, EPA, 22:5n-3 and total n-3 PUFA were significantly reduced compared to 
both other dietary treatments while DHA was significantly reduced compared to FO-
fed fish. The n-3/n-6 PUFA ratio was significantly different in the three dietary 
treatments with the highest value in FO-fed fish and the lowest in SO-fed fish. 
The fatty acid compositions of liver PE are shown in Table 5.6.2. Total monoenoic 
fatty acids were significantly different for each dietary treatment with the highest 
levels in FO-fed fish and the lowest levels in SO-fed fish. Also, 18:2n-6, 20:2n-6, 
20:3n-6 and total n-6 PUFA were significantly affected by dietary treatment with the 
highest levels in SO-fed fish and the lowest levels in FO-fed fish. Levels of 22:5n-6 
were also significantly different in each dietary group with highest values in SO-fed 
fish and lowest in LO-fed fish. AA and 22:4n-6 were significantly increased in fish 
fed SO compared to both other dietary treatments. Also, 18:3n-3, 20:4n-3 and EPA 
were significantly different in each dietary treatment with highest levels in LO-fed 
fish and lowest in SO-fed fish. 22:5n-3 was significantly increased in LO-fed fish 
compared to SO-fed fish whereas DHA was significantly greater in FO-fed fish 
compared to both other treatments. Total n-3 PUFA were significantly lower in SO-
fed fish while total PUFA were significantly different in each dietary treatment with 
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Table 5.6.1. Fatty acid compositions of liver phosphatidylcholine from salmon fed 
diets containing fish oil, sunflower oil or linseed oil. 
Fatty acids FOdiet SO diet LO diet 
Weight % 
Total saturated 29.3± 1.6 29.9±3.5 31.7 ± 3.7 
Total monoenoic 16.0 ± 1.6b 13.2 ± 0.8c 14.6 ± 1.1 bc 
18:2n-6 1.1 ± 0.3d 10.6 ± 1.7b 4.0 ± 0.5c 
18:3n-6 td 0.5 ± 0.3b 0.2 ± O.Oc 
20:2n-6 0.3±0.1d 1.7 ± 0.5b 0.6 ± 0.1c 
20:3n-6 0.3±0.1d 6.4 ± 1.0b 2.0 ± O.Sc 
20:4n-6 0.7 ± 0.1c 5.5 ± 2.2b 0.6 ± 0.1c 
22:4n-6 0.1 ±O.Oc 0.7 ± O.4b 0.1 ± O.Oc 
22:5n-6 0.3±0.1c 0.7 ± 0.3b 0.1 ± O.Oc 
Total n-6 2.8±0.3d 26.0 ± O.4b 7.4 ± O.4c 
18:3n-3 0.3 ±0.1c 0.1 ± O.Od 3.6 ± 1.2b 
18:4n-3 0.1 ±O.OC 0.1 ± O.Oc 0.7 ± 0.2b 
20:3n-3 tC tC 0.4 ± 0.1 b 
20:4n-3 0.8 ±0.2c 0.2 ± 0.1 d 2.9 ± 0.8b 
20:5n-3 9.8 ± 1.0b 3.8 ± O.4c 9.5 ± 1.2b 
22:5n-3 3.0±0.6b 2.0 ± 0.5c 3.3 ± O.4b 
22:6n-3 35.9±2.6b 23.8 ± 3.2c 25.5 ± 1.7c 
Total n-3 49.6± 1.8b 29.7±3.1c 45.8 ± 2.2b 
Total PUFA 52.4± 1.8 55.7±3.2 53.1 ±2.1 
n-3/n-6 18.0 ± 1.6b 1.2 ± 0.1 d 6.2 ± 0.5c 
20:4/20:5 0.1 ±O.Oc 1.5 ± 0.6b 0.1 ± O.Oc 
Results are means ± standard deviation from 4 fish per treatment. t = trace value < 
0.05%. Standard deviation < 0.05 are recorded as 0.0. 
Values in the same row with different superscript letters are significantly different (P 
< 0.05). 
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Table 5.6.2. Fatty acid compositions of liver phosphatidylethanolamine from salmon 
fed diets containing fish oil, sunflower oil or linseed oil. 
Fatty acids Fa diet SO diet La diet 
Weight % 
Total saturated 12.6±0.7 12.7±0.6 13.6 ± 1.4 
Total monoenoic 25.2 ± 1.8b 15.5 ± 2.5d 21.1±0.4c 
18:2n-6 1.7 ± O.4d 12.0 ± 2.1 b 4.7 ± 1.1 c 
18:3n-6 0.1 ± 0.0 0.2±0.1 t 
20:2n-6 0.4±0.1d 2.3 ± O.Sb 0.7±0.1c 
20:3n-6 0.3± 0.1 d 5.1 ± 0.6b 1.5 ± 0.2c 
20:4n-6 1.3±0.4c 9.6 ± 2.7b 1.1 ± 0.1c 
22:4n-6 tC 0.8 ± 0.4b tC 
22:5n-6 0.5±0.Oc 1.0 ± 0.3b 0.3 ± 0.1 d 
Total n-6 4.2±0.4d 30.9 ± 2.5b 8.1 ± 1.1c 
18:3n-3 0.8 ±0.2c 0.3 ± 0.1 d 3.0 ± 0.6b 
20:3n-3 tC tC 0.7 ± 0.1 b 
20:4n-3 0.5±0.1c td 1.7 ± 0.4b 
20:5n-3 8.8 ± 1.2c 3.6 ± 1.0d 11.1 ± 1.1b 
22:5n-3 2.1 ± O.4bc 1.8 ± 0.4c 2.8 ± 0.4b 
22:6n-3 41.9± 1.9b 32.5 ± 2.7c 36.0 ± 0.9c 
Total n-3 54.1 ±0.8b 38.2 ± 2.2c 55.4 ± 0.3b 
Total PUFA 58.3 ± 1.2d 69.2 ±2.7b 63.5 ± 1.4c 
n-3/n-6 12.9 ± 1.2b 1.3 ± 0.1 d 6.9 ± 0.9c 
20:4/20:5 0.2± 0.1c 2.9 ± 1.4b 0.1 ± O.Oc 
Results are means ± standard deviation from 4 fish per treatment. t = trace value < 
0.05%. Standard deviation < 0.05 are recorded as 0.0. 
Values in the same row with different superscript letters are significantly different (P 
< 0.05). 
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the highest levels in SO-fed fish and the lowest in FO-fed fish. The ratio of n-3/n-S 
PUFA was significantly different in each dietary treatment with the highest value in 
FO-fed fish and the lowest in SO-fed fish. The AAIEPA ratio of eicosanoid precursors 
was significantly increased in SO-fed fish compared to both other treatments. 
The fatty acid compositions of liver PS are shown in Table 5.S.3. Total saturated 
fatty acids were significantly increased whereas total monoenoic fatty acids were 
significantly decreased in fish fed SO and LO compared to those fed FO. The level 
of 20:3n-6 was significantly different in each dietary treatment with the highest levels 
in SO-fed fish and the lowest in FO-fed fish. AA and 22:5n-6 were also significantly 
different in each treatment with the highest levels in SO-fed fish and the lowest in 
LO-fed fish. 18:2n-6, 20:2n-6, 22:4n-6 and total n-6 PUFA were all significantly 
increased in fish fed SO compared to the other dietary treatments. Levels of 18:3n-3 
and 20:4n-3 were significantly greater in fish fed LO than in the two other treatments 
while EPA was significantly reduced in SO-fed fish compared to LO-fed fish. Total n-
3 PUFA were significantly reduced in SO-fed fish compared to both other treatments 
while DHA was reduced in fish fed SO compared to those fed FO. Total PUFA were 
significantly greater in SO-fed fish compared to LO-fed fish. The n-3/n-S PUFA ratio 
was significantly lower and the AAIEPA ratio significantly greater in SO-fed fish 
compared to both other treatments. 
The fatty acid compositions of liver PI are shown in Table 5.S.4. Total saturated 
fatty acids were significantly elevated in fish fed SO and LO compared with those 
fed FO. Total monoenoic fatty acids were significantly different in all treatments with 
the highest levels in fish fed FO and the lowest in those fed SO. Levels of 18:2n-S 
and total n-6 PUFA were significantly increased in SO-fed fish compared to the 
other two treatments whereas 20:3n-S was significantly greater in LO-fed fish 
compared to the other treatments. AA was significantly different in all dietary 
treatments with the highest level in SO-fed fish and the lowest level in LO-fed fish. 
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Also, 18:3n-3, 20:4n-3 and total n-3 PUFA were significantly reduced in fish fed SO 
compared to the other two treatments. EPA was significantly different in all 
treatments with the highest level in LO-fed fish and the lowest in SO-fed fish. Levels 
of 22:5n-3 and DHA were significantly different in all treatments with the highest 
levels in FO-fed fish and the lowest in SO-fed fish. Total PUFA were significantly 
greater in SO-fed fish compared to LO-fed fish. The n-3/n-6 PUFA ratio was 
significantly lower and the ANEPA ratio significantly greater in fish fed SO 
compared to both other treatments. 
The major PUFA in gill PC and PE are shown in Figure 5.6.1. In PC 18:2n-6 and 
20:3n-6 were significantly different in all dietary treatments with the highest levels in 
SO-fed fish and the lowest in FO-fed fish. AA was significantly increased and EPA 
significantly decreased in SO-fed fish compared to the other treatments. 
Consequently, the ANEPA ratio was significantly greater in SO-fed fish compared to 
the other two treatments. DHA and total n-3 PUFA were significantly decreased in 
SO-fed fish compared to both other treatments. Largely similar effects occurred in 
gill PE except that 20:3n-6 was significantly greater in SO-fed fish compared to both 
other treatments and DHA was significantly reduced in SO-fed fish compared to FO-
fed fish. 
The major PUFA of gill PS and PI are shown in Figure 5.6.2. In gill PS 18:2n-6 and 
20:3n-6 were significantly different in all dietary treatments with the highest levels in 
SO-fed fish and the lowest levels in FO-fed fish. AA was significantly increased and 
EPA significantly reduced in SO-fed fish resulting in an increased ANEPA ratio 
when compared to fish fed either FO or LO. In gill PI the results were largely similar 
to PS except that DHA was significantly greater in fish fed FO than in both other 
dietary treatments. 
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Table 5.6.3. Fatty acid compositions of liver phosphatidylserine from salmon fed 
diets containing fish oil, sunflower oil or linseed oil. 
Fatty acids FO diet SO diet LO diet 
Weight % 
Total saturated 31.7± 1.5c 35.5 ± 1.4b 35.S ± 1.Sb 
Total monoenes 10.3 ± 0.8b 6.2 ± 0.5c 6.7 ± 1.0c 
18:2n-6 0.5± 0.1 c 1.5 ± 0.2b 0.6 ± 0.1c 
18:3n-6 0.2±0.2 0.2±0.1 t 
20:2n-6 0.2±0.Oc 1.0 ± 0.3b 0.3 ± 0.1C 
20:3n-6 0.2±0.1 d 1.6 ± 0.5b 0.6 ± 0.1c 
20:4n-6 0.5 ± 0.1c 1.7 ± 0.3b 0.2 ± 0.1 d 
22:4n-6 tC 0.8 ± 0.5b tC 
22:5n-6 0.6±0.1c 1.1 ± O.4b 0.3 ± O.Od 
Total n-6 2.0±0.2c 8.0 ± 0.7b 2.0 ± 0.1c 
18:3n-3 0.4 ± 0.1 bc 0.2 ± 0.1c 0.6 ± 0.2b 
18:4n-3 0.4±0.1b tC tC 
20:4n-3 tC tC 0.5 ± 0.1 b 
20:5n-3 1.4 ±0.5bc 0.7 ± 0.3c 1.4 ± 0.3b 
22:5n-3 2.7±0.4 3.2±0.8 3.8±0.6 
22:6n-3 47.3 ± 1.6b 43.2 ± 2.3c 44.6 ± 0.7bc 
total n-3 52.3±0.3b 47.2 ± 1.7c 50.9 ± 0.7b 
total PUFA 54.3± 1.0bc 55.2 ± 1.3b 52.9 ± 0.7c 
n-3/n-6 25.9 ±2.1 b 5.9 ±0.6c 25.8 ± 1.3b 
20:4/20:5 0.4 ±0.2c 3.1 ± 1.6b 0.2±0.1c 
Results are means ± standard deviation from 4 fish per treatment. t = trace value < 
0.05%. Standard deviation < 0.05 are recorded as 0.0. 
Values in the same row with different superscript letters are significantly different (P 
< 0.05). 
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Table 5.6.4. Fatty acid compositions of liver phosphatidylinositol from salmon fed 
diets containing either fish oil, sunflower oil or linseed oil. 
Fatty acids Fa diet SO diet La diet 
Weight % 
Total saturated 33.3± 1.6c 38.1 ± 0.5b 38.4 ± 1.1 b 
Total monoenoic 12.5 ± 1.4b 6.7 ± 0.7d 9.2 ± 0.6c 
18:2n-6 0.5 ± 0.1c 1.4 ± 0.3b 0.6 ± 0.1c 
20:2n-6 0.3± 0.1 0.5 ±0.1 0.3 ± 0.1 
20:3n-6 2.0±0.3c 1.8 ± 0.7c 5.8 ± 1.2b 
20:4n-6 28.4± 0.3c 41.8 ± O.4b 21.0±1.2d 
Total n-6 31.5±0.2c 46.1 ± 0.5b 28.3 ± 1.7c 
18:3n-3 0.4± 0.1 b tC 0.5 ± 0.1 b 
20:4n-3 0.3±0.1b tC 0.5 ± 0.1 b 
20:5n-3 4.9±0.9c 0.7 ± 0.3d 10.1 ± 2.5b 
22:5n-3 2.2±0.3b 0.6 ± 0.1 d 1.7 ± 0.2c 
22:6n-3 12.4 ± 1.2b 4.7 ± 0.5d 8.1 ± 0.4c 
Total n-3 19.7 ± O.4b 6.2 ± 0.6c 21.5 ± 2.9b 
Total PUFA 51.4± 0.7bc 52.2 ± 1.1 b 49.7 ± 1.1 c 
n-3/n-6 0.6±0.Ob 0.1 ±O.Oc 0.7 ± 0.2b 
20:4/20:5 7.0±2.2c 76.1 ± 28.2b 3.2 ±2.2c 
Results are means ± standard deviation from 4 fish per treatment. t = trace value < 
0.05%. Standard deviation < 0.05 are recorded as 0.0. 
Values in the same row with different superscript letters are Significantly different (P 
< 0.05). 
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The production of eicosanoids by isolated gill cells stimulated with A23187 is 
shown in Table 5.6.5. The production of 12-HETE, 12-HEPE and 14-HDHE were all 
significantly reduced in fish fed both LO and SO compared to those fed FO. 
However, the ratio of 12-HETEl12-HEPE was significantly increased in fish fed SO 
compared to both other treatments. While mean values of both TXB2 and PGE2 
were greatest in fish fed SO they were not significantly different from either of the 
other dietary treatments. 
Table 5.6.5. Eicosanoids produced by isolated salmon gill cells stimulated with the 
Ca2+-ionophore A23187. 
Eicosanoid FO diet SO diet LO diet 
12-HETE 17.7 ± 9.6b 5.7 ± 2.9c 5.8 ± 0.5c 
12-HEPE 45.2 ± 12.4b 7.8 ± 3.2c 21.2 ± 8.2c 
12-HETEl12-HEPE 0.354 ± 0.094c 0.791 ± 0.18gb 0.327 ± 0.138c 
14-HDHE 34.1 ± 11.8b 6.8 ± 3.8c 10.4 ± 1.9c 
TXB2 142.8 ± 80.4 229.0 ± 120.9 172.0 ± 59.6 
PGE2 192.3 ± 54.0 807.3 ± 562.3 510.3 ± 177.9 
Values are mean ± standard deviation from four fish per treatment. Values for 12-
HETE, 12-HEPE and 14-HDHE are ng/mg protein whereas those for TXB2 and 
PGE2 are pg/mg protein. Values in the same row with different superscript letters 
are significantly different (P < 0.05). 
Fig. 5.6.1. Levels of the major polyunsaturated fatty acids of gill phosphatidylcholine 
(PC) and phosphatidylethanolamine (PE) from salmon fed diets containing either 
fish oil (Diet 1 ;FO). sunflower oil (Diet 2; SO) or linseed oil (Diet 3; LO). Values are 
means ± SO for four fish per treatment. Values for each fatty acid having a different 
column letter are significantly different (P < 0.05). 
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5.7. Summary 
1. Atlantic salmon post-smolts were fed diets in which the lipid component was 
supplied either as fish oil (FO), sunflower oil (SO) or linseed oil (LO) for 12 weeks. 
Fish fed SO developed a marked cardiac histopathology which, while present in 
FO-fed fish, albeit in a less severe form, was virtually absent in fish fed LO. Fish fed 
SO had increased heart phospholipase A activity compared to those given either 
FO or LO. There were no significant differences between final weights of fish fed the 
three experimental diets. 
2. The tissue phospholipids from fish fed SO had increased levels of 18:2n-6, 20:2n-
6, 20:3n-6 and 20:4n-6 and liver PC, PE and PS also had elevated 22:4n-6 and 
22:5n-6 compared to the other dietary treatments. This was reflected in a decreased 
n-3/n-6 PUFA ratio and an increased 20:4n-6/20:5n-3 eicosanoid precursor ratio in 
SO-fed fish. While the tissue phospholipids from fish fed LO had increased levels of 
18:2n-6, 20:2n-6 and 20:3n-6, the levels of 20:4n-6, 22:4n-6 and 22:5n-6 were 
similar, or significantly reduced compared to fish fed FO. Tissue phospholipid 
compositions from fish fed LO also had increased 18:3n-3 and 20:4n-3 compared to 
both other treatments while in some tissues and phospholipid classes 20:5n-3 was 
increased compared to fish fed FO. 
3. Fish fed LO had reduced PC in heart cell membranes compared to both other 
treatments, resulting in a PC:PE ratio of less than one. 
4. Blood leucocytes stimulated with A23187 produced less TXB2 in fish fed LO 
compared to those fed SO and PGE2 production was reduced in LO-fed fish 
compared to both other treatments. In stimulated cardiac myocytes PGE2 production 
was significantly increased in fish fed both SO and LO compared to those fed FO. 
Production of 12-lipoxygenase metabolites in isolated gill cells stimulated with 
A23187 were significantly reduced in fish fed both SO or LO compared to those fed 
FO. However, the ratio of 12-HETEl12-HEPE was significantly elevated in stimulated 
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gill cells from SO-fed fish compared to both other treatments. 
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Section 6. The incorporation and metabolism of polyunsaturated fatty acids in 
phospholipids of an established cell line derived from chum salmon 
(Oncorhynchus ketal heart. 
6.1 Introduction 
Recent studies with established fish cell lines have confirmed the metabolic 
pathways of fatty acid elongation and desaturation which have been observed in 
intact fish. Thus, cells derived from turbot fin have been demonstrated to be deficient 
in ~5-desaturase while those derived from rainbow trout gonad have been capable 
of synthesising 22:6n-3 from added 18:3n-3 (Tocher, 1990; Tocher and MacKinlay, 
1990). In the preceding studies with Atlantic salmon the development of a severe 
cardiomyopathy in fish fed sunflower oil rich in 18:2n-6 has been observed whereas 
lesions have been largely absent in fish given fish oil or linseed oil, which are rich in 
n-3 PUFA. A number of other cardiac abnormalities including epicarditis and 
haemopericarditis have also been observed in farmed Atlantic salmon (Ferguson 
et al. 1986; Raynard and Houghton, 1992). 
While the preceding experiments, and similar studies in mammals (Swanson and 
Kinsella, 1986) demonstrate that dietary n-3/n-6 PUFA ratio can influence cardiac 
tissue fatty acid composition and subsequent alteration of membrane-bound 
enzyme activities (Leonardi et al. 1987), much less is known about the cellular 
mechanisms regulating uptake and intracellular metabolism of PUFA in cardiac 
cells. One study utilising isolated rat cardiac myocytes suggested that chain 
elongation and desaturation was not performed by myocytes indicating that the fatty 
acid composition of these cells was determined by selective uptake of PUFA which 
had been synthesised by other organs, probably the liver, and carried to the heart in 
the bloodstream (Hagve and Sprecher, 1989). 
In cells which are routinely cultured, the only added lipid tends to be derived from 
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the serum supplememt, which is usually of mammalian origin. This results in 
cultured cells having a fatty acid composition which largely reflects the serum 
supplement (Spector et al. 1981). Fetal calf serum (FCS) is normally the serum of 
choice but fish cells cultured in FCS are generally deficient in n-3 PUFA and usually 
contain elevated concentrations of n-6 PUFA (Tocher et al. 1988). In this study the 
incorporation and metabolism of n-3 and n-6 PUFA was investigated in an 
established epithelial cell line (CHH-1) from chum salmon (Oncorhynchus ketal 
(lannan et al. 1984). These cells had been derived from primary cultures of heart 
cells from juvenile chum salmon prepared as described by Wolf and Quimby (1976). 
The aim of the present experiments was to determine the pathways of desaturation 
and elongation present in these cardiac-derived cells. 
6.2 Lipid class compositions of CHH-1 cells 
The lipid class compositions of CH H·1 cells grown in 10% FCS or 1 % FCS plus 
various fatty acids at 25 ~M are shown in Table 6.2.1. In all treatments, PC was the 
predominant phospholipid closely followed by PE which together accounted for 
approximately 40% of the total lipid. PS and PI were present in approximately equal 
amounts with PI always the more abundant followed by PAlCl and SM. In all cases 
polar lipid was in excess of neutral lipid. Some accumulation of neutral lipid was 
observed in cells supplemented with PUFA compared to FCS. Highest levels were 
in cells supplemented with 18:3n-3, 20:3n-6 and 22:6n-3 but microscopic 
examination of the cells indicated minimal presence of lipid droplets in all of the 
experimental treatments. Cells grew well and attained confluence in 5-7 days with 
all fatty acid supplements except 20:3n-6. Cells supplemented with 20:3n-6 did not 
attain confluence and after 6-7 days they began to detach from the flask (Figures 
6.2.1 and 6.2.2). The supplementation with 20:3n-6 was repeated twice, using the 
same fatty acid concentration, and with two different sources of 20:3n-6. In all cases 
Table 6.2.1. Lipid class compositions of CHH-1 cells cultured in 10% fetal calf serum (FCS) or 1% FCS supplemented 
with various fatty acids. (Values are weight % of total lipid). 
Lipid supplement 
Lipid Class 10% FCS 18:2n-6 18:3n-3 18:3n-6 20:3n-6 20:4n-6 20:5n-3 22:6n-3 
Sphingomyelin 3.1 ± 0.4 3.5±0.1 3.5±0.1 3.6±0.1 3.9±0.S 3.9±0.2 3.7±0.1 3.6±0.1 
PC 23.4±1.Sab 22.9 ± 1.9ac 20.1 ± 0.6a 22.1 ± 1.6ac 28.S ± O.Ob 27.4 ± 1.5ab 23.6 ± 1.3ab 24.0 ± 1.5ab 
PE 16.1 ±1.0b 17.6 ± 0.3ab 16.1 ± 0.6b 16.9 ± 1.1 b 18.1 ± O.4ab 19.9 ± O.Sa 18.6 ± 0.5ab 16.7 ± 1.0b 
PS 9.1 ±0.6a 6.6 ± 0.1bc 6.2 ± 0.2re 6.5 ± O.Obc 4.7 ± 0.2d 7.1 ± 0.8bc 7.3 ± 0.1 b 5.7 ± 0.1 cd 
PI 11.7 ± 0.9a 8.9 ± 0.4b 7.4 ± 0.2bc 7.2 ± 0.1 bc 6.8 ± 0.9bc 7.8 ± 0.6bc 7.8 ± O.Obc 6.3 ± 0.3c 
PAtCl 4.3±02 4.4±0.0 3.9±0.6 3.7±0.1 4.3±0.S 3.6±02 4.0±0.1 4.0 ± 0.2 
Total polar lipid 67.5±5.0oc 63.8 ± 1.1ab 57.1 ± 0.6b 59.7 ± 2.6bc 66.4 ± 1.5ab 69.5 ± 0.6a 64.8 ± 0.7ab 60.2 ± 3.0ab 
T riacylglycerol 5.5±0.1a 8.8 ±0.3b 12.3 ± 0.1 c 11.7 ± 1.9bc 12.6 ± 1.3c 9.0 ± 0.1b 6.4 ± O.4ab 16.3 ± 0.1 d 
Free fatty acid 0.7±0.5a 1.0 ± 0.6ab 3.7 ± 0.2c 3.3 ± 0.6bc 5.0 ± 0.1 cd 5.4 ± 0.2cd 6.3 ± 0.2de 7.6 ± 0.ge 
Diacylglycerol 0.3±0.Oa 1.0 ± 0.6 ab 3.2 ± O.4bc 2.7 ± 0.1 bc 1.9 ± O.Sb 3.3 ± 0.1bc 3.7 ± 0.2d 3.0 ± O.Sbcd 
Cholesterol 21.3±0.9a 23.6 ± 1.8a 21.3 ± 1.3a 21.0 ± 0.9a 14.1 ± 1.8bc 12.8 ± 1.0c 18.7 ± 0.9ab 13.1 ± 1.9c 
Total neutral lipid 27.6± 1.3a 34.6 ± 0.1 bcd 40.4 ± 0.6d 38.6 ± 1.8cd 33.6 ± 1.2bc 30.5 ± 0.8ab 34.9 ± 1.3bcd 39.8 ± 3.2d 
Values are mean ± SO for 3 experiments. Values in the same row having different superscript letters are significantly 
different (P < 0.05). PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine; PI, 
phosphatidylinositol; PA/Cl, phosphatidic acid/cardiolipin. 
Figure 6.2.1 Low magnification light micrograph of CHH-1 cells grown with 25~M 20:3n-6 (top) and 
20:5n-3 supplements (bottom) after 6 days in culture. Note that cells grown with 20:5n-3 have nearly 
attained confluence whereas those with 20:3n-6 are not confluent. The brighter spots on the 20:3n-6-
supplemented flask probably indicate dying cells about to detach from the flask. Scale bar = 1 00 ~m . 
Figure 6.2.2. High magnification light micrograph of CHH-1 cells grown with 20:3n-6 (top) and 20:5n-3 
supplements (bottom) after 6 days in culture. Note characteristic phase-bright cells (arrowed) perhaps 
indicative of dead cells detaching from the flask and lower cell density in cultures supplemented with 
20:3n-6. Scale bar = 50 J.lm. 
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the same effect on cell growth was recorded. 
6.3 Fatty acid compositions of phospholipid classes of CHH-1 cells 
cultured in medium containing 10% FCS or 1 % FCS plus 25 11M PUFA 
The fatty acid compositions of phospholipid classes of cells cultured in 10% FCS 
are shown in Table 6.3.1. The n-9 series PUFA are dominant in all phospholipid 
classes, except PI, where n-6 series PUFA predominate. 18:2n-9 is the predominant 
n-9 PUFA in all phospholipid classes except PI where 20:2n-9 predominates. 20:3n-
9, which could not be separated from 20:2n-6 on this chromatographic system, did 
not accumulate in CHH-1 cells. The n-6 PUFA were generally more abundant than 
n-3 PUFA, except in PS, and the major n-6 fatty acids were 20:4, 18:2 and 20:2. The 
major n-3 PUFA were 22:5 and 22:6. The highest PUFA levels were in PI with the 
lowest in PC, but in all classes the monoenes, especially 18: 1 n-9, and the saturates, 
especially 16:0 and 18:0, formed the main bulk of phospholipid fatty acids. 
In the following tables (6.3.2-6.3.8) the fatty acid compositions are compared to 
those in Table 6.3.1. The n-6 PUFA composition of phospholipid classes from CHH-
1 cells supplemented with 18:2n-6 is shown in Table 6.3.2, where the total n-6 PUFA 
content of all phospholipid classes is significantly increased (compared to those 
grown in 10% FCS, Table 6.3.1). Apart from 18:2n-6, there were significant 
increases in the A6-desaturation product 18:3n-6 and the elongation product 22:3n-
6, in PC and PE. 20:2n-6 and 20:3n-6 were significantly increased in all 
phospholipid classes. 20:3n-6 showed the greatest increase, particularly in PI. The 
highest percentage of 18:2n-6 was observed in PE. 
The n-3 PUFA composition of phospholipid classes from CHH-1 cells 
supplemented with 18:3n-3 is shown in Table 6.3.3. Supplementing the media with 
25 11M 18:3n-3 significantly increased the total n-3 PUFA content of all phospholipid 
classes with the highest levels being found in PE. The A6-desaturase product, 
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Table 6.3.1. Fatty acid compositions of phospholipid classes of CHH-1 cells cultured 
in medium containing 10% fetal calf serum. 
Fatty acid PC PE PS PI 
(Weight %) 
14:0 1.S ± 0.1 0.3±0.0 0.8 ± 0.1 0.4±0.0 
16:0 18.8 ± 0.2 S.0±0.2 9.8 ± 0.1 4.4 i 0.1 
18:0 6.S ± 0.1 S.1 ±0.3 26.4 i 1.4 19.2 ± 1.7 
Total saturates 1 27.6iO.3 10.8 ± 0.4 37.7 i 1.4 2S.0± 1.S 
16:1n-9 S.2±0.2 3.3±0.0 3.1 ± 0.1 0.8 iO.1 
16:1n-7 4.9±0.0 3.2±0.2 2.8± 0.1 1.1 i 0.1 
18:1 n-9 44.2 ± 1.0 36.2± 0.4 2S.1 ±0.3 2S.8 iO.9 
18:1n-7 3.1 i 0.1 2.9± 0.1 1.7± 0.1 2.2±0.S 
20:1n-9 0.8 ±0.4 0.5±0.4 1.0± 0.1 0.4±0.0 
24:1 0.7±0.2 O.S ± 0.1 0.9±0.4 1.0±0.S 
Total monoenes S8.9±0.S 46.6±0.4 34.6±0.6 31.3±0.9 
18:2n-9 4.3±0.2 5.3±0.1 5.6±0.0 2.6±0.3 
20:2n-9 3.8 ± 0.1 4.3±0.1 4.6± 0.1 11.1 ± 0.4 
Total n-9 8.1 ± 0.3 9.6±0.0 10.2 ± 0.2 13.7 ± 0.7 
18:2n-6 0.6iO.1 1.0± 0.1 1.0± 0.1 0.7±0.0 
18:3n-6 0.2iO.1 0.1 i 0.1 0.7±0.4 0.S±0.3 
20:2n-62 0.3±0.0 1.5 ± 0.1 0.3±0.0 3.6±0.1 
20:3n-6 0.3iO.0 O.SiO.O 0.6±0.2 2.1 ± 0.2 
20:4n-6 0.4 ± 0.1 4.S±0.2 0.6±0.1 7.8±1.0 
22:2n-6 0.3±0.1 0.4±0.0 0.S±0.2 
22:4n-6 0.4±0.0 0.6±0.1 O.S ±0.1 
22:Sn-6 0.4±0.3 0.4±0.2 0.7±0.1 0.4±0.0 
Total n-6 2.2±0.4 8.7iO.2 4.9±0.3 16.1 ± 1.S 
18:3n-3 t t 0.1 ±O.O 0.1 ±O.O 
18:4n-3 t 0.1 ±O.O 0.2±0.0 0.2±0.0 
20:Sn-3 0.1 iO.O 1.4±0.0 0.1 ±O.O 0.8iO.3 
22:5n-3 0.3±0.0 2.8±0.0 3.6±0.S 4.2±0.2 
22:6n-3 0.2iO.0 4.2±0.2 2.2±0.3 3.7±0.8 
Total n-3 0.6±O.0 8.S±0.2 6.2±0.7 9.0± 1.2 
Total PUFA 10.9 ± 0.6 26.8 ±0.4 21.3 ± 0.6 38.8 ±O.S 
n-3/n-6 0.3±0.1 1.0±0.1 1.4 ± 0.4 0.6±0.2 
Total dimethyl 0.4±0.0 13.3 i 0.7 
acetals 
Data are means ± SO of triplicate experiments. 1 includes 1S:0, 17:0 and 20:0. 
21ncludes 20:3n-9. t = trace value < O.OS%. - = not detected. 
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18:4n-3 was significantly increased in all phospholipid classes as were the 
elongation products 20:3n-3 and 20:4n-3, with the latter being the main metabolite 
of 18:3n-3. The AS-desaturation product 20:Sn-3 was significantly increased in all 
phospholipid classes with the biggest increase occurring in PI. The elongation and 
desaturation products of 20:Sn-3 were significantly decreased in PS, PI and PE. 
The n-6 PUFA compositions of phospholipid classes from CHH-1 cells 
supplemented with 18:3n-6 are shown in Table 6.3.4. The increase in total n-6 
PUFA resulting from 18:3n-6 supplementation was generally greater than that for 
18:2n-6 with the exception of PE. PC showed the highest incorporation of 18:3n-6 
and its metabolites including a significant increase in the AS-desaturation product, 
20:4n-6. The major metabolite was the elongation product, 20:3n-6 which showed 
greatest incorporation into PI but was also significantly increased in all 
phospholipids. The incorporation of the elongation product 22:3n-6 was significantly 
increased in all phospholipid classes, especially PE. 
The n-6 PUFA compositions of phospholipid classes from CHH-1 cells 
supplemented with 20:3n-6 are shown in Table 6.3.S. The increase in total n-6 
PUFA was of a similar magnitude to that achieved with' 18:3n-6 with the highest 
incorporation into PC. PC showed a significant increase in the AS-desaturation 
product 20:4n-6 but the same fatty acid was significantly reduced in PE. All classes 
had significantly increased levels of the elongation product 22:3n-6. All 
phospholipid classes showed significantly increased 18:3n-6 demonstrating the 
presence of chain shortening activity. 
The n-6 PUFA compositions of phospholipid classes from CHH-1 cells 
supplemented with 20:4n-6 are shown in Table 6.3.6. Supplemented 20:4n-6 
generated total n-6 PUFA levels similar to 20:3n-6 in all phospholipid classes but 
was preferentially incorporated into PI. Chain elongation to 22:4n-6 was extensive 
with maximum incorporation into PS. No A4-desaturation and elongation to 22:Sn-6 
135 
was observed. 
The n-3 PUFA compositions of phospholipid classes from CHH-1 cells 
supplemented with 20:5n-3 are shown in Table 6.3.7. Incorporation of 20:5n-3 was 
greatest into PI although, as a result of extensive elongation to 22:5n-3, the highest 
levels of total n-3 PUFA were in PE. The incorporation of 22:5n-3 was greatest in PE 
and PS where it comprised 70 and 91 % of the total n-3 PUFA respectively. There 
was no evidence of A4-desaturation and elongation to 22:6n-3. 
The n-3 PUFA compositions of phospholipid classes from CHH-1 cells 
supplemented with 22:6n-3 are shown in Table 6.3.8. Supplementation with 22:6n-3 
produced levels of total n-3 PUFA similar to those supplemented with 20:5n-3. 
Incorporation of 22:6n-3 was particularly high in PE and PS (93 and 92% of total n-3 
PUFA respectively) while increased 20:5n-3 in all phospholipid classes suggested 
that significant retroconversion of 22:6n-3 was occurring. 
Table 6.3.2. n-6 PUFA compositions of phospholipid classes from CHH-1 cells 
cultured in medium supplemented with 18:2n-6. 
n-6 PUFA PC PS PI PE 
* * * * 18:2 23.8± 1.5 19.7±1.5 17.2 ± 1.1 34.4 ± 0.2 
• • 18:3 0.8±0.1 1.0 ± 0.1 0.7 ± 0.1 0.9±0.0 
* * • • 20:2 0.8 ± 0.1 1.4 ± 0.3 5.1 ± 0.2 1.9 ± 0.9 
• * • • 20:3 1.2 ± 0.2 3.7 ±0.5 11.8 ± 0.7 1.8 ± 0.1 
* • 20:4 0.2± 0.1 0.5±0.2 5.2±0.8 1.3 ± 0.2 
• 22:2 0.2±0.0 0.4±0.1 0.4 ± 0.1 0.6±0.2 
• • 22:3 0.1 ±O.O 0.6±0.2 0.2±0.2 0.3 ±0.1 
22:4 t 0.2±0.0 • * 0.1 ± 0.1 0.2 ±O.O 
* * 22:5 0.2±0.1 0.2±0.1 0.2 ± 0.1 t 
* * * • Total 27.3± 1.8 27.7 ± 1.0 40.9 ± 2.6 41.4 ± 0.4 
Data are shown as means ± SD of triplicate experiments. results are expressed as % of total fatty acids. t 
* 
= trace value < 0.05%. SD of < 0.05 are tabulated as 0.0. Values are significantly different (P < 0.05) 
compared to cells cultured in 10% FCS. 
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Table 6.3.3. n-3 PUFA compositions of phospholipid classes from CHH-1 cells 
cultured in medium supplemented with 18:3n-3. 
n-3 PUFA PC PS PI PE 
* * * * 18:3 24.9±2.3 21.0 ± 0.8 12.5 ± 1.0 30.1 ± 0.4 
* * * * 18:4 1.4 ± 0.1 1.4 ± 0.1 0.7 ± 0.0 1.3 ± 0.1 
* * * * 20:3 2.0±0.5 1.8 ± 0.3 2.4± 0.2 2.8± 0.6 
* * * * 20:4 3.2±0.5 4.2 ± 0.2 9.4 ± 0.1 5.3± 0.8 
* * * * 20:5 0.3 ±0.1 0.5 ± 0.1 4.5 ± 0.8 2.6± 0.0 
* * * 22:5 0.2±0.0 1.8 ±0.3 1.2 ± 0.3 1.4 ± 0.1 
* * * 22:6 0.1 ±O.O 1.3±0.2 0.7± 0.3 1.2 ± 0.1 
* * * * Total 32.1 ± 3.4 32.0 ± 0.9 31.0 ± 1.3 44.7± 1.9 
Data are shown as means ± SO of triplicate experiments, results are expressed as % of total fatty acids. t 
* = trace value < 0.05%. SO of < 0.05 are tabulated as 0.0. Values are significantly different (P < 0.05) 
compared to cells cultured in 10% FCS. 
Table 6.3.4. n-6 PUFA composition of phospholipid classes from CHH-1 cells 
cultured in medium supplemented with 18:3n-6. 
n-6 PUFA PC PS PI PE 
* * 18:2 0.4 ± 0.1 0.5±0.0 0.5 ± 0.1 0.5 ± 0.1 
* * * * 18:3 27.4±0.3 22.9 ± 0.1 12.7 ± 0.9 18.0 ± 2.4 
* 20:2 0.7±0.0 0.3±0.0 3.6 ± 0.4 1.4± 0.3 
* * * * 20:3 14.3 ± 0.4 6.1 ± 0.0 16.3 ± 0.2 10.4 ± 1.0 
20:4 1.3±0.0 * 0.8±0.2 6.5±0.4 2.9±0.4 * 
* * 22:2 0.2±0.0 0.4 ± 0.1 0.5 ± 0.1 0.6± 0.1 
* * * * 22:3 1.9±0.4 0.9 ±O.O 1.8 ± 0.2 3.1 ± 0.5 
0.2±0.0 0.5±0.0 * 22:4 0.4±0.1 0.6±0.1 
* * * * Total 46.4±0.2 32.4 ± 0.4 42.3 ± 1.9 37.5 ± 4.5 
Footnotes as described in Table 6.3.3. 
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Table 6.3.5. n-6 PUFA compositions of phospholipid classes from CHH-1 cells 
cultured in medium supplemented with 20:3n-S. 
n-S PUFA PC PS PI PE 
* * * * 18:2 0.4 ±O.O 0.7 ± 0.1 0.4± 0.0 0.4 ± 0.1 
* * * * 18:3 2.7 ±0.1 2.0 ± 0.1 1.4 ± 0.1 1.2 ± 0.1 
* * * * 20:2 1.0 ± 0.1 0.7 ± 0.1 5.6 ± 0.4 2.0 ± 0.1 
* * * * 20:3 30.5± 1.9 19.2 ± 1.1 26.3 ± 0.4 22.3 ± 0.5 
* * 20:4 2.0±0.3 0.8±0.2 7.8 ± 1.3 3.0±0.2 
* * * 22:2 0.2±0.0 O.S ± 0.1 0.4 ± 0.1 0.7±0.2 
* * * * 22:3 4.5±0.3 4.6± 0.3 3.4 ± 0.2 9.7± 1.1 
* 22:4 O.3±0.1 0.7 ± 0.1 0.4 ± 0.1 0.5±0.1 
* * * * Total 41.6 ± 1.3 29.3 ± 1.7 45.7±1.4 39.8 ± 1.1 
Data are shown as means ± SO of triplicate experiments, results are expressed as % of total fatty acids. t 
• 
= trace value < 0.05%. SO of < 0.05 are tabulated as 0.0. Values are significantly different (P < 0.05) 
compared to cells cultured in 10% FCS. 
Table 6.3.6. n-6 PUFA compositions of phospholipid classes from CHH-1 cells 
cultured in medium supplemented with 20:4n-S 
n-S PUFA PC PS PI PE 
18:2 0.7±O.3 1.0±0.4 0.6±0.0 0.4±0.0 * 
* * 18:3 0.7±0.1 0.8±0.3 0.8±0.3 0.5±0.1 
* * 20:2 0.4 ± 0.1 t 1.7 ± 0.4 0.7±0.1 
* * * 20:3 1.2 ±0.2 0.4 ± 0.0 0.8 ± 0.1 0.9 ± 0.3 
* * * * 20:4 12.5 ± 0.3 2.2 ± 0.5 23.S ± 1.S 13.3 ± 0.1 
* * 22:2 0.2±0.0 0.2 ±O.O 0.2 ± 0.1 0.2±0.0 
* * * * 22:3 0.2 ±O.1 0.2 ±O.O 0.2 ± 0.0 0.2 ± 0.0 
* * * * 22:4 21.5 ± 1.2 26.8 ± 2.4 14.7 ± 0.8 22.7 ± 1.8 
0.1 ± 0.0 0.1 ± 0.1 * * 22:5 t 0.3 ± 0.1 
* * * * Total 37.5 ± 1.4 35.3 ± 2.8 42.6 ± 1.8 39.2 ± 1.9 
Footnotes as descreibed in Table 6.3.5. 
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Table 6.3.7. n-3 PUFA compositions of phospholipid classes from CHH-1 cells 
cultured in medium supplemented with 20:5n-3 
n-3 PUFA PC PS PI PE 
18:3 t t 
18:4 0.1 iO.O 0.1 iO.O 0.1 iO.O 
* 20:3 t t 0.3±0.1 t 
* * * * 20:4 0.5 ± 0.1 0.4 ± 0.1 0.3 ± 0.1 0.3± 0.0 
* * * * 20:5 11.0 ± 0.3 1.6 ± 0.3 14.8 i 1.1 9.7 ± 0.1 
* * * * 22:5 26.3±0.3 34.6 ± 0.2 23.4 i 1.0 30.7±0.7 
* * * * 22:6 0.5±0.0 1.3 ± 0.1 1.0 ± 0.1 2.9 ± 0.1 
* * * * Total 38.4 ± 0.6 38.0 ± 0.2 39.9 ± 0.3 43.6 ± 0.7 
Data are shown as means ± SO of triplicate experiments. results are expressed as % of total fatty acids. t 
* = trace value < 0.05%. SO of < 0.05 are tabulated as 0.0. Values are significantly different (P < 0.05) 
compared to cells cultured in 10% FCS. 
Table 6.3.8 n-3 PUFA compositions of phospholipid classes from CHH-1 cells 
cultured in medium supplemented with 22:6n-3 
n-3 PUFA PC PS PI PE 
18:3 0.1 ±O.O 
18:4 
* * * 20:3 0.3iO.1 0.3 i 0.1 0.3 ± 0.1 
* * 20:4 0.1 ±O.O t t 0.1 ±O.O 
* * * * 20:5 5.2± 1.0 1.2 ± 0.0 3.8 ± 0.2 2.0± 0.2 
* * * * 22:5 1.9 ± 0.2 1.8±0.0 1.8 ± 0.0 1.1 ± 0.1 
* * * * 22:6 27.2i5.4 37.2 ± 2.6 33.3 ± 1.1 44.0 ± 1.5 
* * * * Total 34.4±6.5 40.5 ± 2.5 40.2 ± 1.5 47.5 ± 1.0 
Footnotes as described in Table 6.3.7. 
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6.4 Summary 
1. Supplementing media with 25 JlM fatty acid considerably altered the fatty acid 
compositions of CHH-1 cells but had only minor affects on the lipid class 
composition and did not result in the appearance of cytoplasmic lipid droplets. 
2. CHH-1 cells supplemented with 20:3n-6 showed reduced growth rate, did not 
achieve confluence and had an increased incidence of cell death, compared to 
cells supplemented with other PUFA. 
3. CHH-1 cells exhibited considerable ~6-desaturase activity but showed no 
preference for n-3 PUFA over n-6 PUFA. 
4. CHH-1 cells also contain significant ~5-desaturase activity which showed a 
preference towards n-3 PUFA. However, A4-desaturation activity was totally absent. 
5. Elongation of C20 PUFA was especially active in CHH-1 cells with C22 PUFA 
being specifically incorporated into PE and PS. 
6. The C20 PUFA were specifically incorporated into PI. 
7. Supplementation with 22:6n-3 generated fatty acid compositions most closely 
resembling those in salmonid cardiac tissue. Substantial chain shortening of 22:6n-
3 to 20:5n-3 was observed. 
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Section 7; Comparison of lipid compositions of heart and liver from wild and 
farmed Atlantic salmon parr. 
7.1 Introduction 
In the previous dietary studies we have shown that the composition of individual 
membrane phospholipids can be altered profoundly by feeding different dietary 
lipids. We felt it would be of interest to examine the lipids of wild Atlantic salmon to 
compare the heart and liver compositions with those found in farmed fish. However, 
the wild adult salmon caught by coastal netting are not a good comparison with 
farmed fish since they will not have been actively feeding for some months while 
undergoing their spawning migration. Therefore, since actively feeding wild post-
smolts are extremely difficult to obtain we decided to compare the compositions of 
wild parr and pre-smolts with their farmed equivalents. 
It has been established that, while farmed salmonid parr may appear outwardly 
healthy, they may be different in terms of their lipid metabolic activities, when 
compared to wild fish found within the same watershed. A study comparing wild and 
farmed salmon undergoing smoltification has revealed that the wild fish contain only 
one quarter of the carcass lipid compared to equivalent farmed fish (Ackman and 
Takeuchi, 1986). In addition, the wild fish contained higher levels of AA compared 
to their farmed counterparts despite the latter containing higher levels of 18:2n-6, 
the precursor of AA formation. The farmed fish also developed dermal lesions 
resulting in erosion of the dorsal, pectoral and caudal fins. 
The seaward migration of anadromous salmonid juveniles is accompanied by 
profound changes in morphology, behaviour and physiology known as parr-smolt-
transformation (Folmar and Dickhoff, 1980). The process involves activation of 
neuroendocrine and endocrine systems which result in biochemical and molecular 
reorganisation within the tissues which prepares the fish, while still in freshwater, for 
life in the marine environment (Hoar, 1976; Wedemeyer et al. 1980). This is an 
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extremely stressful period in the salmonid life cycle, in some ways similar to 
metamorphosis, which renders the fish susceptible to poor husbandry, disease and 
nutritional inadequacy (Folmar and Dickhoff, 1980). Prostaglandins are known to 
mediate fluid and electrolyte fluxes in fish gill and kidney and are important in 
adaptation to changes in salinity (Brown and Bucknall, 1986; Mustafa and 
Srivastava, 1989). In addition, a dietary deficiency of essential PUFA can decrease 
ionic permeability in trout brush border membranes (Oi Constanzo et al. 1983) and 
causes destruction of gill epithelia in turbot (Bell et al. 1985a and b). 
In this experiment the lipid compositions of heart and liver from Atlantic salmon 
parr collected by electrofishing in October, and from pre-smolts collected from smolt 
traps in April, both from tributaries of the River Dee, Grampian, Scotland, were 
compared with farmed salmon collected at the same time pOints. 
7.2 Lipid compositions of hearts and livers from wild and farmed 
salmon parr 
The lipid class compositions of heart from wild and farmed salmon parr are shown 
in Table 7.2.1. The level of PC, PS, PI, PAlCL, PE, total polar lipid, cholesterol and 
free fatty acid were all significantly greater in wild fish compared to farmed. The 
increased level of polar lipids were compensated in farmed salmon parr by a 
Significantly elevated (almost 2-fold) triacylglycerol concentration. 
The fatty acid compositions of PC, PS, PI, PE and TAG from hearts of wild and 
farmed salmon parr are shown in table 7.2.2. In PC there was little difference 
between wild and farmed fish in terms of saturated and monounsaturated fatty acids 
but considerable differences in PUFA content. Wild parr heart PC contained 
considerably more 18:2n-6, AA, 18:3n-3, EPA and 22:Sn-3 but much less DHA 
compared to farmed hearts. 
142 
Table 7.2.1. Lipid class compositions of hearts from wild and farmed Atlantic salmon 
parr 
Lipid Class Wild parr Farmed parr 
(Weight %) 
Lyso phosphatidylcholine 0.1 ± 0.0 0.1 ± 0.1 
Sphingomyelin 1.5 ± 0.1 1.5 ±O.O 
Phosphatidylcholine 14.5 ± 0.6 * 11.0 ± 0.2 
Phosphatidylserine 2.6±0.2 1.2 ± 0.1 * 
Phosphatidylinositol 2.3±0.1 * 1.6 ±0.1 
Phosphatidic acid/Cardiolipin 5.4±0.9 3.5 iO.3 • 
Phosphatidylethanolam ine 13.6 ± 0.9 * 7.8±0.3 
* Total polar lipid 40.1 i 2.1 26.7iO.8 
• Cholesterol 17.5± 1.2 12.5 i 0.3 
• Free fatty acid 4.5±2.3 1.7iO.1 
Triacylglycerol 21.2 ± 4.6 • 40.5±3.1 
Sterol ester 13.3 ± 1.8 16.7±2.5 
Total neutral lipid 56.6±2.1 71.5iO.5 
Values represent mean ± SD from 3 samples of wild and farmed parr where each 
sample comprised hearts from 2 fish. ·Values are significantly different (P < 0.05). 
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Wild parr heart PS contained more saturated fatty acids (mainly 16:0), AA, 18:3n-3 
and EPA but less 22:5n-3 and DHA compared to farmed hearts, whereas wild parr 
heart PI and PE had broadly similar compositions to those of farmed parr. 
Triacylglycerol composition of wild parr hearts contained more 18:2n-6, 18:3n-3 and 
AA but considerably less 20:1n-9, 22:1n-11and DHA compared to farmed salmon 
hearts. 
The lipid class compositions of livers from wild and farmed salmon parr are shown 
in Table 7.2.3. The liver lipid class compositions were very similar in both wild and 
farmed parr with the only significant differences being reduced free fatty acids and 
increased sterol esters in wild compared to farmed parr. 
The fatty acid compositions of individual phospholipids and TAG in livers from wild 
and farmed parr are shown in Table 7.2.4. The differences in fatty acid compositions 
are broadly similar to those found in hearts. Farmed fish contained higher levels of 
20:1 n-9 and 22:1 n-11 but reduced levels of 18:2n-6 and 18:3n-3 compared to wild 
fish. In the long-chain PUFA, M and EPA were increased in livers of wild fish 
whereas DHA was reduced compared to farmed fish. These changes in 
composition resulted in a considerably higher n-3/n-6 PUFA ratio in farmed parr. 
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Table 7.2.2. The fatty acid compositions of individual phospholipids and 
triacylglycerol from hearts of wild and farmed Atlantic salmon parr (Values are 
weight % of total fatty acids). 
Wild Farmed Wild Farmed Wild Farmed Wild Farmed Wild Fanned 
Fattyaci:J PC PS PI PE TAG 
14:0 0.7 1.6 0.4 0.2 0.1 0.2 0.2 0.3 2.7 4.8 
16:0 28.7 29.4 11.6 5.3 5.9 7.3 7.6 6.9 19.6 15.3 
18:0 4.7 2.0 15.3 12.6 24.1 25.7 6.8 6.4 7.4 3.9 
Total sats.1 34.7 33.2 28.3 18.8 30.2 33.4 15.2 13.9 29.9 25.9 
16:1n-7 3.9 1.3 3.2 0.6 1.8 2.4 1.9 1.3 11.8 6.4 
18:1n-9 9.0 7.5 6.8 4.6 5.2 5.3 5.1 5.1 14.6 17.2 
18:1n-7 3.1 1.6 2.5 2.8 3.7 3.3 4.3 3.8 7.1 4.0 
2O:1n-9 0.5 1.6 1.0 2.7 0.2 2.1 0.2 3.0 t 9.1 
22:1 n-11 0.8 0.7 0.1 t 8.8 
24:1 0.5 0.9 1.2 0.5 1.4 1.2 0.4 0.5 3.4 0.9 
Total 17.0 13.7 14.7 11.9 12.3 14.4 11.9 8.3 36.9 47.8 
monos.2 
18:211-6 2.0 1.1 1.6 1.3 1.4 1.5 2.8 3.1 5.8 4.1 
20:211-6 0.5 0.3 0.2 0.2 0.6 0.2 0.4 0.3 0.2 0.1 
20:411-6 4.5 1.6 7.9 2.6 24.0 23.3 4.7 4.5 1.4 0.5 
Total n-63 7.0 3.0 10.2 4.1 26.6 25.2 8.1 8.3 9.0 4.7 
18:3n-3 4.5 0.5 1.4 0.3 1.8 1.7 3.0 0.4 5.3 1.0 
2O:4n-3 0.4 0.6 0.5 0.9 0.4 0.2 0.7 0.6 t 0.9 
2O:5n-3 12.0 7.4 7.6 4.4 7.4 6.4 6.4 6.4 2.7 2.4 
22:5n-3 2.1 1.4 1.9 3.8 1.7 1.6 4.8 4.6 1.5 1.3 
22:6n-3 20.8 34.8 27.0 SO.6 12.2 10.8 35.7 36.3 3.3 9.9 
Total n-34 40.0 44.7 38.4 60.0 23.5 20.7 51.0 48.3 14.5 17.0 
Total PUFA 47.0 47.7 48.6 64.1 SO. 1 45.9 59.1 56.6 23.5 21.7 
n-3'11-6 5.7 14.9 3.8 14.6 0.9 0.8 6.3 5.8 1.6 3.6 
Total 6.3 4.7 
dimethyl acetals 
Values were obtained from pooled samples of 6 hearts. t = trace value < 0.05% .• = not detected. 
1 Includes 15:0, 17:0 and 20:0. 21ncludes 16:1 n-9, 20:1 n-11, 20:1n-7 and 22:1n-9. 31ncludes 18:3n-
6, 20:3n-6 and 22:5n- 6. 41ncludes 18:4n-3 and 20:3n-3. 
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7.2.3. Lipid class compositions of livers from wild and farmed Atlantic salmon parr. 
(Values are weight % of total lipid) 
Lipid class Wild parr Farmed parr 
Sphingomyelin 3.6±0.6 3.6±0.3 
Phosphatidylcholine 28.0± 1.9 29.8 ± 1.1 
Phosphatidylserine 3.3±0.4 3.8 ± 0.1 
Phosphatidylinositol 5.8±0.3 6.1 ±0.3 
Phosphatidic acid/cardiolipin 4.5 ± 0.4 4.1 ±0.4 
Phosphatidylethanolam ine 16.2 ± 1.1 18.3± 0.9 
Total polar lipid 61.3 ±4.2 65.7±2.3 
Cholesterol 13.5 ± 0.8 12.9 ± 0.8 
Free fatty acid t 0.7± 0.4 * 
Triacylglycerol 8.7±0.9 10.8 ± 2.6 
* Sterol ester 14.5 ± 3.5 7.1 ± 0.7 
Total neutral lipid 36.7±3.5 31.3±2.4 
Values are mean ± SO from 3 samples of each group where each sample is 
* composed of two livers. Values are significantly different (P < 0.05). 
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Table 7.2.4. Fatty acid compositions of individual phospholipids and triacylglycerol 
from livers of wild and farmed Atlantic salmon parr (Values are weight %). 
Wild Farmed Wild Farmed Wild Farmed Wild Farmed Wild Farmed 
Fattyaci:J PC PS PI PE TAG 
14:0 1.1 1.2 0.1 0.2 0.3 02 0.1 0.3 1.2 2.8 
16:0 27.9 25.6 14.6 14.1 10.2 9.6 11.4 11.4 11.1 9.1 
18:0 1.7 1.0 16.7 18.1 21.9 26.0 3.7 2.4 6.3 2.9 
Total 5at5.131.5 28.4 32.4 33.1 33.1 36.5 15.6 14.4 19.9 15.1 
16:1rr7 3.9 2.7 0.1 t 0.9 0.4 1.0 0.9 8.4 6.0 
18:1rr9 6.6 7.3 2.2 3.6 3.9 5.9 8.1 10.4 17.1 29.2 
18:1rr7 2.6 1.3 2.6 1.4 2.4 1.5 5.9 3.9 8.3 4.7 
2O:1rr9 0.1 1.5 0.8 3.6 0.2 2.5 0.4 6.1 1.1 13.7 
22:1 n-ll 0.4 0.4 0.4 1.1 6.5 
24:1 0.6 1.2 0.6 0.9 t 0.5 t 0.1 t 0.5 
Total 13.8 14.4 6.3 11.7 7.4 112 15.7 22.8 34.9 60.6 
monos.2 
18:2n-6 2.6 1.2 1.0 0.8 2.9 0.7 5.9 3.4 8.8 4.3 
18:3rH> 0.3 0.1 0.2 t 0.2 0.1 0.3 0.1 0.9 t 
20:2n-6 0.1 0.1 0.1 t 0.4 0.2 0.4 0.4 0.6 0.5 
20:3n-6 0.5 0.2 0.3 t 0.7 1.9 0.9 0.3 0.5 0.4 
2O:4n-6 2.0 0.6 1.0 0.8 27.9 22.2 4.0 0.8 0.9 0.5 
22:5n-6 0.3 0.2 0.6 t 0.1 0.5 0.3 
Total n-63 5.9 2.4 3.4 1.6 32.1 25.2 12.1 5.3 11.7 5.7 
18:30-3 3.8 0.4 0.9 t 4.4 0.4 4.6 0.8 11.9 0.7 
18:4n-3 0.8 0.4 0.3 t t t 0.1 0.1 2.0 1.2 
20:30-3 0.2 t 0.3 t 0.3 0.5 0.1 0.7 t 
2O:4rr3 0.5 0.6 0.1 t 0.4 0.4 0.5 0.8 12 1.7 
20:5n-3 11.3 7.5 2.2 0.8 4.2 7.1 12.6 6.1 6.8 2.4 
22:5n-3 3.5 1.3 4.3 1.4 2.6 1.2 3.5 1.2 2.7 2.1 
22:6n-3 26.2 42.4 46.5 45.0 14.6 14.8 31.9 45.3 3.9 6.1 
Total n-3 46.3 52.6 54.6 47.2 26.5 23.9 53.7 54.4 29.2 13.3 
Total PUFA52.2 55.0 58.0 48.8 58.6 49.1 65.8 59.7 40.9 19.0 
rr3ln-6 7.9 21.9 16.1 29.5 0.8 1.0 4.4 10.3 2.5 2.3 
TotaiDMA 0.2 0.1 0.6 0.2 
20:4120:5 0.2 0.1 0.5 1.0 6.6 3.1 0.3 0.1 0.1 0.2 
Values were obtained from pooled samples of 6 livers. 1 Includes 15:0, 17:0 and 20:0. 21ncludes 
16:1 n-9, 20:1 n-l1, 20:1 n-7 and 22:1 n-9. 31ndudes 22:4n-6. t = trace value < 0.05 .• = not detected. 
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7.3 Lipid compositions of hearts and livers from wild and farmed 
Atlantic salmon pre-smolts. 
The lipid class compositions of hearts from wild and farmed pre-smolts are shown in 
Table 7.3.1. Although the mean value for triacylglycerol content of wild hearts was 
considerably lower than that for farmed fish the large variation in this class in the 
four wild hearts sampled meant that most of the lipid class percentages were not 
significantly different between wild and farmed fish. However, levels of PS, PI and 
phosphatidic acid/cardiolipin were significantly greater while triacylglycerol values 
were significantly lower in wild hearts compared to farmed. The lower accumulation 
of triacylglycerol in wild hearts suggests that the lipid content of commercial parr 
feeds is higher than the lipid content of the natural diet. 
The fatty acid compositions of the individual phospholipids and TAG in pre-smolt 
hearts are shown in Table 7.3.2. In PC the levels of total saturates and total 
monoenes were similar although farmed fish contained more 20:1n-9 and 22:1n-11 
and less 16:1n-7 and 18:1n-9 compared to wild pre-smolts. The levels of 18:2n-6, 
20:2n-6, 20:3n-6, AA and consequently total n-6 PUFA were increased in PC from 
wild fish compared to their farmed counterparts. Among the n-3 PUFA, levels of 
18:3n-3, 20:4n-3, EPA and 22:5n-3 were increased in wild pre-smolts compared to 
farmed equivalents although the total n-3 PUFA levels were similar largely due to 
the high level of DHA in heart PC of farmed fish. In heart PE total saturate levels 
were elevated in farmed pre-smolts compared to wild pre-smolts. While levels of 
total monoenes were similar in PE, farmed fish contained higher levels of 16:1n-7, 
20:1n-9 and 22:1n-11 but lower levels of 18:1n-7, and 24:1 compared to farmed pre-
smolts. The changes in PE n-6 PUFA composition were largely similar to those in 
PC but the levels of AA and 22:5n-6 were considerably higher in wild fish compared 
to farmed. The n-3 PUFA composition of heart PE from wild and farmed pre-smolts 
was broadly similar to that in PC although total n-3 PUFA and total PUFA were 
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considerably higher in PE from wild fish compared to farmed. The total 
dimethylacetal content was greater in wild fish compared to farmed. The fatty acid 
compositions of heart PS showed similar differences between farmed and wild pre-
smolts to those in PC and PE. However, 16:0 and 18:0, and consequently total 
saturates were much higher in heart PS from wild fish compared to farmed. The fatty 
acid compositions of PI from wild and farmed pre-smolts were very similar with the 
only notable differences in the n-3 PUFA where wild fish contained higher levels of 
18:3n-3 and 22:5n-3 but lower levels of DHA compared to their farmed counterparts. 
The total saturated fatty acid level in TAG was similar in hearts from wild and farmed 
presmolts although wild fish contained considerably more 18:0 but much less 14:0 
compared to farmed fish. The total monoenes in heart TAG were higher in farmed 
fish largely due to greater levels of 20: 1 n-9 and 22: 1 n-11 but wild fish did contain 
appreciably more 18:1n-9. Wild pre-smolt TAG contained more total n-6 PUFA than 
their farmed counterparts largely due to the former containing more 18:2n-6, 18:3n-
6 and 20:3n-6. While levels of total n-3 PUFA were similar in heart TAG from both 
groups farmed pre-smolts contained more DHA, 22:5n-3 and EPA but much less 
18:3n-3 compared to wild fish. 
The lipid class compositions of livers from wild and farmed pre-smolts did not 
show any significant differences, both compositions being very similar to those of 
farmed parr (Table 7.2.3). The fatty acid compositions of individual phospholipids 
and TAG from livers of wild and farmed pre-smolts are shown in Table 7.3.3. The 
differences between the fatty acid compositions of the individual phospholipids in 
livers from wild and farmed pre-smolts were very similar to those in pre-smolt hearts. 
In PC, PE and PS from wild fish liver, levels of 18:2n-6, AA, 18:3n-3, EPA and 22:5n-
3 were higher than in farmed fish. In all liver phospholipid classes farmed pre-
smolts contained considerably more DHA than in their wild counterparts. As in pre-
smolt hearts the fatty acid compositions of liver PI were very similar in both wild and 
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farmed fish. The fatty acid compositions of liver TAG from wild and farmed pre-
smolts were broadly similar to those in heart. 
Table 7.3.1. Lipid class compositions of hearts from wild and farmed Atlantic salmon 
pre-smolts. (Values are weight %) 
Lipid class 
Sphingomyelin 
Phosphatidylcholine 
Phosphatidylserine 
Phosphatidylinositol 
Phosphatidic acid/cardiolipin 
Phosphatidylethanolam ine 
Total polar lipid 
Cholesterol 
Free fatty acid 
Triacylglycerol 
Total neutral lipid 
Wild pre-smolts 
2.5 ± 0.1 
24.4±7.6 
3.9±0.9 
4.9 ± 1.1 
10.5 ±2.0 
21.1 ± 8.1 
67.2 ± 19.4 
11.8 ± 5.5 
1.6 ± 0.3 
17.9± 12.5 
31.3 ± 18.0 
Farmed pre-smolts 
1.9 ± 0.3 
16.6 ± 0.5 
* 2.5 ±0.1 
* 3.0± 0.1 
* 7.3± 1.0 
13.3± 1.0 
44.5±2.8 
12.9 ± 1.0 
1.8 ± 0.1 
38.6±2.0 * 
53.3±3.0 
Values are mean ± SD for 4 samples per treatment where each sample comprised 
* two individual hearts. Values are significantly different (P < 0.05). 
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Table 7.3.2. Fatty acid compositions of individual phospholipids and triacylglycerol 
from hearts of wild and farmed Atlantic salmon pre-smolts. (Values are weight %). 
Wild Farmed Wild Farmed Wild Farmed Wild Farmed Wild Farmed 
Fattyaoo PC PS PI PE TAG 
14:0 3.5 27.3 1.1 1.0 0.5 0.5 2.3 4.7 0.9 6.8 
16:0 27.3 25.5 13.2 9.3 7.0 7.8 9.8 13.5 16.0 15.3 
18:0 6.6 7.4 23.1 16.9 29.5 30.1 7.7 8.1 11.0 4.3 
Total 29.8 28.9 34.4 33.9 36.6 36.3 14.3 13.8 30.3 26.1 
saturates 1 
16:1n-7 3.4 2.4 1.5 1.3 0.7 0.5 0.9 1.7 3.1 5.0 
18:1 n-9 10.5 7.7 6.4 5.6 4.7 4.6 6.5 6.9 23.6 16.1 
18:1n-7 1.4 1.2 2.3 1.8 1.8 1.6 4.5 1.4 2.9 3.0 
2O:1n-9 0.4 1.7 5.7 72 5.6 4.2 0.2 3.0 0.5 7.3 
22:1 n-11 t 0.8 0.4 1.1 0.2 0.2 t 0.9 0.4 7.1 
24:1 0.4 0.8 1.5 0.5 1.2 1.1 0.7 0.2 0.2 0.8 
Total 16.1 15.6 19.1 17.5 14.4 12.2 12.8 14.9 19.1 17.5 
monoenes2 
18:2n-6 2.3 1.5 12 0.9 0.9 0.4 2.6 2.3 7.4 4.5 
18:3n-6 t 0.2 1.1 0.7 1.0 0.5 t t 0.5 t 
20:2n-6 0.3 0.1 0.2 0.3 0.1 0.3 0.2 0.4 0.4 
20:3n-6 0.4 t 0.3 t 0.4 02 0.5 0.1 0.4 t 
2O:4n~ 3.4 1.0 1.2 1.3 19.9 19.6 4.7 1.1 0.6 0.5 
22:5n-6 0.4 0.2 0.7 0.6 0.4 0.3 0.8 0.6 0.7 t 
Total n-63 6.8 3.4 5.1 4.5 23.1 20.9 9.5 4.3 9.3 5.4 
18:3n-3 3.1 0.4 0.8 0.3 1.7 0.4 3.6 0.1 13.4 1.9 
18:4n-3 0.4 0.8 0.5 0.7 0.4 0.4 0.8 0.7 2.4 2.3 
2O:4n-3 0.8 0.3 0.4 0.5 0.3 0.3 1.5 0.6 1.1 1.2 
2O:5n-3 8.8 6.1 1.5 1.1 7.9 7.9 6.9 3.0 1.5 3.1 
22:5n-3 1.1 0.6 1.5 1.1 1.6 0.6 2.8 1.8 0.7 1.5 
22:6n-3 16.4 23.4 21.3 35.6 9.2 14.0 31.3 34.2 2.7 14.4 
Total n-330.6 31.6 27.7 40.1 21.1 23.6 46.9 40.6 22.6 24.4 
Total 37.4 35.0 32.8 44.6 44.2 44.5 56.4 44.9 31.9 29.8 
PUFA 
n-31n-6 4.5 9.3 5.4 8.9 0.9 1.1 4.9 9.4 2.4 4.5 
Values were obtained from pooled samples of eight hearts from wild and farmed fish. t = trace value < 
0.05%. - = not detected. 1 Includes 15:0, 17:0 and 20:0. 21ncludes 16:1 n-9, 20:1 n-11, 20:1 n-7 and 
22:1 n-9. 31ncludes 18:3n-6, 20:3n-6 and 22:5n- 6.4lncludes 18:4n-3 and 20:3n-3. 
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Table 7.3.3. Fatty acid compositions of individual phospholipids and triacylglycerol 
from livers of wild and farmed Atlantic salmon pre-smolts. (Values are Weight %) 
Wild Fanned Wild Fanned Wild Fanned Wild Fanned Wild Fanned 
Fattyaci::f PC PS PI PE TAG 
14:0 1.9 2.7 1.3 0.5 1.5 1.0 0.5 0.6 3.3 3.2 
16:0 25.4 24.2 14.1 15.6 11.4 12.4 10.8 17.6 14.3 12.3 
18:0 1.7 1.5 17.6 15.6 22.2 21.8 2.5 2.3 10.4 7.6 
Total 29.8 28.9 34.4 33.9 36.6 36.3 14.3 13.8 30.3 26.1 
saturates 1 
16:1n-7 3.5 2.7 1.1 0.6 2.2 1.4 1.4 1.2 6.3 5.5 
18:1n-9 6.8 7.4 3.3 42 7.4 7.4 10.6 11.4 25.5 27.6 
18:1n-7 12 1.1 1.1 1.1 1.7 1.6 3.4 2.8 3.9 3.2 
2O:1n-9 0.6 0.9 5.7 3.0 1.6 2.3 2.0 4.7 1.7 3.7 
22:1 n-ll 0.3 0.3 0.2 0.4 1.3 0.4 0.4 0.8 0.6 1.7 
24:1 0.8 0.5 1.0 0.8 0.7 0.7 0.1 0.1 1.1 1.5 
Total 13.3 13.1 13.4 10.9 14.7 14.0 18.1 21.3 40.6 45.4 
monoenes2 
18:2n-6 1.6 1.5 0.5 0.4 1.3 1.8 3.8 3.0 4.1 4.6 
18:311-6 0.1 0.6 0.3 0.2 0.1 0.4 
2O:2n-6 0.1 0.2 0.2 0.2 0.2 0.3 0.5 0.4 0.3 0.3 
20:3n-6 0.4 0.3 0.6 0.1 1.7 1.0 0.6 0.4 0.2 t 
2O:4n-6 1.7 0.7 1.0 0.4 20.7 18.7 3.1 0.9 0.5 0.3 
22:5n-6 0.4 0.2 0.7 0.6 0.4 0.3 0.8 0.6 0.7 t 
Total n-63 4.4 2.9 3.6 2.1 24.3 22.3 5.4 3.6 6.2 5.2 
18:3n-3 2.5 1.3 0.6 0.4 1.1 0.8 0.8 0.6 3.9 2.1 
18:4n-3 0.6 0.5 0.2 0.2 0.6 0.3 0.2 0.1 0.9 4.3 
2O:4n-3 0.9 0.7 0.9 0.1 0.3 0.4 12 0.8 0.6 0.3 
2O:5n-3 8.4 6.5 1.6 0.5 3.7 5.6 8.5 5.5 1.0 1.0 
22:5n-3 1.7 12 1.7 1.3 1.1 1.1 1.8 1.1 0.4 0.6 
22:6n-3 30.6 39.1 34.6 44.0 9.8 17.9 38.4 45.7 3.2 3.8 
Total n-3 44.7 49.3 39.6 46.5 16.6 26.1 54.6 54.8 10.0 12.1 
Total 49.1 52.2 43.2 48.6 40.9 48.4 63.7 60.2 16.2 17.3 
PUFA 
n-3/n-6 10.2 17.0 11.0 22.1 0.7 1.2 6.0 10.2 1.6 2.3 
Values were obtained from pooled samples of eight livers from wild and farmed fish. t = trace value < 
0.05%. - = not detected. 1 Includes 15:0, 17:0 and 20:0. 21ncludes 16:1 n-9, 20:1 n-ll, 20:1 n-7 and 
22:1 n-9. 31ncludes 18:3n-6, 20:3n-6 and 22:5n- 6. 41ncludes 18:4n-3 and 20:3n-3. 
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7.4 Summary 
1. Triacylglycerol levels were significantly greater in hearts of both wild Atlantic 
salmon parr and pre-smolts compared to their farmed counterparts. 
2. The fatty acid compositions of triacylglycerols and phospholipids in hearts and 
livers of both farmed parr and pre-smolts contained considerably more monoenoic 
fatty acids, largely due to increased levels of 20: 1 n-9 and 22: 1 n-11, compared to 
their wild counterparts. 
3. Triacylglycerol, PC and PE contained greater amounts of 18:2n-6 and 20:4n-6 in 
tissues of wild fish compared to farmed, although heart phospholipids (except PI) 
generally contained more AA than livers. 
4. Linolenic acid was considerably greater in all tissue lipid classes examined in 
wild fish compared to farmed fish while the opposite was generally true for 18:4n-3. 
EPA and 22:Sn-3 were generally higher in PC, PS and PE from heart and liver of 
wild fish compared to farmed fish. 
5. DHA levels were considerably higher in tissues of farmed fish, particularly in 
heart PC, PS and TAG, although similar trends were apparent in liver. High DHA 
levels in farmed parr would tend to inhibit t16-desaturation of 18:2n-6 (and 18:3n-3) 
and contribute to the lower AA levels found in farmed parr. 
6. In general, the fatty acid compositions of PI were most conserved between wild 
and farmed fish, especially with respect to AA and EPA concentrations. 
7. The n-3/n-6 PUFA ratios were generally lower in heart than in liver and were 
lower in wild compared to farmed fish. This effect was largely due to increased 
levels of n-6 PUFA in wild fish, and in particular of AA. 
8. The results from this study, which highlight the differences in lipid composition 
between wild and farmed parr, suggest that the diet formulations currently used by 
the aquaculture industry may be less than ideal and may explain the problems of 
seawater adaptation which are often encountered. 
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Section 8. 
8.1 General Discussion 
In the relatively small number of fish species which have been studied to date 
evidence suggests that freshwater fish can elongate and desaturate C18 PUFA to 
C22 PUFA, whereas marine fish require C20 and probably C22 PUFA to be 
supplied in the diet, due to the very low ~5 and ~4 desaturation activities in the 
latter. In anadromous fish like Atlantic salmon, which start life in freshwater before 
migrating to seawater following smoltification, the situation is less clear. Evidence 
suggests that salmon parr can convert C18 PUFA to C22 PUFA and that this 
proceeds rapidly prior to parr-smolt transformation (smoltification) as part of the 
physiological adaptation to the marine environment (Sheridan et al. 1985; Li and 
Yamada, 1992). The fatty acid composition data from the present study, using wild 
and farmed salmon parr, support the capability to elongate and desaturate C18 
PUFA to C22 PUFA in this species. Studies suggest that the freshwater invertebrate 
species which comprise the major dietary input of Atlantic salmon parr contain 
18:2n-6, 18:3n-3 and EPA as their principle PUFA, but contain only trace amounts of 
DHA (Hanson et al. 1985; Bell et al. 1994a). The presence of high levels of DHA, 
and also of AA, in the tissue phospholipids of wild salmon parr suggests they are 
capable of converting C18 to C22 PUFA. 
However, while parr are thought to express fully the enzymes required to perform 
. 
these conversions, the ability of salmon undergoing smoltification, or salmon 
adapted to the marine environment to perform these desaturation and elongation 
reactions is not clear (Ackman and Takeuchi, 1986). The wild Atlantic salmon parr 
used by Ackman and Takeuchi (1986) contained much higher levels of AA 
compared to their farmed counterparts, despite the latter containing higher levels of 
18:2n-6 as a result of dietary input. This suggested that desaturation of 18:2n-6 to 
AA was impaired in farmed parr. 
, 
.. 
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In the present studies, feeding diets containing increased levels of 18:2n-6 (> 
10% of dietary fatty acids), due to the presence of sunflower oil (SO), resulted in 
increased incorporation of this fatty acid into the membrane phospholipids of all 
tissues studied. The incorporation of increased levels of 20:3n-6 and AA in 
phospholipids from fish fed SO confirms the presence of active ~6- and ~5-
desaturation and elongation of C18 PUFA in post-smolt Atlantic salmon. The 
increased incorporation of 22:5n-6, in fish fed SO compared to those fed Fa, 
particularly into liver PE and PS (Tables 5.6.1-5.6.3), indicates that post-smolt 
Atlantic salmon are also capable of ~4-desaturation (The "Sprecher shunt"). In 
addition, fish fed linseed oil (La) contained levels of EPA in tissue phospholipids 
which were greater than or equal to those from fish fed fish oil (Fa) (e.g. Tables 
5.5.2., 5.5.3., 5.5.4 etc), despite dietary levels of EPA being lower compared to both 
Fa and SO-fed fish. This further supports the evidence for active ~6- and ~5· 
desaturation being present in post-smolts. The high activity of ~6-desaturase is 
particularly apparent in the liver where the elongation and desaturation of 18:2n-6 
results in an accumulation of 20:3n-6 such that this fatty acid becomes the most 
abundant C20 PUFA in PC, PS and PE of SO-fed fish. Although AA was increased, 
particularly in PC and PE, in fish fed SO the level of 20:3n-6 was increased up to 
25-fold in liver, compared to fish fed FO. This accumulation of 20:3n-6 suggests that, 
while salmon possess high ~6-desaturase and elongase activities the activity of ~5· 
desaturase is somewhat lower. A low L.\5·desaturase activity has been observed 
previously by Hagve et al. (1986) in isolated hepatocytes from a related salmonid, 
the rainbow trout. 
In dietary trial C there were no significant differences in the final weights of salmon 
fed the experimental diets. However, in dietary trial 8, where fish were fed linoleic 
acid at 10, 25 and 45% of dietary fatty acids, there were statistically significant 
differences in the final weights between dietary treatments. The results suggest that 
a moderate dietary input of linoleic acid (25%) may stimulate growth rate. In a study 
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with juvenile turbot (Scophthalmus maxim us) Castell et al. (1994) observed 
increased growth rate with increasing dietary level of AA, which is the product of A6 
and A5-desaturation and elongation of linoleic acid. While the precise mechanism 
of growth promotion is not clear, studies with mammals have indicated that skeletal 
muscle synthesis is stimulated by PGI2 and inhibited by PGE2 (McLennan, 1991). 
While PGI2 (or its stable metabolite 6-ketoPGF1 ex) and PGE2 were not measured in 
muscle during dietary trial B it is possible that the ratio of these two prostanoids was 
altered by the dietary treatments and, thus, had an influence on the relative rates of 
protein synthesis and degradation. 
The increase in 18:3n-6 and 20:3n-6 on supplementation with 18:2n-6 and the 
increase in 18:4n-3 and 20:4n-3 on supplementation with 18:3n-3 clearly indicates 
the presence of A6-desaturase activity in CHH-1 cells. Although conversion of both 
18:2n-6 and 18:3n-3 to AA and EPA respectively, was observed, in general the 
accumulation of 20:3n-6 and 20:4n-3 suggested a lower A5-desaturase activity in 
CHH-1 cells compared to both RTG-2 (rainbow trout gonad) and AS (Atlantic 
salmon, whole body) cell lines (Tocher, 1990; Tocher and Dick, 1990). CHH-1 cells, 
like other salmonid-derived established cell lines, appear to possess both A6- and 
A5-desaturase activities, while A4-desaturation appears to be absent. Whether the 
full desaturase complement was lost as a result of continuous culture or whether the 
original cells were never capable of A4-desaturation is not known. However, a 
number of cell lines are known to lose their ability to express desaturase activities 
after long-term culture. Among six mammalian cultured cell lines investigated, A6-
desaturation was absent in three, although in two of those A5-desaturation was 
present. However, A5-desaturation was only present in two cell lines out of six, while 
A4-desaturation was only present in one (Maeda et al. 1978; Robert et al. 1978). 
Recent evidence suggests that A4-desaturation of EPA to DHA proceeds via initial 
elongation of EPA to 24:5n-3 followed by A6-desaturation to 24:6n-3 and chain-
shortening to give DHA (The "Sprecher Shunt") (Voss et al. 1991). Since the chain 
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shortening step requires peroxisomal oxidation it is possible that impaired 
peroxisomal function after long-term culture could explain the apparent loss of .14-
desaturase activity in some established cell lines. 
The considerable accumulation of C22 PUFA in comparison to other fish cell lines 
studied (Tocher, 1990; Tocher and MacKin lay, 1990; Tocher and Dick, 1990) 
suggests that appreciable elongase activity is present in CHH-1 cells. The large 
concentration of elongation products arising from supplementation with both AA and 
EPA suggests an important functional role for long-chain PUFA in these cells. DHA 
is a major component of rat cardiac phospholipids (Swanson and Kinsella, 1986) as 
well as Atlantic salmon cardiac phospholipids, as observed in this study. 
Interestingly, the ability of CHH-1 cells to elongate extensively both AA and EPA is 
contrary to the situation in rat heart and isolated cardiac myocytes which are unable 
to perform elongation (Mohammed et al. 1990) or desaturation reactions (Hagve 
and Sprecher, 1989). 
Both essential fatty acids, 18:2n-6 and 18:3n-3, are metabolised by the same 
enzyme systems of sequential desaturation and elongation which result in the 
production of long-chain PUFA of the n-6 and n-3 series (Sprecher, 1981). The first 
two dietary experiments in this study suggest that feeding diets rich in 18:2n-6 
results in increased AA in the membrane phospholipids. However, an important 
consideration in such dietary experiments concerns the influence which one type of 
fatty acid can have on the metabolism of the other (Garcia and Holman, 1965). 
Thus, an excess of n-6 PUFA may inhibit the metabolism of 18:3n-3 although, in 
general, the n-3 PUFA are more efficient in inhibiting the metabolism of n-6 PUFA 
than vice versa (Horrobin, 1991). Feeding both SO and LO to post-smolt Atlantic 
salmon results in increased levels of 18:2n-6, 20:2n-6 and 20:3n-6 (the product of 
66-desaturation and elongation) into tissue phospholipids compared to fish fed FO 
(p113, 116, 117, 118-126). However, in most phospholipid classes, the incorporation 
of AA (the product of 65-desaturation) was increased when SO was fed but reduced 
157 
when LO was the dietary lipid source, compared to fish fed Fa. Similarly 22:5n-6, 
the product of 64-desaturation and elongation of AA was increased in fish fed SO 
but decreased in fish fed LO compared to fish fed Fa (pages 113-126). Therefore, it 
appears that dietary La, which is rich in 18:2n-6 but much richer in 18:3n-3, has an 
inhibitory effect on the 65-desaturase enzyme responsible for converting 20:3n-6 to 
AA. Since there is more n-3 PUFA than n-6 PUFA in both C18 and C20 fatty acids in 
LO-fed fish compared to SO-fed fish, it is inevitable that 18:2n-6 is metabolised to 
AA in SO-fed fish whereas the same does not occur in LO-fed fish to the same 
extent. That is, in LO-fed fish, there is competition at the 66-desaturase between 
18:2n-6 and 18:3n-3 and also at the 65-desaturase between 20:3n-6 and 20:4n-3 
the net result of which is an apparent inhibition of 65-desaturation of 20:3n-6. 
Similar results regarding the ability of 18:3n-3 to inhibit conversion of 18:2n-6 to AA 
have been observed in mammals (Brenner, 1981). Similar competitive effects 
presumably operate to increase or reduce 22:5n-6 levels in SO- and LO-fed fish 
respectively. 
The apparent inability of farmed parr undergoing smoltification to convert 18:2n-6 
to AA, as described by Ackman and Takeuchi (1986), may be explained by 
competitive interactions between fatty acids for the desaturase binding sites. The 
increased PUFA levels in cell membranes of salmonids, particularly EPA and DHA, 
of fish undergoing smoltification are well documented and are believed to occur in 
freshwater prior to seawater entry (Sheridan et al. 1985; Li and Yamada, 1992). The 
importance of long-chain PUFA in adaptation to changes in salinity has been 
observed in essential fatty acid deficient trout, which had reduced ionic permeability 
in brush border membranes (Di Constanzo et al. 1983) while a similar EFA-
deficiency caused morphological changes in gills of turbot (Bell et al. 1985a). In 
addition, membrane PUFA composition is known to affect the activity of a number of 
ion pumps and membrane-bound enzymes including Na+, K+-ATPase (Spector and 
Yorek, 1985; Gerbi et al. 1994). The recent identification of lithe Sprecher shunt" 
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demonstrates that A4-desaturation of EPA to DHA actually proceeds via A6-
desaturation of 24:Sn-3 to 24:6n-3, followed by chain shortening to DHA (Voss et 
al. 1991). Thus, given the preference of n-3 over n-6 PUFA at the A6-desaturase 
binding site (Horrobin, 1991) both in mammals, and in fish (Hagve et al. 1986; 
Henderson and Tocher, 1987), the apparent inability of salmon undergoing 
smoltification to convert 18:2n-6 to AA can be accounted for. In addition, in farmed 
salmon fed diets containing marine fish oils the high levels of DHA will further 
prevent conversion of 18:2n-6 to AA by end-product feedback inhibition of d6-
desaturase (Garcia and Holman, 1965). 
In a previous study using rainbow trout no increase in elongated and desaturated 
products of 18:3n-3 were observed in the polar lipid fraction of fish fed an 18:3n-3 
enriched diet (Sowizral et al. 1990). However, in the present study with Atlantic 
salmon, although dietary EPA levels were similar in both LO and SO diets, the fatty 
acid compositions of tissue phospholipid classes showed decreased EPA in SO-fed 
fish, but LO-fed fish had EPA values greater than or equal to those of FO-fed fish 
(pages 113,116,121, 122, 125, 126). These results suggest that salmon can 
synthesise EPA from 18:3n-3 utilising the pathways of A6- and A5-desaturation and 
elongation. Although some phosphOlipid classes from liver of LO-fed fish had 
elevated 22:5n-3, there was no apparent increase in DHA compared to fish fed FO. 
Previous studies with salmonid parr suggest that synthesis of DHA frOm 18:3n-3 
should be possible (Henderson and Tocher, 1987) but in the larger post-smolts 
used in the present study A4-desaturation is either very low or, more likely, the 
requirement for DHA is met by dietary input (derived from fish meal; page 36). 
In CHH-1 cells the relative percentages of the d6-desaturation products of 18:2n-6 
and 18:3n-3 indicated that there was no specificity for either substrate. This result is 
similar to that of Tocher et al. (1989) with RTG-2 and turbot fin (TF) cells, but differed 
from AS cells which showed a preference for the n-3 substrate (Tocher and Dick, 
1990). However, the A5-desaturase in CHH-1 cells showed a preference towards 
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the n-3 substrate since supplementation with 18:3n-3 resulted in increased EPA 
while 18:2n-6 supplementation resulted in minimal AA production (pages 135-136). 
This does not reflect a specific adaptation of fish cells since similar substrate 
preferences have also been observed in mammalian cells (Stubbs and Smith, 
1984) and may be enhanced by the n-3 PUFA deficiency which exists in cells 
routinely cultured in foetal calf serum (FCS). Interestingly, culture of CHH-1 cells in 
medium supplemented with 1 % FCS and 25J.1M DHA resulted in phospholipid fatty 
acid compositions similar to those in intact salmon hearts. The ability to return these 
cells to a lipid composition approaching that of the salmonid heart makes them a 
useful model system to study the effects of membrane fatty acid composition on a 
number of biochemical and physiological functions, including eicosanoid 
production and membrane-bound enzyme activities etc. 
While considerable data have been accumulated, from both mammals and fish, on 
the effects of different dietary lipids on tissue fatty acid compositions, the effects on 
lipid class composition are less well documented. In dietary trial C, salmon fed LO 
had significantly reduced levels of heart PC compared to both other dietary 
treatments resulting in a PC:PE ratio less than unity. In the vast majority of fish 
species and tissues studied PC is the dominant phospholipid class (Henderson and 
Tocher, 1987), although, as in mammals, some fish brain tissue has PE in excess of 
PC Tocher and Harvie, 1988). Acclimation to low environmental temperature can 
decrease the PC:PE ratio in fish tissues (Miller et al. 1976) which is accompanied by 
increased incorporation of n-3 PUFA, principally DHA, into membrane 
phospholipids especially PE. In the present series of experiments DHA was not 
significantly increased in heart membrane phospholipids although there was an 
overall increase in n-3 PUFA in PE largely as a result of elevated 18:3n-3. While the 
exact reason for the decreased PC:PE ratio in fish fed LO is unclear, the 
consequences in terms of membrane physiology and biochemistry could be 
important in, for example, homeoviscous adaptation and function of membrane-
160 
associated proteins including enzymes, ion channels and receptors (Spector and 
Yorek, 1985; Tocher, 1995). 
Nutritional cardiomyopathy has been recorded in a number of fish species, 
particularly in intensive culture, and especially associated with vitamin E and 
selenium deficiences (Ferguson, 1989). Focal aggregation and infiltration of 
leucocytes on or in a myotome is often the pathological manifestation of an 
inflammatory stimulation. In the absence of detectable infectious agents or other 
antigenic sources in the affected areas, it is reasonable to conclude that such 
lesions are a direct result of local tissue damage (i.e. necrosis). Loss of individual 
myotome integrity and loss of muscle striation and occurrence of necrotic debris 
was confirmed in a sufficient number of lesions in dietary trials A and C to confirm 
that this was the primary cause of the inflammation. These latter lesions are difficult 
to photograph properly with the light microscope as they require a variety of different 
focal planes and even different lighting conditions (e.g. phase) to be detectable. 
Similar myopathies have been observed in mammals, including man, which can be 
attributed to deficiencies of selenium and/or vitamin E (Halliwell and Gutteridge, 
1985; Porter and Whelan, 1983), but no cardiomyopathy has been specifically 
associated with n-6 fatty acid intake. Fjolstad and Heyeraas (1985) found muscular 
and myocardial degeneration in their study on Hitra disease in Norwegian farmed 
salmon and suggested a relationship to dietary deficiency of vitamin E and/or 
selenium. An extensive degenerative cardiomyopathy studied by Ferguson et al. 
(1986) in association with pancreas disease (PO) of farmed salmon was also 
attributed by these authors to vitamin E and/or selenium deficiency. Although these 
authors considered the lesions of the pancreas to be linked to those of heart and 
muscle, McVicar (1987) gave evidence that heart and muscle lesions are not 
consistently or primarily associated with PD. In addition, Bell et al. (1987) 
considered that the depletion of vitamin E in PD-affected salmon was a 
consequence, rather than a cause of the disease. 
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In the three dietary studies the oil source was the only difference between the 
experimental diets. The high proportion of damaged hearts (page 58, 108) 
associated with the SO diet in comparison with the rarity of the condition in Fa-fed 
fish indicates that the damage was a consequence of the dietary lipids. Vitamin E is 
probably not involved in the cardiomyopathy because, although high amounts of 
PUFA are present in the SO diet, dietary vitamin E was included in the diets at or 
above a threefold excess of requirement (U.S. National Research Council, 1981). In 
addition measurement of heart vitamin E content showed no significant differences 
between dietary treatments (15.4 ± 7.5, Fa diet; 17.0 ± 4.0, SO diet; 16.6 ± 2.3, LO 
diet, mean (Jl9/g tissue) ± SO, n =4) and these values were more than 7-fold higher 
than those recorded in a study by Raynard et al. (1991) in which no cardiac lesions 
were observed. In dietary trial C focal cardiac myopathy was observed in fish fed 
SO and while some degeneration of cardiac tissue was also observed in fish fed FO 
these were much less severe. Cardiac myopathy was virtually absent in fish fed LO 
suggesting that dietary 18:3n-3 may have an attenuating effect on development of 
the pathological lesion. 
Although the exact cause of the cardiac lesion is not known a number of aspects 
deserve comment. The first is the similarity, in some ways, to the fainting or shock 
syndrome described by Sinnhuber (1969) and Castell et al. (1972) in trout fed a diet 
deficient in n-3 PUFA. This syndrome was similar to a transportation shock 
syndrome originally described by Black and Barrett (1957). In rainbow trout given 
18:2n-6 and lauric acid (14:0) as their only dietary lipids, Castell et al. (1972) 
observed an unusual heart condition, described as local myocarditis, with some 
degeneration and hypertrophy. A similar myopathy was observed in the present 
study, although the ventricular swellings observed in rainbow trout did not occur in 
SO-fed salmon. However, the extent to which either the shock syndrome described 
by Sinnhuber (1969) or the transportation induced mortalities described in this work 
involved cardiac or cardiovascular malfunction is not known. Clearly the SO-fed fish 
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in dietary trials A and C were not deficient in n-3 PUFA on an absolute basis, but 
they could be considered to be relatively deficient in n-3 PUFA in the sense that 
their diet contained a considerable excess of n-6 compared with n-3 PUFA. 
This raises concern as to the level at which the dietary ratio of n-6/n-3 PUFA 
becomes high enough to be pathological to fish. As far as I are aware, there is no 
evidence in the literature to suggest that a high ratio of these lipids is deleterious to 
fish, despite the now well established fact that high dietary ratios of n-6/n-3 PUFA 
can lead to the development of pathological conditions in humans (Lands, 1986; 
Crawford, 1987). Indeed, lowering the high dietary ratio of n-6/n-3 PUFA by taking n-
3 PUFA-rich fish oil concentrates is known to be beneficial in alleviating a number of 
human disorders, including cardiac disease (Lands, 1986; Budowski, 1988). 
The experiments with cardiac-derived CHH-1 cells showed that cell cultures grew 
well when supplemented with 1 % FCS and fatty acids, attached to BSA, added at a 
concentration of 25 ~M. The exception was those cells which were supplemented 
with 20:3n-6 which did not achieve confluence and began to detach from the flask 
after 6-7 days. The experiment was repeated twice using the same fatty acid 
concentration, with two different sources of 20:3n-6 and the same deleterious effect 
on growth was recorded. While the exact cause of the growth inhibition remains 
unclear, it seems unlikely that it was due to the presence of toxic lipid oxidation 
products since measurement of thiobarbituric acid reactive material in the PUFA-
BSA complexes indicated the greatest levels of oxidation products were present in 
the EPA and DHA supplements which demonstrated no growth inhibition (Results 
not shown). While CHH-1 cells supplemented with 20:3n-6 had a considerably 
reduced n-3/n-6 PUFA ratio, similar to the cardiac tissue from fish fed a diet 
containing SO, it is unlikely that this was the only explanation for the growth 
inhibition since supplementation with other n-6 PUFA, including AA, at the same 
concentration did not affect cell growth. However, it is important to note that in 
cardiac tissue from SO-fed fish, some of which developed cardiac lesions, 20:3n-6 
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showed the biggest percentage increase of any C20 PUFA when compared to fish 
fed FO. 
Alterations in the dietary n-3/n-6 PUFA ratio can alter the physico-chemical 
properties of the membranes and consequently the activities of membrane-
associated enzymes. Examples include mitochondrial ATPase (Robblee and 
Clandinin, 1984), sarcolemmal 5' -nucleotidase (Awad and Chattopadhyay, 1983), 
ornithine decarboxylase (Bunce and Abou-EI-Ela, 1990) and sarcoplasmic 
reticulum (SR) Ca2+-Mg2+ ATPase (Swanson et al. 1989). The latter enzyme is an 
assymetric integral transmembrane protein (Scales and Inesi, 1976) of the SR 
which controls calcium flux in excitable tissues e.g. cardiac myocytes. Swanson et 
al. (1989) showed that a relatively small increase in the n-3/n-6 PUFA ratio in the SR 
phospholipid could cause a large decrease (around 6-fold) in murine Ca2+-Mg2+ 
ATPase activity. In the present study with salmon heart, considerable changes in the 
n-3/n-6 PUFA ratio in cardiac phospholipids caused no significant alteration in SR 
Ca2+-Mg2+ ATPase activity. The major alteration in the fatty acid composition of 
murine SR was an increase in DHA, particularly in PC of mice given menhaden oil, 
whereas the present study showed no significant dietary-induced alteration in 
phospholipid DHA. Rabbits given menhaden oil showed no incorporation of DHA 
but some incorporation of EPA into skeletal muscle SR and consequently, no 
alteration of skeletal muscle SR Ca2+-Mg2+ATPase was observed (Gould et al. 
1987). Thus, it appears that DHA may be essential in the control of the SR calcium 
pump. While the work of Swanson et al. (1989) indicates decreased activity of the 
SR calcium pump in mice fed menhaden oil, a study by Karmazyn et al. {1987} 
observed enhanced uptake of Ca2+ in cardiac myocytes from rats fed cod-liver oil. 
Infante (1987) suggests that low dietary n-3 (or high n-6) PUFA may encourage 
uncoupling of the SR Ca2+ ATPase, such that ATP hydrolysis may be occurring in 
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the absence of calcium translocation. This possibility was not examined in the 
present work. The importance of the dietary n-3/n-6 PUFA ratio on the 
microenvironment of the Ca2+-Mg2+ATPase and thus, the control of Ca2+/ATP 
coupling is an obvious area for further study. 
A recent study has shown that alterations in the membrane n-3/n-6 PUFA ratio in 
cultured rat ventricular myocytes can influence the activity of enzymes involved in 
lipid metabolism. Nalbone et al. (1990) demonstrated that cardiomyocyte cultures 
supplemented with n-6 PUFA had a higher phospholipase A activity and lower 
Iysophospholipase activity compared to those supplemented with n-3 PUFA. In this 
study the activity of cardiac phospholipase A was significantly increased in fish fed 
18:2n-6-rich SO compared to fish fed either Fa or La. Increased phospholipase 
activity towards endogenous phospholipids could increase turnover of membrane 
fatty acids, provide increased substrate for eicosanoid synthesis and generally have 
a destabilising effect on membrane integrity. Although Iysophospholipase activity 
was not measured in the present study increased hydrolysis of PC could lead to 
increased production of Iyso PC which is a potent cytolytic agent (Choy et al. 1989). 
The term eicosanoid was first used by Corey et al. (1980) to describe a number of 
biologically active metabolites of eicosapolyenoic fatty acids which include 
prostaglandins and thromboxanes (collectively called prostanoids) and leukotrienes 
(Johnson et al. 1983). Eicosanoids are produced in response to various 
extracellular stimuli by two main dioxygenase enzymes, cyclooxygenase and 
lipoxygenase, and their products have been identified in almost all mammalian 
tissues and fluids (Horrobin, 1978). Eicosanoids have been found in a large range 
of freshwater and marine fish (Mustafa and Srivastava, 1989) and virtually all fish 
tissues studied, including spleen, kidney, gill, heart, liver, stomach, intestine, muscle, 
brain, skin, reproductive organs and blood cells have shown cyclooxygenase 
activity (Tocher, 1995). 
Many of the beneficial effects of fish oil supplements in attenuating a number of 
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atherothrombotic, autoimmune and inflammatory conditions are, in part, due to the 
modulation of M-derived eicosanoids by EPA and DHA (Weber, 1990). 
Suppression of AA-derived eicosanoids by dietary 18:3n-3 has also been observed 
in mammals (Marshall and Johnson, 1982). The enzymatic pathway producing 
eicosanoids is often called the larachidonic acid cascade', since AA, which yields 2-
series prostaglandins, is the principal precursor in mammals (Horrobin, 1983). 
However, 20:3n-6 and EPA are also eicosanoid precursors, yielding 1- and 3-series 
prostaglandins, respectively, although both are poorer substrates than AA for 
prostaglandin synthetase (Crawford, 1983). While both 20:3n-6 and EPA are inferior 
to M as substrates for prostaglandin production they can act as competitive 
inhibitors of M for the enzyme binding sites (Willis, 1981). In addition, 1- and 3-
series prostanoids generally have lower biological activity compared to their 2-
series homologues and thus dietary supplementation with 20:3n-6, EPA or their C18 
precursors can attenuate production and efficacy of AA-derived eicosanoids (Willis, 
1981; Weber, 1990). 
Feeding salmon increasing levels of 18:2n-6 resulted in moderately increased 
phospholipid AA with simultaneously reduced phospholipid EPA and thereby 
substantially increased the 20:4/20:5 eicosanoid precursor ratio in membrane 
phospholipids (page 83-86, 88-92, 94-97). In dietary experiment C feeding LO 
resulted in decreased AA and increased EPA in tissue phospholipids. Thus, the 
feeding of dietary SO or LO might be expected to alter the spectrum of eicosanoids 
produced by these fish compared to those fed FO. This effect is well illustrated by 
comparing the fatty acid compositions of liver PI from the third dietary experiment 
(page 126). M was increased from 28% in FO-fed fish to 42% in SO-fed fish while 
the value in LO-fed fish was reduced to 21%. EPA was reduced from 4.9% in FO-fed 
fish to 0.7% in SO-fed fish but increased to 10.1 % in fish fed LO. The tendency for 
the PI fraction to accumulate C20 PUFA in fish has resulted in the hypothesis that 
this phospholipid might be the source of precursor fatty acids for eicosanoid 
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production (Bell et al. 1983, German and HU,1990). 
Given the changes in eicosanoid precursor availability resulting from feeding 
dietary SO, the possibility exists that the cardiac myopathy observed in the present 
study arises from an over production of AA-derived eicosanoids. Cardiac-derived 
prostaglandins are important modulators of myocardial function (Karmazyn and 
Dhalla, 1983) with prostacyclin (PGI2) being the primary cyclooxygenase-derived 
product in mammalian heart (Karmazyn et al. 1987). In this study, the production of 
6-keto PGF1 a' the stable metabolite of PGI2, and TXB2, the stable metabolite of 
thromboxane (TXA2), were both increased in stimulated cardiac myocytes from 
salmon fed high 18:2n-6 compared to those fed FO. Production of PGE2 by 
stimulated cardiac myocytes was increased in fish fed both SO and LO compared to 
those fed FO, although the antibody used to measure PGE2 is equally reactive with 
PGE3 and thus the precise effect on the AA-derived homologue could not be 
determined. Therefore, the results presented in the present studies should really be 
interpreted as total PGE and total TXB, although evidence suggests that the majority 
of these will be AA-derived (Anderson etal. 1981; Bell etal. 1994b). Thromboxane 
is an important mediator of platelet aggregation, vascular tone and intracellular 
calcium concentration (Weber, 1990). Studies investigating skeletal muscle 
synthesiS have shown that PGI2 is stimulatory whereas PGE2 is inhibitory to muscle 
fibre formation (McLennan, 1991). PGE2 can also stimulate protein catabolism 
(Barnett and Ellis, 1987). If similar effects were active in salmon cardiac myocytes it 
may explain the apparent loss of musculature which occurred in fish fed SO. 
In addition to eicosanoids produced by cardiac myocytes themselves heart tissue 
is also subjected to eicosanoids produced in the bloodstream. Fish which 
developed the histopathological cardiac lesion showed extensive leucocyte 
infiltration at the lesion site. Thus, increased production of highly bioactive AA-
derived eicosanoids by leucocytes may be responsible for the severity of lesion 
development. For these reasons the levels of plasma eicosanoids and those 
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produced by blood stimulated by the calcium ionophore, A23187, were measured. 
Stimulated whole blood was used in these studies, instead of isolated leucocytes, to 
study eicosanoid production because this more closely resembles the in vivo 
situation where interactions between different cell types are known to have 
profound effects on the spectrum of eicosanoids produced (Lagarde et al. 1989). 
Studies with rainbow trout have indicated that leucocytes are the only blood cells 
which are directly capable of eicosanoid production and that no eicosanoids are 
generated by ionophore-stimulated erythrocytes (Pettitt et al. 1989). The changes in 
leucocyte membrane fatty acid composition in the present study are reflected in the 
nature of the eicosanoids produced on stimulation with A23187. Salmon given SO 
showed significantly increased levels of plasma 6-keto PGF1 ex and TXB2 while 
LTB4 was increased and LTBs decreased after stimulation of blood cells with 
A23187 compared to fish fed FO. LTB4 is a particularly powerful chemotactic agent 
for neutrophils and it is also a potent agonist in stimulating cellular uptake of 
calcium (Strasser et al. 1985). EPA-derived LTBS' however, is up to 30 times less 
potent in mammals (Lee ef al. 1984) and one study in fish suggests that rainbow 
trout leucocytes are indeed less sensitive to this isomer (Secombes et al. 1994). 
Levels of the 12-lipoxygenase product, 12-HEPE derived from EPA were 
significantly increased in stimulated blood cells, while levels of AA-derived 12-
HETE were significantly reduced in fish fed FO compared to those fed SO. 
In addition to cardiac myocytes and blood cells it was decided to look at 
eicosanoid production in gill cells since they are known to possess a highly active 
12-lipoxygenase (German ef al. 1986) and also contain significant cyclooxygenase 
activity (Tocher, 1995). While trout gill homogenates have a 12-lipoxygenase 
capable of converting exogenous radiolabeled AA and EPA to their 12-hydroxy 
metabolites (German et al. 1986), there has been little information on the production 
of these metabolites from endogenous precursor fatty acids derived from gill 
phospholipids. Dietary study A (page 72) demonstrates that in Atlantic salmon given 
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FO the major product from gill cells is EPA-derived 12-HEPE. This is in contrast to a 
study using gill homogenates from rainbow trout which demonstrated that AA was 
the major fatty acid released from membrane phospholipids and that 12-HETE was 
the predominant metabolite (German and Hu, 1990). While the diet used by German 
and Hu (1990) is not known, in the present study only in salmon given the highest 
level of dietary SO did the ratio of 12-HETEl12-HEPE increase towards unity. 
Stimulated gill cells from fish fed LO produced a level of 12-HEPE greater than SO-
fed but lower than FO-fed fish and the 12-HETEl12-HEPE ratio was not significantly 
different to that in FO-fed fish. 
While feeding SO caused a reduction in the ratio of EPA:AA-derived lipoxygenase 
products in gills, it also caused a dramatic reduction in totallipoxygenase 
metabolites produced from both AA and EPA. Similarly, there was a decrease in 6-
keto PGF1 (l but no significant decrease in TX82 produced by gill cells from fish fed 
SO. It is difficult to account for the marked decrease in eicosanoid products in gills in 
terms of altered levels of their substrate fatty acids esterified in phospholipids. 
However, it may be notable that the amount of 20:3n-6 was increased up to 7 -fold in 
fish fed SO and this fatty acid is known to inhibit production of AA-derived 
lipoxygenase metabolites (Miller et al. 1990) and prostaglandins (8ell et al. 1994b). 
PGE1' which is derived from 20:3n-6, can cause increased synthesis of cAMP, a 
potent inhibitor of AA mobilisation (Horrobin, 1980). Recent studies with rats have 
shown that a decrease in dietary n-3/n-6 PUFA ratio can affect the activity of 
phospholipase A2' being either decreased in gastric mucosa (Grataroli et al. 1988) 
or increased in cardiac myocytes (Nalbone et al. 1990). In a very recent study the 
activity of gill phospholipase A activity was reduced in salmon fed SO (66%) and LO 
(40%) compared to fish fed FO (8ell et al. 1996). A decrease in phospholipase 
activity in the gills of salmon fed SO in the present studies would result in less 
available substrate for lipoxygenase and cyclooxygenase and could explain the 
diminished eicosanoid production which were observed in gills. However, in dietary 
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trial C the reduction in gill lipoxygenase products was accompanied by increased 
production of prostanoids, suggesting that PUFA substrates which were not utilised 
by lipoxygenase were metabolised via cyclooxygenase. Clearly, the spectrum of 
eicosanoids produced by a particular cell is dependent on a more complex 
mechanistic process than the concentration or ratios of substrate PUFA esterified in 
membrane phospholipids alone. 
Previous studies with rainbow trout leucocytes (Pettitt and Rowley, 1990) and with 
rat platelets and guinea-pig epidermis (Careaga-Houck and Sprecher, 1989; Miller 
et al. 1990) have failed to detect DHA-derived lipoxygenase metabolites from 
endogenous DHA, although human platelets could synthesise 14-HDHE from 
exogenous [1 J4C]-DHA (Aveldano and Sprecher, 1983). In dietary study B, (page 
100) gill cells from fish fed FO produced greater amounts of 14-HDHE than 12-
HETE and only marginally less than 12-HEPE. Feeding SO resulted in reduced 
production of 14-HDHE as well as 12-HEPE and 12-HETE. While the production of 
14-HDHE, derived from endogenous DHA, has been observed in homogenates of 
trout gill (German and Hu, 1990), the present work shows that 12-lipoxygenase 
products of DHA are generated, from endogenous precursors, by intact gill cells. 
The ability of gills to synthesise 14-HDHE has also been observed in rainbow trout 
(Oncorhynchus mykiss) (Knight et al. 1995). 
The tendency for PI to accumulate C20 PUFA, especially AA, in fish which 
otherwise contain large amounts of DHA and EPA, has suggested that this lipid 
class may be a potential source of eicosanoid precursors (Bell et al. 1983; German 
and Hu, 1990). However, the ratio of 12-HETEl12-HEPE produced by stimulated gill 
cells in the current experiments was most similar to the ANEPA ratio present in gill 
PC (0.20, 0.61 and 0.20 for the FO, SO and LO diets respectively). Comparison of 
the precursor fatty acid ratios of both PC and PI would make the former class the 
more likely source of lipoxygenase substrate fatty acids. PC-specific 
phospholipases have been identified in mammalian platelets and cultured umbilical 
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cells (Fischer et al. 1984; Takayama et at. 1989). In contrast, stimulated whole blood 
cells (Dietary experiment 2) showed average values for 12-HETEl12-HEPE and 
LTB4/LTBS ratios which most closely resemble the AA:EPA ratio in leucocyte PE. It is 
possible that PI may represent a slowly turning over pool of eicosanoid precursors 
whereas in a rapid turnover situation, such as stimulation with A23187, the 
precursors are derived from the major phospholipid classes, PC and PE. 
Although few specific physiological roles have been identified for lipoxygenase 
products a number of recent studies have implicated 12-HETE as a modulator of 
ion-channels (Buttner et al. 1989; Massferrer et al. 1990). Clearly this activity would 
be particularly important in gills which, along with the posterior kidney are vital in 
controlling osmoregulation in fish. The ability of fish kidney and gill to synthesise 
prostaglandins has been established for some time although their functions were 
largely unknown (Ogata et al. 1978; Christ and van Dorp, 1972). However, PGE2 
and PGE1 are both active antiduiretic agents in trout and eel kidney (Wales and 
Gaunt, 1986; Brown et al. 1991) while PGE2 inhibits ion transport in gill epithelia 
(Van Praag et al. 1987). Clearly diet-induced changes in gill (and kidney) 
eicosanoid products might therefore affect the ability of salmon to adapt to salinity 
changes which would be especially important in salmon parr about to undergo 
transition to seawater. Prostaglandins can reduce the activity of Na+fK+-ATPase in 
kidney tubules allowing more Na+ to be lost via urinary excretion (Jabs et al. 1989) 
and can function in conjunction with hormones to control osmoregulation (Mustafa 
and Srivastava, 1989). In addition, leukotrienes and HETES, products of 
lipoxygenases, can inhibit Na+, K+ and cr absorption by the kidney (Egan et al. 
1992; Satoh et al. 1993). The gills and gut epithelium are other important sites of 
osmoregulation in fish (Girard et al. 1977; Di Constanzo et al. 1983) and both 
tissues had increased levels of AA in masu salmon (Oncorhynchus masou) 
undergoing parr-smolt transformation (U and Yamada, 1992). Wild Atlantic salmon 
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parr contain much higher levels of AA than their farmed counterparts, and this factor 
could be especially important during smoltification and transition to seawater, where 
the functionality of eicosanoids in osmoregulatory tissues would be vital to achieve 
physiological adaptation to increased salinity. 
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8.2 Overall summary 
1. Practical-type diets containing either fish oil (FO), sunflower oil (SO) or linseed oil 
(LO) as their lipid component were fed to Atlantic salmon post-smolts for up to 16 
weeks. All diets contained levels of n-3 PUFA sufficient to satisfy growth and 
development. No differences in final weights between the different dietary 
treatments were observed in trials A and C. However, in trial B fish fed the 
intermediate level of linoleic acid (25%) had significantly higher final weights 
compared to both other treatments while fish fed the highest level of linoleic acid 
(45%) had significantly lower final weights compared to both other treatments (page 
BO). 
2. A number of fish fed SO developed severe cardiac lesions which caused thinning 
of the ventricular wall and necrosis. In addition the fish fed SO suffered a 
transportation-induced shock syndrome which resulted in mortalities in excess of 
30%. A small number of fish fed FO developed a similar cardiac lesion, albeit in a 
less severe form, whereas the lesion was virtually absent in fish fed LO. 
3. Incorporation of linoleic acid into membrane phospholipids was increased in 
response to dietary intake. In addition to linoleic acid, tissue phospholipids from fish 
fed SO showed increased 20:2n-6 (up to 4-fold), 20:3n-6 (up to 7-fold) and AA (up 
to 3-fold), and decreased 20:5n-3 (up to 2-fold). The ratio of n-3/n-6 PUFA in fish fed 
SO decreased (up to 4-fold) and the AAlEPA ratio increased (up to 9-fold) in tissue 
phospholipids. 
4. The tissue phospholipids from fish fed LO had increased levels of 1B:2n-6, 20:2n-
6 and 20:3n-6 but AA, 22:4n-6 and 22:5n-6 were similar, or significantly reduced, 
compared to fish fed FO. Tissue phospholipids from fish fed LO also had increased 
18:3n-3 and 20:4n-3 compared to both other treatments while in certain tissues and 
phospholipid classes EPA was increased compared to fish fed FO. In addition, fish 
fed LO had reduced levels of PC in cardiac membranes, compared to fish fed FO or 
SO, which resulted in a PC:PE ratio of less than unity. 
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5. These changes in eicosanoid precursor ratios were reflected in altered 
eicosanoid production. 12-HEPE, derived from EPA, was the major 12-lipoxygenase 
product produced by gill cells, from Fa-fed fish, stimulated with A23187. Production 
of 12-HEPE and also 12-HETE, 14-HDHE and TXB2 were all significantly 
decreased in fish fed both SO and La compared to fish fed Fa. However, the ratio of 
12-HETEl12-HEPE generally reflected phospholipid ANEPA ratios. 
6. Blood leucocytes stimulated with A23187 showed increased production of LTB4' 
12-HETE and TXB2, and reduced production of LTBS and 12-HEPE in fish fed SO 
compared to fish fed Fa. Stimulated blood leucocytes from fish fed La produced 
less TXB2 compared to those fed SO and less PGE2 compared to those fed both 
SO and Fa. 
7. In isolated cardiac myocytes stimulated with A23187, TXB2 production was 
significantly increased in fish fed the highest dietary level of 18:2n-S (45% of total 
fatty acids) compared to fish fed the lower levels of dietary linoleic acid (10 and 25% 
of total fatty acids). The activity of heart sarcoplasmic reticulum Ca2+-Mg2+ ATPase 
was not affected by dietary lipid. 
8. In an established cell line derived from chum salmon hearts (CHH-1) ~S 
desaturase activity was considerable but showed no preference for n-3 substrates 
over n-S. CHH-1 cells also exhibited significant ~s desaturase activity which 
showed a preference towards n-3 PUFA. No ~4 desaturation activity was observed. 
Elongation of C20 PUFA was particularly active in CHH-1 cells with C22 PUFA 
being incorporated specifically into PE and PS. 
9. CHH-1 cells supplemented with 20:3n-S showed reduced growth rate, cell death 
and unusual pycnotic appearance, compared to those supplemented with other 
PUFA. 
10. The fatty acid compositions of triacylglycerols (TAG) and phospholipids in hearts 
and livers of both farmed parr and pre-smolts contained greater amounts of 
monoenoic fatty acids, largely due to increased 20:1n-9 and 22:1n-11, compared to 
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their wild counterparts. TAG, PC and PE from heart and liver of wild fish contained 
more 18:2n-6 and AA compared to farmed fish. Linolenic acid was increased in all 
lipid classes of wild fish while EPA and 22:Sn-3 were increased in hearts and livers 
of wild fish compared to farmed. DHA levels were considerably higher in both 
tissues from farmed fish but particularly in heart PC, PS and TAG. The n-3/n-6 PUFA 
ratios were generally lower in hearts compared to livers and were lower in wild 
compared to farmed fish, largely due to increased n-6 PUFA in wild fish, and in 
particular AA. 
8.3 Future studies 
The development of a pronounced cardiac lesion in salmon fed diets containing 
high levels of 18:2n-6 (and having a low n-3/n-6 PUFA ratio) was unexpected and 
previously unrecorded in the literature. The accompanying increase in AA-derived 
eicosanoids in fish fed SO suggests that over production of series 2 prostaglandins 
and series 4 leukotrienes may be implicated in the lesion development. This 
suggestion is supported by the apparent ability of LO, which significantly reduces 
phospholipid AA but maintains or increases EPA compared to fish fed FO, to reduce 
the incidence of cardiac lesions. It would therefore be interesting to see if a similar 
suppression of the lesion occurred on feeding an oil enriched in EPA, for example a 
southern hemisphere fish oil like sardine oil. 
Supplementation of the cardiac-derived cell line, CHH-1, with 20:3n-6 resulted in 
reduced growth rate, cell death and unusual cellular appearance. Interestingly, 
feeding diets rich in 18:2n-6 resulted in 20:3n-6 being increased, in percentage 
terms, to a greater degree than any other C20 PUFA. Thus, increased levels of 
20:3n-6 in salmon membrane phospholipids may also be involved in the cellular 
damage to cardiac tissue recorded in fish fed SO. A dietary trial utilising borage oil 
or evening primrose oil would be useful because they are rich in 18:3n-6 which 
should lead to an accumulation of 20:3n-6 since the activity of the C18 elongase is 
considerably greater than that of the d5 desaturase. A trial with an 1B:3n-6-rich oil 
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would be doubly interesting since these oils are generally regarded as anti-
inflammatory, at least in mammals, due to their ability to reduce AA levels and the 
ability of 20:3n-6 to act as a competitive inhibitor of cyclooxygenase and 
lipoxygenase. Thus, 20:3n-6 can reduce the amount of AA-derived eicosanoids 
produced, in a similar manner to EPA, and also forms series 1 prostaglandins 
which, in mammals at least, are less biologically potent compared to their series 2 
homologues. Indeed the reduced production of eicosanoids in gills of salmon fed 
SO may be attributed to the inhibitory actions of series 1 prostaglandins, especially 
PGE1' on the hydrolysis of AA from membrane phospholipids. PGE1 has a range of 
pharmacological activities in mammals, including stimulation of cAMP formation 
which in turn can inhibit phospholipase A2 and thus the mobilisation of AA in a 
manner similar to steroids (Horrobin, 1992). 
In the present study the prostaglandins measured were restricted to those of the 2 
series i.e. derived from AA. Recent developments in our laboratory, coupled with the 
availability of standards, have allowed measurement of prostaglandins of the 3-, 2-
and 1-series from the same sample. These techniques would be applied in future 
dietary trials to ascertain the effects of diets which increase membrane EPA and 
20:3n-6 on concentrations of prostaglandins derived from all three C20 precursors. 
The CHH-1 established cell line proved useful in studying the incorporation and 
metabolism of polyunsaturated fatty acids in cardiac-derived cells from a salmonid 
fish. In addition, it would be useful to prepare primary cultures of salmon cardiac 
myocytes, as myocytes can be routinely cultured from mammals, to further 
investigate lipid metabolism in heart cells and also to test the effects of 
supplementaion with 20:3n-6, AA and EPA on cell growth and eicosanoid 
production in vitro. 
176 
Ackman, RG. 1980. Fish Lipids part 1. In Advances in Fish Science and 
Technology, Connell, J.J. ed. Fishing News Books, Farnham, U.K. pp. 87-103. 
Ackman, RG. and Takeuchi, T. 1986. Comparison of fatty acids and lipids of 
smolting hatchery fed and wild Atlantic salmon (Sa/mo safar). Lipids 21,117-
120. 
Alam, S.Q., Ren, Y.F. and Alam, B.S. 1988. [3H] forskolin- and [3H] dihydroalprenol-
binding sites and adenylate cyclase activity in heart of rats fed diets containing 
different oils. Lipids 23, 207-213. 
Anderson, AA, Fletcher, T.C. and Smith, G.M. 1981. Prostaglandin biosynthesis in 
the skin of the plaice, P/euronectes p/atessa L. Compo Biochem. Physiol. 70C, 
195-199. 
Anon. 1992. Unsaturated fatty acids, nutritional and physiological significance. The 
report of the British Nutrition Foundation's Task Force. 211 pages. Chapman and 
Hall, London, 
Applegate, K.R and Glomset, J.A 1986. Computer-based modelling of the 
conformation and packing properties of docosahexaenoic acid. J. Lipid Res. 27, 
658-680. 
Argyropoulou, V., Kalogeropoulos, N. and Alexis, M.N. 1992. Effect of dietary lipids 
on growth and tissue fatty acid composition of grey mullet (Mugi/ cepha/us). 
Compo Biochem. Physiol. 101A, 129-135. 
Armstrong, D.T. and Grimwich, 0.1. 1972. Blockade of the spontaneous and LH 
induced ovulation in rats by indomethacin, an inhibitor of prostaglandin 
biosynthesis. Prostaglandins 1 I 21-28. 
Aveldano, M.1. and Specher, H. 1983. Synthesis of hydroxy fatty acids from 4, 7, 10, 
13, 16, 19-[1-C 14]-docosahexaenoic acid by human platelets. J. BioI. Chem. 
258, 9339-9343. 
177 
Awad, A.B. and Chattopadhyay, J.P. 1983. Effect of dietary fats on the lipid 
composition and enzyme activities of rat cardiac sarcolemma. J. Nutr. 113, 1878-
1884. 
Bandyopadhyay, G.K., Datta, J. and Ghosh, S. 1982. Synthesis of diene 
prostaglandins in freshwater fish. Lipids 17, 755-758. 
Barnett, J.G. and Ellis, S. 1987. Prostaglandin E2 and the regulation of protein 
degradation in skeletal muscle. Muscle and Nerve 10, 556-559. 
Bartlett, M.S. 1937. Some examples of statistical methods of research in agriculture 
and applied biology. J. Royal Statist. Soc. Suppl. 4,137-170. 
Bazan, N.G. 1990. Supply of n-3 polyunsaturated fatty acids and their significance 
in the central nervous system. In Nutrition and the Brain vol. 8. Wurtman, R.J. 
and Wurtman, J.J. eds. pp. 1-24. Raven Press, New York. 
Bell, J.G., McVicar, A.H. and Cowey, C.B. 1987. Pyruvate kinase and antioxidant 
parameters in pancreas disease. Aquaculture 66, 33-41. 
Bell, J.G., Ghioni, C. and Sargent, J.R. 1994a. Fatty acid compositions of 10 
freshwater invertebrates which are natural food organisms of Atlantic salmon 
parr (Sa/rno sa/ar): a comparison with commercial diets. Aquaculture 128,301-
313. 
Bell, J.G., Tocher, D.R. and Sargent, J.R. 1994b. Effect of supplementation with 
20:3(n-6), 20:4(n-6) and 20:5(n-3) on the production of prostaglandins E and F 
of the 1-, 2- and 3-series in turbot (Scophthalrnus maxim us) brain astroglial cells 
in primary culture. Biochim. Biophys. Acta. 1211, 335-342. 
Bell, J.G., Farndale, B.M., Dick, J.R. and Sargent, J.R. 1996. Modification of 
membrane fatty acid composition, eicosanoid production, and phospholipase A 
activity in Atlantic salmon (Sa/mo safar) gill and kidney by dietary lipid. Lipids 
31,1163-1171. 
178 
Bell, J.G., Youngson, A, Mitchell, A.I., and Cowey, C.B. 1989. The effect of enhanced 
intake of linoleic acid on the fatty acid composition of tissue polar lipids of post-
smolt Atlantic salmon (Sa/mo sa/ar). Lipids, 24,240-242. 
Bell, M.V. and Dick, J.R. 1991. Molecular species composition of the major 
glycerophospholipids from the muscle, liver, retina and brain of cod (Gadus 
morhua). Lipids 26, 565-573. 
Bell, M.V. and Tocher, D.R. 1989. Molecular species composition of the major 
phospholipids in brain and retina from rainbow trout (Sa/mo gairdneri) 
Occurrence of high levels of di-(n-3) polyunsaturated fatty acid species. 
Biochem. J. 264, 909-915. 
Bell, M.V., Henderson, R.J. and Sargent, J.R. 1985b. Changes in fatty acid 
compositions of phospholipids from turbot (Scophtha/mus maximus) in relation 
to dietary polyunsaturated fatty acid deficiencies. Compo Biochem. Physio!. 81 B, 
193-198. 
Bell, M.V., Simpson, C.M.F. and Sargent, J.R. 1983. (n-3) and (n-6) polyunsaturated 
fatty acids in the salt-secreting epithelia from two marine fish species. Lipids 18, 
720-726. 
Bell, M.V., Henderson, R.J., Pirie, B.J.S. and Sargent, J.R. 1985a. Effects of dietary 
polyunsaturated fatty acid deficiencies on mortality, growth and gill structure in 
turbot (Scophtha/mus maxim us, Linnaeus). J.Fish BioI. 26: 181-191. 
Bell, M.V., Batty, R.S., Dick, J.R., Fretwell, K., Navarro, J.C. and Sargent, J.R. 1995. 
Dietary deficiency of docosahexaenoic acid impairs vision at low light intensities 
in juvenile herring (Clupea harengus L.). Lipids 30, 443-449. 
Black, E.C. and Barrett, I. 1957. Increase in the levels of lactic acid in the blood of 
cut-throat and steelhead trout following handling and live transport. Can. Fish 
Cult. 20, 13-20. 
179 
Blackwell, G.J., Flower, R.J., Nijkamp, F.P. and Vane, J.R. 1978. Phospholipase A2 
activity of guinea-pig isolated perfused lungs: stimulation and inhibition by anti-
inflammatory steroids. Br; J. Pharmacol. 62,79-89. 
Bolger, P.M., Eisner, G.M. and Ramwell, P.W. 1978. Renal actions of prostacyclin. 
Nature (London) 271,467-469. 
Bonis, D., Chanbaut-Buerin, A.M. and Rossignol, B. 1985. ATP-dependent calcium 
transport in rat parotid microsomes. I. Localization properties, Ca2+-ATPase 
activity and phosphoenzyme formation. BioI. Cell. 55, 55-62. 
Brenner, R.R. 1981. Nutritional and hormonal factors influencing desaturation of 
essential fatty acids. Prog. Lipid Res. 20, 41·47. 
Breton, B., Jalabert, B. and Foster, A. 1975. Induction de decharges des 
gonadotrophes hypophysaires chez la carpe (Cyprinus carpio) a I'aide du 
citrate de cisclomiphene. Gen. Compo Endocrinol. 25, 400-404. 
Brown, J.A. and Bucknall, R.M. 1986. Antidiuretic and cardiovascular actions of 
PGE2 in the rainbow trout Sa/rno gairdneri . Gen. Compo Endocrino!. 61, 330-
337. 
Brown, J.A., Gray, C.J., Hattersley, G. and Robinson, J. 1991. Prostaglandins in the 
kidney, urinary bladder and gills of the rainbow trout and European eel adapted 
to freshwater and seawater. Gen. Compo Endocrinol. 84, 328-335. 
Brown, M.F. 1994. Modulation of rhodopsin function by properties of the membrane 
bilayer. Chem. Phys. Lipids 73, 159-180. 
Bruckner, G.G., Lokesh, B., German, B. and Kinsella, J.E. 1984. Biosynthesis of 
prostanoids, tissue fatty acid composition and thrombotic parameters in rats fed 
diets enriched with docosahexaenoic (22:6n-3) or eicosapentaenoic (20:5n-3) 
acids. Thromb. Res. 34, 479-497. 
180 
Budowski, P. 1988. Omega-3 fatty acids in health and disease. In Aspects of Human 
Nutrition and Dietetics (Bourne, G.H. ed.) vol. 57, pp. 214-274. Karger, Basel, 
Switzerland. 
Bunce, O.R. and Abou-EI-Ela, S.H. 1990. Eicosanoid synthesis and ornithine 
decarboxylase activity in mammary tumors of rats fed varying dietary levels and 
types of n-3 and/or n-6 fatty acids. Prostaglandins, Leukotrienes and Essent. 
Fatty Acids. 41, 105-113. 
Buttner, N., Siegelbaum, S.A. and Volterra, A. 1989. Direct modulation of Aplysia S-
K+ channels by a 12-lipoxygenase metabolite of arachidonic acid. Nature 342, 
553-555. 
Cagen, L., Qureshi, Z. and Nishimura, H. 1983. Metabolism of arachidonic acid by 
saline washed toadfish Opsanus tau red cells. Biochem. Biophys. Res. 
Commun. 110,250-255. 
Carreaga-Houck, M. and Sprecher, H. 1989. The effect of a fish oil diet on the fatty 
acid composition of individual phospholipids and eicosanoid production by rat 
platelets. Lipids 24, 477-481. 
Castell, J.D., Bell, J.G., Tocher, D.R. and Sargent, J.R. 1994. Effects of purified diets 
containing different combinations of arachidonic and docosahexaenoic acid on 
survival, growth and fatty acid composition of juvenile turbot (Scophtha/mus 
maxim us). Aquaculture 128, 315-333. 
Castell, J.D., Sinnhuber, RO., Wales, J.H. and Lee, D.J. 1972. Essential fatty acids 
in the diet of rainbow trout (Sa/mo gairdneri): growth, feed conversion and 
some gross deficiency symptoms. J. Nutr. 102, 77-86. 
Casterlin, M.E. and Reynolds, W.W. 1978. Prostaglandin E1 fever in the crayfish 
Camborus bartoni. Pharmacol. Biochem. Behav. 9, 593-595. 
181 
Charnock, J.S., McLennan, P.L., Abeywardena, M.Y. and Dryden, W.F. 1985. Diet 
and Cardiac Arrhythmia: Effects of lipids on age-related changes in myocardial 
function in the rat. Ann. Nutr. Metab. 29,306-318. 
Christ. E.J. and Van Dorp, D.A. 1972. Comparative aspects of prostaglandin 
biosynthesis in animal tissues. Biochim. Biophys. Acta 270,537-545. 
Choy, P.C., 0, K., Man, R.Y.K. and Chan, A.C. 1989. Phosphatidylcholine 
metabolism in isolated rat heart: modulation by ethanol and vitamin E. Biochim. 
Biophys. Acta. 1005, 225-232. 
Christie, W.W. 1982. Lipid analysis. 2nd Edition. 207pp. Pergamon Press, Oxford. 
Cinti, D.L, Cook, L., Nagi, M.N. and Suriega, S.K. 1992. The fatty acid chain 
elongation system of mammalian endoplasmic reticulum. Prog. Lipid Res. 31, 1-
52. 
Connor, W.E., Neuringer, M. and Reisbick, S. 1992. Essential fatty acids: The 
importance of n-3 fatty acids in the retina and brain. Nutr. Rev. 50,21-29. 
Cook, H.W. 1985. Fatty acid desaturation and chain elongation in eukaryotes. In 
Biochemistry of lipids and membranes. Vance, D.E. and Vance, J.E. Benjamin-
Cummings eds., Menlo Park, CA, USA. pp 181-212. 
Corey, E.J., Albright, J.O., Barton, A.E. and Hashimoto, S. 1980. Chemical and 
enzymatic syntheses of 5-HPETE, a key biological precursor of slow reacting 
substance of anaphylaxis (SRS) and 5-HETE. J. Am. Chem. Soc. 102, 1435-
1436. 
Cossins, A.R. 1977. Adaptation of biological membranes to temperature: the effect 
of temperature acclimation of goldfish upon the viscosity of synaptosomal 
membranes. Biochim. Biophys. Acta 470,395-411. 
Crawford, M.A. 1983. A background to essential fatty acids and their prostanoid 
derivatives. Br. Med. Bull. 39, 210-213. 
182 
Crawford, M.A. 1987. The requirements of long chain n-6 and n-3 fatty acids for the 
brain: In Polyunsaturated fatty acids and eicosanoids. Lands, W.E.M. ed. Amer. 
Oil Chem. Soc. Champaign, IL., pp. 270-295. 
Crawford, M.A., Casperd, N.M. and Sinclair, A.J. 1976. The long chain metabolites 
of linoleic and linolenic acids in liver and brain in herbivores and carnivores. 
Compo Biochem. Physio!. 54B, 395-402. 
Crow, R.T. and Liley, N.R. 1979. A sexual pheremone in the guppy Poe cilia 
reticulata (Peters). Can J. Zool. 57, 184-188. 
Culp, B.A., Lands, W.E.M., Luchesi, B.A., Pitt, B. and Romson, J. 1980. The effects of 
dietary supplementation of fish oil on experimental myocardial infarction. 
Prostaglandins 20, 1021-1023. 
Dennis, E.A., Ackermann, E.J., Deems, R.A. and Reynolds, L.J. 1995. Multiple forms 
of phospholipase A2 in macrophages capable of arachidonic acid release for 
eicosanoid biosynthesis. In Advances in prostaglandin, thromboxane and 
leukotriene research. Vol. 23. pp. 75-80. Samuelsson, B., Ramwell, P.W., 
Paoletti, R., Folco, G., Granstrom, E. and Nicosia, S. eds. Raven Press Ltd., New 
York. 
Dhalla, N.S., Das, P.K. and Sharma, G.P. 1978. Subcellular basis of cardiac 
contractile failure. J. Mol. Cell. Cardiol. 10, 363-385. 
Di Constanzo, G., Duportail, G., Florents, A. and Leray, C. 1983. The brush border 
membrane of trout intestine: influence of its lipid composition on ion 
permeability, enzyme activity and membrane fluidity. Mol. Physiol. 4, 279-290. 
Dratz, E.A. and Deese, A.J. 1986. The role of docosahexaenoic acid, 22:6(n-3), in 
biological membranes: examples of photo receptors and model membrane 
bilayers. In Health effects of polyunsaturated fatty acids in seafoods. 
Simopoulos, A.P., Kifer, R.A. and Martin, R.E. eds. pp 319-351. Academic Press, 
New York. 
183 
Egan, M.E., Wagner, M.H., Zeitlin, P.L. and Guggino, W.B. 1992. Modulation of ion 
transport in cultured tracheal epithelium by lipoxygenase metabolites. Am. J. 
Respir. Cell Mol. BioI. 7, 500-506. 
Farkas, T. and Csengeri, I. 1976. Biosynthesis of fatty acids by the carp, Cyprinus 
carpio L., in relation to environmental temperature. Lipids 11, 401-407. 
Fasman, G.D. (ed.) 1975. CRC Handbook of Biochemistry and Molecular Biology. 
Lipids, Carbohydrate, Steroids 3rd edition. CRC Press, Cleveland, USA 
Ferguson, H.W. 1989. Systemic Pathology of Fish, Iowa State University Press, 
Ames, Iowa, U.S.A 
Ferguson, H.W., Roberts, A.J., Richards, A.H., Collins, A.O. and Rice, D.A. 1986. 
Severe degenerative cardiomyopathy associated with pancreas disease in 
Atlantic salmon (Sa/rna safar) L. J. Fish Dis. 9, 95-98. 
Fischer, S., von Shacky, C., Seiss, W., Strasser, T. and Weber, P.C. 1984. Uptake, 
release and metabolism of docosahexaenoic acid in human platelets and 
neutrophils. Biochem. Biophys. Res. Commun. 120,907-918. 
Fjolstad, M. and Heyeraas, AL. 1985. Muscular and myocardial degeneration in 
cultured Atlantic salmon (Sa/rna safar L.), suffering from "Hitra disease". J. Fish 
Dis. 8, 367-372. 
Folch, J., Lees, M. and Sloane-Stanley, G.H. 1957. A simple method for the 
isolation and purification of total lipids from animal tissues. J.Biol. Chem. 226, 
497-509. 
Folmar, L.C. and Dickhoff, W.W. 1980. The parr-smolt transformation (smoltification) 
and seawater adaptation in salmonids: a review of selected literature. 
Aquaculture, 21, 1-37. 
Froud, R.J., Earl, C.R.A., East, J.M. and Lee, A.G. (1986) Effects of lipid acyl chain 
structure on the activity of (Ca2+-Mg2+) ATPase. Biochim. Biophys. Acta. 860, 
354-360. 
184 
Garcia, P.T. and Holman, R.T. 1965. Competitive inhibitions in the metabolism of 
polyunsaturated fatty acids studied via the composition of phospholipids, 
triglycerides and cholesteryl esters of rat tissues. J. Am. Oil Chem. Soc. 42, 
1137-1141. 
Garg, M.L., Thomson, A.B.A. and Clandinin, M.T. 1988b. Effect of dietary cholesterol 
and/or n-3 fatty acids on lipid composition and A5-desaturase activity of rat liver 
microsomes. J. Nutr. 118, 661-668. 
Garg, M.L., Thomson, A.B.A. and Clandinin, M.T. 1990. Interactions of saturated, n-6 
and n-3 polyunsaturated fatty acids to modulate arachidonic acid metabolism. J. 
Lipid Res. 31, 271-277. 
Garg, M.L., Sebokova, E., Thomson, A.B.A. and Clandinin, M.T. 1988a. A6-
desaturase activity in liver microsomes of rats fed diets enriched with cholesterol 
and/or omega-3 fatty acids. Biochem. J. 249, 351-356. 
Gerbi, A., Zerouga, M., Debray, M., Durand, G., Chanez, C. and Bourre, J-M. 1994. 
Effect of fish oil diet on fatty acid composition of phospholipids of brain 
membranes and on kinetic properties of Na+, K+-ATPase isoenzymes of 
weaned and adult rats. J. Neurochem. 62, 1560-1569. 
German, J.B. and Creveling, A.K. 1990. Identification and characterisation of a 15-
lipoxygenase from fish gills. J. Agr. Fd. Chem. 38,2144-2147. 
German, J.B. and Hu, M.-L. 1990. Oxidant stress inhibits the endogenous 
production of lipoxygenase metabolites in rat lungs and fish gills. Free Rad. BioI. 
Med. 8, 441-448. 
German, J.B. and Kinsella, J.E. 1986. Production of trihydroxy derivatives of 
arachidonic acid and docosahexaenoic acid by lipoxygenase activity in trout gill 
tissue. Biochim. Biophys. Acta 877,290-298. 
185 
German, J.B., Bruckner, G.G. and Kinsella, J.E. 1986. Lipoxygenase in trout gill 
tissue acting on arachidonic, eicosapentaenoic and docosahexaenoic acids. 
Biochim. Biophys. Acta 875, 12-20. 
German, J.B., Chen, S.E. and Kinsella, J.E. 1985. Lipid oxidation in fish tissue. 
Enzymic initiation via lipoxygenase. J. Agric. Fd. Chem. 33, 680-683. 
Girard, J.-P., Thomson, A.J. and Argent, J.R.S. 1977. Adrenalin induced turnover of 
phosphatidic acid and phosphatidylinositol in chloride cells from the gills of 
Anguilla anguilla. FEBS Lett. 73,267-270. 
Goetz, F.W., Smith, D.C. and Krickl, S.P. 1982. The effects of prostaglandins, 
phosphodiesterase inhibitors, and cyclic AMP on ovulation of brook trout 
(Sa/velinus fontinalis) oocytes. Gen. Compo Endocrinol. 48, 154-160. 
Gould, G.W., McWhirter, J.M., East, M. and Lee, A.G. 1987. Effects of diet on the 
function of sarcoplasmic reticulum. Biochem. J. 245, 751-755. 
Grataroli, R., Leonardi, J., Charbonnier, M., Lafont, H. and Nalbone, G. 1988. Effects 
of dietary corn oil and salmon oil on lipids and PGE2 in rat gastriC mucosa. 
Lipids 23, 666-670. 
Gudbjarnason, 5., Oskarsdottir, G., Doell, B. and Hallgrimsson, J. 1978. Myocardial 
membrane lipids in relation to cardiovascular disease. Adv. Cardiol. 25, 130-
144. 
Gupta, O.P., Lahlou, B., Botella, J. and Porthe-Nibelle, J. 1985. In vivo and in vitro 
studies on the release of cortisol from interrenal tissue in trout. I. Effects of ACTH 
and prostaglandins. Exp. BioI. 43, 201-212. 
Gurr, M.1. and Harwood, J.L. 1991. Lipid Biochemistry; An Introduction. (4th edition) 
406pp. Chapman and Hall, London. 
Hagve, T.-A. and Sprecher, H. 1989. Metabolism of long-chain polyunsaturated fatty 
acids in isolated cardiac myocytes. Biochim. Biophys. Acta 1001, 338-344. 
186 
Hagve, T.-A., Christopherson, B.O. and Dannevig, B.H. 1986. Desaturation and 
chain elongation of essential fatty acids in isolated liver cells from rat and 
rainbow trout. Lipids 21, 202-205. 
Halliwell, B. and Gutteridge, J.M.C. 1985. Free Radicals in Biology and Medicine, 
Oxford University, Press, Oxford U.K. ISBN 0-19-854137-6. 
Hanson, B.J., Cummins, K.W., Cargill, A.S. and Lowry, R.R. 1985. Lipid content, fatty 
acid composition, and the effect of diet on fats of aquatic insects. Compo 
Biochem. Physiol., 80B: 257-276. 
Harwood, J.L. 1988. Fatty acid metabolism. Ann. Rev. Plant Physiol. 39,101-138. 
Harwood, J.L. and Russell, N.J. 1984. Lipids in plants and microbes. 162pp. Allen 
and Unwin, Hemel Hempstead, U.K. 
Hazel, J.R. 1979. The influence of thermal acclimation on the structure and 
metabolism of cell membranes in fish. Am. J.Physiol. 236, R91-R 101. 
Hazel, J.R. 1984. Effects of temperature on the structure and metabolism of cell 
membranes in fish. Am. J. Physiol. 246, R460-R470. 
Hazel, J.R. and Williams, E.E. 1990. The role of alterations in membrane lipid 
composition in enabling physiological adaptation of organisms to their physical 
environment. Prog. Lipid Res. 29, 167-227. 
Henderson, R.J. 1995. Fatty acid metabolism in freshwater fish with particular 
reference to polyunsaturated fatty acids. Arch. Anim. Nutr. 48, 1·18. 
Henderson, R.J. and Tocher, D.R. 1987. The lipid biochemistry of freshwater fish. 
Prog. Lipid Res. 26, 281-347. 
Henderson, R.J., Bell, M.V. and Sargent, J.R. 1985. The conversion of 
polyunsaturated fatty acids to prostaglandins by tissue homogenates of the 
turbot, Scophthalmus maximus (L.) J. Exp. Mar. BioI. Ecol. 85, 93-99. 
187 
Herman, C.A., Zimmerman, P.R. and Doolittle, K.D. 1984. Prostaglandin synthesis in 
goldfish heart, Caraccius auratus. Gen. Compo Endocrino!. 54, 478-485. 
Hoar, W.S. 1976. Smolt transformation: Evolution, behaviour and physiology. J. Fish 
Res. Board Can. 33, 1234-1252. 
Hoffman, D.A., Birch, E.E., Birch, D.G. and Uauy, A.D. 1993. Effects of 
supplementation with n-3 long-chain polyunsaturated fatty acids on retinal and 
cortical development in premature infants. Am. J. Clin. Nutr. 57, 807S-812S. 
Horrobin, D.F. 1978. Prostaglandins: physiology, pharmacology and clinical 
significance. Book Press, Brattlebro, VT, USA. 
Horrobin, D.F. 1980. The reversability of cancer: The relevance of cAMp, calcium, 
essential fatty acids and prostaglandin E1' Med. Hypotheses. 6, 469-486. 
Horrobin, D.F. 1983. The regulation of prostaglandin biosynthesis by the 
manipulation of essential fatty acid metabolism. Rev. Pure Apll. Sci. 4, 339-383. 
Horrobin, D.F. 1991. Interactions between n-3 and n-6 essential fatty acids (EFAs) in 
the regulation of cardiovascular disorders and inflammation. Prostaglandins, 
Leukotrienes Essent. Fatty Acids 44, 127-131. 
Horrobin, D.F. 1992. Nutritional and medical importance of gamma-linolenic acid. 
Prog. Lipid Res. 31, 163-194. 
Horseman, N.D. and Meier, A.H. 1978. Prostaglandin and the osmoregulatory role 
of prolactin in a teleost. Life Sci. 22, 1485-1490. 
Hwang, D.H., Boudreau, M. and Chanmugam, P. '988. Dietary linolenic acid and 
longer chain n-3 fatty acids: comparison of effect on arachidonic acid 
metabolism in rats. J. Nutr. 118, 427-437. 
Infante, J.P. 1987. Docosahexaenoate-containing phospholipids in sarcoplasmic 
reticulum and retinal photoreceptors. A proposal for a role in Ca2+-ATPase 
calcium transport. Mol. Cell. Biochem. 74, 111-116. 
188 
Irvine, RF. 1982. How is the level of free arachidonic acid controlled in mammalian 
cells? Biochem. J. 204, 3-16. 
Jabs, K, Zeidel, M.L. and Silva, P. 1989. Prostaglandin E2 inhibits Na+-K+-ATPase 
activity in the inner medullary collecting duct. Am. J. Physiol. 257, F424-430. 
Jalabert, B. and Szollosi, D. 1975. In vitro ovulation of trout oocytes: effect of 
prostaglandins on smooth muscle-like cells of the theca. Prostaglandins 9, 765-
779. 
Johnston, M., Carey, F. and McMillan, RM. 1983. Alternative pathways of 
arachidonate metabolism: prostaglandins, thromboxanes and leukotrienes. In 
Essays in Biochemistry (Campbell, P.N. and Marshall, RD. eds.) vol. 19, pp. 40-
141. Academic Press, London. 
Kalogeropoulos, N., Alexis, M.N. and Henderson, RJ. 1992. Effects of dietary 
soybean and cod-liver oil levels on growth and body composition of gilthead 
bream (Sparus aurata) Aquaculture 104,293-308. 
Kanazawa, A. 1985. Essential fatty acid and lipid requirement of fish. In Nutrition 
and Feeding in Fish. Cowey, C.B., Mackie, A.M. and Bell, J.G. eds. Academic 
Press, London. 
Kapoor, K and Toor, H.S. 1979. The effect of clomiphene citrate on ovulation and 
spawning of indomethacin treated carp, Cyprinus carpio. J. Fish BioI. 14,59-66. 
Karmazyn, M. 1985. A role for prostaglandins in reperfusion injury? In Advances in 
Myocardology (Edited by Dhalla, N.S. and Hearse, D.J.) Vol. 6, pp. 429-436. 
Plenum Publishing Corp. New York. 
Karmazyn. M. and Dhalla, N.S. 1983. Physiological and pathophysiological 
aspects of cardiac prostaglandins. Can. J. Pharmacol. 65, 201-209. 
189 
Karmazyn. M .• Horackova. M. and Murphy, M.G. 1987. Effects of dietary cod liver oil 
on fatty acid composition and calcium transport in isolated adult rat ventricular 
myocytes and on the response of isolated hearts to ischemia and reperfusion 
Can. J. Physiol. Pharmac. 65, 201-209. 
Kayama, M., Sado, T. and lijima, N. 1986. The prostaglandin synthesis in rainbow 
trout thrombocyte. Bull. Jap. Soc. Sci. Fish. 52, 925. 
Kayama, M., Sado, T., lijima, N., Asada. T., Igarishi, M., Shiba, T. and Yamaguchi, A. 
1985. The prostaglandin synthesis in carp thrombocyte. Bull. Jap. Soc. Sci. Fish. 
51,1911-1912. 
Kinsella, J.E. 1990. Possible mechanisms underlying the effects of dietary n-3 
polyunsaturated fatty acids. Omega 3 News 5, 1-4. 
Knight, J., Holland, J.W., Bowden, L.A., Halliday, K. and Rowley, A.F. 1995. 
Eicosanoid generating capacities of different tissues from the rainbow trout, 
Oncorhynchus mykiss. Lipids 30, 451-458. 
Kruskal, W.H. and Wallis, W.A. 1952. Use of ranks in one-criterion analysis of 
variance. J. Amer. Staist. Assoc. 47,583-621. 
Lagarde, M., Gualde, N. and Rigaud, M. 1989. Metabolic interactions between 
eicosanoids in blood and vascular cells. Biochem. J. 257, 313-320. 
Lands, W.E.M. 1986. Fish and Human Health. Academic Press, London, U.K. 
Lands, W.E.M. 1989. Differences in n-3 and n-6 eicosanoid precursors. In 
Advances in Prostaglandin, Thromboxane and Leukotriene Research. 
Samuelsson. B., Wong, P.Y.K. and Sun. F.F.) Vol. 19 pp. 602-605. Raven Press, 
New York. 
Lands, W.E.M. 1991. Dose response relationships for omega 3/omega 6 effects. In 
Health effects of Omega 3 polyunsaturated fatty acids in sea foods. Simopoulos, 
A.P., Kifer, A.A., Martin, R.E. and Barlow, S.M. pp 177-194. Karger Press, Basel. 
190 
Lands, W.E.M., Lettelier, P.E., Rome, L.H. and Vanderhoek, J.Y. 1973. Inhibition of 
prostaglandin biosynthesis. Adv. Biosci. 9, 15-28. 
Lannan, C.N., Winton, J.R. and Fryer, J.L. 1984. Fish cell lines: Establishment and 
characterization of nine cell lines from salmon ids. In Vitro 20, 671-676. 
Lee, T.H., Mencia-Garcia, J.M., Shih, C., Corey, E.J., Lewis, R.A. and Austen, K.F. 
1984. Characterization and biologic properties of 5, 12 dihydroxy derivatives of 
eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase 
product. J. BioI. Chem. 259, 2383-2389. 
Leger, C., Fremont, L. and Boudon, M. 1981. Fatty acid composition of lipids in the 
trout-1. Influence of dietary fatty acids on the triglyceride fatty acid desaturation 
in serum, adipose tissue, liver, white and red muscle. Compo Biochem. physio!. 
69B, 99-105. 
Lehninger, A.L. 1975. Biochemistry 2nd Edition. pp.659-691. Worth Publishers Inc. 
New York. 
Leonardi, J., Termine, E., Morand, F., Lafont, R., Portugal, H., Lafont, H. and 
Nalbone, G. 1987. Effect of dietary lipids on the deacylating enzyme activities of 
rat heart. Lipids 22, 517-522. 
Li, H.-O. and Yamada, J. 1992. Changes of the fatty acid composition in smolts of 
masu salmon (Oncoryhnchus masou) I associated with desmoltification and 
seawater transfer. Compo Biochem. Physio!. 103A, 221-226. 
Lowry, C.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951). Protein 
measurement with the Folin phenol reagent. J. BioI. Chem. 193, 265-275. 
Maeda, M., Doi, O. and Akamatsu, Y. 1978. Metabolic conversion of 
polyunsaturated fatty acids in mammalian cultured cells. Biochim. Biophys. Acta 
530, 153-164. 
191 
Margulis, L. 1993. In The illustrated glossary of protoctista. (Margulis, L., McKhann, 
H.1. and Olendzenski, L. eds.) 288 pages. Jones and Bartlett, Boston. ISBN 0-
86720-081-2. 
Marshall, L.A. and Johnston, P.V. 1982. Modulation of tissue prostaglandin 
synthesising capacity by increased ratios of dietary alpha-linolenic acid to 
linoleic acid. Lipids 17,905-913. 
Massferrer, J.L., Rios, A.P. and Schwartzman, M.L. 1990. Inhibition of renal, cardiac 
and corneal (Na+-K+) ATPase by 12(R)-hydroxyeicosatetraenoic acid. Biochem. 
Pharmacol. 39, 1971-1974. 
Matsumoto, H., lijima, N. and Kayama, M. 1989. The prostaglandin synthesis in 
marine fish thrombocyte. Compo Biochem. Physiol. 93B, 397-402. 
McClennan, I.S. 1991. A study of the capacity of various eicosanoids to stimulate 
skeletal muscle formation in chicken embryos. J. Anat. 174, 115-124. 
McVicar, A.H. 1987. Pancreas disease of farmed Atlantic salmon (Sa/mo safar), 
Scotland: epidemiology and early pathology. Aquaculture 67,71-78. 
Miller, C.C., Ziboh, V.A., Wong, T. and Fletcher, M.P. 1990. Dietary supplementation 
with oils rich in (n-3) and (n-6) fatty acids influences in vivo levels of epidermal 
lipoxygenase products in guinea pigs. J. Nutr. 120,36-44. 
Miller, N.G.A., Hill, M.W. and Smith, M.W. 1976. Positional and species analysis of 
membrane phospholipids extracted from goldfish adapted to different 
environmental temperatures. Biochim. Biophys. Acta. 455, 644-654. 
Milton, A.S. 1982. Prostaglandins in fever and the mode of action of antipyretics. In: 
Handbook of experimental pharmacology, vol. 60. Springer, Berlin Hiedelberg, 
New York, pp. 257-304. 
Mohammed, B.S., Hagve, T.-A. and Sprecher, H. 1990. The metabolism of 20- and 
22-carbon unsaturated acids in rat heart and myocytes as mediated by feeding 
fish oil. Lipids 25, 854-858. 
192 
Moon, T.W., Walsh, P.J. and Mommsen, T.P. 1985. Fish hepatocytes: A model 
metabolic system. Can. J. Fish Aquat. Sci. 42, 1772-1782. 
Mourente, G. and Tocher, D.R. 1992. Effects of weaning onto a pelleted diet on 
docosahexaenoic acid (22:6n-3) levels in brain of developing turbot 
(Scophthalmus maximus L.). Aquaculture 105, 363-377. 
Mourente, G., Tocher, D.R. and Sargent, J.R. 1991. Specific accumulation of 
docosahexaenoic acid (22:6n-3) in brain lipids during development of juvenile 
turbot Scophthalmus maximus L. Lipids 26, 871-877. 
Mustafa, T. and Srivastava, K.C. 1989. Prostaglandins (eicosanoids) and their role 
in ectothermic organisms. Adv. Compo Environ. Physio!. 5, 157-207. 
Nalbone, G., Grynberg, A., Chevalier, A., Leonardi, J., Termine, E. and Lafont, H. 
1990. Phospholipase A activity of cultured rat ventricular myocytes is affected by 
the nature of cellular polyunsaturated fatty acids. Lipids 25, 301-306. 
Neuringer, M., Anderson, G.J. and Connor, W.E. 1988. The essentiality of n-3 fatty 
acids for the development and function of the retina and brain. Ann. Rev. Nutr. 8, 
517-541. 
Nomura, T. and Ogata, H. 1976. Distribution of prostaglandins in the animal 
kingdom. Biochim. Biophys. Acta. 431,127-131. 
Nomura, T., Ogata, H. and Ito, M. 1973. Occurence of prostaglandins in fish testis. 
Tohoku J. Agric. Res. 24, 138-144. 
Nordoy, A. and Goodnight, S.H. 1990. Dietary lipids and thrombosis: Relationship to 
atherosclerosis. Atherosclerosis 10, 149-163. 
Neuringer, M., Anderson, G.J. and Connor, W.E. 1988. The essentiality of omega 3 
fatty acids for the development and function of the retina and brain. Ann. Rev. 
Nutr. 8, 517-541. 
193 
Ninno, R.E., De Torengo, M.AAP., Castuma, J.C. and Brenner, R.R. 1974. 
Specificity of i\5- and i\6- fatty acid desaturases in rat and fish. Biochim. Biophys. 
Acta 360, 124-133. 
Ogata, H., Nomura, T. and Hata, M. 1978. Prostaglandin biosynthesis in tissue 
homogenates of marine animals. Bull. Jap. Soc. Sci. Fish. 44, 1367-1370. 
Ogata, H., Nomura, T. and Hata, M. 1979. Prostaglandin PGF2a changes induced 
by ovulatory stimuli in the pond loach, Misgurnus anguillacaudatus. Bull. Jap. 
Soc. Sci. Fish. 45, 929-931. 
Okuyama, H. 1992. Minimum requirements of the n-3 and n-6 essential fatty acids 
for the function of the central nervous system and for the prevention of chronic 
disease. Proc. Soc. Exp. BioI. Med. 200, 174-176. 
Olomu, J.M. and Baracos, V.E. 1991. Prostaglandin synthesis and fatty acid 
composition of phospholipids and triglycerides in skeletal muscle of chicks fed 
combinations of flaxseed oil and animal tallow. Lipids 26,743-749. 
Owen, J.M., Adron, J.W., Middleton, C. and Cowey, C.B. 1975. Elongation and 
desaturation of dietary fatty acids in turbot (Scophthalmus maxim us) and 
rainbow trout (Sa/mo gairdneri) Lipids 10, 528-531. 
Palmer, R.M. 1990. Prostaglandins and the control of muscle protein synthesis and 
degradation. Prostaglandins, Leukotrienes and Essent. Fatty Acids 39, 95-104. 
Peter, RE. and Billard, R 1976. Effects of third ventricle injection of prostaglandins 
on gonadotrophin secretion in goldfish, Carassius auratus . Gen. Compo 
Endocrinol. 30, 451-456. 
Pettit, T.R and Rowley, AF. 1990. Uptake, incorporation and calcium ionophore-
stimulated mobilisation of arachidonic, eicosapentaenoic and docosahexaenoic 
acids by leucocytes of the rainbow trout, Sa/mo gairdneri. Biochim. Biophys. 
Acta 1042, 62-69. 
194 
Pettit, T.R. and Rowley, AF. 1991. Fatty acid composition and lipoxygenase 
metabolism in blood cells of the lesser spotted dogfish, Scyliorhinus canicula. 
Compo Biochem. Physiol. 99B, 647-652. 
Pettit, T.A., Rowley, AF. and Barrow, S.E. 1989. Synthesis of leukotriene B and other 
conjugated trien Iipoxygenase products by blood cells of the rainbow trout, 
Sa/mo gairdneri. Biochim. Biophys. Acta 1003, 1-8. 
Pettit, T.A., Rowley, AF., Barrow, S.E., Mallet, AI. and Secombes, C.J. 1991. 
Synthesis of lipoxins and other lipoxygenase products by macrophages from the 
rainbow trout, Oncorhynchus mykiss. J. BioI. Chem. 266,8720-8726. 
Peyraud-Waitzenegger, M., Nomura, T. and Peyraud, C. 1976. Cardiovascular 
effects of PGE2 in the carp (Cyprinus carpio). In Samuelsson, B. and Paoletti, R. 
eds. Advances in prostaglandin and thromboxane research, Vol. 2. pp.912-918. 
Raven Press, New York. 
Piomelli, D. 1985. Leukotrienes in teleost fish gills. Naturwissenschaften 72, S.276. 
Porter, R. and Whelan, J. 1983. Biology of Vitamin E. Pitman Books Ltd. London. 
ISBN 0 272 79748 O. 
Powell, T., Terrar, D.A. and Twist, V.W. 1980. Electrical properties of individual cells 
isolated from adult rat ventricular myocardium. J. Physiol. 302, 131-153. 
powell, W.S. 1982. Rapid extraction of arachidonic acid metabolites from biological 
samples using octadecyl silica. Methods Enzymo!. 86, 467-477. 
Raynard, R.S. and Houghton, G. 1992. Pancreas disease of Atlantic salmon. 
Scottish Aquaculture Research Report No.1 (ISSN No. 09649484). Scottish 
Office, Edinburgh. 
Raynard, R.S., McVicar, A.H., Bell, J.G., Youngson,.A., Knox, D. and Fraser, C.O. 
1991. Nutritional aspects of pancreas disease of Atalntic salmon: The effects of 
dietary vitamin E and polyunsaturated fatty acids. Compo Biochem. Physio!. 98A, 
125-131. 
195 
Reynolds, W.W., Casterlin, M.E. and Covert, J.B. 1976. Behavioral fever in teleost 
fish. Nature (London) 259, 41-42. 
Rittenhouse-Simmons, S. 1979. Production of diglyceride from phosphat idyl inositol 
in activated human platelets. J. Clin. Invest. 63, 580-587. 
Robblee, N.M. and Clandinin, M.T. 1984. Effect of dietary fat level and 
polyunsaturated fatty acid content on the phospholipid composition of rat cardiac 
mitochondrial membranes and mitochondrial ATPase activity. J. Nutr. 114, 263-
269. 
Robert, J., Rebel, G. and Mandel, P. 1978. Utilization of polyunsaturated fatty acid 
supplements by cultured neuroblastoma cells. J. Neurochem. 30, 543-548. 
Roberts, R.J. and Bullock, A.M. 1989. Nutritional Pathology. In Fish Nutrition. 
(Halver, J.E. ed.) Academic Press, London, New York, pp. 423-473. 
Rosenthal, M.D., Garcia, M.C., Jones, M.R. and Sprecher, H. 1991. Retroconversion 
and delta-4 desaturation of docosatetraenoate [22:4(n-6)] and 
docosapentaenoate [22:5(n-3)] by human cells in culture. Biochim. Biophys. 
Acta 1083, 29-36. 
Rowley, A.F., Barrow, S.E. and Hunt, T.C. 1987. Preliminary studies on eicosanoid 
production by fish leucocytes, using GC-mass specrometry. J. Fish BioI. 31 
(Suppl. A). 107-111. 
Sargent, J.R. and Henderson, R.J. 1986. In The biological chemistry of marine 
copepods. Corner, E.D.S. and O'Hara, S.C.M. eds. Clarendon Press, Oxford. pp. 
59-108. 
Sargent, J.R., Henderson, R.J. and Tocher, D.R. 1989. The Lipids. In Fish Nutrition 
Halver, J.E. ed. Academic Press, New York, pp. 154-218. 
Sastry, P.S. 1985. Lipids of nervous tissue: composition and metabolism. Prog. 
Lipid Res. 24, 69-176. 
196 
Sato, J., Jyujo, T., Hirono, M. and lesaska, T. 1975. Effects of indomethacin, an 
inhibitor of prostaglandin synthesis in rats. J. Endocrinol. 64, 777-779. 
Satoh, T., Cohen, H.T. and Katz, AI. 1993. Intracellular signalling in the regulation 
of renal ATPase II. Role of eicosanoids. J. Clin. Invest., 91,409-415. 
Scales, D. and Inesi, G. 1976. Localization of ATPase protein in sarcoplasmic 
reticulum membranes. Arch. Biochem. Biophys. 176,392-394. 
Schlenk, H., Sand, D.M. and Gellerman, J.L. 1969. Retroconversion of 
docosahexaenoic acid in the rat. Biochim. Biophys. Acta 187,201-207. 
Schwartz, D.P. and Bright, R.S. 1974. A column procedure for the esterification of 
organiC acids with diazomethane at the microgram level. Anal. Biochem. 61, 
271-274. 
Secombes, C.J., Clements, K., Ashton, I. and Rowley, AF. 1994. The effect of 
eicosanoids on rainbow trout, Oncorhynchus mykiss, leucocyte proliferation. Vet 
Immuno!. Immunopathol. 42, 367-378. 
Sellner, P.A. and Hazel, J.R. 1982. Incorporation of polyunsaturated fatty acids into 
lipids of rainbow trout hepatocytes. Am. J. Physiol. 243, R223-228. 
Sheridan, M.A., Allen, W.V. and Kerstetter, T.H. 1985. Changes in the fatty acid 
composition of steelhead trout, Sa/mo gairdnerii Richardson associated with 
parr-smolt transformation. Compo Biochem. Physio!. 80B, 671-676. 
Simopoulos, A P., Kifer, R.R. and Wykes, A.A 1991. ro 3 fatty acids: Research 
advances in support of the field since June 1985. In Health effects of ro 3 fatty 
acids in seafoods (Simopoulos, A.P., Kifer, R.R., Martin, R.E. and Barlow, S.E. 
eds.) pp. 51-73. Karger Press, Basle. 
Singh, AK. and Singh, T.P. 1976. Effect of clomid, sexovid, and prostaglandins on 
induction of ovulation and gonadotrophin secretion in a freshwater catfish, 
Heteropneustes tossili (Bloch). Endokrinologie 68, 129-136. 
197 
Sinnhuber, R.O. 1969. The role of fats. In Fish in Research. (Neuhaus, O.W. and 
Halver, J.E. eds.) pp. 245-264, Academic Press, London, U.K. 
Smith, W.L. 1989. The eicosanoids and their biochemical mechanisms of action. 
Biochem. J. 259, 315-324. 
Sowizral, K.C., Rumsey, G.L. and Kinsella, J.E. 1990. Effect of dietary a-linolenic 
acid on n-3 fatty acids of rainbow trout lipids. Lipids 25, 246-253. 
Spector, A.A. and Hoak, J.C. 1969. An improved method for the addition of long-
chain free fatty acids to protein solutions. Anal. Biochem. 32, 297-302. 
Spector, A.A. and Yorek, 1985. Membrane lipid composition and cellular function. J. 
Lipid Res. 26, 1015-1035. 
Spector, A.A., Mathur, S.N., Kanduce, T.L. and Hyman, B.T. 1981. Lipid nutrition and 
metabolism of cultured mammalian cells. Prog. Lipid Res. 19, 155-186. 
Sprecher, H. 1981. Biochemistry of essential fatty acids. Prog. Lipid Res. 20,13-22. 
Sprecher, H. 1989. (n-3) and (n-6) fatty acid metabolism. In Dietary omega 3 and 
omega 6 fatty acids. Biological effects and nutritional essentiality. (Galli, C. and 
Simopoulos, A.P.) pp. 69-79. NATO ASI series. Series A: Life Sciences Vol 171, 
Plenum Press, New York and London. 
Spies, H.G. and Norman, R.L. 1973. Luteinising hormone release and ovulation 
induced by the intraventricular infusion of prostaglandin E1 into pentobarbitone-
blocked rats. Prostaglandins 4, 131-141. 
Srivastava, K.C. and Mustafa, T. 1984. Arachidonic acid metabolism and 
prostaglandins in lower animals. Mol. Physiol. 5, 53-60. 
Stacey, N.E. 1976. Effects of indomethacin and prostaglandins on spawning 
behaviour of female goldfish. Prostaglandins 12, 113-126. 
Stacey, N.E. 1981. Hormonal regulation of sexual behaviour in teleosts. Am. Zoo I. 
21, 305-316. 
198 
Stacey, N.E. and Goetz, F.W. 1982. Role of prostaglandins in fish reproduction. Can. 
J. Fish Aqu. Sci. 39, 92-98. 
Stacey, N.E. and Liley, N.R 1974. Regulation of spawning in the female goldfish. 
Nature (London) 247, 71-72. 
Stacey, N.E., Cook, A.F. and Peter, RE. 1979. Ovulatory surge of gonadotrophin in 
the goldfish, Carassius auratus. Gen. Compo Endocrinol. 37,246-249. 
Stacey, N.E., Zheng, W-B. and Cardwell, J. 1994. Milt production in common carp 
(Cyprinus carpio) : Stimulation by a goldfish steroid pheromone. Aquaculture, 
127, 265-276. 
Stanton, M.G. 1968. Colorimetric determination of inorganic phosphate in the 
presence of biological material and adenosine triphosphate. Anal. Biochem. 22, 
27-37. 
Strasser, T., Fischer, S. and Weber, P.C. 1985. Leukotriene B5 is formed in human 
neutrophils after dietary supplementation with eicosapentaenoic acid. Proc. 
Natn. Acad. Sci. U.S.A. 82, 1540-1543. 
Stubbs, C.D. and Smith, A.D. 1984. The modification of mammalian membrane 
polyunsaturated fatty acid composition in relation to membrane fluidity and 
function. Biochim. Biophys. Acta. 779, 89-137. 
Swanson, J.E. and Kinsella, J.E. 1986. Dietary n-3 polyunsaturated fatty acids: 
modification of rat cardiac lipids and fatty acid composition. J. Nutr. 116, 514-
523. 
Swanson, J.E., Lokesh, B.R and Kinsella, J.E. 1989. Ca2+-Mg2+ ATPase of mouse 
sarcoplasmic reticulum is affected by membrane n-6 and n-3 polyunsaturated 
fatty acid content. J. Nutr. 119, 364-372. 
199 
Szymanska, G., Pikula, S. and Zbrowski, J. 1991. Effect of hyper- and 
hypothyroidism on phospholipid fatty acid composition and phospholipase 
activity in sarcolemma of rabbit cardiac muscle. Biochim. Biophys. Acta. 1083, 
265-270. 
Takeuchi, T., Arakawa, T., Satoh, S. and Watanabe, T. 1992. Supplemental effect of 
phospholipids and requirement of eicosapentaenoic acid and docosahexaenoic 
acid of juvenile striped jack. Nippon Suisan Gakkaishi 58, 707-713. 
Tan, C.H., Lam, T.J., Wong, L.Y. and Pang, M.K. 1987. Prostaglandin synthesis and 
its inhibition by cyclic AMP and forskolin in postpartum follicles of the guppy. 
Poe cilia reticu/ata. Prostaglandins 34, 697-715. 
Takayama. H., Kroll, M.H., Gimbrone, M.A. and Schafer, A.1. 1989. Turnover of 
precursor fatty acids among phospholipid classes and subclasses of cultured 
human umbilical vein endothelial cells. Biochem. J. 258, 427-434. 
Terano, T., Salmon, J.A., Higgs, G.A. and Moncada, S. 1986. Eicosapentaenoic acid 
as a modulator of inflammation. Effect on prostaglandin and leukotriene 
synthesis. Biochem. Pharmacol. 35, 779-785. 
Tocher, D.R. 1990. Incorporation and metabolism of (n-3) and (n-6) polyunsaturated 
fatty acids in phospholipid classes in cultured rainbow trout (Sa/rno gairdneri) 
cells. Fish Physio\. Biochem. 8, 239-249. 
Tocher, D.R. 1995. Glycerophospholipid metabolism in Biochemistry and Molecular 
Biology of Fishes Vol. 4 Metabolic Biochemistry (Hochachka, P.W. and 
Mommsen, T.P. eds.) pp. 119-158. Elsevier Science Press, Amsterdam, The 
Netherlands. 
Tocher, D.R. and Dick, J.R. 1990. Polyunsaturated fatty acid metabolism in cultured 
fish cells: Incorporation and metabolism of (n-3) and (n-6) series acids by 
Atlantic salmon (Sa/rno safar) cells. Fish Physio\. Biochem. 8: 311-319. 
200 
Tocher, D.R. and MacKinlay, E.E. 1990. Incorporation and metabolism of (n-3) and 
(n-6) polyunsaturated fatty acids in phospholipid classes in cultured turbot 
(Scophthalmus maxim us) cells. Fish Physiol. Biochem. 8, 251-260. 
Tocher, D.R. and Sargent, J.R. 1987. The effects of calcium ionophore A23187 on 
the metabolism of arachidonic and eicosapentaenoic acids in neutrophils from a 
marine teleost fish rich in (n-3) polyunsaturated fatty acids. Compo Biochem. 
Physiol. 878, 733-739. 
Tocher, D.R. and Sargent, J.R. 1990. Effect of temperature on the incorporation into 
phospholipid classes and the metabolism via desaturation and elongation of (n-
3) and (n-6) polyunsaturated fatty acids in fish cells in culture. Lipids 25, 435-
442. 
Tocher, D.R., 8ell, J.G. and Sargent, J.R. 1991. The incorporation of [3H] 
arachidonic and [14C] eicosapentaenoic acids into glycerophospholipids and 
their metabolism by lipoxygenases in isolated brain cells from rainbow trout, 
Oncorhynchus mykiss. J. Neurochem. 57, 2078-2085. 
Tocher, D.R., Carr, J. and Sargent, J.R. 1989. Polyunsaturated fatty acid metabolism 
in fish cells: Differential metabolism of (n-3) and (n-6) series acids by cultured 
cells originating from a freshwater teleost fish and a marine teleost fish. Compo 
8iochem. Physio!. 948, 367-374. 
Tocher, D.R., Sargent, J.R. and Frerichs, G.N. 1988. The fatty acid compositions of 
established fish cell lines after long term culture in mammalian sera. Fish 
Physio!. 8iochem. 5, 219-227. 
U.S. National Research Council. 1981. Nutrient requirements of coldwater fishes. 
Washington D.C. National Academy Press. 
Van Praag, D., Farber, S.J., Minkin, E. and Primor, N. 1987. Production of 
eicosanoids by the killifish gills and opercular epithelia and their effect on active 
transport of ions. Gen. Compo Endocrinol. 67, 50-57. 
201 
Van den Bosch, H. 1980. Intracellular phospholipases A. Biochim. Biophys. Acta 
604, 191-246. 
Vitiello, F. and Zanetta, J.-P. 1978. Thin-layer chromatography of phospholipids. J. 
Chromatogr. 166, 637-640. 
von Shacky, C., Fischer, S. and Weber, P.C. 1985. Long term effects of dietary 
marine n-3 fatty acids upon plasma and cellular lipids, platelet function and 
eicosanoid formation in humans. J. Clin. Invest. 76, 1626-1631. 
Voss, A., Reinhart, M., Sankarappa, S. and Sprecher, H. 1991. The metabolism of 7, 
10, 13, 16, 19-docosapentaenoic acid in rat liver is independent of a A4-
desaturase. J. BioI. Chem. 266, 19995-20000. 
Wakil, S.J., Stoops, J.K. and Joshi, V.C. 1983. Fatty acid synthesis and its 
regulation. Ann. Rev. Biochem. 52, 537-579. 
Wales, N.A.M. and Gaunt, T. 1986. Hemodynamic, renal, and steroidogenic actions 
of prostaglandins E1, E2, A2 and F2a. in European eels. Gen. Compo Endocrin. 
62,327-334. 
Weber, P.C. 1990. The modification of the arachidonic acid cascade by n-3 fatty 
acids. In Advances in prostaglandin, thromboxane and leukotriene research. 
Vol. 20. pp. 232-240. Samuelsson, B., Dahlen, S-E., Fritsch, J. and Hedqvist, P. 
eds. Raven Press Ltd., New York. 
Wedermeyer, G.A., Saunders, R.L. and Clarke, w.e. 1980. Environmental factors 
affecting smoltification and early marine survival of anadromous salmonids. Mar. 
Fish Rev. 42, 1-14. 
Willis, A.L. 1981. Nutritional and pharmacological factors in eicosanoid biology. 
N utr. Rev. 39, 289-301. 
202 
Wodke, E. 1981. Temperature adaptation of biological membranes. The effects of 
acclimation temperature on the unsaturation of the main neutral and charged 
phospholipids in mitochondrial membranes of the carp (Cyprius carpio L.) 
Biochim. Biophys. Acta. 640, 698-709. 
Wolf, K. and Quimby, M.C. 1976. Primary monolayer cultures of fish cells initiated 
from minced tissues. TCA manual 2, 445-448 
Wolfe, L.S. 1982. Eicosanoids: Prostaglandins, thromboxanes, leukotrienes, and 
other derivatives of carbon-20 unsaturated fatty acids. J. Neurochem. 38, 1-9. 
Wood, B.J.B. 1988. Lipids of algae and protazoa. In Microbial Lipids Vol. 1. 
Ratledge, C. and Wilkinson, S.G. eds. Academic Press, London. pp. 808-868. 
Yu, T.C. and Sinnhuber, RO. 1972. Effect of dietary linolenic acid and 
docosahexaenoic acid on growth and fatty acid composition of rainbow trout 
(Sa/rno gairdneri) Lipids 7, 450-454. 
Yu, T.C. and Sinnhuber, RO. 1976. Growth response of rainbow trout (Sa/rno 
gairdneri) to dietary w3 and w6 fatty acids. Aquaculture 8, 309-317. 
Yu, T.C. and Sinnhuber, RO. 1979. Effect of dietary ro3 and ro6 fatty acids on growth 
and feed conversion efficiency of coho salmon (Oncorhynchus kisutch) 
Aquaculture 16, 31-38. 
Zubay, C. 1988. Biochemistry 2nd Edition. pp. 669-688. Macmillan, London. 
IMAGING SERVICES NORTH 
Boston Spa, Wetherby 
West Yorkshire, LS23 7BQ 
www.bl.uk 
PAGE NUMBERING AS 
ORIGINAL 
Lipids 
High Dietary Linoleic Acid Affects the Fatty Acid 
Compositions of Individual Phospholipids from 
Tissues of Atlantic Salmon (Salmo salar): 
Association with Stress Susceptibility and 
Cardiac Lesion 
J. GORDON BELL, ALASDAIR H. McVICAR, * MOIRA T. PARK AND 
JOHN R. SARGENT 
Natural Environment Research Council, Unit of Aquatic Blochemistry, School of Natural 
Sciences, University of Stirling, Stirling FK9 4LA, Scotland, and 
"Department of Agriculture and Ftsheries for Scotland, Marine Laboratory, 
Aberdeen AB9 BOB, Scotland 
ABSTRACT For 16 wk Atlantic salmon (Sa/mo salar) 
post-smolts were fed practical-type diets that contained 
either fish 00 (FO) or sunflower 00 (SO) as the lipid 
component- Both diets contained adequate (n-3) polyun-
saturated fatty acids (PUFA). AU the phospholipids of 
heart and Uver from SO-fed fish had increased levels of 
18:2(n-6), 20:2(n-6) and 20:3(n-6); phosphatldyl 
choOne (PC) and phosphatldyl ethanolamine (PE) also 
had Increased 20:4(n-6)_ There was a general decrease 
In 20:5(n-3) in the phospholipids, reflected In an in-
crease In the 20:4(n-6)120:5(n-3) ratio, especlaDy In PC 
and PE. The fatty acid compositions of phosphoDplds 
from brain and retina were much less affected by dietary 
Unoleate than those of heart and Uver. Fish fed SO 
developed severe heart lesions that caused thinning of 
the ventricular waD and muscle necrosis. The fish fed SO 
also were susceptible to a transportation-Induced shock 
syndrome that caused 30% mortaDty. These results es-
tabUsh that a diet with a low (n-3)/(n-6) ratio can cause 
changes In fatty add metaboUsm that are deleterious to 
the health of salmonld fish, especlaDy when subjected to 
stress. J. Nutr. 121: 1163-1172, 1991. 
INDEXING KEY WORDS: 
• linoleiC add • If.sh • stress 
• heart • phospholipids 
Freshwater fish le.g., rainbow trout, eel, ayu) can 
metabolize linoleic acid [18:2(n-6)) by ~-6-desatu­
ration to gammaHnolenic acid [18:3(n-6)], which can 
undergo elongation to dihomogammalinolenic acid 
[20:3In-6)] and subsequently be converted to arachi-
donic acid [20:4(n-6)] by ~-5-desaturation 11). Marine 
fish such as turbot (Scoptbalmus maximusl seem to 
be deficient in ~-5-desaturase and therefore require 
the polyunsaturated fatty acids IPUFA)1 eicosapen-
taenoic acid [20:5(n-3)], docosahexaenoic acid [22: 
6(n-3)) and probably 20:4(n-61 to be supplied by the 
diet (2,3). Studies with an anadramous fish, Atlantic 
salmon (Salmo salarl, suggest an inability to 
desaturate and elongate 18:2(n-6) during smoltifi-
cation (41, but this inability is not apparent during the 
post-smolt seawater phase of the salmon life cycle (5). 
In this study Atlantic salmon post-smolts were fed 
diets in which the dietary lipid was supplied either as 
fish oil (FO) or sunflower oil (SO), although the latter 
diet contained adequate (n-J) PUFA (6) derived from 
dietary fish meal. Our objective was to alter the In-J)/ 
In-6) fatty acid ratio in salmon by feeding a diet high 
in (n-61 fatty acids and to specifically investigate the 
incorporation of 18:2(n-61 and its metabolites into the 
individual phospholipids of heart, liver, brain and 
retina. Hear: and liver were chosen because of their 
known high metabolic activity, whereas brain and 
retina were investigated because they are especially 
rich in In-3) PUFA 17). The In-3) PUFA are reported to 
have an important functional role in both brain and 
retina (81, which could be seriously impaired if signif-
icant incorporation of (n-6) PUFA were to occur. This 
supposition has now been established for primates (9). 
IAbbreviationa used: BHT, butylated hydroxytoluc:ne, FO, fish 
oil, PC, phosphatidyl choline, PD, pancn:u diac:aac, PE, pho,-
phatidyl ethanolamine, PI, phosphatidyl inositol, PS, phosphat idyl 
serine, PUPA, polyunsaturated fatty acid, SO, sunflower oU. 
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Ingredient 
Fishmea1 
Starchl 
OiP 
Vitainin JDixI 
Mineral ~ 
a-Cellulose 
Antioxidant JIlixS 
Choline chloride 
TABLE 1 
Composition 01 tlJ. blUm did 
Amount 
g/kg 
650 
150 
100 
10 
24 
61.5 
0.4 
4 
lpa88elli WA4, Tunnel Avebe Starches, Gillingham, U.K. 
IPoaol, Seven Seas, Hull, U.K. or sunflower oil, Tesco, 
Cheshunt, U.K. 
. 'Supplied (mgJkg diet): all-rac-a-tocopheryl acetate, 401 mena-
dione, 101 ascorbic acid, 10001 thiamine hydrochloride, 101 ribo-
flavin, 201 pyridoxine hydrochloride, 121 calcium pantothenate, 44; 
nicotinic acid, 1501 biotin, II folic acid, 51 cyanocobalamin, 0.02; 
mya-inositol, 4001 retinyl acetate, 7.31 cholecalciferol, 0.06. 
'Supplied (per kg diet): ~PO., 22 SI peSO.·mO, 1.0 SI 
ZnSO.·~O, 0.13 BJ MnSO.·4~O, 52.8 mBJ CuSO.·5HsO, 12 mSi 
CoSO.·~O, 2 m~ XI, 2 mg. 
'Dissolved in propylene glycol and contained (gIL): butylated 
hydroxy anisole, 601 propyl gallate, 601 citric acid, 40. 
MATERIALS AND METHODS 
Animals and diets. Three hundred Atlantic salmon 
Sl smolts (initial mean weight, -51 g) were obtained 
from the D.A.F.S. Fish Cultivation Unit (Aultbea, 
Wester Ross, Scotland) and transferred to seawater 
tanks at the same facility. The fish were transported 
from the Fish Cultivation Unit to the laboratory 
aquarium in sealed black polythene bags. Each bag 
contained -12 L of seawater and 2 kg biomass of fish 
and was sealed after inflation with 25 L of oxygen. 
The initial water temperature was 13·C, and the final 
temperature was IS·C. The salmon were randomly 
distributed into two tanks of 2OOO-L capacity each; 
these tanks were supplied with seawater at a rate of 
26 L/min. The tanks were subjected to natural photo-
period, and the temperature over the experimental 
period (June-October) was 9-13·C. The diets were 
supplied by automatic feeders, which were activated 
for a few seconds every 15 min during daylight hours 
and adjusted to provide 20 gfkg biomass each day. 
Fish were bulk weighed every 28 d, and the ration was 
adjusted accordingly. Initial sampling was performed 
after 16 wk of the feeding experiment. The ex-
periment was conducted in accordance with the 
British Home Office guidelines regarding research on 
experimental animals. 
The fish meal-based diets were formulated to meet 
the nutritional requirements of salmon (10) and con-
tained 46% protein and 17% lipid (Table 1). Salmonid 
fish require -1 % of their dry diet as (n-3) lipid (11), 
TABLE 1 
Fatty acid compositiOlJ 01 dieu 
Fatty acid 
14:0 
16:0 
18:0 
16:1(n-7) 
18:1(n-9) 
18:1In-7) 
20:1(n-91 
22:1(n-lll 
24:1 
18:2(n-6) 
18:3(n-6) 
20:2(n·6) 
20:3(n-6) 
20:4(n·6) 
18:3In-3) 
18:4(n.3) 
20:5(n-3/ 
22:5(n-3) 
22:6(n-3) 
total /n-6) 
total In-3) 
(n-3//(n-6) 
Unsaturation index I 
Fish oil diet Sunflower oil diet 
5.7 
13.8 
2.5 
5.2 
12.0 
2.3 
8.9 
13.8 
1.4 
1.4 
0.2 
0.2 
0.2 
0.6 
1.3 
2.9 
7.2 
1.2 
10.4 
2.5 
23.8 
9.4 
173.5 
weigbt% 
2.0 
9.7 
3.4 
2.2 
14.7 
2.3 
3.2 
4.0 
0.4 
42.1 
1.1 
<0.1 
0.1 
0.4 
0.4 
0.7 
3.4 
O.S 
4.6 
43.6 
9.9 
0.2 
168.3 
IUnsaturation index - wt % x number of double bonds. 
which was supplied by both the FO and SO diets. The 
fatty acid compositions of the two diets are shown in 
Table 2. 
Sampling procedure. Fish were sampled from both . 
dietary treatments at 16, 18 and 20 wk after the stan 
of the experiment. In total 21 fish fed the FO diet and 
24 fish fed the SO diet were sampled. Fish were 
starved for 2 wk before the final sampling. The fish 
were killed by decapitation. The liver, heart, brain 
and eyes were quickly dissected and placed in liquid 
N1• The cardiosomatic index was determined by di-
viding the heart weight in mj))jgrams by the total 
body weight in grams. Samples were stored at -20·C 
prior to lipid analysis. Immediately before lipid ex-
traction, the eyes were partly defrosted and cut in 
half, and the frozen lens and humor were removed. 
The whole retina, including the pigment layer, was 
dissected from the underlying tissues and placed in 
ice-cold chloroform:methanol (2:1, v/v). 
Lipid extraction and analysis. Total lipid was ex. 
tracted from tissues and diets by the method of Folch 
et al. (12). After homogenization in approximately 10 
volumes of ice-cold chloroform.:methanol (2:1, v/v) 
the homogenates were filtered, 0.2 volume of 8.8 ~ 
KClfL was added and the solutions were mixed on a 
vortex mixer. After separation the chloroform layer 
was evaporated under a stream of nitrogen. The lipids 
were dried by vacuum dessication before weighing. 
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TABLE 3 
PrevalDJU of beart muscle lJecrosi. bJ salmoa polt-lIlJolts fed diets COlJtailJbJr flu oil or .rmflo'Wer oil 
Fish oil diet Sunflower oil diet 
Sampling time Total Normal Fish with Total Normal Fish with 
(wk) sample fish necrosis 
16 5 5 
18 6 6 
20 10 9 
Total 21 20 
The extracts were redissolved in chloroform: 
methanol (2:1, v/v) at a final concentration of 100 g 
lipid/L and stored at -20·C. All solvents contained 50 
mg of butylated hydroxytoluene (BHT) per liter as an 
antioxidant. Lipid extracts were separated into phos-
phatidyl choline IPq, phosphatidyl ethanolamine 
(PE), phosphatidyl serine (PS) and phosphatidyl in-
ositol (PI) fractions by TLC using methyl acetate: 
isopropanol:chloroform:methanol:2.S g KCI/L (a-
queous) (25:25:25:10:9, v/v/v/v/v) as developing 
solvent as described by Vitiello and Zanetta 1131. The 
plates were sprayed with 1 g 2,7 -dichlorofluorescein/L 
prepared in 970 mL/L methanol containing 50 mg 
BHT /L, and the lipid bands were visualized under UV 
light. The phospholipid classes were scraped from the 
plates and converted to fatty acid methyl esters by 
acid-catalyzed transmethylation performed overnight 
at 50·C according to Christie (14). The fatty acid 
methyl esters were separated and quantified by gas-
liquid chromatography (Carlo Erba Fractovap 4160, 
Fisons, Crawley, U.K.) using a SO-m capillary column 
coated with free fatty acid phase (S.G.E., Milton 
Keynes, U.K.I. Hydrogen was used as carrier gas and 
teIllperature programming was from IS0'C at S·C/ 
min to 200·C (20 minI and then to 220'C at lO'e/min 
for 20 min. Individual methyl esters were identified 
by comparison with known standards and by 
reference to published data (15, 16). 
Histology. Samples of liver, pancreas, kidney, 
. spleen, heart and gills were fixed in 20% buffered 
fOrIllol saline and wax embedded, and sections were 
stained with hematoxylin and eosin. Pathological as-
sessIllent was initially made on slides in sequencej 
but when significant pathology was observed, code 
n~ers were concealed and slides were randomized 
before final assessment of results to eliminate any 
bisS in interpretation. 
Materials. The TIC plates (20 cm x 20 cm x 0.25 
D1JIlI, precoated with silica gel 60, were obtained from 
Merck (Darmstadt, Germany). All solvents were of 
}-{pLe grade and were obtained from Rathburn Chem-
icals (Walkerbum, U.K·I· 
Statistical tuJalysis. Significance of difference (P < 
0.05) between dietary treatments was determined by 
0 
0 
1 
1 
sample fish necrosis 
5 1 4 
10 1 9 
9 5 4 
24 7 17 
Student's t test. Data identified as nonhomogeneous 
(by means of an F testl were subjected to arcsin square 
root transformation before applying the t test. Data 
that were nonhomogeneous after transformation were 
analyzed by the Kruskal-Wallis test. 
RESOLTS 
Good growth was achieved with both dietary treat· 
ments over the 16-wk experimental period (46 to 243 
g, FO diet; 55 to 241 g, SO diet), and mortalities were 
low with both diets. However, when 30 fish per 
treatment were transported to the University 
aquarium at Stirling from the experimental unit (a 
4-h journey), 30% of the SO-fed fish died, whereas all 
of the FO-fed fish survived. Although no fish were 
dead on arrival, several of the SO-fed fish were in a 
distressed condition, i.e., lying upside down and 
breathing with difficulty. The tanks were immedi-
ately bubbled with oxygen (for 30 minI, but within 24 
h 30% were dead. These symptoms are similar to the 
shock syndrome described by Castell et ale (17) in 
essential fatty acid-deficient rainbow trout. 
The cardiosomatic index (measured in nonstressed 
fish prior to transportation) was significantly reduced 
IP < 0.051 in the SO-fed fish compared with the FO-fed 
fish (0.51 ± 0.l0 and 0.74 ± 0.03, values are means ± 
SD for three fish per treatment I although the total 
lipid (percent by weight) values were similar. No 
other gross pathologies were evident in fish from 
either dietary regimen. 
No significant histopathology was observed in the 
pancreas, kidney, spleen, heart and gills of the salmon 
fed the FO diet. However, one fish fed the SO diet 
showed areas of focal degenerative necrosis in the 
liver, and another fish had a similar lesion in the 
spleen and kidney. These organs were normal in all 
other fish sampled hom this group; therefore, little 
significance probably can be attributed to these obser-
vations. However, a high proportion of fish fed the SO 
diet showed hea.."1 ventricle lesions ranging from mild 
to severe (Table 31. At low magnifications 45% of all 
hearts from SO-fed fish showed a marked depletion in 
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FIGURE 1 Light micrograph of heart tissue from Atlantic 
salmon fed the sunflower oil-{;ontaining diet. Micrograph 
indicates the presence of focal necrosis (arrow) and 
depletion in the amount of muscle present in both spongy 
and compact layers, resulting in thinning of the heart wall. 
(Scale - 20 j.Ull). 
the amount of muscle present in both the spongy and 
compact layers, with (in extreme instances) the heart 
wall becoming exceedingly thin (Fig. 1) compared 
with the normal organ (Fig. 2). Although it is not 
possible to quantify accurately heart wall thickness 
from sections because of differences in muscle con-
traction at fixation, this observation can be directly 
associated with the observed differences in cardioso-
rnatic indices described earlier. Closer histological 
examination of affected hearts, as well as some not 
showing obvious muscle depletion, typically showed 
active focal myodegeneration, particularly in the 
spongy tissue (Fig. 1). The foci of degeneration ranged 
from single small lesions to multiple extensive areas. 
FIGURE 2 Light micrograph of heart tissue from Atlantic 
salmon fed the £ish oil-containing diet. (Scale - 20 IUD), 
shOWing nonnal appearance of compact and spongy muscle 
layers. 
Similar lesions also w ere present in atrial muscle (Fig. 
3). The observed gross wasting of the heart may h ave 
been a result of this active cardiomyopathy perSisting 
over a prolonged period; although relatively few 
damaged areas may be seen in one section, the effect 
may be cumulative. 
The tatty acid compositions of heart phospholipid 
classes are shown in Tables 4 and 5. In PC from SO-
fed fish there were significant increases in 18: 
2(n-6), 18 :3(n-6), 20 :2(n-6), 20:3(n-6) and 20:4(n -6 ) 
compared with FO-fed fish. The SO-fed fish also 
showed significantly reduced 20 :5(n-3) and total 
monoenes_ In PE the same pattern of changes was 
observed, and in both classes the (n-3)/(n-6) ratio was 
significantly reduced in the SO-fed fish . A significant 
decrease in total saturates was also seen in PE. In PS 
of SO-fed fish there were increases in the (n -6) PUFA 
mentioned above, except for 20:4(n-6), which w as 
unchanged. The levels of l8 :3(n-3), 20:5(n-3) and 2 2 : 
5(n-3) were significantly reduced as were tOtal 
monoenes. Total saturates were significantly in -
creased in the heart of SO-fed fish compared with 
those fed Fa. In PI of hearts from SO-fed fish, there 
were increases in 18:2(n-6), 20:2(n-6), 20:3(n-6) and 20: 
4(n-6), whereas 20:5(n-3) and 22:6(n-3) were signifi -
cantly reduced. The 20:4(n-6)/20:5(n-3) ratio was sig-
nificantly increased in all phospholipid classes of fish 
fed SO. The (n-3)/(n-6) ratio was significantly reduced 
in both PS and PI of SO-fed fish_ 
The fatty acid composition of the liver phospho-
lipid classes are shown in Tables 6 and 7. Liver PC 
from SO-fed fish showed significantly increased 18 : 
2(n-6), 18:3(n-6), 20:2(n-6) and 20:3(n-6); the latter was 
elevated -25 times that in Fa-fed fish. Significant 
decreases in 20:5(n-3) and 22:5(n-3) were observed in 
the liver PC of SO-fed fish . Similar changes were 
apparent in liver PE, but, in addition, 20:4(n-6) and 
3 
FIGURE 3 Light micrograph of heart atrium from At-
lantic salmon fed the sunflower oil-containing diet. Micro-
graph indicates active focal myodegeneration in the muscle 
(Scale - 10 J.1lll) . 
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TABLE 4 
Patty add composition of pbospbatidyl cb.oline ad pbo,pbatidyl etbtmolamiDe from beam of .Dlmon fed dim COIItaizWJg 
fish oil (PO) or .rmflower oil (SO, 
Ph08phatidyl choline Phosphat idyl ethanolamine 
Fatty acid PO diet SO diet FO diet SO diet 
weight 0/0 
Total saturates 40.8 ± 2.3 40.6 ± 1.3 24.0 ± 0.5" 20.8 ± 0.7 
Total monoenes lS.3 ± 1.1" 14.S ± 1.0 10.5 ± 0.6" 8.3 ± 0.7 
lS:2/n-6) 0.4 ± 0.1" 
IS:3/n-6) 0.1 ± 0.0" 
2O:2/n-6) 0.1 ± 0.0" 
6.6 ± 0.5 0.7 ± 0.2" 6.7 ± 0.4 
0.3 ± 0.1 0.2 ± 0.0" 0.1 ± 0.0 
0.6 ± 0.1 0.1 ± 0.0" 0.7 ± 0.1 
2O:3/n-6) 0.1 ± 0.0" 
2O:4(n-6) 1.6 ± 0.1" 
Total (n-6)2 2.8 ± 0.2" 
0.9 ± 0.2 0.1 ± 0.0" O.S ± 0.2 
2.6 ± 0.4 I.S ± 0.2" 2.9 ± 0.5 
11.3 ± 0.2 3.6 :t 0.1" 12.1 ± 0.4 
IS:3In-3) 0.2 ± 0.1 0.1 ± 0.0 0.2 ± 0.1 0.1 ± 0.0 
2O:5In-3) 6.4 ± 0.2" 
22:5(n-3) 0.9 ± 0.1 
22:6In-3) 24.2 ± 1.9 
Total /n-31' 32.1 ± 1.6 
4.2 ± 0.3 3.9 ± 0.4" 2.S ± 0.1 
0.9 ± 0.0 2.7 ± 0.0 2.5 ± 0.2 
22.6 ± 2.1 42.1 ± 1.4 43.5 :t 1.6 
28.0 ± 2.0 49.4 ± 1.6 4S.S ± 1.6 
Total PUPA· 34.9 ± 1.8 39.3 ± 1.9 53.0 ± 1.6" 61.0 ± 1.8 
/n-3)/ln-6) 11.5 ± 0.4" 2.5 ± 0.2 13.5 ± 0.5" 4.0 ± 0.2 
20:4/20:5 0.2 ± 0.1" 0.6 ± 0.2 0.4 ± 0.0"" 1.1 ± 0.3 
IValues are means ± so from three salmon. "Values are significantly different IP < 0.05) as determined by Student's t test. ""Values are 
significantly different IP < 0.05) as determined by Kruskal-Wallis analysis. so < 0.05 are tabulated as 0.0. 
2Includes 22:4(n-6) and 22:S(n-6). 
3Iocludes lS:4(n-3) and 2O:4(n-3). 
'pUPA - polyunsaturated fatty acids. 
TABLE 5 
Patty add eompoaition of pbospbatidyl uriD. ad p]Jo.p]Jatitlyl moaitol from beam of .Dlmon fed dietJ COlIta1n1ng 
fish oil (PO) or srmflower oil (Sal 
Phosphatidyl serine Ph08phatidyl inositol 
Fatty acid FO diet SO diet FO diet SO diet 
weight 0/0 
ToW saturates 30.6 :t 1.4* 34.9 ± 1.7 31.2 ± 0.6 34.6 ± 3.0 
ToW monoenes 13.3 ± 0.7* 8.0 ± 0.1 9.4 ± 0.1 7.8 ± 1.2 
18:2(n-6) 0.9 ± 0.1* 8.0 ± 0.1 0.6 ± 0.1* 4.2 ± 0.4 
18:3/n -6) 0.7 ± 0.1" 0.4 ± 0.1 0.3 ± 0.0" 0.1 ± 0.0 
2O:2In-6) 0.2 ± 0.0* 0.9 ± 0.2 trace" 0.3 ± 0.1 
2O:3(n-6) 0.1 ± 0.0" 1.0 ± 0.1 0.1 ± 0.1* 0.8 ± 0.2 
2O:4/n -6) 1.8 ± 0.8 1.9 ± 0.3 13.5 ± 0.1"" 16.1 ± 2.1 
ToW (n-6)' 4.4 ± O.S* 12.8 ± 0.4 15.0 ± 0.3" 22.0 ± 1.9 
lS:3In -3) 0.6 ± 0.1 * 0.1 ± 0.1 0.3 ± 0.0* trace 
2O:s(n-3) 1.8 ± 0.3* 0.9 ± 0.2 7.6 ± O.S" 3.6 ± 0.3 
22:5/n-3) 3.2 ± 0.3" 2.1 ± 0.4 1.1 ± 0.2 1.4 ± 0.5 
22:6(n-3) 37.3 ± 0.7 35.4 ± 2..l 18.9 ± 0.8* 22.6 ± 1.5 
ToW (n-31' 43.4 ± O.S" 36.9 ± 1.5 38.3 ± 0.2** 28.0 ± 2.8 
ToW pUPA' ·47.8 ± 1.0 49.8 ± 1.9 sa.3 ± 0.3* SO.O ± 4.7 
In-3)/(n-6) 10.1 ± 1.0** 1.9 ± 0.1 2.6 ± 0.1· 1.3 ± 0.0 
20:4/20:5 1.0 ± 0.4* 1.1 ± 0.3 1.8 ± 0.1· 4.5 ± 0.9 
--;Values are means ± so from three salmon. ·Values are signilicantly different (P < 0.05) as determined by Student's t test. "Values are 
significantly different (P < 0.05) as determined by Kruabl-Wallis analysis. Tracc, values <D.l%. SD < 0.05 are tabulated as 0.0. 
'Includes 22:4(n-6) and 22:S(n-6). 
'Includes 18:4(n-3) and 2O:4(n-3). 
'pUPA - polyunsaturated fatty acids. 
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TABLE 6 
Fatty add compo4ltioa 01 plJOtJpAatidyi cbol1a" _d pAospAlltidyl etbllllolllllJin, from liver of ulmoa fed tU,t. c:oufllbUnll 
lisIJ oil (PO) or _flower oll (SO)' 
Ph08phaddyl choline Phosphatidyl ethmolamine 
Fatty acid FO diet SO diet Fa diet SO diet 
weigbt % 
Total saturates 41.1 ± 4.3 3S.2 ± 2.9 25.6 ± 2.7 22.9 ± 2.6 
Total monoenes IS.3 ± 2.7 16.5 ± 3.5 23.2 ± 0.7* 15.1 ± 1.9 
IS:2{n-6) 0.6 ± 0.1" 11.9 ± 2.9 0.8±0.1"" 12.1 ± 2.1 
IS:3{n-6) trace" 0.6 ± 0.4 trace trace 
2O:2/n-6) 0.3 ± 0.2· 2.1 ± 1.1 0.3 ± 0.1· 2.S ± 0.9 
2O:3{n-6) 0.2 ± 0.1· 5.1 ± 1.2 0.2±0.1· 4.3 ± 0.2 
2O:4{n-6) 1.3 ± 1.0 2.7 ± 1.6 1.8 ± 0.2· 4.2 ± 0.2 
Total (n-6)1 2.9 ± 1.5· 22.8 ± 1.6 4.0 ± 0.5· 24.1 ± 2.4 
18:3{n-3) 0.1 ± 0.0 trace 0.2 ± 0.1· trace 
2O:S(n-3) 4.S ± 0.4· 1.9 ± 0.2 5.2 ± 0.4· 2.7 ± 0.4 
22:S(n-3) 1.3±0.1· 0.9 ± 0.1 1.6 ± 0.3 1.0 ± 0.3 
22:6(n-3) 21.2 ± 3.3 15.0 ± 3.1 32.0 ± 1.6 30.1 ± 2.0 
Total (n-3)' 27.6 ± 3.6· 17.S ± 2.9 39.S ± 1.7" 33.8 ± 1.7 
Total PUFA4 30.5 ± 4.7 40.6 ± 4.1 43.7 ± 1.5· 57.9 ± 3.4 
(n-3J/(n-6J 10.7 ± 3.S·" 0.8 ± 0.1 10.1 ± 1.5· 1.4 ± 0.1 
20:4/20:5 0.3 ± 0.2 1.5 ± 0.9 0.4±0.1· 1.6 ± 0.2 
IValues are means ± so from three salmon. ·Values are significantly different (P < 0.05) as determined by Student', t test. "·Values are 
significantly different (P < 0.05) as determined by Kruskal-Wa1lia analysis. Trace, values <0.1%. so < 0.05 are tabulated as 0.0. 
2Includes 22:4{n-6) and 22:5{n-6). 
"Includes 18:4{n-3) and 2O:4{n-3). 
4PUFA • polyunsaturated fatty acids. 
TABLE 7 
FIItty IIdd compositioa of pAosplJlltitlylserill' l1li41 pbospbatidyl inositol from liver 01 Wmoa 'tld tlitIU COZIttJiniBll 
fisb oil (PO) or _flower oll (SO, 
Phosphatidyl serine Phosphaddyl inositol 
Fatty acid Fa diet SO diet Fa diet SO diet 
weight % 
Total saturates 34.9 ± 1.0 34.8 ± 3.8 36.5 ± 3.9 35.1 ± 3.2 
Total monoenes 25.9 ± 4.5 24.3 ± 9.2 13.3 ± 1.1 10.4 ± 2.8 
18:2(n-61 1.2 ± 0.3· 9.2 ± 3.9 0.5 ± 0.0"" 3.4 ± 1.2 
18:3{n-6) 0.9 ± 0.3 0.4 ± 0.2 0.6 ± 0.1" 0.2 ± 0.1 
2O:2{n-6) 0.3 ± 0.2 1.1 ± 0.5 0.2±0.1" 1.1 ± 0.3 
2O:3(n-6) 0.1 ± 0.1" 2.0 ± 0.3 0.7 ± 0.1" 3.9 ± 1.1 
2O:4(n-61 0.4 ± 0.1 1.0 ± 0.5 19.5 ± 1.7 20.6 ± 4.2 
Total (n-6)1 2.7 ± 0.2" 13.9 ± 3.9 21.8 ± 1.6" 29.5 ± 2.9 
18:3(n-3) 0.3 ± 0.1" trace 0.1 ± 0.1" trace 
1O:S(n-3) 1.4 ± 0.6 0.7 ± 0.1 3.1 ± 0.3 1.6 ± 0.7 
22:S(n-3) 1.1 ± 0.2 1.5 ± 0.5 1.5 ± 0.5 0.9 ± 0.1 
22:6(n-31 10.5 ± 3.8 13.1 ± 1.9 14.1 ± 1.2 13.1 ± 3.7 
Total (n-3)' 24.0 ± 4.6 14.7 ± 3.3 19.4 ± 1.0 16.6 ± 4.1 
Total PUFA4 16.7 ± 4.7 18.5 ± 5.4 41.1 ± 0.4 46.1 ± 3.0 
(n-3llln-6) 8.7 ± 1.4" 1.1 ± 0.4 0.9 ± 0.2 0.6 ± 0.2 
20:4/10:5 0.3 ± 0.1 1.4 ± 0.7 6.1 ± 1.2 8.3 ± 3.0 
IValues are meana ± so from three salmon. ·Values are significantly different (P < 0.05) as determined by Student', t test. ""Values are 
significantly different (P < 0.05) as determined by Krusbl-Wallis analysis. Trace, values cO. 1 %. SD < 0.05 are tabulated as 0.0. 
lJncludes 12:4{n-6J and 12:S(n-6l. 
lJncludes 18:4{n-31 and 1O:4{n-3). 
4PUFA - polyunsaturated fatty acids. 
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TABLE 8 
Fatty add compos/tJoa of pIJMpIJatidyl cbolioe IUId plJosplJatJdyl etlJlUloJamilJlI from retilIa of salmoa led dim c:ont4itWJg 
lisIJ on (PO) or srmpowu on (501 
Phosphatidyl choline Phosphatidyl ethanolamine 
Fatty acid FO diet SO diet FO diet SO diet 
weight % 
Total saturates 35.4 ± 1.1 33.3 ± 0.4 14.7 ± 0.9 14.6 ± 1.7 
Total monoenes 20.3 ± 0.2 20.8 ± 0.4 18.8 ± 2.9 22.1 ± 3.4 
18:2(0-61 0.4 ± 0.1' 5.6 ± 0.1 0.5 ± 0.1** 2.8 ± 0.9 
18:3(0-61 trace 0.1 ± 0.0 0.1 ± 0.1 trace 
20:2(0-61 trace' 0.8 ± 0.1 trace" 0.5 ± 0.1 
20:3(0-61 trace' 0.9 ± 0.1 0.2 ± 0.1' 0.6 ± 0.1 
20:4(0-61 0.9 ± 0.0" 1.1 ± 0.0 1.7 ± 0.0 2.3 ± 0.6 
Total (0-6)2 1.6 ± 0.1" 8.7 ± 0.2 2.7 ± 0.3' 6.5 ± 0.6 
18:3(0-31 0.1 ± 0.0 trace 0.2 ± 0.1 0.2 ± 0.1 
20:5(0-3) 4.4 ± 0.1" 3.9 ± 0.2 3.0 ± 0.3" 2.4 ± 0.1 
22:5(0-31 0.8 ± 0.1 0.8 ± 0.1 1.9 ± 0.7 1.4 ± 0.1 
22:6(0-3) 31.2 ± 2.6" 26.2 ± 0.6 43.6 ± 0.8 39.9 ± 5.5 
Total (0-3)3 36.6 ± 2.2'" 31.2 ± 0.5 48.5 ± 0.9 41.8 ± 5.6 
Total PUPA' 38.4 ± 1.7 39.6 ± 0.3 SO.8 ± 0.9 48.3 ± 5.9 
(n-3)/l0-6) 23.4 ± 1.8' 3.6 :t: 0.2 18.1 ± 1.5" 6.5 ± 0.8 
20:4/20:5 0.2 ± 0.0· 0.3 ± 0.0 0.6 ± 0.1 1.0 ± 0.3 
IValues are means ± so from three salmon. ·Values are significantly different (P < 0.05) as determined by Student" t test .• 'Values are 
Significantly different (P < 0.051 as determined by Kruskal-Wallis analysis. Trace, values <0.1%. so < 0.05 are tabulated as 0.0. 
2Jncludes 22:4(0-61 and 22:510-6). 
3tncludes 18:4(0-31 and 20:4(0-3). 
'pUPA - polyunsaturated fatty acids. 
total PUFA were signi.ficantly increased and 18: 
3(n-3 1, 20:5(n-31 and total monoenes were signifi-
cantly decreased in SO-fed fish. In liver PS, 18: 
2(n-61 and 20:3(n-61 were signi.ficantly elevated and 
18:3(n-31 was significantly decreased in SO-fed fish. In 
liver PI, values for 18:2(n-6I, 20:2(n-61 and 20: 
3(n-61 were signi.ficantly increased in SO-fed fish. The 
(n-3)/(n-6) ratio in liver phospholipid classes was sig-
nificantly reduced in SO-fed fish, except in PI. The 20: 
4(1l-61/2O:5(n-3) ratio was generally increased in fish 
fed SO, although this was only significant in PE. No 
cbaI1ges were observed in the amount of 22:4(n-6) and 
22:5(n-6) in both heart and liver (data not shown). 
'l'he fatty acid compositions of the phospholipid 
classes from brain and retina were much less affected 
by dietary lipid composition than those of heart and 
liver. Changes generally were confined to PC and PE, 
and these fatty acid compositions are shown in Tables 
8 and 9. In retinal PC and PE, significant increases 
were observed in 18:2(n-61, 2O:2(n-6) and 20:3(n-61. In 
so-fed fish, 2O:4(n-6) was increased in PC but not PE. 
In both PC and PE 20:5(n-3) was decreased, and 22: 
6(D-3) was decreased in PC but not PE. In retinal PI, 
22:6(1l-3) also was significantly decreased (23.0% ± 1.6 
to 15.2% ± 0.9). A similar pattern was observed in 
brain PC and PE where 18:2(n-6), 2O:2(n-6) and 20: 
3(1l-61 were increased in SO-fed fish but 20:5(n-3) was 
significantly decreased only in PC. 
DISCUSSION 
The presence of increased levels of 20-carbon (n-61 
fatty acids in the individual phospholipid classes of 
heart and liver in SO-fed fish could be accounted for 
by appreciable ~-6- and ~-5-desaturase activity in 
these tissues. The high activity of the ~-6-desaturase 
is particularly apparent in the liver where the elon-
gation and desaturation of 18:2(n-6) could cause an 
accumulation of 20:3(n-6) and result in this fatty acid 
being the most abundant 20-carbon species in PC, PE 
and PS. Although 20:4(n-6) was increased in SO-fed 
fish, particularly in PC and PE of heart and liver, the 
accumulation of 20:3(n-6) is compatible with a rather 
low ~-5-desaturase activity in Atlantic salmon. In 
fact, a low ~-5-desaturase activity already has been 
observed by Hagve et al. (181 in isolated hepatocytes 
of rainbow trout. Salmon fed SO showed depressed 
levels of 20:5(n-3) in most phospholipid classes of 
heart and liver, subsequently, the 2O:4(n-61/20: 
5(n-3 I ratio was considerably increased in these fish. 
Although both these fatty acids (after release from 
membrane phospholipids by phospholipase ~I are 
substrates for both cyclooxygenase and lipoxygenase, 
mammalian studies indicate that 20:5(n-3~erived ei-
cosanoids tend to be of lower efficacy compared with 
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TABLE 9 I 
Patty add compositJem of phollphatidyl c1Joline and plJosplJatidyJ etlJlIlJoltJmine from bram of solmozJ fed diet5 COIJtaining fjslJ oj] \ 
~M~~~~ I 
Phosphatidyl ethanolamine I 
------------------------. 
Phosphatidyl choline 
SO diet FO diet SO diet • ~-------------------------------------------------( Fatty acid FO diet 
weight % 
Total saturates 33.2 ± 2.6 31.3 ± l.l 
Total monoenes 47.6 ± 2.0 46.5 ± 0.4 
18:2(n-6) 0.3 ± 0.0* 1.2 ± 0.3 
18:3(0-6) trace trace 
2O:2(n-6) trace * 0.3 ± 0.1 
2O:3(n-6) trace * 0.3 ± 0.0 
20:4(0-6) 0.4 ± 0.1 0.6 ± 0.1 
Total (0-6)1 0.9 ± 0.0* 2.7 ± 0.3 
18:3(0-3) trace trace 
20:5(0-3) 2.9 ± 0.1* 2.5 ± 0.1 
22:5(0-3) 0.9 ± 0.1 1.0 ± 0.4 
22:6(0-3) 11.5 ± 1.3 12.7 ± 0.7 
Total (n_3)l 15.4 ± 1.5 16.3 ± 0.4 
Total PUFA4 16.3 ± 1.5 18.9 ± 0.1 
16.9 ± 0.2 
30.9 ± 0.3 
0.3 ± 0.0* 
0.1 ± 0.1 
trace* 
trace* 
0.7 ± 0.1 
1.2 ± 0.2* 
trace 
4.8 ± 0.2 
1.8 ± 0.2 
20.9 ± 1.8 
27.8 ± 2.0 
29.0 ± 1.9 
17.1 ± 0.2 
31.1 ± 0.4 
1.1 ± 0.2 
trace 
0.4 ± 0.1 
0.3 ± 0.1 
1.1 ± 0.2 
3.0 ± 0.1 
trace 
4.4 ± 0.1 
1.6 ± 0.1 
21.5 ± 0.8 
27.7 ± 0.8 
30.6 ± 0.8 
I 
i 
I 
( 
I 
. 
I 
I 
. , 
I 
10-3'/ln-6) 17.2 ± 1.6" 
20:4/20:5 0.1 ± 0.1 
6.2 ± 1.0 22.9 ± 4.3 H 9.3 ± 0.1 
0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 
'Vd_ "" meu>' ± '0 fro .. due", ulman. 'V,"u~ "" .;gnli;=dy dili=, IP < 0.05' .. ~ by Srud=". t ""t. "V.lu~ u, I 
significantly different (P < 0.05) as determined by Kruskal-Wallis analysis. Trace, values <0.1 'Yo. so < 0.05 arc tabulated as 0.0. 
1Jncludes 22:4(n-6) and 22:5(n-6). 
lIncludes 18:4(n-3) and 2O:4(n-3). 
4PUFA _ polyunsaturated fatty acids. 
their 20:4(n-6~erived homologues (19, 20). Thus ei-
cosanoids generated by heart and liver of SO-fed fish 
would tend to be of higher biological activity than 
those from FO-fed fish. However, 20:3(n-6) also is a 
substrate for cyclooxygenase and lipoxygenase, and 
the resulting eicosanoids are antagonistic to their 20: 
4(n-6~erived counterparts (21). The eicosanoid 
status of the fish in this study, particularly after being 
subjected to stress, is an obvious area for further 
study. The fatty acid composition of phospholipids 
from brain and retina show only minor alterations as 
a result of dietary treatment. This probably reflects 
the slow turnover of fatty acids in these tissues as 
well as the relatively short period of the experiment. 
Interestingly, 22:6(n-3) was reduced in retinal PI of 
SO-fed fish (data not shown), a fact also observed in 
rat neural tissues when animals were fed Fa or SO 
(22). Possibly 22:6(n-3) is redistributed into PS and PE 
[63 and 44% 22:6(n-3), respectively; data not shown in 
tables] when the dietary supply of this fatty add is 
limited. 
Nutritional cardiomyopathy has been recorded in a 
number of fish, particularly in intensive culture and 
especially associated with vitamin E and selenium 
deficiencies (23), but no cardiomyopathy has been 
specifically associated with (n-6) fatty acid intake. 
Fjolstad and Heyeraas (24) found muscular and my-
ocardial degeneration in their study on Hitra disease 
in Norwegian farmed salmon and suggested a rela-
tionship to dietary deficiency of vitamin E and/or 
selenium. An extensive degenerative cardiomyopathy 
studied by Ferguson et al. (25) in association with 
pancreas disease (PD) of farmed salmon also was at-
tributed by these authors to vitamin E and/or 
selenium deficiency. Although these authors con-
sidered the lesions of the pancreas to be linked to 
those of heart and muscle, McVicar (26) gave evidence 
that heart and muscle lesions are not consistently or 
primarily associated with PD. In addition, Bell et aI. 
(27) considered that the depletion of vitamin E in PD-
affected salmon was a consequence, rather than the 
cause, of the disease. 
In the present study the oil source was the only 
difference between the two experimental diets. The 
high proportion of damaged hearts associated with the 
SO diet in comparison to the rarity of the condition in 
FO-fed fish indicates that the damage was a conse-
quence of the dietary lipids. The apparent recovery 
from the cardiomyopathy by a proportion of the SO-
fed fish observed in the study between wk 18 and 20 
during which time no food was provided to the fish: 
tends to support this conclusion. Vitamin E probably 
is not involved in the cardiomyopathy because, al-
though high amounts of PUFA are present in the SO 
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diet, dietary vitamin E was included in the diet at or 
above a threefold excess of requirement (10). 
Although the exact cause of the cardiac lesion was 
not defined, two aspects deserve comment. The first 
is the similarity in some ways to the fainting or shock 
syndrome described by Sinnhuber (28) and Castell et 
al. (17) in trout fed a diet deficient in (n-3) PUF A. This 
syndrome was similar to a transportation shock syn-
drome originally described by Black and Barrett (29). 
In rainbow trout given linoleic [18:2(n-611 and lauric 
acids (14:0) as their only dietary lipids, Castell et al. 
(17) observed an unusual heart condition, described as 
local myocarditis, with some degeneration and hyper-
trophy. A similar myopathy was observed in our 
present experiment, although the ventricular 
swellings observed in rainbow trout did not occur in 
SO-fed salmon. However, the extent to which either 
the shock syndrome described by Sinnhuber (28) or 
the transportation syndrome in the present study in-
volved cardiac or cardiovascular malfunction is not 
known. Clearly the SO-fed fish in the present study 
were not deficient in (n-3) PUFA on an absolute basis, 
but they could be considered to be relatively deficient 
in (n-3) PUFA in the sense that their diet contained a 
considerable excess of (n-6) compared with (n-3) 
pUFA. 
The second aspect concerns the level at which the 
dietary ratio of (n-6)/(n-3) PUFA becomes high enough 
to be pathological to fish. As far as we are aware, 
there is no evidence in the literature to suggest that a 
high ratio of these lipids is deleterious to fish, despite 
the now well-established fact that high dietary ratios 
of (n-6)/(n-3) PUFA can be deleterious to humans (30, 
31). Indeed, lowering the high dietary ratio of (n-6)/(n-
3) PUFA by taking (n-3) PUFA-rich fish oil concen-
trates is known to be beneficial in alleviating a wide 
range of human disorders, including cardiac disease 
(30, 32). Furthermore, beneficial effects stem at least 
in part from reduced production of arachidonic acid 
[20:4(n-6)J-derived 2-series prostaglandins and 4-series 
leukotrienes. Possibly the cardiac myopathy observed 
in the present study of salmon arises from an over-
production of (n-6) PUFA-derived eicosanoids, which 
are known to regulate protein biosynthesis in 
IIlsmmals (33). 
These considerations, albeit speculative, are im-
portant in terms of human health because the high (n-
3)/(n-6) PUFA ratio in fish lipid is particularly useful 
in counteracting the excesses of (n-6) PUFA currently 
coJ]llDon in Western diets. Therefore, oversup-
plementing fish food formulations with (n-6) 
pUPA-rich vegetable oils to generate fish rich in (n-6) 
pUFA may be undesirable. 
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The Effect of Dietary Linoleic Acid on the Fatty Acid Composition 
of Individual Phospholipids and Lipoxygenase Products from Gills 
and Leucocytes of Atlantic Salmon (Sa/rno sa/ar) 
J. Gordon Bella,·, Robert S. Raynardb and John. R. Sargenta 
ONERe Unit of Aquatic Biochemistry. University of Stirling. Scotland. U.K. and bD.A.F.S. Morine Laboratory. Aberdeen. Scotland 
Diets containing either fish oil or sunflower oil, both of 
which supplied the minimum required level of n-3 fatty 
acids, were given to Atlantic salmon (Salmo Bolar) post-
smolts for a period of 16 weeks. In fish fed sunflower oil, 
the phospholipids of gills showed increased 18:2n-6 
(2-13-fold~, 20:2n-6 (4.5-12-fold~ and 20:30-6 (2-8-fold~. In 
addition, ph08phatidylethanolamine had increased 20:40-6 
(1.5-fold~. Changes of a similar magnitude were observed 
in the phospholipids of blood leucocytes except that, in 
addition, 20:4n-6 was elevated in ph08phatidylserine 
(1.7-fold~ and ph08phatidylinositol (1.4-fold~. Both tissues 
showed a general decrease in phospholipid 20:5n-3 (up to 
3-fold), which caused an increase in 20:4n-6/20:5n-3 ratio 
(1.3-6-fold). The elongation and desaturatioo products of 
20:40-6, 22:4n-6 and 22:5n-6 were not increased as a result 
of feeding sunflower oil. When isolated gill cells were 
stimulated with the calcium ionophore A23187, 12-
hydroxy-8,10,14,17-eicosapentaenoic acid (12·HEPE) was 
the major lipoxygenase product from salmon given fish 
oil. 12-HEPE was significantly reduced in salmon given 
sunflower oil. When stimulated with A23187, the lipoxy-
genase products derived from whole blood of fish given 
sunflower oil showed decreased levels of leukotriene B5, 
12-HEPE and 12·hydroxy-5,8,10,14-eicosatetraenoic acid. 
Lipids 26, 445-450 (1991). 
Most mammals can metabolize linoleic acid (LA), 18:2n·6 
by A6 desaturation to gamma-linolenic acid 18:3n·6 which, 
after elongation to dihomogamma-linolenic acid 20:3n·6, 
can subsequently undergo lI5 desaturation to arachidonic 
acid (AA), 20:4n-6 (1). Generally freshwater fish are 
capable of utilizing the same pathway (2), whereas marine 
species, such as turbot (Scophthalmus maximums), ap-
parently lack A5 desaturase and thus require their diet 
to supply the highly unsaturated fatty acids (HUFA), 
eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) 
and probably AA (3,4). Studies with an anadramous 
species, Atlantic salmon (Salmo salar), indicated art ap-
parent inability to metabolize LA to AA during smolting 
(the transition from freshwater to seawater) (5), although 
post-smolts given linoleic acid as corn oil showed increased 
AA in the phospholipids of liver and muscle (6). 
AA and EPA can be metabolized by cyclooxygenase and 
lipoxygenase enzymes to yield a group of biologically 
.To whom correspondence should be addressed. 
Abbreviations: AA. arachidonic acid; BHT, butylated hydrox, 
ytoluene; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; 
FO, fish oil; HEPE, hydroxy·5.8,lO,14.17-eicosapentaenoic acid; 
MEPES, N-(2·hydroxyethyllpiperazine-N' -(2-ethanesulfonic acidl; 
METE, hydroxy-S,8. 10,1 4-eicosatetraenoic. acid; HPLC, high·per-
formance liquid chromatography; HUF A, highly unsaturated fatty 
acid; LA. linoleic acid; L TB., leukotrien~ B.; L TB~, le~otriene B~; 
pC phosphstidylcholine; PE, phosphatldylethanolanune; PI, phos-
ph~tidylinositol; PS, phosph~tidylserin~; PUF A, polyunsaturated 
fatty acid; SFO, sunflower oil; TLC, thin·layer chromatography. 
active products known collectively as eicosanoids. While 
the AA-derived eicosanoids are powerful agonists in a 
number of pathophysiological conditions such as psoriasis 
and cardiovascular disease (7,8), the EPA-derived eicosa-
noids are generally of decreased efficacy, and thus their 
generation in vivo may allow them to function as anti-
inflammatory mediators (9). This fact underlies the use 
of n-3 HUFA-rich fish oils in the treatment of a number 
of inflammatory conditions in humans (10). 
Fish are an ideal model system for studying the pro· 
duction and interaction of AA- and EPA-derived eicosa-
noids because their tissues Me naturally rich in n·3 HUFA. 
In this study Atlantic salmon post·smolts were given diets 
in which the lipid was supplied either as fish oil or 
sunflower oil. Although the latter diet had a markedly 
reduced n-3/n-6 ratio, it contained sufficient n-3 HUFA 
derived from the dietary fish meal to meet the normally 
recommended requirements of salmon (11). Our aims were 
i) to study the incorporation of LA and its metabolic prod· 
ucts into the individual phospholipids of gills and leuco-
cytes. These tissues are highly active in eicosanoid pro-
duction (12-14). ii) 1b determine lipoxygenase products 
from endogenous fatty acid precursors in isolated gill cells 
and whole blood challenged with the calcium ionophore 
A23187. 
MATERIALS AND METHODS 
Materials. Leukotriene B5 (LTB5), 12·hydroxyeicosatetra-
enoic acid (12(R,S)-HETE) and 12·hydroxyeicosapenta-
enoie acid (12(S)·HEPE) were purchased from Cascade 
Biochem Ltd. (Reading, u.K.). Leukotriene B. (LTB 4). 
A23187 and "Sigmacote" were from Sigma Chemical Co. 
Ltd. (Poole, u.K.). 15-Hydroxyeicosatetraenoic acid (15(S)-
HETE) and 5-hydroxyeicosatetraenoic acid (5(R,S)-HETE) 
were purchased from Novabiochem Ltd. (Nottingham, 
U.K.). 
Thin-layer chromatography (TLC) plates (20 X 20 cm 
X 0.25 mm) precoated with Silica Gel 60 were obtained 
from Merck (Darmstadt, Germany). All solvents were of 
high-performance liquid eM tography (HPLC) grade 
and were obtained from Rathb .... o Chemicals Ltd. (Walker-
burn, U.K.). 
Animals and diets. Three hundred Atlantic salmon 81 
smolts (Salmon undergoing transition to seawater in one 
year, mean wt. co. 51 g) were obtained from the D.A.F.8. 
Fish Cultivation Unit (Aultbea, Wester Ross, Scotland) 
and transferred to sea water tanks at the same unit. The 
diets were supplied by automatic feeders whieh were ad-
justed to provide 20 glkg biomass per day, 7 days each 
week. Fish were bulk weigbed every 28 days and the ra· 
tion adjusted accordingly. Samples for analytical 
measurements were collected after 16 weeks of the feeding 
experiment. The fish meal-based diets were formulated to 
meet the nutritional requirements of salmon (15) and con-
tained 46% erudp. protein and 17% lipid (Table 1). The 
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TABLE 1 
Composition or the Basal Diet 
Constituent 
Fishmeal 
Starcha 
Oilb 
Vitamin mixe 
Mineral mixd 
a-Cellulose 
Antioxidant mixe 
Choline chloride (40% w/vl 
Amount (g/kgl 
650 
150 
100 
10 
24 
65.5 
0.4 
10 mL 
a Passelli W A4. Tunnel Avebe Starches Ltd .• Gillingham. U.K. 
bFosol. Seven Seas Ltd. (Hull. U.K.) or Sunflower oil (Tesco Ltd. 
U.K.)_ 
cSupplied (mg/kg): a-tocopherol acetate. 40; menadione. 10; ascor-
bic acid. 1000; thiamin hydrochloride. 10; riboflavin. 20; pyridox-
ine hydrochloride. 12; calcium pantothenate. 44; nicotinic acid. 150; 
biotin. 1; folic acid. 5; cyanocobalamin. 0.02; myo-inositol. 400; 
retinyl acetate. 2500 I.U.; and cholicalciferol. 24001.U. 
dSupplied per kg diet: KH2PO •• 22 g; FeS04.7H20. 1.0 g; 
ZnS04·7H20. 0.13 g; MnS04.4H20. 52.8 mg; CuS04.5H20. 12 mg; 
CoS04·7H20. 2 mg; and KI. 2 mg. 
eContained (giL): Butylated hydroxy anisole. 60; propyl gallate. 60; 
citric acid. 40; dissolved in proylene glycol. 
TABLE 2 
Fatty Acid Composition or Diets 
Fatty acids 
14:0 
16:0 
18:0 
16:1n-7 
18:1n-9 
20:1n-9 
22:1n-l1 
24:1 
18:2n-6 
18:3n-6 
20:2n-6 
20:3n-6 
20:4n-6 
18:3n-3 
18:4n-3 
20:5n-3 
22:5n-3 
22:6n-3 
Total n-6 
Total n-3 
n-3/n-6 
Fish oil diet 
(weight %) 
5.7 
13.8 
2.5 
5.2 
12.0 
8.9 
13.8 
1.4 
1.4 
0.2 
0.2 
0.2 
0.6 
1.3 
2.9 
7.2 
1.2 
10.4 
2.5 
23.8 
9.4 
Sunflower oil diet 
(weight %) 
2.0 
9.7 
3.4 
2.2 
14.7 
3.2 
4.0 
0.4 
42.1 
1.1 
<0.1 
0.1 
0.4 
0.4 
0.7 
3.4 
0.5 
4.6 
43.6 
9.9 
0.2 
dietary lipid was supplied either as fish oil (FO) or 
sunflower oil (SFO), and both diets fulfilled the require-
ment for n-3 fatty acids to be co. 1% of the dry diet. The 
fatty acid compositions of the two diets are shown in 
Table 2_ 
Leucocyte preparation and lipid extraction. Five mL of 
blood were collected in heparinized syringes from the 
caudal vein of six fish from each dietary treatment. The 
blood was diluted with two volumes of phosphate buffered 
LIPIDS. Vol. 26. No. 6 (1991) 
saline (PBS). Four mL of t:le diluted blood were layered 
onto 6 mL of lymphocyte separation medium (Gibco Ltd .. 
Paisley. Scotlandl and centrifuged at 400 X g for 30 min 
at 4°C. The cells around the interface of the erythrocytes 
were harvested and washed in PBS. If erythrocyte con-
tamination was greater than 1%. the gradient centrifuga-
tion was re:-eated. The leucocytes obtained from six 
samples per dietary treatment were pooled and the lipids 
extracted by the method of Folch et aL (16)_ The extracts 
were stored at -20°C prior to further analysis. All 
solvents contained 0.05% butylated hydroxy toluene 
(BHT) as an antioxidant. 
Extraction of gill lipids. Intact gill arches were dissected 
from three fish per treatment, blotted on paper tissue to 
remove excess blood and immediately frozen in liquid 
nitrogen. Samples were stored at -20°C prior to lipid ex-
traction. After thawing. the gill filaments were dissected 
from the gill arches. weighed and homogenized in 
chloroform/methanol (2;1, v/v) using a "Polytron" tissue 
macerator. The remaining procedures were as described 
for leucocyte lipis extraction. Lipids were extracted from 
1.0 g samples of the diets by a similar procedure. 
Lipid class separation and fatty acid analysis. Lipid ex-
tracts were separated into phosphatidylcholine (PCI. 
phosphatidylethanolamine (PE), phosphatidylserine (PS) 
and phosphatidylinositol (PI) fractions by TLC as describ-
ed by Vitiello and Zanetta (17). The plates were sprayed 
with 0.1% 2',7'-dichlorofluorescein in 97% methanol con· 
taining 0.05% BHT, and the lipid bands were visualized 
under UV light. Acid-catalyzed transmethylation was per-
formed overnight at 50°C by the method of Christie (181. 
The fatty acid methyl esters were separated and quan-
tified by gas-liquid chromatography (Carlo Erba Frac-
tovap 4160, Fisons Ltd., Crawley, u.K.) using a capillary 
column (50 m X 0.22 mm i.d.) coated with free fatty acid 
phase (S.G.E. Ltd .• Milton Keynes, u.K.). Individual 
methyl esters were identified by comparison with known 
standards and by reference to published data (19.20). 
Preparation of isolated gill cells. Fish were killed by a 
blow to the head. The pericardium was opened and the 
bulbus arteriosus was perfused with 20 mL of ice-cold 
0.9% NaCI (w/v) to flush blood from the gills. The gill 
arches were then removed and placed in ice-cold Hank's 
medium This is a calcium-free medium which is specially 
modified for use with salmonid fish as described by Moon 
et aL (21). The composition was: 10.29 gIL NaCl, 0.4 gIL 
KCl, 0.2 gIL MgSO •. 7H20, 0.06 gIL KH2PO., 0.13 giL 
Na2HP04.12H20, 0.5 giL NaHC03, and 2.38 gIL 
HEPES. The arches were then blotted on tissue and the 
epithelial layer scraped with a blunt scalpel blade to 
remove cells. The cells were then suspended in ice-cold 
Ca2+-free Hank's medium, gently separated by stirring 
with a magnetic stirrer and filtered through a 100 ",m 
nylon gauze. The cells were collected by centrifugation at 
100 X g for 5 min. 
Ionophore challenge. Glass test tubes (15 mL) used in 
the incubations were pre-coated with "Sigmacote" prior 
to use. Gill cells were suspended in modified Hank's 
medium (containing 2 mM CaC12) at a concentration of 
100 mg wet weight per mL. An aliquot of the suspension 
was retained for protein determination (22). One mL of 
whole blood was mixed with an equal volume of modified 
Hank's medium and both blood and gill cell suspensions 
were incubated in a shaking water bath at 15°C for 
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10 min. Calcium ionophore A23187 was added in 5 /AL 
dimethylsulfoxide at a final concentration of 20 /AM. 
Eicosanoid extraction. After 30 min incubation, the 
samples were centrifuged at 12,000 X g for 2 min and the 
eicosanoids extracted by the method of Pettitt et aL (14). 
High-performance liquid chromatography. The profiles 
of the hydroxy fatty acids and leukotrienes from the gill 
and blood extracts were determined by reverse phase high-
performance liquid chromatography (HPLC) using a 
Spherisorb 5 /Am octadecylsilica (ODS2) column (25 cm X 
4.6 mm Ld., Scotlab, Bellshill, Scotland). The chromato-
graphic system was equipped with Waters Model M-45 
pumps and 680 Automated Gradient Controller and the 
effluent was monitored at 280 nm and 235 nm to detect 
leukotrienes and hydroxy fatty acids, respectively, using 
a Pye Unicam LC-UV detector. '!\vo isocratic solvent 
systems were used at a flow rate of 1 mUmin. Th separate 
the monohydroxy acids, solvent A containing methanol! 
water/acetic acid (80:20:0.05, vlvIv) was used. Th separate 
leukotrienes and monohydroxy acids, solvent B contain-
ing acetonitrile/methanol/water/acetic acid/phosphoric 
acid/ammonia (40:29:30:0.5:0.3:0.2, by vol) was used. Quan-
titations were based on external standards of 12-HEPE, 
12-HETE, LTB5 and LTB4 • A representative chromato-
gram of leukotriene and hydroxy fatty acid standards is 
shown in Figure 1. 
Preparation and chromatography of hydroxy acid 
methyl esters. Methyl esters of standard hydroxy acids 
and peaks collected from HPLC were methylated using 
diazomethane as described by Schwartz and Bright (23). 
The methyl esters were purified using HPLC (Solvent A) 
and analyzed by gas-liquid chromatography (Philips PU 
4500 chromatograph) using a CP Sil 5 column (50 m X 
0.32 mm Ld.; Chrompak, Middelberg, The Netherlands). 
Hydrogen was used as carrier gas and the temperature 
was programmed from 50°C to 260°C at 4°C/min. 
Statistical analysis. Significance of difference (P<0.05) 
between dietary treatments was determined by Student's 
t-test. 
RESULTS 
The fatty acid compositions of leucocyte phospholipid 
classes are shown in Tables 3 and 4. In PC from SFO fish 
there were increases in 18:2n-6. 18:3n-6. 20:2n-6 and 
20:3n-6 as compared to FO fish. The SFO fish also showed 
decreased 20:5n-3, 22:6n-3, total saturated acids and total 
monoenes. In PE a similar pattern of changes was ob-
served, although 20:4n-6 was also increased in SFO fish 
as compared to FO fish. In both lipid classes of SFO fish 
the n-3/n-6 ratio was reduced. In PS of SFO fish the n-6 
pUFA were also elevated compared to the FO fish, and 
20:5n-3 and 22:6n-3 were reduced. In PI 20:3n-6 and 
20:4n-6 were increased in SFa fish but the n-3 HUFA were 
also elevated. In general, PI was the least altered by 
dietary lipid and this was reflected by little change in 
either the n-3/n-6 ratio or the 20:4n-6/20:5n-3 ratio. In ps. 
as with PC and PE, the n-3/n-6 ratio was decreased and 
the 20:4n-6/20:5n-3 ratio was increased. 
The fatty acid compositions of gill phospholipid classes 
are shown in Thbles 5 and 6. PC from SFO fish showed 
significantly increased 18:2n-6, 20:2n·6 and 20:3n-6. The 
SFO fish also had decreased 20:5n-3 and total n-3 PUFA, 
but increased total PUFA as compared to FO fish. Similar 
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FIG. 1. (AI A typical HPLC chromatollram or leukotriene and 
hydroxy acid standards separated usinll solvent aystem described 
in Materials and Methods. \BI A typical HPLC chromatogram or 
IipoxYllen88e producta obtained after stimulation of whole blood with 
A23187 120 ~MI. Experimental conditioDl are described in Materials 
and Methods. 
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TABLE 3 
Fatty Acid Compositions of Phosphatidylcholine 
and Phosphatidylethanolamine from Salmon Leucocytesa 
Fatty acids PC PE 
(weight %1 FO diet SFO diet FO diet SFO diet 
Total saturated 34.8 32.6 22.5 18.2 
Total monoenoic 25.0 20.6 25.4 14.2 
18:2n·6 l.0 8.8 2.4 12.2 
18:3n-6 0.2 0.5 0.1 0.6 
20:2n-6 0.2 1.6 0.3 2.0 
20:3n-6 0.2 1.6 0.2 1.5 
20:4n-6 2.8 2.8 2.8 4.2 
Total n-6 b 4.9 15.5 6.5 20.9 
18:3n-3 0.2 0.2 0.3 0.2 
20:5n-3 8.8 5.1 4.1 2.8 
22:5n-3 1.1 0.9 l.0 1.8 
22:6n-3 18.6 14.6 29.1 31.1 
Total n-3c 29.3 20.9 35.5 36.2 
Total PUFA 34.2 36.4 42.0 57.0 
n-3/n·6 6.0 1.4 5.4 1.7 
20:4/20:5 0.3 0.7 0.6 1.5 
a Results are from pooled leucocyte samples from six salmon. 
blnc1udes 22:4n-6 and 22:5n-6. 
c Includes 18:4n-3 and 20:4n-3. 
TABLE 4 
Fatty Acid Compositions of Phosphatidylserine 
and Phosphatidylinositol from Salmon Leucocytesa 
Fatty acids PS 
(weight %1 FO diet SFO diet FO diet 
Total saturated 31.9 34.9 26.7 
Total monoenoic 11.4 7.1 12.5 
18:2n-6 1.0 3.8 1.2 
18:3n-6 <0.1 0.2 0.3 
20:2n-6 <0.1 1.0 0.2 
20:3n-6 <0.1 0.9 0.4 
20:4n-6 1.6 2.7 13.0 
Total n-6b 2.8 9.1 15.2 
18:3n-3 0.2 0.3 0.3 
20:5n-3 2.1 1.7 2.4 
22:5n-3 l.7 l.9 1.8 
22:6n-3 41.8 38.4 25.3 
Total n-3c 46.0 42.4 3l.7 
Total PUFA 48.7 51.4 47.4 
n-3/n-6 16.7 4.7 2.1 
20:4/20:5 0.8 l.6 5.4 
Footnotes as for Table 3. 
. PI 
SFO diet 
22.9 
6.6 
1.4 
0.2 
0.3 
0.8 
17.8 
21.1 
<0.1 
2.7 
l.8 
30.4 
34.9 
56.0 
1.7 
6.6 
changes were apprent in gill PE. In gill PS, 18:2n-6, 
20:2n-6 and 20:3n-6 were significantly elevated in SFO 
fish, while significant decreases were observed in 20:5n-3 
and 22:5n-3. Similar changes were observed in gill PI. The 
n-3/n-6 ratio in all gill phospholipids was reduced in fish 
given the SFO diet. The mean value of the ratio 
20:4n-6/20:5n-3 was generally increased in SFO fish but. 
due to large standard deviations, the increase was only 
significant in PS. In the phospholipids from both 
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TABLE 5 
Fatty Acid Compositions of Phosphatidylcholine 
and Phosphatidylethanolamine from Salmon Gilla 
Fatty acids PC PE 
(weight %1 FO diet SFO diet FO diet 
Total 
saturated 40.6 ± 2.3 40.5 ± 1.1 19.1 ± 0.7 
Total 
monoenoic 24.9 ± 1.5 22.3 ± 0.9 14.8 ± 1.3 
18:2n-6 0.6 ± O.lb 7.9 ± l.0 0.9 ± 0.2b 
18:3n-6 0.2 ± 0.1 0.2 ± 0.2 0.4 ± 0.2 
20:2n-6 0.1 ± O.Ob 1.2 ± 0.2 0.2 ± O.l b 
20:3n-6 0.1 ± O.Ob 1.6 ± 0.3 0.1 ± O.Ob 
20:4n-6 1.4 ± 0.2 2.2 ± 0.9 2.8 ± 0.4 
Total n-6c 2.6 ± O.4 b 13.4 ± 0.6 5.0 ± 0.6b 
18:3n-3 <0.1 <0.1 0.1 ± 0.0 
20:5n-3 4.9 ± 0.6 b 2.6 ± 0.2 4.a ± 0.5 b 
22:5n·3 0.8 ± 0.3 0.5 ± 0.1 1.2 ± 0.2 
22:6n-3 15.3 ± 1.3 13.8 ± 0.6 33.7 ± 0.6 
Total n·ad 21.3 ± 2.0b 16.9 ± 0.7 39.4 ± 0.6 
Total PUFA 23.9 ± 2.4b aO.3 ± 1.3 44.5 ± 0.4 
n-3/n-6 8.1 ± 0.5b 1.3 ± 0.0 8.0 ± 0.9b 
20:4/20:5 0.3 ± 0.1 0.9 ± 0.4 0.7 ± 0.2 
SFO diet 
21.5 ± 4.1 
16.2 ± 4.1 
4.8 ± 0.8 
0.2 ± 0.1 
0.9 ± 0.1 
0.7 ± 0.3 
4.2 ± 2.3 
11.4 ± 2.6 
<0.1 
2.2 ± 0.2 
0.8 ± 0.3 
26.9 ± 5.2 
30.4 ± 5.2 
41.8 ± 7.7 
2.7 ± 0.3 
1.9 ± 0.9 
a Results are "'c by weight ± standard deviation from three salmon. 
bValues are significantly different (P<0.051. 
c Includes 22:4n-6 and 22:5n·6. 
dInc1udes 18:4n-3 and 20:4n-3. 
TABLE 6 
Fatty Acid Compositions of Phosphatidylserine 
and Phosphatidylinositol from Salmon Gillsa 
Fatty acids PS PI 
(weight %1 FO diet SFO diet FO diet SFO diet 
Total 
saturated 36.1 ± 0.5 b 45.8 ± 1.5 36.0 ± 4.8 40.3 ± 4.5 
Total 
monoenoic 15.0 ± 0.7 b 10.7 ± 1.2 14.6 ± 0.6 14.6 ± 0.3 
18:2n-6 0.8 ± 0.3b 2.8 ± 0.5 1.6 ± O.l b 3.9 ± 0.4 
18:3n·6 0.8 ± 0.1 0.6 ± 0.2 1.0 ± 0.5 0.6 ± 0.2 
20:2n-6 O.lb 0.9 ± 0.1 <O.l b 0.5 ± 0.0 
20:3n-6 <O.l b 0.9 ± 0.1 <O.4b l.2 ± 0.1 
20:4n-6 0.8 ± 0.1 1.1 ± 0.2 9.1 ± 0.8 8.7 ± 2.1 
Total n-6c 3.3 ± 0.4b 6.9 ± 0.3 12.1 ± 0.5 15.4 ± 1.9 
18:3n-3 0.1 ± 0.0 <0.1 0.5 0.2 ± 0.1 
20:5n-3 1.3 ± 0.3b 0.4 ± 0.1 2.5 ± 0.3b 1.3 ± 0.1 
22:5n-3 1.7 ± O.l b 1.2 ± 0.2 l.0 ± 0.2 0.6 ± 0.1 
22:6n-3 27.6 ± 1.0 25.2 ± 1.4 21.5 ± 2.9 17.6 ± 0.8 
Total n·3d 30.8 ± l.2 26.9 ± 1.7 25.4 ± 3.3 19.7 ± 0.7 
Total PUFA 34.2 ± l.0 33.8 ± 1.7 37.5 ± 3.8 35.1 ± 2.5 
n·3/n·6 9.3 ± l.4b 3.9 ± 0.4 2.1 ± 0.3b l.3 ± 0.2 
20:4/20:5 0.7 ± 0.2b 2.5 ± 0.7 3.7 ± 0.3 6.9 ± 1.9 
Footnotes as described in Table 5. 
leucocytes and gills, no changes in the very small amounts 
of 22:4n-6 and 22:5n-6 detected were observed (data not 
shown). 
The major lipoxygenase products from gill and blood are 
shown in Thbles 7 and 8 and a typical HPLC chromatogram 
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TABLE 7 
Lipoxygenase Products from Gill of Salmon Given Diets 
Containing Either Fish Oil or Sunflower Oila 
Eicosanoid 
12·HEPE 
12·HETE 
12·HETE/12·HEPE 
FO diet 
(ng/mg protein) 
108.3 ± 7.2b 
54.8 ± 10.9 
O.S ± O.lb 
SFO diet 
(ng/mg protein) 
43.1 ± 1.7 
52.7 ± 7.4 
1.3 ± 0.2 
a Values are mean ± standard error for five fish per treatment. 
bValues are significantly different (P<O.OS). 
TABLE 8 
Lipoxygenase Products from Blood of Salmon Given Diets 
Containing Either Fish Oil or Sunflower Oila 
Eicosanoid 
L TB4 
LTBs 
LTB4/LTB; 
12·HEPE 
12·HETE 
12·HETE/12·HEPE 
FO diet 
(ng/mL blood) 
23.2 ± 2.2 
3S.2 ± 10.2b 
0.7 ± 0.2b 
109.0 ± 25.5b 
185.0 ± 17.3b 
2.1 ± 0.3 
SFO diet 
(ng/mL blood) 
18.1 ± 7.4 
9.6 ± 1.6 
1.9 ± 0.6 
38.1 ± 4.5 
97.2 ± 14.8 
2.7 ± 0.2 
aValues are mean ± standard error for three fish per treatment. 
bValues are significantly different (P<O.OS). 
of the products produced by incubation of blood with 
A23187 is shown in Figure 1. Peak identity was confirmed 
by high resolution capillary GC of methyl esters prepared 
from hydroxy fatty acids recovered from the HPLC 
separation. No HPLC peaks were detected when blood 
was incubated with dimethylsulfoxide alone (data not 
shown). 
Gill cells from both dietary treatments produced sub-
stantial amounts of both 12-HEPE and 12-HETE. The 
amount of 12-HETE produced did not vary with dietary 
n-3/n-6 ratio but the amount of 12-HEPE produced was 
significantly reduced in fish given SFO. No LTB. or 
LTBs were detected in gill cell extracts. A reduction in 
the dietary n-3/n-6 ratio did not alter production of 
leUCocyte LTB4, but the production of LTBs was signifi-
cantly reduced in fish given SFO. However, SFO signifi-
cantly reduced the formation of both 12·HEPE and 
12-HETE as compared to leucocytes from fish given FO. 
DISCUSSION 
The increased levels of 20-carbon n-6 fatty acids present 
in the individual phospholipids of gill and leucocytes from 
fish given SFO indicate that both A6 and A5 desaturation 
are occurring in these tissues. In gill cells A5 desaturase 
appears less active than AS desaturase. This is confirmed 
by the accumulation of 20:3n-6 in all phospholipids, where-
as 20:4n-6 is only increased in PE. There was a similar 
accumulation of 20:3n-6 in leucocytes, although 20:4n-6 
was also increased in PE, PS and PI. This relatively low 
A5 desaturase activity also was observed in isolated hepa-
toCYtes from a related salmonid, the rainbow trout (24). 
While trout gill homogenates have a 12-lipoxygenase 
capable of converting exogenous radiolabeled AA and 
EPA to their 12-hydroxy metabolites (25), there has been 
no information on the production of these metabolites 
from endogenous precursor fatty acids derived from gill 
phospholipids. This study demonstrates that in Atlantic 
salmon given a FO containing diet. the major 12-lipoxy-
genase product from gill cells is EPA-derived 12-HEPE. 
The reduced production of 12-HE PE in gills of SFO fish 
corresponds with a reduction of EPA and an increase in 
the AA/EPA ratio in the gill phospholipids. The ratio of 
12-HETE/12-HEPE produced by gill cells and the ratio 
of the precursor fatty acids in gill PC suggest a possible 
relationship between the levels of these fatty acids in PC 
and their metabolism by gilllipoxygenase. A similar rela-
tionship has also been suggested by Fischer et aL (26) and 
Takayama et aL (27) for mammalian platelets and cultured 
mammalian umbilical tissue, respectively. 
The precise physiological role of 12-HETE is not 
presently well established. although recent studies have 
postulated a possible role for this eicosanoid in the con-
trol of ion channels (28.29). This role would be particularly 
important in gills which, along with renal tissue, are 
responsible for osmoregulation in fish. In general. EPA-
derived eicosanoids have less biopotency relative to their 
AA-derived counterparts (30.31). Therefore. the alteration 
of 12·HETE/12·HEPE ratio as a result of SFO intake 
could have a profound effect on gill physiology and 
function. 
The quantity of lipoxygenase products derived from en-
dogenous precursors in salmon gill was very substantial 
in that the recorded value of approximately 100 ng 
12-HEPE/mg tissue protein represents 0.3 mg 12-HEPE/g 
tissue lipid or 0.7% of total precursor fatty acid metabo-
lized by lipoxygenase. The significance of this high lipoxy· 
genase activity is not clear. 
We used whole blood. instead of isolated leucocytes, to 
study eicosanoid production because this most closely 
resembled the in vivo situation where interactions bet-
ween different cell types are known to have profound in-
fluences on eicosanoid production (32). Studies with rain-
bow trout have indicated that leucocytes are the only 
blood cells which are directly capable of eicosanoid pro-
duction and that no eicosanoids are generated by 
ionophore-stimulated erythrocytes (14). Salmon given 
SFO showed decreased production of LTB& and. conse-
quently, an increased LTB./LTB6 ratio as compared to 
those given FO. LTB. is an extremely powerful 
chemotactic agent and is a potent agonist in increasing 
intracellular calcium (33). EPA-derived LTB5, however. is 
up to 30 times less potent than LTB. (34). Clearly the 
changes induced by high n-6 PUFA intake could have 
significant consequences for immune function. 
Both 12-HEPE and 12-HETE production were reduced 
in fish given SFO even though AA was slightly increased 
in their phospholipids. However, 20:3n-6 was increased 
from 1.5% (in FO fish) to 13% (in SFO fish) of the total 
20-carbon PUFA in leucocyte total phospholipids (Tables 3 
and 4) and this fatty acid. which is also a substrate for 
lipoxygenase, is known to inhibit production of AA-
derived eicosanoids in guinea-pig epidermis (7). In trout. 
endogenous 20:3n-6 was not utilized directly for prosta-
glandin production. but it was an effective inhibitor of AA-
derived prostaglandin formation (35). Changes in dietary 
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n-3/n-6 PUFA ratio can increase (36) or decrease (37) the 
activity of phospholipase A2 depending on the tissue. A 
decrease in phospholipase A2 activity, which would result 
in less available substrate for lipoxygenase, could explain 
the decline in both 12-HETE and 12-HEPE production 
in leucocytes of fish given SFO. Under our experimental 
conditions, no lipoxygenase products of 22:6n-3 were 
detected in the eicosanoid extracts from either gill cells 
or leucocytes. Similar studies with rainbow trout (38) and 
mammals supplemented with 22:6n-3 (7,39) also found no 
lipoxygenase-derived products of this fatty acid. While 
this may be surprising in cells containing large amounts 
of 22:6n-3, it may reflect a selective conservation mecha-
ism for a fatty acid considered vital in maintaining mem-
brane structure and function (40,41). 
In general, therefore. the inclusion of linoleic acid in the 
diets of salmon results in alterations in the phospholipid 
fatty acid compositions in gills and leucocytes paralleled 
by an altered eicosanoid spectrum in these tissues. The 
biological consequences of these changes remain to be 
assessed. However, the very high biological activity of AA-
derived eicosanoids suggest that caution is required in 
over-supplementing commercial fish oils with n-6 rich 
vegetable oils in fish feeds, especially under conditions 
where the fish are likely to be stressed. 
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Abstract-I. Atlantic salmon post-smolts were fed practical-type diets containing linoleic acid at 10 25 
or 45% of total dietary fatty acids for a period of 20 weeks. . 
2. As dietary linoleic acid was increased, individual phospholipids of heart contained increased levels 
of 18:2n-6. 20:2n-6, 2.o:3.n-6 and 20:4n-~ ~nd reduced levels of 20:5n-3. The ratio of n-3/n-6 
polyunsa.turated fatty aCIds In heart phospholipids decreased and the ratio of :!0:4n-6/20: 5n-3 increased. 
3. ~n Incre~sed pr~duc.t1on ~f thromboxane B~. occurred in isolated cardiac myocytes from fish given 
the highest dietary linoleiC aCid but the production of 6-keto prostaglandin F was not significantly 
affected. nor was the activity of heart sarcoplasmic reticulum Ca~+-Mg~+ ATP~~ (EC 3.6.1.4). 
INTRODUcnON 
A number of mammalian studies have demonstrated 
that the polyunsaturated fatty acid (PUF A) compo-
sition of heart membrane lipids can be influenced by 
modifying dietary fat intake (Swanson and Kinsella. 
1986; Leonardi et al .• 1987). In a previous study with 
Atlantic salmon (Salrno salar), we demonstrated that 
the fatty acid composition of the membrane phospho-
lipids of heart could be altered profoundly by feeding 
diets in which the fat component was either fish oil 
or sunflower oil (Bell et al .• 1991). Fish given 
sunflower oil also developed a severe cardiomyopathy 
I. which, was absent in fish given fish oil. The lesion 
;. caJised extensive thinning of the ventricular and atrial 
wall, as well as active muscle necrosis. 
The desaturation and elongation of linoleic acid 
(LA; 18: 2n-6) produces arachidonic acid (AA; 
20: 4n-6) which can be metabolised by cyclooxy-
genase and lipoxygenase enzymes to yield a wide 
range of biologically active eicosanoids (Samuelsson, 
1983). Eicosapentaenoic acid (EPA; 20:5n-3), a 
PUFA ubiquitous in fish tissues (Henderson and 
Tocher. 1987; Ackman. 1980), is also a precursor for 
eicosanoid synthesis although the biological potency 
of the compounds formed in mammals is consider-
ably less than those derived from AA (Lands, 1989). 
Additionally. both EPA and docosahexaenoic acid 
(DHA; 22:6n-3). the major PUFA in fish tissues 
(Henderson and Tocher, 1987; Ackman, 1980) can 
directly inhibit the activity of cyclooxygenase (Terano 
et al., 1986; Corey et al., 1983), leading to decreased 
production of prostaglandins. tbromboxanes and 
prostacyclins. Prostaglandins are important me-
diators of myocardial function (Kannazyn, 1985) and 
-To whom all correspondence should be addressed. 
are also involved in the control of muscle protein 
synthesis (Palmer. 1990). 
:"-Iteration~ .in cell membrane phospholipid fatty 
aCId composItion can also have direct effects on the 
activities of membrane-bound enzymes and the con-
trol of ion permeability (Stubbs and Smith. 1984). In 
particular. the activity of cardiac sarcoplasmic reticu-
lum (SR) Ca2+-Mg=+ ATPase (EC 3.6.1.4) can be 
influenced greatly by the membrane n-3 and n-6-
PUFA composition (Swanson et al .• 1989). Thus. in 
mice fed diets containing either menhaden oil or corn 
oil, Ca l +-Mg2+ ATPase activity in SR was increased 
6.S-fold in the latter dietary treatment. The SR 
regulates intracellular calcium concentration during 
the contraction-relaxation cycle of the myocardium 
and the calcium-dependent ATPase within the 
SR membrane is r~ndamental in this regulatory 
process. Therefore. dIetary modifications which influ-
ence the enzyme and thereby alter intracellular Cal + 
concentration can affect the severity of cardiac necro-
sis resulting from ischemia and reperfusion (Dhalla . 
et al., 1978). 
Our objectives in the present study were to investi-
gate the effects of different dietary levels of linoleic 
acid on the fatty acid compositions of individual 
phospholipids in Atlantic salmon hearts. and to 
measure both Cal +-Mg2+ ATPase activity in heart 
SR and eicosanoid production by stimulated cardio-
myocytes. 
MATERIAlS AND METHODS 
Animals and ditlS 
~ree hundred Atlantic: salmon SI smolts (inilial mean 
weight ca 36.4 g) were obtained from the S.O.A.F.D. Fish 
Cultivation Unit, Aultbea. Wester Ross. U.K. The salmon 
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were randomly distributed into three tanks of I m diameter 
containing 500 I of sea-water which was supplied at a rate 
of 101/min. The tanks were subjected to natural photo-
period and the water temperature over the experimental 
period (May-November) varied from 9 to 14"C~Diets were 
supplied by automatic feeders which were activated for a few 
seconds every 15 min (during daylight hours) and were 
adjusted to provide 20 glkg biomass per day, 7 days each 
week. Fish were bulk weighed every 28 days and the feed 
ration adjusted accordingly. 
The practical-type diets using fish meal as protein source 
were formulated to meet the nutritional requirements of 
salmon (U.S. National Research Council. 1981) and con-
tained 46% protein and 16% lipid (Table I). The lipid 
component was formulated to supply linoleic acid at 10,25 
and 450/. of dietary lipid for the three dietary treatments. All 
diets satisfied the minimum requirement of salmonids for 
n-3PUF A (Kanazawa. 1985). The fatty acid compositions of 
the three diets are given in Table 2. 
Sampling procedure 
Samples for lipid analysis were collected after 20 and 24 
weeks of the dietary treatment. Fish were killed by a blow 
to the head and immediately weighed. after which the heart 
(including the bulbous arteriosus) was dissected. weighed 
and frozen in liquid nitrogen. Samples were stored at - 20"C 
prior to lipid analysis. Cardio-somatic index was calculated 
as heart weight in mg/body weight in g. 
Lipid eXlraclion and analysis 
Total lipid was extracted from hearts and diets by 
the method of Folch el al. (1957). The procedures 
employed have been described in detail previously (Bell 
el al .• 1991). All solvents contained 0.05% butylated hy-
droxytoluene (BHT) as antioxidant. Total lipid extracts 
were separated into phosphatidylcholine (PC). phos-
phatidylethanolamine (PE). phosphatidylserine (PS) and 
phosphatidyl inositol (PI) fractions by thin layer chroma-
tography using methyl acet-
ate: isopropanol: chloroform :methanol: 0.25% aqueous 
KCI (25:25:25:10:9. v/v/v/v/v) as developing solvent. as 
described by Vitiello and Zanetta (1978). The plates were 
sprayed with 0.1 % 2.7-dichlorofluorescein dissolved in 97% 
methanol with 0.05% BHT as antioxidant and the lipid 
bands visualised under UV light. The phospholipids were 
scraped from the plates and converted to fatty acid methyl 
esters by acid-catalysed transmethylation carried out 
overnight at sa"C according to Christie (1982). The fatty 
acid methyl esters were separated and quantified by 
gas-liquid chromatography. the details of which have been 
.- described previously (Bell el aI .• 1991). Individual methyl 
esters were identified by comparison with known standards 
and by reference to published data (Ackman. 1980; Bell 
el 01 .• 1983). 
Table I. Composition of eJtperimental diets 
Diet I Diet 2 Diet 3 
Ingredient (IIkg) 
Fishmeal 6SO 6SO 6SO 
Starch (pR<ooked) ISO ISO ISO 
Fish oil 78 40 
Sunllower oil 22 60 
Vitclma oil- 100 
Mineral mid 24 24 24 
Vitamin mixt 10 10 10 
.-Cellulose 61.6 61.6 61.6 
Choline chloride 4 4 4 
Antioxidant mixt 0.4 0.4 0.4 
-Vitclma it a blend of sunllower. SIftIower and IJ1Ipeseed oil supplied 
by Vandemoonele (UK) Ltd., Hounslow. Middlesex. U.K.. 
tThc composition or thetc pre-mixes have been aiven in detail 
prniolllly (Bell *t aI.. 1991) • 
• 
Table 2. Fauy acid composition of diets 
Diet I Diet 2 Diet 3 
Fatly acid 
14:0 
16:0 
18:0 
16: l{n-7) 
18: I(n-9) 
20: I(n-9) 
22: I(n-II) 
24: I 
18:2(n-6) 
20:2(n-6) 
20:3(n-6) 
20:4(n-6) 
18:3(n-3) 
18:4(n-3) 
20:S(n-3) 
22:S(n-3) 
22:6(n-3) 
Total (n-6) 
Total (n-3) 
(n-3)/(n-6) 
4.9 
12.6 
2.6 
4.0 
12.1 
7.2 
9.9 
0.9 
10.4 
0.2 
trace 
0.7 
1.0 
2.8 
6.4 
1.3 
9.4 
11.9 
21.8 
1.8 
Trace - value < O.OS%. 
(weight "!o) 
3.7 
11.9 
3.3 
3.3 
15.0 
5.5 
6.7 
0.7 
25.3 
0.2 
trace 
0.6 
0.8 
2.1 
5.1 
0.8 
6.5 
26.4 
IS.8 
0.6 
IS(l/alion of cardiac sarcoplasmic reticulum 
2.1 
9.8 
3.S 
2.4 
14.1 
2.8 
3.0 
0.4 
46.3 
trace 
trace 
O.S 
O.S 
1.1 
3.S 
O.S 
4.7 
46.8 
10.6 
0.2 
Salmon were killed by a blow to the head and the heans 
quickly removed. The procedure used was largely that 
described by Swanson el aI. (1989). Hearts from two fish 
were pooled (300-500 mg wet weight) and homogenised in 
20 volumes of ice-cold 20 mM Tris-HCI (pH 7.4) buffer 
containing 30 mM L-histidine and 250 mM sucrose using a 
Polytron tissue homogeniser. The homogenate was cen-
trifuged at 1600 I for 10 min at 4"C to remove nuclei and cell 
debris. The supernatant was retained and the pellet re-
homogenised and centrifuged as described above. The com-
bined supernatants were then centrifuged at 14.000 I for 
15 min at 4'C to remove mitochondria and Iysosomes. The 
pellet was discarded and the supernatant centrifuged at 
45.000, for 50 min at 4"C. The pellet was resuspended in 
20 ml homogenisation buffer and recentrifuged at 48,000 I 
for 50 min at 4'C. The final SR pellet was resuspended 
in 0.25 ml of homogenisation buffer prior to Caz+-Mg2+ 
ATPase assay. 
Caz+-Mg!+ ATPase assay 
The assay was performed largely as described by Bonis 
el aI. (1985). SR vesicles (25-50 JIg protein) were incubated 
in a 2.0 ml reaction medium containing SO mM Tris-HCI 
(PH 7.1),5 mM potassium oxalate. 60 JIM CaCll • 30mM 
KCI and 5 mM MgCll for S min at 20·C. The reaction was 
initiated by addition of 2 mM disodium-A TP and the 
incubation was continued for a further 45 min before the 
reaction was terminated by addition of 1.0 ml of 50;. (w/v) 
trichloroacetic acid. Total ATPase activity was determined 
by measurement of inorganic phosphorous released from 
A TP by the method of Stanton (1968). using a diagnostic kit 
(Sigma Chemical Co., Poole. U.K.). Calcium-dependent 
ATPase activity was determined by subtracting the basal 
value obtained in the presence of 0.1 mM (ethyl-
enebis (oxyethylene nitrilo») tetraacelie acid and the absence 
of calcium from values obtained with 60 JI M CaCI1. Protein 
was determined by the method of Lowry ,1 al. (195 I ). 
Isolalion of cardiac myocyles 
The procedure for enzymatic isolation of cardiac myo-
cytes is based on the method of Powell el al. (1980). Hearts 
from two salmon were cannulated via the bulbous arteriosus 
and perfused with modified Hanks' medium (Moon el al .• 
1985) (concentrations in gil; NaCl. 10.29; KCI. 0.4; 
MgSO,' 7Hp. 0.2; KH1PO •• 0.06; Na1HPO,' 12H10. 0.13; 
NaHCO). 0.5; HEPES. 2.38). which was continuously 
gassed with 95% 0 1, 50/. COl' After 15 min. the system was 
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changed to recirculation and the medium changed to 
modified Hanks' containing 0.6% collagenase. The per-
fusion was continued for a further 45 min, after which the 
hearts were removed and chopped finely in perfusion 
medium. This material was filtered through 190 "m nylon 
gauze and the myocytes collected by centrifugation (100 g, 
2 min). The myocytes were washed twice in Hanks' medium 
(without collagenase) and finally, resuspended in 1.0 ml of 
the same medium containing I mM Cael:. The suspensions 
routinelv contained ~5% of the total cells present as 
rod-shaPe<!. cardiac myocytes. Fifty microlitres of suspen-
sion were retained for protein determination. 
Stimulation with calcium ionophor~ and ,xtraction of ~;co­
sanoicis 
The myocytes were incubated in a shaking water bath at 
18°C for 10 min before addition of calcium ionophore 
(A23 187. final concentration 20"M in 5,,1 dimethyl 
sulphoxide). The incubation was continued for 20 min, after 
which the cells were sedimented by centrifugation (12,000 g, 
2 min). The prostanoids were extracted from the super-
natant largely by the method of Powell (1982). Absolute 
ethanol was added (final concentration. 15% v/v) and the 
supernatant adjusted to pH 3.>-4.0 by addition of 2 M 
formic acid (50" I/ml). The sam pies were mixed and cen-
trifuged at 12.000 g for 2 min. The supernatant was loaded 
on to a 'Sep-Pak' CI8 column (Millipore, Watford, U.K.) 
which had been pre-washed with 5 ml methanol and 10 ml 
distilled water. The sample was washed with 10 ml of 
distilled water followed by 5 ml hexane : chloroform (65: 35, 
v/v) to remove non-esterified fatty acids and hydrollY acids, 
before elution of prostanoids with 10 ml of ethyl acetate. 
The eth\'1 acetate elltract was dried under nitrogen and the 
eicosanoids dissolved in 100 "I of methanol and stored 
at -20'C prior to radioimmunoassay. Determination of 
6-ketoprostaglandin Flo' thromboxane B:, 6ketoPGF •• and 
TXB, were measured by radioimmunoassay using the tri-
tium -isotope kits supplied by Amersham (U.K.) Ltd. 
Materials 
TLC plates (20 )( 20 em )( 0.25 mm) pre-coated with silica 
gel 60 were obtained from Merck, Darmstadt, Germany. 
Disodium ATP, A23187 (hemicalcium salt) and collagenase 
(type ·IV) were obtained from Sigma. All solvents were of 
HPLC grade and were obtained from Rathburn Chemicals, 
Walkerburn. U.K. 
Statistical analysis 
Significance of difference (P < 0.05) between dietary 
treatments was determined by analysis of variance. Data 
\lihich were non-homogeneous (identified by application of 
an F-test) were subjected to arc sine square root transform-
ation before analysis. Differences between means were cal-
culated using Duncan's mUltiple range test (Duncan, 1960). 
RESULTS 
Good growth was achieved with all three dietary 
treatments over the 20-week experimental period, 
although mortalities were increased in the fish fed the 
two highest levels of LA (16 and 17% mortality), 
compared with those fed the lowest LA (10% mor-
tality). The cardia-somatic index was significantly 
reduced in fish fed the highest concentration of 
dietary LA (Table 3), compared with those fed the 
lowest level. The amounts of total cardiac lipid were 
not significantly altered by dietary lipid neither was 
the activity of the sarcoplasmic reticulum (SR) 
Ca2+-Mg!+ ATPase (Table 3). 
The fatty acid compositions of heart phospholipids 
are shown in Tables 4-7. In PC (Table 4), 18: 2n-6. 
20: 2n-6. 20: 3n-6 and total n-6PUFA all increased 
significantly with increasing dietary intake of LA. 
Arachidonic acid was significantly increased in fish 
fed the highest dietary LA (45%),· compared with 
those fed the lowest LA (10%). The fish fed the 
highest LA also had significantly reduced EPA. 
22: 5n-3 and total n-3PUFA compared with those fed 
the lowest and intermediate (25%) dietary LA. Total 
PUF As were significantly increased in fish fed the 
intermediate and highest level of LA compared with 
those fed the lowest LA. The n-3/n-6PUFA ratio 
decreased significantly with increasing level of dietary 
LA and the 20:4/20:5 ratio was significantly in-
creased in fish fed the highest dietary LA. 
The fatty acid compositions of heart PE are shown 
in Table 5. Total monoenes were significantly reduced 
in fish fed the highest dietary LA compared with 
those fed the lowest LA. The changes in n-6PUF A 
were similar to those observed in PC but EPA was 
significantly reduced with each increase in dietary 
LA. 22: 5n-3 was significantly reduced in fish fed the 
highest dietary LA compared with those fed the 
lowest LA. The n-3/n-6 ratio decreased significantly 
with increasing dietary LA. but the 20:4/20:5 ratio 
was significantly increased only in fish given the 
highest dietary LA. 
The fatty acid compositions of heart PS are shown 
in Table 6. Total saturates and 18:2n-6 were signifi-
cantly increased in fish fed the intermediate and 
highest levels of LA compared with those fed the 
lowest LA. 20: 2n-6. 20: 3n-6 and total n-6PUF A 
were all significantly increased. while EPA was signifi-
cantly decreased with increasing dietary LA. 22: 5n-3 
was significantly decreased in fish fed the intermedi-
ate and highest dietary LA and 22: 6n-3 was signifi-
cantly decreased in fish given the highest LA 
compared with those given the lowest. The n-3/ 
n-6PUFA ratio was significantly decreased in fish fed 
the intermediate and highest dietary LA. but the 
20: 4/20: S ratio was only increased in those fed the 
highest dietary LA. 
Table J. Cardio-somatic index. heart total lipid and sarcoplasmic reticulum Cal+-Mi+ 
A TPa5e activity in salmon red diets containinl increaslna levets or Iinoletc acid 
Diet I Diet 2 Diet J 
Cardia-somatic indue 1.34 ± 0.17' 1.J0 ± O.I6§tt 1.17 ± 0.15M 
Heart total lipidt \.97 ± 0.28 2.07 ± 0.11 2.16 ± 0.08 
Cal+_Mgl+ ATPase activityt 6SO.7± 161.3 3M.B± 100.7 48B.9± 173.1 
eDetails described in Materials and Methods, values represent mean ± SO for 20 fish per 
treatment. 
tTolllllipid (weilht ~e) measured u described in Materials and Methods, values represent 
mean ± SO (or rour fish per treatment. 
:nmol P, released/min ma protein, values represent mean ± SO ror rour sarcoplasmic reticula 
samples per treatment. Values in the same row with different symbols are silnificantly 
different (I' < 0.05). 
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Table 4. Fatty acid compositions of heart phosphatidylcholine from 
salmon fed increasing levels of linoleic acid 
Diet I Diet 2 Diet 1 
Fatty acid (weight '!o) 
Total saturates 
Total monocnes 
18:2(n-6) 
20:2(n-6) 
20:l(n-6) 
20:4(n-6) 
Total (n-6)' 
20:5(n-l) 
22:5(n-3) 
22:6(n-3) 
Total (n-3)t 
Total PUFA 
n-3/n-6 
20:4/20: S 
4S.9 ± 4.8 
17.2:!: 2.0 
1.7 ± 0.2! 
0.2 ± 0.1: 
0.2 ± 0.0: 
\.3 ± 0.2: 
3.8 ± 0.6: 
4.4 ± 1.1: 
0.6 ± O.I! 
20.9: 1.1 
25.S: 1.8: 
29.1 ± 2.0! 
7.S ± 1.2! 
OJ· O.I! 
4l.2 ± 2.9 
16.2 ±0.9 
4.0 ±0.3§ 
0.4±0.1§ 
O.S ±O.I§ 
1.6 ± o.l:n 
7.2 ± 0.2§ 
3.9 ±0.4: 
O.H O.lt 
22.6 ± 3.1 
27.2 ± 3.5: 
34.S ± 3.4§ 
4.0 ±0.7§ 
0.4 + O.Ot 
Results are mean ± SD for four fish per treatment. 
'Includes 18:3(n-6), 22:4(n-6) and 22:5(n-6). 
tlncludes 18:3(n-3), 18:4(n-3) and 20:4(n-3). 
47.3 ± 2.3 
14.7 ± \.3 
7.2 ± 0.611 
0.6±0.1" 
J.J ± 0.111 
2.0 ± 0.4§ 
11.6±0.4" 
2.2 ± 0.3§ 
0.4±0.1§ 
17.8 ± 0.7 
20.8 ± 0.6§ 
33.\ ± I.O§ 
1.7 ± 0.211 
0.9 + 0.3§ 
Values in the same row with different symbols are significantly 
different (P < 0.05). 
The fatty acid compositions of heart PI are shown 
in Table 7. 18:2n-6, 20:3n-6 and total n-6PUFA 
were all significantly increased and 20: 5n-3 and 
n-3/n-6PUF A ratio were both significantly decreased 
with increasing dietary LA. 20:2n-6 was significantly 
increased in fish fed the intermediate and highest 
dietary LA compared with those fed the lowest LA, 
Total n-3PUFA were significantly decreased and 
both AA and the 20: 4/20: S ratio significantly in-
creased in fish given the highest dietary LA. 
~he amounts .of 6-ketoPGF II and TXB1 produced 
by Isolated cardiac myocytes stimulated with A23187 
are given in Table 8. 6-ketoPGF.1 production was 
increased, but not significantly so, by isolated cardiac 
myocyt~s as a result. of increasing dietary LA. TXBl 
production was also Increased with increasing dietary 
levels of LA, but the increase (more than two-fold) 
was only significant at the highest level of dietary LA. 
DlSClJSSION 
The results indicate that increasing dietary LA is 
~t1ected in increased incorporation of this fatty acid 
I~to all me~brane phospholipid classes. In conjunc-
tion, there IS a concomitant increase in 20: 3n-6 and, 
. to a lesser extent, 20: 4n-6. These results confirm 
previous findings which suggest appreciable d-6- and 
Table 5. Fatty acid composition of heart phosphatidylethanolamine 
from salmon fed increasing levels of linoleic acid 
Diel I 
Fatty acid 
Total saturates 3O.l ± 1.9 
Total moncenes 10.2 ± 0.4! 
18:2(n-6) 2.S ± O.I! 
2O:2(n-6) 0.2 ± 0.1: 
2O:3(n-6) 0.2 ± 0.1: 
20: 4(n-6) 1.6 ± 0.2t 
Total (n-6)' S.I ± 0.4: 
20:5(n-l) 3.4 ±O.I! 
22:5(n-3) 2.2±0.1: 
22:6(n-3) 41.8 ± J.J 
Total (n-3)t 47.8 ± \.2 
Total PUFA 52.9 ± 1.0 
(n-3)/(n-6) 9.5 = 0.8: 
20:4120: S O.S:!: 0.1: 
Foolnotes as described in Table 4. 
• 
Diet 2 
(weilht "I.) 
ll.7 ± 3.0 
9.1 ± 1.7:1 
S.H 0.9§ 
0.4 ± O.O§ 
O.stO.lt 
1.7 ± 0.2t 
8.7 ± I.O§ 
2.9 ±0.2§ 
2.0 ± 0.4:t 
36.9 ± 3.9 
41.9 ± 4.3 
SI.O ± 3.8 
4.6 ± 0.7§ 
0.6 + 0.1: 
Dietl 
3O.S ± \.I 
7.8 ±0.2§ 
7.9 % 0.91 
0.7±0.111 
1.\ ± 0.311 
2.S ± 0.3§ 
13.5 ± 1.4U 
2.0 % 0.311 
1.61 0.3§ 
37.4 % J.3 
42.2 ± J.6 
5S.6 ± \.3 
l.2 ± O.4R 
1.3 + 0.3§ 
Table 6. Fatty acid composition of heart phosphatidylscrioe from 
salmon fed increasing levels of linoleic acid 
Diet I Diet 2 
Fatty acid 
TOlal saturates 
Total moncenes 
18:2(n-6) 
20:2(n-6) 
20:3(n-6) 
20:4(n-6) 
T"..!I (n-6)' 
20:4(n-3) 
20: S(n-3) 
22:S(n-3) 
22:6(n-3) 
Total (n-3)t 
TotalPUFA 
(n-3)/(n-6) 
20:4120: S 
38.1 ± 4.S: 
10.2 % 0.7: 
3.0 ± D.6: 
O.l%O.I: 
0.3± O.lt 
0.4±0.1 
S.3 ± 0.8! 
0.5 ± 0.1: 
1.2 ± 0.1: 
2.2 ± OJ: 
34.8 ± 3.9 
38.914.1! 
44.2 ± 3.5 
7.6 ± \.8! 
0.4 + 0.1: 
Foolnotes as described in Table 4. 
Trace - value < O.OS. 
(weight '!o) 
46.S ± 3.S§ 
8.S ± 0.9§ 
S.O ± 0.7§ 
0.5 ± O.I§ 
0.6 ± 0.2§ 
0.4±0.1 
7.6% 0.9§ 
trace§ 
0.9 ± O.I§ 
1.6 ± 0.2§ 
.3\.7 ± 2.4 
34.3 ± 2.2!§ 
41.9 ± 2.6 
4.6 ± 0.6§ 
0.4 ± 0.1: 
Dietl 
46.6 ± 1.8§ 
5.7 ± 0.5U 
6.4 ± 1.\ H 
0.8 ±O.ln 
1.2 ::0.2:1 
0.5 ±O.I 
9.8:!: I.2n 
trace§ 
O.S ±O.lq 
\.4: 0.2§ 
29.9 ± 1.5 
3\.8 ± 1.7§ 
41.6:: 1.7 
3.3 ± O.S" 
1.2 + O.S§ 
d-5-desaturase activity in salmon and incorporation 
of the n-6 products into cardiac tissue (Bell et 01., 
1991). Increasing dietary LA caused a decrease in 
phospholipid EPA and also a small (but not statisti-
cally significant) decrease in docosahexaenoic acid 
(DHA; 22:6n-3) which, combined with the increase 
in n-6PUFA, resulted in a lowered n-3/n-6PUFA 
ratio and an increased 20: 4/20: S eicosanoid precur-
sor ratio. 
Alterations in the dietary n-3/n-6PUFA ratio can 
alter the physico-chemical properties of membranes 
and the activities of associated enzymes. Examples 
include mitochondrial ATPase (Robblee and Clan-
dinin, 1984), sarcolemmal S'-nucleotidase (Awad and 
Chattopadhyay, 1983), ornithine decarboxylase 
(Bunce and Abou-EI-Ela, (990) and sarcoplasmic 
reticulum Cal+ -Mg2+ ATPase (Swanson el 01., (989). 
The latter enzyme is an asymmetric integral 
transmembrane protein (Scales and Inesi, 1976) of the 
SR which controls calcium ftux in excitable tissues, 
e.g. cardiac myocytes. Swanson el 01. (1989) showed 
that a relatively small increase in the n-3/n-6PUF A 
ratio in SR phospholipid could cause a large decrease 
(around six-fold) in murine ATPase activity. In the 
present study with salmon heart, considerable 
changes in the n-3/n-6PUF A ratio in cardiac phos-
pholipids caused no significant alteration in SR 
Table 7. Fatty acid composition of heart phosphatidylinositol from 
salmon fed increaSing levels of linoleic acid 
Diet I Diet 2 Diet 3 
Fally acid (weilht "I.) 
Total saturates 3S.9 ±4.S 37.2 ± J.2 40.3 ± \.6 
TOlal monocnes 9.6 ± D.6: 7.9 ± 0.4§ 5.9 :to,)" 
18:2(n-6) 2.6 ±0.2: S.3 ± O.S§ 6.1 ± D.611 
20:2(0-6) trace: 0.3 ± O.I§ O.3±O.lt 
20: 3(n-6) O.S ± 0.1: 0.9±0.1§ 1.3 ± O.lft 
20:4(n-6) 12.210.9: J3.3± D.6: 14.9 ± 0.8§ 
Total (n-6)' 16.5 ± 1.9: 20.9 ± 1.2§ 23.4 ± O.sg 
20:4(n-3) O.SiO.I: 0.4 ±O.lt trace§ 
20: 5(n-l) 6.6 ±0.7: 5.l ± O.l§ 1.0 ± 0.6~ 
22: S(n-3) 1.0±0.4 0.7 ±O.I 0.6 ±0.2 
22:6(n-l) 2S.9 ± 5.0 2S.7± 1.7 21.8 ± 0.6 
Total (n-3)t 34.2 ± S.8t 32.2 ± 2.0t 2S.4 ± O.S§ 
Total PUFA SO.7 % 5.6 5l.0 ± 2.9 48.8 ±0.3 
(n-3)/(n-6) 2.1 ± 0.4: J.6 ± O.I§ J.J ± 0.\1 
20:4/20: S 1.9 ± O.lt 2.6 ± 0.1: 5.1 + 1.2§ 
Footnotes as described in Table 4. 
Trace _ values < O.OS . 
, 
. 
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Table 8. Production of eicosanoids by isolated cardiac-myocytcs 
from salmon fed increasing levels of linoleic acid 
Diet I Diet :! Diet 3 
Eicosanoid (pg/mg protein) 
6-ketoPGF,. 363.3:t 76.5 531.7 ± 71.5 533.9 ± 290.1 
TXBl 194.8 :t 35.6- 238.0'" 42.0- 43 •. 4 + 71.9t 
Values are mean ± SO for three cardiac-myocyte preparations per 
treatment. Values in the same row with different symbols are 
significantly different (P < 0.05). 
Ca2+-Mg~+ ATPase activity. The major alteration in 
the fatty acid composition of murine SR was an 
increase in DHA, particularly in PC of mice given 
menhaden oil, whereas the present study showed no 
significant dietary-induced alteration in phospholipid 
DHA. Rabbits given menhaden oil showed no incor-
poration of DHA but some incorporation of EPA 
into skeletal muscle SR and consequently. no alter-
ation of skeletal muscle SR Ca2+-Mi+ ATPase was 
observed (Gould el al., 1987). Thus. it appears that 
DHA may be essential in the control of the SR 
calcium pump. While the work of Swanson et al. 
(1989) indicates decreased activity of the SR calcium 
pump in mice fed menhaden oil, a study by Kar-
mazyn et al. (1987) observed enhanced uptake of 
Ca2+ in cardiac myocytes from rats fed cod-liver oil. 
Infante (1987) suggests that low dietary n-3 (or high 
n-6) PUFA may encourage uncoupling of the SR 
Ca2+ -ATPase. such that ATP hydrolysis may be 
occurring in the absence of calcium translocation. 
This possibility was not examined in the present 
work. The importance of the dietary n-3/n-6PUF A 
ratio on the microenvironment of the Cal+-Mi+ 
ATPase and thus. the control ofCa!+/ATP coupling 
ratio is an obvious area for further study. 
The beneficial effects of fish oil supplements in 
attenuating a number of atherothrombotic, auto-
immune and inflammatory conditions in mammals 
are, in part, due to the modulation of AA-derived 
eicosanoid production by EPA and DHA (Weber, 
1990). These effects may be due to direct inhibition of 
cyclooxygenase by EPA and/or DHA (Culp et al., 
1979). or by the production of EPA-derived ei-
cosanoids which have much less biopotency com-
' .. pared with their AA-derived homologues (Bruckner 
ei al., 1984). Cardiac-derived prostaglandins are 
important modulators of myocardial function 
(Karmazyn and Dhalla, 1983) with prostacyclin 
(PGIl ) being the primary cyclooxygenase-derived 
product in the heart (Karmazyn et al., 1987). In this 
study, the Atlantic salmon fed increased levels of LA 
had correspondingly increased 20: 4/20: S ratios in 
their membrane phospholipids which could, in prin-
ciple, alter the balance and biopotency of eicosanoid 
production. In the present study, the production of 
6-ketoPGF t • the stable metabolite of PGI l , and 
TXB:, the stable metabolite ofthromboxane (TXAl) 
were both increased in stimulated cardiac myocytes 
from· salmon fed increasing levels of dietary LA. 
However. the observed increases were only significant 
with TXBl production at the highest level of dietary 
LA. Thromboxane is an important mediator of 
platelet aggregation. vascular tone and intracellular 
calcium concentration (Weber, 1990). Studies investi-
gating skeletal muscle synthesis have shown that 
PGIl is stimulatory whereas PGE: is inhibitory to 
muscle fibre formation (McLennan. 1991). PGE l can 
also stimulate protein catabolism (Barnett and Ellis, 
1987). Further studies with salmon cardiomyocytes 
will address the influence of dietary lipids on the 
production of these two eicosanoids. 
A recent study has shown that alterations in mem-
brane n-3/n-6PUFA ratio in cultured rat ventricular 
myocytes can influence the activity of enzymes in-
volved in lipid metabolism (Nalbone et al., 1990). 
Specifically, myocytes cultured in high n-6PUFA-
containing media had increased phospholipase Al 
activity and decreased Iysophospholipase activity 
when compared with myocytes grown in high n-
3PUFA-containing media. In n-6PUFA enhanced 
tissues these changes could affect fatty acid turnover 
and result in enhanced production of eicosanoids. In 
addition. Iyso PC is a known cytolytic agent (Choy 
et al., 1989) and its production could disrupt mem-
brane integrity. 
This present study with Atlantic salmon demon-
strates that cardiac membrane fatty acid composition 
and eicosanoid production can be profoundly altered 
by increasing dietary LA. These modifications and 
their possible consequences in terms of cardiac physi-
ology and pathophysiology (Bell et at., 1991) are the 
subject of continuing research. 
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Effects of Increasing Dietary Linoleic Acid on Phospholipid Fatty Acid 
Composition and Eicosanoid Production in I .. eucocytes and Gill Cells of 
Atlantic Salmon (Safmo safar) 
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ABSTRACT. Diets containing linoleic acid at 10. 25 and 45% of total dietary fally acids were fed to three 
groups of post-smolt Atlantic salmon (Salmo salar) for 18 weeks. Incorporation of linoleic acid into membrane 
phospholipids of leucocytes and gills increased in response to dietary intake. In general, there was an increase 
in arachidonic acid and a decrease in eicosapentaenoic acid in the individual phospholipids of both cell types 
in response to increasing dietary linoleic acid. These changes in eicosanoid precursors were renected in sig-
nificantly increased plasma concentrations of 6-keto-PGF I" and TXB l in salmon given the highest dietary 
linoleic acid. In whole blood stimulated with the calcium ionophore A23187. LTB4• 12-HETE and TXBz were 
significantly increased and 12-HEPE significantly decreased in response to increasing dietary linoleic acid. 
In isolated gill cells stimulated with A23187, 12-HEPE, 12-HETE, 14-HDHE and TXBl were all decreast'd 
in response to increasing dietary linoleic acid. although the ratio of I2-HEPE/12-HETE was also decreased. 
INTRODUCTION 
The availability of polyunsaturated fatty acids 
(PUFA) for eicosanoid production is dictated by 
phospholipid fatty acid composition which is. in 
turn. influenced by dietary PUFA intake (I). In 
humans consuming 'Western-type' diets high in n-6 
PUF A. arachidonic acid (20:4( n-6); AA) is the 
dominant precursor for eicosanoid production and 
this dietary regime is probably. at least partly. 
responsible for the high incidence of atherothrom-
botic. auto-immune and inflammatory conditions 
prevalent in Western society (2). Considerable 
evidence now suggests that many of these conditions 
can be attenu3ted by intake of dietary fish oil 
supplements which are rich in eicosapentaenoic 
acid (20:5(n-3); EPA) and docosahexaenoic acid 
(22:t\(n-3); DHA) (3). 
Fish offer a particularly useful model system for 
studying the production and interaction of 
eicosanoids derived from both AA and EPA be-
cause their tissues are naturally abundant in n-3 
PUFA (4. 5). However. despite their abundance of 
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n-3 PUFA. fish tissues tend to produce considcrahlc 
amounts of AA-derived prostaglandins (6. 7) and in-
deed AA would seem to be the preferred substrate 
for cyclooxygenase in plaice skin and neutrophils 
and in turbot gills (7-9). Atlantic salmon given diets 
containing corn oil showed increased AA and 
decreased EPA in their tissue phospholipids (10). 
The same species given diets containing sunflower 
oil had an increased AA: EPA ratio in individual 
phospholipids and subsequently showed decreased 
production of EPA-derived lipoxygenase metab-
olites by leucocytes and gill cells (11). 
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Like humans. farmed Atlantic salmon are sus-
ceptible to stress-induced disease conditions. One 
particularly serious condition in salmon is known as 
'pancreas disease' which is characterised by total 
loss of the exocrine pancreas (12) and is sometimes 
accompanied by cardiomyopathy (13). Due to the 
inclusion of some plant-derived lipids in their 
dietary regime. farmed salmon contain around 5 
times the amount of n-6 PUFA compared to their 
wild counterparts and it is possible that the sub-
sequent reduction in n-3/n-6 PUF A ratio is 
responsible for increased AA-derived eicosanoid 
production in farmed salmon. 
In the present study three groups of Atlantic sal-
mon were given diets containing linoleic acid 
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(18:2n-6; LA) at 10, 25 and 45% of total dietary 
fatty acids. Our objectives were: 
1. To measure the effects of the different diets 
on the fatty acid compositions of the 
phospholipid classes in leucocytes and gill cells. 
These cells were chosen because of their high 
potential for synthesising eicosanoids (14, 15). 
2. To measure the levels of the antagonistic 
cyclooxygenase products 6-keto prostaglandin 
Fla (6-keto-PGFIJ and thromboxane B2 
(TX~) in blood plasma. 
3. To measure the production of TXB2 , 
leukotriene (LT) B4 and 8 s in leucocytes 
stimulated with the calcium ionophore A23187. 
4. To measure the 12-lipoxygenase products and 
the above cyclooxygenase metabolites derived 
from isolated gill cells stimulated with A23187. 
MATERIALS AND METHODS 
Animals and diets 
300 Atlantic salmon SI smolts (salmon undergoing 
seawater transition in 1 year) were distributed ran-
domly into three tanks supplied continuously with 
non-recirculated seawater. The salmon (mean 
weight 36 g) were obtained from the S.O.A.F.D. 
Fish Cultivation Unit, Aultbea, Wester Ross, Scot-
land, and were subjected to natural photoperiod 
over the experimental period (May-October). The 
water temperature varied from 1O-14°C over this 
period. Diets were provided by automatic feeder 
and were adjusted to provide 2% of biomass per 
day, 7 days each week. Total biomass was measured 
every 28 days and the ration adjusted accordingly. 
The diets were formulated to satisfy the nutritional 
requirements of salmon (Table 1) (16). The lipid 
component was formulated to supply linoleic acid at 
10, 25 and 45% of dietary fatty acids by blending 
fish oil, sunflower oil, grapeseed oil and safflower 
oil. All diets satisfied the minimum requirement of 
Table I Compositions of experimental diets (g/kg) 
Ingredient Diet 1 
Fishmeal 650 
Starch (pre-cooked) 150 
Fish oil 78 
Sunl10wer Oil2 22 
'Vitelma' oie 
Mineral mix· 24 
Vitamin mix· 10 
a-Cellulose 61.6 
Choline chloride 4 
Antioxidant mix· 0.4 
, 'Fosol', Seven Seas Ltd, Hull, UK. 
2 Tesco Ltd, Cheshunt, UK. 
Diet 2 
650 
150 
40 
60 
24 
JO 
61.6 
4 
0.4 
Diet 3 
650 
150 
HX) 
24 
10 
61.6 
4 
0.4 
l 'Vitelma' is a blend of sunl1ower, safllower and grapeseed 
oil produced by Vandemoortele (UK) Ltd, Hounslow, UK. 
4 The composition of these mixes have been described in 
detail previously (21). 
Table 1 Fatty acid compositions of diets (weight %) 
Fatty acid Diet 1 Diet 2 Diet 3 
14:0 6.1 4.4 2.5 
16:0 14.4 12.7 12.0 
18:0 2.8 3.2 4.3 
16: In-7 4.6 3.4 2.3 
18: In-9 13.5 15.8 15.3 
18:1n-7 2.1 1.8 1.5 
20: In-9 7.0 5.5 2.9 
22:1n-ll 9.0 7.0 3.3 
24:1 0.8 0.6 0.3 
18:2n-6 10.5 24.6 44.7 
20:2n-6 0.1 0.1 trace' 
20:3n-6 trace trace trace 
20:4n-6 0.6 0.4 0.2 
18:3n-3 0.9 0.7 0.5 
18:4n-3 2.3 1.6 0.9 
20:5n-3 5.7 4.6 2.4 
22:5n-3 0.8 0.6 0.2 
22:6n-3 7.6 6.2 3.2 
Total n-6 12.0 25.8 45.2 
Total n-3 18.0 14.1 7.4 
n-3/n-6 1.5 0.6 0.2 
I Trace = value < 0.05% 
salmonids for n-3 PUFA (c. 1 % of diet as n-3 
PUFA) (17). The fatty acid compositions of the 
three diets are given in Table 2. Analyses were per-
formed between 18 and 20 weeks after the start of 
the experiment. 
Leucocyte isolation 
Five ml of blood were collected in heparinised syrin-
ges from the caudal vein of 6 fish per dietary 
treatment and diluted with 2 volumes of phosphate 
buffered saline (PBS). Four ml of the diluted blood 
were layered onto 6 ml of lymphocyte separation 
medium (Gibco Ltd, Paisley, Scotland) and 
centrifuged at 400 x g for 30 min at 4°C. The cells 
around the interface of the erythrocytes were har-
vested and washed in PBS. If erythrocyte 
contamination was greater than 1%, the gradient 
centrifugation was repeated. The leucocytes ob-
tained from 6 samples per dietary treatment were 
pooled prior to lipid extraction. 
Preparation of isolated gill cells 
Fish were killed by a blow to the head, the pericar-
dium cut open and the gills perfused via the bulbous 
arteriosus with 15 ml of ice-cold modified Hanks' 
medium to remove blood. The Hanks' medium is a 
specially formulated calcium-free medium for use 
with salmonid fish (18). The composition was: 
10.29 giL NaCl, 0.4 gIL KCI, 0.2 gIL MgS04.7H20, 
0.06 gIL KH2P04, 0.13 gIL Na2HP04.12HzO, 
0.5 gIL NaHC03, and 2.38 gIL (N-[2-
Hydroxyethyl]piperazine-N' -[2-ethanesulphenic acid)) 
(HEPES). The intact gill arches were dissected out 
and placed in ice-cold medium. The gill filaments 
Effects of Increasing Dietary Linoleic Acid on Phospholipid Fatty Acid Composition and Eicosanoid Production 199 
were dissected from the arches and chopped finely 
with scissors before addition of 25 ml of medium 
containing 0.1% (w/v) collagenase (type IV, Sigma 
Chemical Co, Poole, Dorset). This suspension was 
incubated for 45 min at room temperature and was 
constantly stirred using a magnetic stirrer. The 
suspension was finally filtered through nylon gauze 
(190 & 100 JLm) and the filtered cells collected by 
centrifugation at 400 x g for 2 min. The cells were 
washed twice in Hanks' medium and finally 
resuspended in 1 ml of the same medium containing 
1 mM CaCh, 50 /.LI was removed for protein deter-
mination (19). 
Extraction of lipids and fatty acid analysis 
Total lipid was extracted from leucocytes, gills and 
diets by the method of Folch et al (20). The pro-
cedures have been described in detail elsewhere 
(21). All solvents contained butylated hydroxy-
toluene (BHT) (0.05% w/v) as antioxidant. Total 
lipid extracts from leucocytes and gills were sep-
arated into phosphatidylcholine (PC), phos-
phatidylethanolamine (PE), phosphatidylserine (PS) 
and phosphatidylinositol (PI) by thin-layer 
chromatography (TLC) using chloroform: ethanol: 
triethylamine: water (35: 35: 35: 6 by volume) as 
developing solvent, as described by Leray et al (22). 
The plates were sprayed with 0.1 % 2' ,7'-
dichlorofluorescein in 97% methanol containing 
0.05% butylated hydroxy toluene (BHT) and the 
lipid bands visualised under UV light. The phos-
pholipids were scraped from the plates and 
converted to fatty acid methyl esters by acid-
catalysed transmethylation carried out overnight at 
50°C according to Christie (23). The analysis of fatty 
acid methyl esters was performed using a Packard 
436 gas chromatograph (Chrompak UK Ltd, Lon-
don) equipped with a capillary column 
(50 m x 0.22 mm) coated with free fatty acid phase 
(S.G.E. Ltd, Milton Keynes, UK). Individual 
methyl esters were identified by comparison with 
known standards and by reference to published data 
(5, 24). 
Ionophore challenge and eicosanoid extraction 
Glass test-tubes used in the incubations were pre-
coated with 'Sigmacote' prior to use to prevent cell 
adhesion. Isolated gill cells were suspended in 1 ml 
of modified Hanks' medium containing 1 mM CaClz 
as described above. One ml of whole blood was 
mixed with an equal volume of the above medium 
and both blood and gill cells were incubated in a 
shaking water bath at 18°C for 10 min. Calcium 
ionophore A23187 was added in 5 JLI of dimethyl 
sulphoxide at a final concentration of 20 JLM and 
the incubation continued for a further 20 min. The 
cells were sedimented by centrifugation (12 000 x 
g, 2 min) and the eicosanoids extracted from the su-
pernatant using CI8 ODS 'Sep-Pak' mini-columns 
(Millipore (UK) Ltd., Watford) by the method of 
Powell (25). 
High performance liquid chromatography 
Hydroxy fatty acids and leukotrienes were quan-
tified by reverse phase high performance liquid 
chromatography (HPLC) using a Spherisorb 5 JLm 
octadecyl silane (ODS) 2 column (25 cm x 4.6 mm, 
Anachem, Luton, UK). The chromatographic sys-
tem was equipped with Waters Model M-45 pumps 
and the effluent was monitored at 280 nm and 
235 nm to detect leukotrienes and hydroxy fatty 
acids, respectively, using a Pye-Unicam LC-UV 
detector. An isocratic solvent system contain-
ing acetonitrile: methanol: water: acetic acid: phos-
phoric acid:ammonia (40:29:30:0~5:0.3:0.2 by 
vol) was used. Leukotrienes and monohydroxy fatty 
acids were eluted isocratically at a flow rate of 
1 mVmin as described previously (11). Quantitation 
was performed with external standards of 12-
hydroxy-5,8, 10,14, 17-eicosapentaenoic acid (12-HEPE), 
12-hydroxy-5,8.1O.14-eicosatetraenoic acid (12-HETE). 
L TBs and L TB4• 
Labeling of gill cells with [l.J4C]-DHA 
Isolated gill cells produced as described above were 
resuspended in 2 ml Dulbeccos' modification of 
Eagles' medium (DMEM). After 10 min at 18°C in 
a shaking water bath, 0.5 /.LCi radiolabeled DHA 
(in 5 /.LI ethanol) was added and the incubation con-
tinued for 5 h. The cells were sedimented by 
centrifugation (400 x g. 5 min) and washed in 5 ml 
PBS containing 1% Bovine serum albumin (fatty 
acid free). The cells were resuspended in 2 ml 
DMEM and incubated in the shaking water bath for 
10 min, before addition of A23187, as described 
previously. Eicosanoids were extracted as described 
above and dissolved in 0.2 mt prior to HPLC. 
Eicosanoids were separated by HPLC as described 
above and the 1 ml fractions collected were counted 
in a scintillation counter after addition of 5 ml 
'Ecoscint A' (BS and S (Scotland) Ltd, Edinburgh, 
UK). 
Determination of 6-keto-prostaglandin Flo< and 
thromboxane 8 1 
6-Keto-PGFjo< and TXBz, the stable metabolites of 
prostacyclin (PGIz) and TXAz, respectively, were 
measured by radioimmunoassay using the tritium 
isotope kits supplied by Amersham (UK) Ltd. 
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Materials 
LTB4, A23187, 'Sigmacote' and collagenase were 
from Sigma Chemical Co Ltd, Poole, UK. LTB5, 
12(R, S)-HETE and 12(S)-HEPE were from Cas-
cade Biochem Ltd, Reading, UK. [l)4C)-DHA was 
obtained from Du Pont (UK) Ltd, Stevenage, UK. 
TLC plates pre-coated with silica gel 60 were ob-
tained from Merck, Darmstadt, Germany. All 
solvents were of HPLC grade and were obtained 
from Rathburn Chemicals Ltd, Walkerburn, UK. 
Statistical analysis 
Significance of difference (p <0.05) between dietary 
treatments was determined by analysis of variance. 
Data which were non-homogeneous were subjected 
to arc sin square root transformation before 
analysis. Differences between means were calcu-
lated using Duncans' multiple range test (26). 
RESULTS 
The fatty acid composItIOns of leucocyte phos-
pholipids are summarised in Tables 3-6. In PC 
Table 3 Fatty acid compositions of leucocyte 
phosphatidylcholine from salmon given increasing levels of 
dietary linoleic acid 
Fatty acid Diet 1 Diet 2 Diet 3 
(10% LA) (25% LA) (45% LA) 
weight % 
14:0 3.7 3.3 2.9 
16:0 31.7 30.1 31.8 
18:0 2.3 2.5 2.9 
Total saturates I 38.9 36.6 38.3 
16: In-7 3.4 2.8 2.9 
18:1n-9 17.9 16.3 16.6 
18:ln-7 4.0 3.1 3.2 
20: In-9 0.9 1.0 0.6 
24:1 0.3 0.2 0.2 
Total monoenes2 26.6 23.4 23.6 
18:2n-6 3.1 5.5 8.4 
20:2n-6 0.4 1.1 1.3 
20:3n-6 0.4 1.1 1.8 
20:4n-6 2.7 4.2 4.9 
Total n-6) 7.4 12.8 17.4 
20:5n-3 8.1 5.3 4.7 
22:5n-3 0.9 0.7 0.7 
22:6n-3 11.7 10.6 11.5 
Total n-3~ 21.6 17.3 17.3 
Total PUFA 29.0 30.1 34.7 
n-3/n-6 2.9 1.4 1.0 
20:4/20:5 0.3 0.8 1.0 
Results are obtained from pooled leucocyte samples from 6 
fish per dietary treatment (see Materials and Methods for 
details) 
~ Includes 15:0, 17:0, 20:0 and 22:0. 
! ~~~l~~:: r:~i~iYi:~i:~f~~~~~t 
Table 4 Fatty acid composition of leucocyte 
phosphatidylethanolamine from salmon given increasing levels 
of dietary linoleic acid 
Fatty acid Diet 1 Diet 2 Diet 3 
(10% LA) (25% LA) (45% LA) 
weight % 
14:0 2.0 2.4 1.4 
16:0 13.0 11.1 11.3 
18:0 5.5 5.9 6.8 
Total saturates l 21.2 20.3 20.6 
16:1n-7 3.0 2.1 1.9 
18: In-9 12.9 11.2 8.8 
18:1n-7 3.4 2.5 2.3 
20: In-9 2.2 1.2 0.7 
24: I 0.3 0.2 0.2 
Total monoenes2 22.9 17.6 14.0 
18:2n-6 5.6 9.5 12.0 
20:2n-6 0.5 1.0 1.2 
20:3n-6 0.3 0.9 1.2 
20:4n-6 3.4 5.6 6.5 
Total n-6~ 10.2 17.6 21.6 
20:5n-3 3.3 2.6 2.0 
22:5n-3 0.9 1.0 0.8 
22:6n-3 29.2 29.1 29.0 
Total n-3' 34.3 33.4 32.0 
Total PUFA 44.5 51.0 53.6 
n-3/n-6 3.4 1.9 1.5 
20:4/20:5 1.0 2.2 3.3 
Footnotes as described in Table 3. 
Table 5 Fatty acid composition of leucocyte 
phosphatidylserine from salmon given increasing levels of 
dietary linoleic acid 
Fatty acid Diet I Diet 2 Diet 3 
(10% LA) (25% LA) (45% LA) 
weight % 
14:0 2.1 3.1 3.4 
16:0 23.9 22.1 17.1 
18:0 17.4 24.6 20.2 
Total saturatesl 44.7 50.9 41.8 
16:ln-7 2.2 1.1 2.1 
18: In-9 11.6 9.8 11.1 
18: In-7 2.9 1.0 1.5 
20:ln-9 1.8 0.5 2.1 
24:1 0.6 0.3 0.4 
Total monoenes~ 19.3 13.0 17.6 
18:2n-6 1.5 1.7 4.7 
20:2n-6 0.3 0.4 0.7 
20:3n-6 0.2 0.5 0.6 
20:4n-6 0.8 1.7 2.7 
Total n-6' 3.5 5.2 9.4 
20:5n-3 1.0 0.7 0.4 
22:5n-3 1.3 1.8 1.0 
22:6n-3 21.8 23.7 21.9 
Total n-3~ 24.4 26.3 23.3 
Total PUFA 27.9 31.5 32.7 
n-3/n-6 7.0 6.1 2.5 
20:4/20:5 0.8 2.4 6.8 
Footnotes as described in Table 3. 
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Table 6 Fatty acid composition of leucocyte 
phosphatidylinositol from salmon given increasing levels of 
dietary linoleic acid 
Fatty acid Diet 1 Diet 2 Diet 3 
(10% LA) (25% LA) (45% LA) 
weight % 
14:0 0.7 3.5 3.7 
16:0 11.6 9.5 6.4 
18:0 26.9 32.0 35.8 
Total saturates· 40.3 46.3 47.1 
16:1n-7 2.0 2.1 1.0 
18: In-9 12.4 7.1 5.0 
18:1n-7 2.6 1.1 0.8 
20:1n-9 4.2 0.4 0.1 
24:1 0.6 0.1 0.1 
Total monoenes~ 22.4 10.7 6.8 
18:2n-6 2.0 1.6 2.7 
20:2n-6 0.2 0.5 0.5 
20:3n-6 0.2 0.4 0.6 
20:4n-6 22.8 32.0 36.9 
Total n_61 25.5 34.5 40.7 
20:5n-3 0.5 0.5 0.4 
22:5n-3 0.3 trace trace 
22:6n-3 2.1 3.3 2.9 
Total n-3~ 3.5 3.8 3.3 
Total PUFA 29.0 38.3 44.0 
n-3/n-6 0.14 0.11 0.08 
20:4/20:5 45.6 64.0 92.3 
Footnotes as described in Table 3. 
(Table 3) 18:2n-6. 20:2n-6. 20:3n-6. 20:4n-6 and 
total n-6 PUF A all increased with increasing dietary 
intake of LA. EPA and total n-3 PUF A all 
decreased with increasing dietary LA. Consequent-
ly, the n-3/n-6 PUFA ratio decreased and the 
20:4/20:5 ratio increased with' increasing dietary 
LA. Similar changes occurred in the fatty acid com-
positions of leucocyte PE and PS (Tables 4 & 5). 
The fatty acid composition of leucocyte PI was less 
affected by dietary LA but AA was increased with 
increasing LA (Table 6). In general. the saturated 
and monoenoic fatty acids in leucocyte phos-
pholipids reflected dietary intake. 
The fatty acid compositions of gill phospholipids 
are shown in Tables 7-10. In PC (Table 7) 18:2n-
6. 20:2n-6. 20:3n-6 and total n-6 PUF A were all 
increased significantly with increasing dietary LA. 
but AA and the 20:4/20:5 ratio were only increased 
significantly in the fish given the highest dietary LA. 
EP A, total n-3 PUF A and n-3/n-6 PUF A ratio were 
significantly reduced with increasing dietary LA 
while DHA was significantly reduced in fish given 
25 and 45% LA. Very similar changes occurred in 
gill PE fatty acid composition (Table 8). but EPA 
and total n-3 PUF A were significantly reduced only 
in fish given the highest dietary LA, while DHA 
was unaffected_ Gill PS fatty acid composition 
(Table 9) showed changes similar to those in PE 
except that LA, 20:2n-6 and 20:3n-6 were only sig-
Table 7 Fatty acid composition of gill phosphatidylcholine 
from salmon given increasing levels of dietary linoleic acirl 
Fatty acid Diet 1 Diet 2 Diet 3 
(10% LA) (25% LA) (45% LA) 
weight % 
2.8 ± 0.4h 14:0 3.9 ± 0.4" 3.3 ± O.lh 
16:0 33.8 ± 2.4 35.5 ± 0.8 35.9 ± 1.3 
18:0 2.6 ± O.!' 3.0 ± O.lh 4.2 ± 0.1' 
Total saturates· 41.8 ± 2.6 43.1 ± 0.9 44.1 ± 2.2 
16:ln-7 4.2 ± 0.4" 3.6 ± O.!' 2.9 ± O.lh 
18:1n-9 17.4 ± 1.2 18.5 ± 1.0 17.7 ± 0.7 
18:1n-7 2.5 ± O.!' 2.3 ± O.Z'h 1.9 ± O.t 
20:ln-9 1.1 ± 0.1" 0.9 ± 0.1" 0.6 ± O.lh 
22:ln-11 0.4 ± 0.1" 0.2 ± O.loh 0.1 ± (ui' 
24:1 0.4 ± 0.1 0.8 ± 0.3 0.5 ± 0.3 
Total monoenes~ 26.1 ± 1.7" 26.6 ± 1.53 23.7 ± I.(i' 
18:2n-6 2.4 ± O.!' 5.0 ± 0.3h 8.9 ± 0.8' 
20:2n-6 0.3 ± 0.1" 0.7 ± O.lh 1.2 ± O.t 
20:3n-6 0.2 ± 0.1" 0.6 ± O.lh 1.5 ± 0.1 
20:4n-6 1.3 ± O.Z' 1.5 ± 0.3" 2.5 ± O.t 
Total n_61 4.8 ± 0.6" 8.3 ± O.6h 14.4 ± IS 
20:5n-3 3.7 ± 0.3" 2.9 ± 0.7" 1.7 ± n.t 
22:5n-3 0.5 ± 0.0 0.4 ± 0.1 0.4 ± n.1 
22:6n-3 15.7 ± 1.7" \.l.6 ± O.6h 12.1 ± ().~ 
Total n-3~ 20.1 ± 1.7" 17.1 ± I.t 14.2 ± (J.t{ 
Total PUFA 24.9 ± 1.8 25.4 ± 1.8 28.6 ± 2.2 
n-3/n-6 4.3 ± 0.6" 2.1 ± O.(i' I.(J ± 0.1< 
20:4/20:5 0.4 ± 0.1" 0.5 ± 0.1" 1.5 ± O.~ 
Results are mean ± SD for 4 fish per treatment. 
I Includes 15:0. 17:0. 20:0 and 22:11. 
2 Includes 2(J: I n-7. 
3 Includes 18:3n-6. 22:4n-6 and 22:5n-6 . 
.. Includes 18:3n-3. 18:4n-3 and 20:4n-3. 
Values in the same row with different superscript letters are 
significantly different (p <0.(5). 
SD of 0.0 is less than 11.05. 
nificantly increased in fish given the highest dietary 
level of LA. The n-3/n-6 PUFA ratio was significant-
ly decreased only in fish given the highest dietary 
LA. In gill PI fatty acid composition (Table 10) 
18:2n-6, 20:2n-6, 20:3n-6, total n-6 PUF A and the 
20:4/20:5 ratio were all increased significantly with 
increasing dietary LA. while total PUFA were in-
creased significantly only in fish given the highest 
LA. EPA. total n-3 PUFA and n-3/n-6 PUFA ratio 
were all significantly reduced with increasing dietary 
LA, while 22:5n-3 and DHA were significantly 
reduced in fish given 25 and 45% LA. As with 
Icucocytes. the saturated and monoenoic fatty acid 
composition of gill phospholipids reflected dietary 
intake. 
The concentrations of plasma 6-keto-PGFta and 
TXB2 are shown in Table 11. Both cyclooxygenase 
products were significantly increased in plasma of 
salmon given the highest dietary LA. However. 
while 6-kcto-PGFla was increased around 1.5-fold, 
TXB 2 was increased over 3.5-fold. The production 
of eicosanoids by whole blood stimulated with the 
calcium ionophore A23187 is shown in Table 12. 
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Table 8 Fatty acid composition of gill 
phosphatidylethanolamine from salmon given increasing levels 
of dietary linoleic acid 
Fatty acid Diet I Diet 2 Diet 3 
(10% LA) (25% LA) (4S% LA) 
weight % 
14:0 1.1 ± 0.4 1.2 ± 0.4 0.7 ± 0.3 
16:0 IS.2 ± 1.0 13.6 ± 1.3 IS.2 ± 1.6 
18:0 6.1 ± O.t 7.0 ± 0.4h 8.3 ± 0.1 
Total saturates· 2S.7 ± 0.8 25.4 ± 1.9 27.3 ± 2.0 
16:ln-7 1.7 ± 0.2 t.5 ± 0.4 1.8 ± 0.6 
18: In-9 8.0 ± 0.6 8.0 ± 0.4 7.1 ± 0.5 
18: In-7 2.3 ± O.t 2.1 ± O.t 1.4 ± 0.2" 
20: In-9 1.5 ± O.t l.l ±O.lh 0.8 ± 0.1< 
24:1 0.3 ± 0.1 0.3 ± 0.3 0.2 ± 0.1 
Total monoenes~ 14.2 ± 0.9' 13.2 ± 0.8" 10.8 ± 0.6h 
18:2n-6 2.8 ± 0.3" S.9 ± 0.6h 8.4 ± 0.6< 
20:2n-6 0.4 ± 0.1" 0.8 ± I.t 1.2 ± 0.1' 
20:3n-6 0.2 ± O.la 0.6 ± O.lh 1.2 ± 0.1' 
20:4n-6 2.6 ± OS 2.9 ± 0.4" 5.1 ± I.3h 
Total n_63 6.6 ± l.fl' 10.9 ± I.1h 16.7 ± 1.1 
20:5n-3 3.2 ± 0.6" 2.9 ± 0.4" 2.0 ± O.3h 
22:5n-3 0.8 ± 0.1 0.8 ± 0.1 0.6 ± 0.1 
22:6n-3 36.2 ± 1.5 32.6 ± 2.9 31.6 ± 2.7 
Total n_34 40.4 ± I.!' 36.3 ± 2.1' 34.2 ± 3.lh 
Total PUFA 47.0 ± 1.3 47.2 ± 2.3 51.5 ± 3.3 
n-3/n-6 6.2 ± 1.1" 3.4 ± (J.5h 2.0 ± 0.1' 
20:4/20:5 O.S ± 0.11' 1.0 ± 0.2" 2.7 ± ut 
Footnotes as described in Table 7 except; 3 Includes 20:ln-7 
and 22: In-II. 
Table 9 Fatty acid composition of gill phosphatidylserine from 
salmon given increasing levels of dietary linoleic acid 
Fatty acid Diet I Diet 2 Diet 3 
(10% LA) (25% LA) (45% LA) 
weight% 
14:0 0.4 ± 0.1" 0.3 ± O.2"h 0.2 ± O.th 
16:0 10.7 ± 0.4 10.2 ± 1.1 10.2 ± 0.4 
18:0 20.4 ± 0.1 21.6 ± 2.8"b 23.9 ± O.t 
Total saturates· 32.8 ± IS 33.6 ± 2.8"b 36.2 ± O.s" 
16:1n-7 1.6 ± 0.2' 1.4 ± 0.4- 0.8 ± O.lh 
18: In-9 7.3 ± 0.3' 6.4 ± 0.6" 5.2 ± O.t 
18:ln-7 1.3 ± 0.1" I.l ± 0.1"" 1.0 ± O.lh 
20: In-9 1.9 ± 0.4" l.2±0.lh 0.9 ± O.t 
24:1 1.0 ± O.!' 0.7 ± O.lab 0.5 ± O.th 
Total monoenes2 14.2 ± IS 11.7 ± 1.(1' 9.0 ± O . .f 
18:2n-6 1.9 ± 0.2" 2.3 ± 0.3-h 2.9 ± O.4h 
20:2n-6 0.4 ± 0.1" 0.7 ± 0.2" 1.1 ± O.lh 
20:3n-6 0.5 ± 0.1" 0.7 ± O.th 1.1 ± O.t 
20:4n-6 0.9 ± 0.1" 1.5 ± 0.6"h 1.6 ± O.t 
Total n_63 5.4 ± 0.2' 6.3 ± 0.7" 8.1 ± O.6h 
20:Sn-3 0.9 ± 0.1" 0.9 ± 0.1" 0.6 ± O.lh 
22:5n-3 1.3 ± 0.1 1.3 ± 0.2 1.1 ± O.lh 
22:6n-3 33.5 ± 1.1 35.0 ± 3.3 32.1 ± 0.3 
Total n_34 36.6 ± J.3 37.6 ± 3.5 33.8 ± 0.1 
Total PUFA 42.0 ± 1.5 43.9 ± 3.8 41.9 ± 0.6 
n-3/n-6 6.7 ± 0.2' 6.0 ± 0.6" 4.2 ± 0.4h 
20:4/20:5 6.7 ± O.t 1.6 ± OS 2.8 ± 0.4b 
Footnotes as described in Table 8. 
Table 10 Fatty acid composition of gill phosphatidylinositol 
from salmon given increasing levels of dietary linoleic acid 
Fatty acid Diet I Diet 2 Diet 3 
(10% LA) (2S% LA) (4S% LA) 
weight % 
14:0 0.7 ± 0.2 0.7 ± 0.2 0.6 ± 0.2 
16:0 10.9 ± OS 14.7 ± O.4h 14.2 ± 0.6h 
18:0 22.6 ± 0.'1 21.2 ± 2.4"h 20.6 ± o.if 
Total saturates· 35.6 ± 1.0 38.S ± 2.4 36.4 ± 0.7 
16:ln-7 2.S ± O.t 2.6 ± OS 3.7 ± 0.3h 
18:ln-9 10.0 ± 0.4" 11.5 ± O.t 11.2 ± 0.4h 
18:ln-7 1/7 ± 0.1" 3.1 ± 0.3h 2.1 ± 0.1< 
20:ln-9 1.5 ± O.t 1.8 ± 0.3h 1.0 ± O.lh 
24:1 0.9 ± 0.1 0.8 ± 0.2 0.8 ± 0.2 
Total monoenes~ 16.0 ± 0.7" 19.7 ± 1.2" 18.8 ± O.t 
18:2n-6 2.2 ± 0.2" 4.7 ± O.~ 6.8 ± O.J 
20:2n-6 0.3 ± 0.1" 0.5 ± 0.1" 1.0 ± O.lh 
20:3n-6 O.S ± 0.1" 1.1 ± O.lh I.S ± 0.1< 
20:4n-6 8.2 ± 0.3 8.0 ± 0.8 9.0 ± 0.3 
Total n-6· 12.S ± 0.3" 17.S ± O.s" 20.3 ± 0.1 
20:5n-3 2.7 ± O.t 2.0 ± O.t 1.2 ± O.t 
22:5n-3 1.2 ± O.!' 0.7 ± O.lh O.S ± O.lh 
22:6n-3 17.2 ± 0.4" 14.S ± 0.6h 14.6 ± 0.3h 
Total n_32 22.2 ± 0.1" IS.2 ± 0.4h 17.2 ± 0.4< 
Total PUFA 34.7 ± O.!' 3S.7 ± 0.4" 37.5 ± O.¢ 
n-3/n-6 1.8 ± (J.I- 1.0 ± O.lh 0.8 ± O.lh 
20:4/20:S 3.0 ± O.t 4.t ± 0.3h 7.9 ± 1.1< 
Footnotes as described in Table 8. 
Table II Plasma 6-keto-PGF ... and TXB 2 concentrations in 
salmon given increasing dietary levels of linoleic acid 
Eicosanoid Diet I Diet 2 Diet 3 
(10% LA) (25% LA) (45% LA) 
pg/ml plasma 
1664 ± 323h 6-keto-PGF.o 1103 ± 84" HillS ± 177" 
TXB! 402 ± 130- 293 ± 54" 1418 ± J083h 
Values are mean ± SD for 4 fish per treatment. 
Values in the same row with different superscript leiters are 
significantly different. 
LTB4 • 12-HETE, TXB2 and 12-HETE/12-HEPE 
ratio were all significantly increased, whereas 12-
HEPE was significantly reduced in fish given the 
highest dietary LA. While LTBs was not significant-
ly affected, the ratio of L TBJL TBs was significantly 
increased in fish given the highest dietary LA. 
The production of eicosanoids by isolated gill 
cells stimulated with A23187 is shown in Table 13. 
The production of both 12-HEPE and 12-HETE was 
significantly reduced with increasing dietary linoleic 
acid although the ratio 12-HETE/12-HEPE indi-
cated that the EPA-derived species was more 
affected. The production of a DHA-derived 12-
lipoxygenase product, eluting immediately before 
12-HETE on HPLC, was confirmed by labeling gill 
I 
I 
I 
I 
I 
I ( 
I 
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Table 12 Eicosanoid production by whole blood of salmon given increasing dietary linoleic acid. after 
stimulation with calcium ionophore A23187 
Eicosanoid Diet I Diet 2 Diet 3 
(\0% LA) (25% LA) (45% LA) 
n!'lml whole blood 
± 27.3b LTB. 54.8 ± 21.8" 75.3 ± 15.(fb 101.4 
LTB~ 38.3 ± 10.2 28.7 ± 8.3 29.2 ± 2.2 
LTBjLT~ 1.44 ± 0.60' 2.85 ± O.99"h 3.53 ± 1.1f 
12-HETE 55.6 ± 7.1' 53.3 ± 14.1" 92.7 ± 8.gb 
12-HEPE 40.5 ± 6.8" 24.7 ± 3.~ 20.8 ± 3.4b 
12-HETE/12-HEPE 1.69 ± 0.31)' 2.20 ± O.6O"b 3.81 ± l.51b 
TXB1 36.4 ± 8.1' 53.1 ± 19.9' 136.5 ± 41.1
b 
Footnotes as described in Table 11. 
Table 13 Eicosanoid production by isolated gill cells from salmon given diets with increasing linoleic acid. 
after stimulation with calcium-ionophore A23187 
Eicosanoid Diet I 
(10% LA) 
12-HEPE 4&.8 ± 11.3J 
12-HETE 17.7 ± 4.g' 
12-HETE/12-HEPE 0.33 ± 0.04" 
14-HDHE 43.1 ± 15.4J 
6-keto-PGF1• 0.23 ± O'!)6' 
TXB1 ().30 ± 0.14 
Footnotes as described in Table II. 
ND = not determined. 
cells with [l.l4C]-DHA. The peak detected by ab-
sorbance at 235 nm co-eluted with the maximum 
radioactive peak when eicosanoids derived from gill 
cells labeled with [l.l4C]-DHA were analysed by 
HPLC. We presume it is the I2-lipoxygenase 
product of DHA, 14-hydroxy-4,7,1O,13,16,I9-docosa-
hexaenoic acid (14-HDHE). Production of the puta-
tive 14-HDHE was also decreased with increasing 
dietary linoleic acid. Production of TXB2 was not 
affected by dietary linoleic acid but the amount of 
6-keto-PGF\IJ was significantly reduced. 
DISCUSSION 
The increase in dietary LA is reflected by increased 
incorporation of this fatty acid into the membrane 
phospholipids of leucocytes and gill cells. The con-
comitant incorporation of increased levels of 
20-carbon n-6 PUF A in these phospholipids con-
firms the presence of active a-6- and a-5-
desaturation and elongation of CI8 PUFA in sal-
mon. 20:3n-6 is increased by up to 4-fold in 
leucocyte and 7-fold in gill phospholipids which is 
considerably greater than the rise in AA. The 
accumulation of 20:3n-6 suggests that 6-5-
desaturase is rate limiting in Atlantic salmon which 
Diet 2 Diet 3 
(25"1" LA) (45% LA) 
ng/mg protein 
22.1 ± 5.t/' 5.9 ± 2.1< 
13.1 ± 2.5"b 6.9 ± 3.1t 
11.64 ± 0.16b 0.9& ± O.IS< 
19.7 ± 4.4b 10.8 ± 4.4< 
ND 0.14 ± O.()6b 
ND 11.311 ± 0.12 
is in agreement with a previous study in isolated 
hepatocytes of rainbow trout (27). While increasing 
dietary LA caused a moderate increase in phos-
pholipid AA, it simultaneously resulted in 
decreased EPA and thereby a substantially 
increased 20:4/20:5 eicosanoid precursor ratio. 
However, while the diets contained increasing levels 
of LA they al1>o contained decreasing levels of EPA. 
Therefore, the observed increase in phospholipid 
AA as a result of increasing dietary LA may not 
purely reflect increased desaturation and elongation 
of LA but may also result from decreased dietary 
EPA. In a previous study (10), the sum of AA and 
EPA in liver and muscle polar lipids was maintained 
at a constant level despite dietary fluctuation and 
thus it appeared that these two fatty acids were 
interchangeable. Therefore, although fish will 
preferentially incorporate EPA into their tissue 
phospholipids, they can substitute AA when dietary 
EPA, which may be specifically required for 
production of DHA, is reduced. 
In the present study we used whole blood, rather 
than isolated leucocytes, to study eicosanoid metab-
olism. This method was chosen because it closely 
resembles the in vivo situation where interaction be-
tween cell types can profoundly influence the 
overall eicosanoid spectrum produced (28). Studies 
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with a related salmonid species, the rainbow trout, 
suggest that erythrocytes are not capable of 
eicosanoid synthesis (29). The changes in leucocyte 
membrane fatty acid composition in the present 
study are, reflected in the nature of the eicosanoids 
generated on stimulation with A23187. Increasing 
dietary LA results in increased production of AA-
derived eicosanoids and increased ratios of 
LTBJLTBs and 12-HETE/12-HEPE. LTB4 is a par-
ticularly powerful chemotactic agent for neutrophils 
and it is also active in stimulating cellular uptake of 
calcium (30). While LTBs has similar activity it is 
around 30 times less potent (31). TXA2 is a potent 
agonist for platelet aggregation, vasoconstriction 
and increasing intracellular calcium (32). The 
production of these highly bioactive species, which 
is enhanced in salmon given increased levels of LA, 
could clearly result in altered immune function, in-
creased inflammatory activity and other undesirable 
pathophysiological effects. 
A previous study using gill homogenates from 
rainbow trout demonstrated a 12-lipoxygenase ac-
tivity capable of converting exogenous radiolabeled 
AA and EPA to their corresponding 12-hydroxy 
metabolites (15). The same authors, again using gill 
homogenates, demonstrated that AA was the major 
fatty acid released from endogenous PUF A and that 
12-HETE was the predominant metabolite (33), and 
they postulated that the precursors for the 
lipoxygenase metabolites were derived from AA-
rich PI. In a previous study using salmon given diets 
containing fish oil (11) and in the present study with 
salmon given 10% LA, the major lipoxygenase me-
tabolite produced by intact, isolated gill cells was 
EPA-derived 12-HEPE. Only in salmon given the 
highest level of dietary LA did the ratio of 12-
HETE/12-HEPE increase towards unity. The ratio 
of the two 12-lipoxygenase products in gill cells is 
most closely related to the ratio of AA: EPA in gill 
PC and least closely to the corresponding ratio in 
PI. This suggests that the former phospholipid is 
much more likely than the latter to be the source 
of precursors for the gill Jipoxygenase. A similar 
relationship has also been observed in mammalian 
platelets (34) and cultured umbilical cells (35). 
However, the present studies with whole blood 
show that the average ratios for 12-HETE/12-HEPE 
and L TBIL TB 5 most closely approach the 
AA/EP A ratio in PE. 
Previous studies showed that human platelets 
could synthesise 14-HDHE from exogenous [1-'4C)-
DHA (36) but rat platelets and guinea-pig epidermis 
did not produce DHA-derived lipoxygenase metab-
olites from endogenous DHA (37, 38). In the 
present study we demonstrated that DHA released 
after stimulation of gill cells with A23187 was a sub-
strate for 12-lipoxygenase. While the production of 
14-HDHE, from endogenous DHA, has been ob-
served in homogenates of trout gill (33), this is the 
first evidence that 12-lipoxygenase products of 
DHA are generated by intact gill cells. 
While increasing dietary LA caused a reduction 
in the ratio of EPA:AA-derived lipoxygenase 
products in gills, it also caused a dramatic reduction 
in total Jipoxygenase metabolites produced from 
AA, EPA and DHA. Similarly, there was a 
decrease in 6-keto-PGF ta but no significant decrease 
in TXB2 produced by gill cells in fish given the 
highest dietary LA. It is difficult to account for the 
marked decrease in eicosanoid products in gills in 
terms of altered levels of their substrate fatty acids 
esterified in phospholipids, especially in the cases of 
AA and DHA. It may be notable, however, that 
the amount of 20:3n-6 was increased up to 7-
fold in fish given the highest dietary LA and this 
fatty acid is known to inhibit production of AA-
derived lipoxygenase metabolites (38). PGE" which 
is derived from 20:3n-6, can cause increased syn-
thesis of cAMP, a potent inhibitor of AA 
mobilisation (39). Recent studies with rats have 
shown that alteration of dietary n-3/n-6 PUF A ratios 
can affect the activity of enzymes involved in lipid 
metabolism. Thus, the activity of phospholipase A;! 
was found to be either increased (40) or decreased 
(41), depending on the tissue, when dietary n-3/n-6 
PUF A was reduced. A decrease in phospholipase 
activity in gills of salmon given high dietary LA, 
which would result in less available substrate for 
lipoxygenase and cyclooxygenase, could explain the 
diminished eicosanoid production in gills observed 
in the present study. While the role of 12-
lipoxygenase metabolites is, at present, not clearly 
understood there is evidence that they are involved 
in the regulation of ion channels (42, 43). Gills are 
fundamentally involved in osmoregulation and any 
compromise in the control of ionic fluxes could 
clearly have very serious implacations for the 
physiological integrity of the fish. 
This study has demonstrated that membrane 
phospholipid fatty acid compositions in gills and 
leucocytes of salmon can be altered by giving diets 
with increasing levels of dietary LA. The resulting 
changes in eicosanoid precursors are generally 
reflected in an increase in AA-derived eicosanoids 
which could have important consequences for the 
occurence of stress-induced conditions in these fish. 
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Abstract 
The incorporation and metabolism of (n - 3) and (n - 6) polyunsaturated fatty acids were studied in a cell 
line derived from chum salmon heart (CHH-I). Supplementing media with 25 Io'M fatty acid considerably 
altered the cellular fatty acid composition but did not affect the lipid class composition or cause the appear-
ance of cytoplasmic lipid droplets. CHH-l cells exhibited considerable .a-6-desaturase activity but showed 
no preference between (n - 3) and (n - 6)PUFA substrates. CHH-l cells also possess .:l-5-desaturase activity 
which showed preference towards (n - 3)PUFA, but .:l-4-desaturase activity was totally absent. Elongation 
of 20-carbon PUF A was especially active in CHH-I cells with 22-carbon PUFA being specifically incorporat-
ed into PE and PS lipid classes. The fatty acid composition of PI indicated specific incorporation of 
20-carbon PUFA into this lipid class. Supplementation with 22:6(n - 3) generated fatty acid compositions 
more closely resembling those of intact salmonid hearts. Substantial chain shortening of 22:6(n - 3) to 
20:5(n - 3) occurred. 
Introduction 
Fish tissues are characterized by high levels of poly-
unsaturated fatty acids (PUF A) which are pre-
dominantly of the (n - 3) series as opposed to the 
(n - 6) series PUF A which predominate in terres-
trial animals (Padley et 01. 1986; Henderson and 
Tocher 1987). In general, freshwater fish can 
metabolize linolenic acid, 18:3(n - 3), by .:l-6-desa-
turation to 18:4(n - 3) and after subsequent elonga-
tion and .:l-S- and .:l-4-desaturation, produce 
docosahexaenoic acid, 22:6(n - 3) (Henderson and 
Tocher 1987). Marine fish, such as the turbot 
(Scophthalmus maxim us) , apparently lack .:l-S-de-
saturase and require the long chain PUF A ei-
cosapentaenoic acid, 20:S(n - 3), and 22:6(n - 3) to 
be supplied by the diet (Owen et 01. 1975). These 
metaboliC' pathways have recently been confirmed 
in cultured cells from turbot and rainbow trout 
(Oncorhynchus mykiss) (Tocher 1990; Tocher and 
MacKinlay 1990). In an anadramous species, At-
lantic salmon (Salmo solar), the ability to elongate 
and desaturate 18:2(n - 6) was apparently lost dur-
ing smoltification (Ackman and Takeuchi 1986) but 
Abbreviations: BHT, butylated hydroxy toluene; BSA. bovine serum albumin; CL, cardiolipin; FCS, fetal calf serum; PA, phosphatidic 
acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine; PUFA, polyunsatu-
rated fatty acid; SM, sphingomyelin. 
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was regained in post-smolts (Bell et 01. 1989). 
In cultured cells, the only added lipid tends to be 
derived from the serum supplement which is usually 
of mammalian origin. This results in cultured cells 
having a fatty acid composition which largely 
reflects that of the serum supplement (Spector et al. 
1981). Fetal calf serum (FCS) is normally the serum 
of choice but fish cells cultured in FCS are generally 
deficient in (n - 3)pUF A and usually contain 
elevated concentrations of (n - 6)PUFA (Tocher et 
01. 1988). 
In a recent study with Atlantic salmon, we ob-
served the development of a severe cardiomyopathy 
in fish given diets containing sunflower oil (high in 
18:2(n - 6» whereas no lesion was seen in fish given 
diets containing fish oil (Bell et 01. 1991). A number 
of other cardiac abnormalities including epicarditis 
and haemopericarditis have also been observed in 
farmed Atlantic salmon (Ferguson et 01. 1986; Ray-
nard and Houghton 1991). 
Feeding diets with varying levels of (n - 3) and 
(n - 6)pUFA to rats resulted in modification of 
cardiac membrane lipids (Swanson and Kinsella 
1986) and subsequent alteration of membrane 
bound enzyme activities (Leonardi et 01. 1987; 
Swanson et 01. 1989). In the present study we inves-
tigated the incorporation and metabolism of (n - 3) 
and (n - 6)PUF A in an established cell line 
(CHH-l) from chum salmon (Oncorhynchus keto) 
(Lannan et 01. 1984). These cells had been derived 
from primary cultures of heart cells from juvenile 
salmon prepared as described by Wolf and Quimby 
(1976). Our aim was to determine the pathways of 
desaturation and elongation present in these cells 
and to observe whether there was preferential 
metabolism of (n - 3)pUF A compared to (n - 6) 
PUFA. 
Materials and methods 
Materials 
Eagle's Minimum Essential Medium (EMEM), 
trypsin-EDT A and fetal calf serum (FCS) were ob-
tained from Northumbria Biologicals Ltd., Cram-
lington, U.K. Tryptose phosphate broth, 10 x con-
ccntrated non-essential amino acids, sodium bicar-
bonate, antibiotics and HCl were obtained from 
Flow Laboratories, Rickmansworth, U.K. All 
PUF A (approx. 99070 pure), fatty acid-free bovine 
serum albumin (BSA), butylated hydroxy toluene 
(BHT), and Trizma were obtained from Sigma 
Chemical Co. Ltd., Poole, U.K. All solvents were 
HPLC grade and were obtained from Rathburn 
Chemicals, Walkerburn, U.K. 
Cells and medium 
The chum salmon heart cell line (CHH-l) was ob-
tained from Dr. D. Smail, S.O.A.F.D. Marine 
Laboratory, Aberdeen, U.K., and was maintained 
in EMEM (with Earle's salts) containing 10;0 tryp-
tose phosphate broth, 4 mM Tris-HCl buffcr (TriL-
rna, pH 7.4), 1070 non-essential amino adds, 
0.275070 sodium bicarbonate, 2 mM HCI. antibiot-
ics (50 I.U.ml- 1 penicillin and 50 /lg.ml- I strep-
tomycin) and either 10% or 1070 FCS. 
PUFA supplements 
PUFA supplements were added to the CHH-l cul-
tures as BSA complexes prepared largely by the 
method of Spector and Hoak (1969). To reduce oxi-
dation all procedures were carried out at room tem-
perature under a stream of nitrogen. The PUF A-
BSA complexes were filter sterilized through 0.1 
/lm filters (Flowpore, Flow Laboratories) prior to 
use. The fatty acid concentrations were assayed af-
ter addition of an internal standard (17 :0) to an ali-
quot of the complex. The lipids were then extract-
ed, transmethylated and quantitated by gas-liquid 
chromatography. PUF A concentrations were in the 
range 1.5-2.0 mM (BSA = 0.25 mM) giving a 
PUFA:BSA ratio of 6-8. The PUFA:BSA mix-
tures were stored under nitrogen at - 20°C in dar-
kened vials. 
Incubation conditions 
For routine cell cultivation the cultures were grown 
in sealed 75 cm2 flasks (Northumbria Biological 
I 
I 
r 
I 
\ 
I 
r 
Ltd.) in 15 ml medium containing 10070 or 2070 FCS. 
Cells were harvested for analysis or subculture wi-
thin 24h of achieving confluence (usually after 5-7 
days). Cells incubated with PUF A were subcultured 
into 225 cm2 flasks with 50 ml medium containing 
1070 FCS and an appropriate volume of PUFA:BSA 
complex to give a final fatty acid concentration of 
25 ILM. FCS contains approximately 0.37070 lipid of 
which around 50070 is fatty acid. The lipid class 
composition and fatty acid composition of FCS has 
been given in detail previously (Tocher et 01. 1988). 
Previous studies with cultured fish cells (Tocher et 
01. 1988, 1989) indicated that this fatty acid concen-
tration resulted in considerable incorporation and 
metabolism into phospholipids without causing in-
creased deposition of neutral lipid. Control flasks 
received the same volume of fatty acid free BSA so-
lution. All incubations were performed at 22°C. 
Cell harvesting and lipid extraction 
Cells were harvested within 24h of reaching CO.l-
fluence. The media were removed by aspiration and 
the cells were washed with 20 ml phosphate-
buffered saline before addition of 3 ml trypsin-
EDT A (0.05070 and 0.02070 respectively). Once the 
cells became dissociated 6 ml of basal medium were 
added to inhibit trypsin activity. Cells from two 225 
cm2 flasks were pooled and centrifuged at 600 x g 
for 10 min at 4°C, the supernatant poured off and 
the cell pellet washed twice with 25 ml of phos-
phate-buffered saline to ensure removal of serum. 
Total lipid was extracted from the cells largely by 
the method of Folch et 01. (1957). Cells were 
homogenised in 5 ml of ice-cold chloroform: 
methanol (2: 1, v Iv), 1 ml of 0.88070 KCl added, fol-
lowed by mixing on a vortex mixer. The phases were 
separated by centrifugation, the chloroform layer 
removed and dried under nitrogen and the residue 
dissolved in chloroform:methanol (2:1, v/v) con-
taining 0.05070 BHT at a final concentration of 50 
mglml. 
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Lipid class analysis 
Approximately 10 Ilg of total lipid were applied to 
a 10 x 10 cm high-performance thin-layer chro-
matography (HPTLC) plate that had been pre-run 
in "exane:diethyl ether (1: I, v Iv) and activated at 
110°C for 30 min. The plates were developed to 6 
cm in methylacetate:isopropanol:chloroform:me-
thanol:0.25070 aqueous KCI (25:25:25: 10:9 by 
volume) to separate phospholipid classes with neu-
trallipids running at the solvent front (Vitiello and 
Zanetta 1978). After drying, the plates were devel-
oped fully in hexane:diethyl ether:acetic acid 
(85: 15: 1.5, v lv/v) to separate neutral lipids and 
cholesterol. Lipid classes were visualised by char-
ring at 160°C for 15 min after spraying with 31170 
copper acetate (w/v) in 8070 phosphoric acid (v/\') 
and identified by comparison with commercially 
available standards. Lipid classes were quantified 
by scanning densitometry using a Shimadzu CS-930 
dual wavelength TLC scanner and a DR-2 record-
ing integrator. Data are means of triplicate ana-
lyses; standard deviations are omitted for clarity 
but were generally less than 5070 of the mean. 
Lipid class separation and fatty acid analysis 
Total lipid (approx. I mg) was applied in a 1 cm 
streak to a 10 x 10 cm HPTLC plate and separated 
into phosphatidylcholine (PC), phosphatidyletha-
nolamine (PE), phosphatidylserine (PS) and phos-
phatidylinositol (PI) fractions as decribed by Vitiel-
lo and Zanetta (1978). The plates were sprayed with 
0.1070 2',7' -dichlorofluorescein in 97070 methanol 
containing 0.05070 BHT, and the lipid bands were 
visualised under UV light. The lipid bands were 
scraped from the plate and acid-catalysed trans-
methylation was performed overnight at 50°C by 
the method of Christie (1982). The fatty acid 
methyl esters were separated and quantified by gas-
liquid chromatography (Carlo Erba GC 6000 Vega 
series 2, Fisons Ltd., Crawley, U.K.) using a capil-
lary column (CP-Wax 51, 50 m x 0.32 mm, 
Chrompack (U.K.) Ltd., London) with on-column 
injection using hydrogen as carrier gas and with a 
two-stage thermal gradient from 50°C to 225°C. 
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Table I. Lipid class composition of CHH-I cells cultured in 10070 fetal calf serum (FCS) or 1070 FCS supplemented with various fatty 
acids. Results arc means of triplicate experiments 
Lipid 10070 18:2 18:3 
FCS n-6 n-3 
OJoPhospholipids 69.0 63.8 57.1 
070 Neutral lipids 29.6 34.6 40.4 
Phospholipid classes: 
(OJo total lipid) 
SM 3.3 3.S 3.5 
PC 23.0 22.9 20.1 
PE 16.2 17.6 16.1 
PS 9.6 6.6 6.2 
PI 12.3 8.9 7.4 
PAlCL 4.6 4.4 3.9 
Neutral classes: 
(070 total lipid) 
Triacylglycerol S.9 8.8 12.3 
Free Fatty Acids 0.8 1.3 3.7 
Diacylglycerol 0.3 1.0 3.2 
Cholesterol 22.5 23.6 21.3 
-
= not detected. 
Individual methyl esters were identified by compar-
ison with known standards and by reference to pub-
lished data (Ackman 1980; Bell et 01. 1983). 
Statistical analysis 
Significance of difference (p < 0.05) between data 
in Table 2 and data in Tables 3-9 was determined 
by Student's t-test. 
Results 
The lipid class compositions of CHH-l cells grown 
in 100/0 FCS or 1 % FCS plus various fatty acids at 
25 ",M are shown in Table 1. In all cases, PC was 
the predominant phospholipid closely followed by 
PE which together accounted for approximately 
40% of the total lipid. PS and PI were present in ap-
proximately equal amounts with PI always the 
dominant species followed by PA/CL and SM. 
Some accumulation of neutral lipid was observed in 
cells supplemented with 18:3(n - 3) and 22:6(n - 3) 
Lipid Supplement 
18:3 20:3 20:4 20:5 22:6 
n-6 n-6 n-6 n-3 n-3 
59.7 66.4 69.5 64.8 60.2 
38.6 33.6 30.5 34.9 39.8 
3.6 3.9 3.9 3.7 3.6 
22.1 28.8 27.4 23.6 24.0 
16.9 18.1 19.9 18.6 16.7 
6.S 4.7 7.1 7.3 5.7 
7.2 6.8 7.8 7.8 6.3 
3.7 4.3 3.6 4.0 -'.0 
11.7 12.6 9.0 6.4 16.3 
3.3 S.O 5.4 6.3 7.1> 
2.7 1.9 3.3 3.7 3.ll 
21.0 14.1 12.8 18.7 13.1 
but microscopic examination of the cells indicated 
minimal presence of lipid droplets in all of the ex-
perimental treatments. Cells grew well and attained 
confluence in 5 -7 days with all fatty acid supple-
ments except 20:3(n - 6)_ Cells supplemented with 
20:3(n - 6) did not attain confluence, after 4-5 
days they appeared pyknotic and after 6-7 days 
they began to detach from the flask. 
The fatty acid compositions of phospholipid 
classes of cells cultured in 10% FCS are shown in 
Table 2. The (n - 9) series PUFA are dominant in 
all phospholipid classes, except PI, where (n - 6) 
species predominate. 18 :2(n - 9) is the predominant 
(n - 9)PUFA in all phospholipid classes except PI 
where 20:2(n - 9) predominates. 20:3(n - 9), which 
could not be separated from 20:2(n - 6) in this chro-
matographic system, did not accumulate in CHH-I 
cells. The (n - 6)PUF A were generally more abun-
dant than (n - 3)PUF A, except in PS, and the 
major (n - 6) species were 20:4, 18:2 and 20:2. The 
major (n - 3)PUFA were 22:5 and 22:6. The 
greatest amount of PUF A were found in PI with the 
least being in PC, but in all classes the monoenes , 
mostly 18:1(n-9), and the saturates, mostly 16:0 
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Table 2. Fatly acid composition of phospholipid classes of CHH·I cells cultured in medium containing 100io fetal calf serum 
Fatly acid 
14:0 
16:0 
18:0 
Total saturates' 
16:ln-9 
16:ln-7 
18:ln-9 
18:ln-7 
20:ln-9 
24:1 
Total monoenes 
18:2n-9 
20:2n -9 
Total n-9 
18:2n -6 
18:3n-6 
20:2n-6b 
20:3n -6 
20:4n -6 
22:2n -6 
22:4n -6 
22:5n -6 
Total n-6 
18:3n - 3 
18:4n - 3 
20:5n -3 
22:5n - 3 
22:6n- 3 
Total n-3 
Total PUFA 
n-3/n-6 
Total dimethyl acetals 
Total unidentified 
PC 
\.5 ± 0.1 
18.8 ± 0.2 
6.5 10 0.1 
27.6 ± 0.3 
5.2 ± 0.2 
4.9 ± 0.0 
44.2 ± 1.0 
3.1 ± 0.1 
0.8 ± 0.4 
0.7 ± 0.2 
58.9 ± 0.5 
4.3 ± 0.2 
3.8 ± 0.1 
8.1 ± 0.3 
0.6 10 0.1 
0.2 1: 0.1 
0.3 ± 0.0 
0.3 ± 0.0 
0.4 ± 0.1 
0.4 ± 0.3 
2.2 ± 0.4 
t 
0.1 ± 0.0 
0.3 ± 0.0 
0.2 1: 0.0 
0.6 ± 0.0 
10.9 ± 0.6 
0.3 ± 0.1 
0.4 ± 0.0 
2.2 ± 0.2 
Phospholipid class 
PS 
0.8 ± 0.1 
9.8 ± 0.1 
2604 ± 104 
37.7 ± 1.4 
3.1 ± 0.1 
2.8 ± 0.1 
25.1 ± 0.3 
I. 7 ± 0.1 
1.0 ± 0.1 
0.9 ± 0.4 
34.6 ± 0.6 
5.6 ± 0.0 
4.6 ± 0.1 
10.2 ± 0.2 
1.0 ± 0.1 
0.7 ± 0.4 
0.3 ± 0.0 
0.6 ± 0.2 
0.6 ± 0.1 
0.4 ± 0.0 
0.6 ± 0.1 
0.7 ± 0.1 
4.9 ± 0.3 
0.1 ± 0.0 
0.2 ± 0.0 
0.1 ± 0.0 
3.6 ± 0.5 
2.2 ± 0.3 
6.2 ± 0.7 
21.3 ± 0.6 
1.4 ± 0.4 
6.4 ± 0.2 
PI 
0.4 ± 0.0 
4.4 ± 0.1 
19.2 ± 1.7 
25.0 ± 1.5 
0.8 ± 0.1 
1.1 ± 0.1 
25.8 ± 0.9 
2.2 ± 0.5 
0.4 ± 0.0 
1.0 ± 0.5 
31.3 ± 0.9 
2.6 1: 0.3 
11.1 ± 0.4 
13.7 ± 0.7 
0.7 ± 0.0 
O.S ± 0.3 
3.6 :t 0.1 
2.1 ± 0.2 
7.8 10 1.0 
O.S ± 0.2 
O.S ± 0.1 
0.4 ± 0.0 
16.1 ± I.S 
0.1 ± 0.0 
0.2 ± 0.0 
0.8 ± 0.3 
4.2 ± 0.7 
3.7 ± 0.8 
9.0 ± 1.2 
38.8 ± 0.5 
0.6 ± 0.2 
4.9 ± 2.0 
PE 
0.3 ± 0.0 
5.0 ± 0.2 
5.1 ± 0.3 
10.8 ± 004 
3.3 ± 0.0 
3.2 ± 0.2 
36.2 ± 0.4 
2.9 ± 0.1 
0.5 ± 0.4 
0.5 ± 0.1 
46.6 ± 0.4 
5.3 ± 0.1 
4.3 10 0.1 
9.6 :t 0.0 
1.0 1: 0.1 
0.1 1: 0.1 
U ± 0.1 
O.S 1: 0.0 
4.~ 10 0.2 
0.3 :t 0.1 
0.4 ± 0.0 
0.4 1: 0.2 
8.7 ± 0.2 
t 
0.1 :t 0.0 
1.-' :t 0.0 
2.8 :t 0.0 
4.2 :t 0.2 
8.5 :t 0.2 
26.8 ± 0.-' 
1.0 ± 0.1 
13.3 ± 0.7 
2.5 ± 0.3 
Data are shown as means ± SD of triplicate experiments: results are expressed as f1Jo by weight; a includes 15:0, 17:0 and 20:0; bin-
cludes 20:3n - 9; t = trace value less than 0.1 f1Jo; SD < 0.05 are tabulated as 0.0. 
and 18:0, formed the main bulk of phospholipid 
fatty acids. 
The data in the following tables (Tables 3-9) are 
dealt with in comparison to data in Table 2. The 
(n - 6)PUF A composition of phospholipid classes 
from CHH-I cells supplemented with 18:2(n - 6) is 
shown in Table 3, where the total (n - 6)PUFA con-
tent of all phospholipid classes is significantly in-
creased. Apart from 18:2(n - 6), there were signifi-
cant increases in the ~-6-desaturation product 
18:3(n - 6) and the elongation product 22:3(n - 6) 
in PC and PE. 20:2(n - 6) and 20:3(n - 6) were sig-
nificantly increased in all phospholipid classes. 
20:3(n - 6) showed the greatest increase, particular-
ly in PI. The highest percentage of 18:2(n - 6) was 
observed in PE. 
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Table 3. (n - 6)PUFA composition of phospholipid classes from CHH·I cells cultured in medium ~lIpplemented with 18:2(n _ 6) 
n 6PUFA PC PS PI PE 
18:2 23.8 ± 1.5- 19.7 ± 1.5- 17.2 ± 1.1" 34,4 ± 0.2" 18:3 0.8 ± 0.1" 1.0 ± 0.1 0.7 ± 0.1 0.9 :!: 0.0" 
20:2 0.8 ± 0.1" 1,4 :!: 0.3' 5.1 ± 0.2" 1.9 :t 0.1" 20:3 1.2 ± 0.2' 3.7 :!: 0.5' 11.8 ± 0.7- 1.8 ± 0.1" 20:4 0.2 ± 0.1 0.5 :t 0.2 5.2 :t 0.8' I.J ± o ~. 
22:2 0.2 ± 0.0' 0.4 :t 0.1 0.4 ± 0.1 0.6 ± 0.2 
22:3 0.1 ± 0.0' 0.6 ± 0.2 0.2 ± 0.2 0.3 ± 0.1' 
22:4 0.2 ± 0.0" 0.1 ± 0.1' 0.2 ± 0.0 
22:5 0.2 ± 0.1 0.2 ± 0.1' 0.2 :t 0.1' 
Total 27.3 ± 1.8' 27.7 ± 1.0' 40.9 ± 2.6' 41.4 ± 0.4" 
Data are shown as means ± SD of triplicate experiments; results are expressed as a (1:'0 of total fatty acids; t = trace value less than 
0.1070 ; SD < 0.05 are tabulated as 0.0; " Values are significantly different (p < 0.05) compared to cells cullured in 100-0 res. 
Table 4. (n - 3)PUFA composition of phospholipid classes from CHH-I cells cultured in medium supplemented with IS:J(n - 3) 
n - 3PUFA PC PS PI PE 
18:3 24.9 ± 2.3' 21,0 ± 0.8' 12.5 :!: 1.0' 30.1 ± 0.4' 
18:4 1.'1 ± 0.1' U :!: 0.1" 0.7 ::: 0.0' U :: 0.1' 
20:3 2.0 ± 0.5- 1.8 :!: 0.3" 2.4 ± O.Z' ~.S ::: n.h" 
20'4 3.2 ± 0.5" 4.2 ± 0.2- 9.4 ± 0.1" 5.3 :!: O.S· 
20:5 0.3 ± 0.1" 0.5 ± 0.1' 4.5 ± O.S" 2.6 ::: lUI" 
22:5 0.2 ± 0.0 1.8 ± 0.3" 1.2 1: 0.3' 1.4 ::: 0.1" 
22:6 0.1 ± 0.0 1.3 ± 0.2' 0.7 1: 0.3' 1.2 ::: O. I-
Total 32.1 ± 3,4' 32.0 ± 0.9' 31.0 1: I. 3' 44.-: ± 1.9" 
Data presented as described in Table 3. 
The (n - 3)pUF A composition of phospholipid 
classes from CHH-l cells supplemented with 
18:3(n - 3) is shown in Table 4. Supplementing the 
media with 25 ~M 18:3(n - 3) significantly in-
creased the total (n - 3)PUF A content of all phos-
pholipid classes with the highest levels again occur-
ring in PE. The ~-6-desaturase product, 18:4(n - 3) 
was significantly increased in all phospholipid 
classes as were the elongation products 20:3(n - 3) 
and 20:4(n - 3), with the latter being the major 
metabolite of 18:3(n - 3). The ~-5-desaturation 
product 20:5(n - 3) was significantly increased in all 
phospholipid classes with the biggest increase oc-
curring in PI. The elongation and desaturation 
products of 20:5(n - 3) were significantly decreased 
in PS, PI and PE. 
The (n - 6)PUFA composition of phospholipid 
classes from CHH-l cells supplemented with 
18:3(n - 6) is shown in Table 5. The increase in total 
(n - 6)pUF A resulting from 18:3(n - 6) supplemen-
tation was generally greater than that for 18:2 
(n - 6), .vith the exception of PE. PC showed the 
highest incorporation of 18:3(n - 6) and its metabo-
lites including a significant increase in the ~-5-
desaturase product, 20:4(n - 6). The major meta-
bolite was the elongation product, 20:3(n - 6) 
which showed greatest incorporation into PI but 
was also significantly increased in all phos-
pholipids. The incorporation of the elongation 
product 22:3(n - 6) was significantly increased in all 
phospholipid classes, especially PE. 
The (n - 6)PUFA composition of phospholipid 
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Table 5. (n - 6)PUFA composition of pho~pholipid classes from CHH·I .:dls ,ultured in medium ~upplemented with 18:3(n - 6) 
n-6PUFA PC PS PI PE 
18:2 0.4 ± 0.1 0.5 ± 0.0" 0.5 ± 0.1" 0.5 ± 0.1' 
18:3 27.4 :t 0.3' 22.9 ± 0.1' 12.7 ± 0.9' 18.0 ± 2A' 
20:2 0.7 :t 0.0" 0.3 :t 0.0 3.6 ± 004 104 ± 0.3 
20:3 I·U ± 0.4' 6.1 1: 0.0' 16.3 ± 0.2" lOA ± 1.0* 
20:4 1.3 ± 0.0" O.S ± 0.2 6.5 ± OA 2.9 ± 0.4" 
22:2 0.2 ± 0.0" 0.4 ± 0.1 O.S ± 0.1 0.6 ± 0.1" 
22:3 1.9 :t 004' 0.9 ± 0.0' 1.8 ± 0.2' 3.1 ± 0.5" 
22:4 0.2 ± 0.0 0.5 ± 0.0 OA ± 0.1 0.6 ± 0.1" 
Total 46.4 ± 0.2' 32.4 ± 004" 42.3 ± 1.9" 37.5 1: 4.5" 
Dala presented as described in Table 3. 
Table 6. (n - 6)pUFA composition of phospholipid classes from CH H·I cells .:ultured in medium supplemented with ~0:3t n - 6) 
n-6PUFA PC PS PI PE 
18:2 OA 1: 0.0" 0.7 1: 0.1" 004 :t 0.0' 0.4 1: 0.1' 
18:3 2.7 :t 0.1" 2.0 :t 0.1' 104 ± 0.1" I.~ !: 0.1' 
20:2 1.0 1: 0.1" 0.: 
= 
0.1' 5.6 1: 004' ~.O ~ 0.1' 
20:3 30.5 ± 1.9" 19.~ :t 1.1' ~6.3 1: OA" 2:U .- o.~" 
20:4 2.0 ± 0.3" 0.8 
= 
0.2 7.8 ± 1.3 3.0 :t 0.2' 
22:2 0.2 1: 0.0" 0.6 
= 
0.1' 0.4 ± 0.1 0.7 1: 0.2' 
22:3 4.5 ± 0.3" 4.6 ± 0.3" 3.4 ± 0.2" 9.7 1: 1.1' 
22:4 0.3 ± 0.1' 0.7 :t 0.1 004 ± 0.1 (l.S :.: 0.1 
TOlal 41.6 ± 1.3" 29.3 
Data presented as described in Table 3. 
classes from CHH-l cells supplemented with 
20:3(n - 6) is shown in Table 6. The increase in total 
(n - 6)PUFA was of a similar magnitude to that 
achieved with 18:3(n - 6) with the highest incorpo-
ration into PC. PC showed a significant increase in 
the .:l-5-desaturase product 20:4(n - 6) but the same 
fatty acid was significantly reduced in PE. All class-
es had significantly increased levels of the elonga-
tion product 22:3(n - 6). All phospholipid classes 
showed significantly increased 18:3(n - 6) demon-
strating the presence of chain shortening activity. 
The (n - 6)PUF A composition of phospholipid 
classes from CHH-l cells supplemented with 20:4 
(n - 6) is shown in Table 7. Supplemented 20:4 
(n - 6) generated total (n - 6)PUFA levels in all 
phospholipid classes similar to 20:3(n - 6) but was 
preferentially incorporated into PI. Chain elonga-
1: 1.7' 45.7 ± 104' 39.S 1: I. I • 
tion to 22:4(n - 6) was extensive with maximum in-
corporation into PS. No ~-4-desaluration and elon-
gation to 22:5(n - 6) was observed. 
The (n - 3)pUF A composition of phospholipid 
classes from CHH-l cells supplemented with 
20:5(n - 3) is shown in Table 8. Incorporation of 
20:5(n - 3) was greatest into PI although, as a result 
of extensive elongation to 22:5(n - 3), the highest 
levels of total (n - 3)PUFA were in PE. The incor-
poration of 22:5(n - 3) was greatest in PE and PS 
where it comprised 70 and 91070 of the total 
(n - 3)PUF A respectively. There was no evidence of 
A-4-desaturation and elongation to 22:6(n - 3). 
The (n - 3)pUFA composition of phospholipid 
classes from CHH-l cells supplemented with 
22:6(n - 3) is shown in Table 9. Supplementation 
with 22:6(n - 3) produced levels of total (n - 3) 
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Table 7. (n - 6)PUFA composition of phospholipid classes from CHH-I cells cultured in medium supplemented with 20:4(n - 6) 
n-6PUFA PC PS PI PE 
18:2 0.7 :!: 0.3 1.0 ± 0.4 0.6 ± 0.0 0.4 ± 0.0" 
18:3 0.7 ± 0.1" 0.8 ± 0.3 0.8 ± 0.3 0.5 ± 0.1' 
20:2 0.4 ± 0.1 t 1.7 ± 0.4' 0.7 ± 0.1' 
20:3 1.2 ± 0.2' 0.4 :!: 0.0 0.8 ± 0.1' 0.9 ± 0.3' 
20:4 12.5 ± 0.3' 2.2 :!: 0.5' 23.6 ± 1.6' 13.3 ± 0.1' 
22:2 0.2 ± 0.0' 0.2 ± 0.0' 0.2 ± 0.1 0.2 :!: 0.0 
22:3 0.2 ± 0.1" 0.2 ± 0.0' 0.2 ± 0.0' 0.2 ± 0.0' 
22:4 21.S :!: 1.2' 26.8 :!: 2.4' 14.7 :!: 0.8' 22.7 :!: 1.8' 
22:5 0.1 ± 0.0 0.1 ± 0.1' t" 0.3 :!: 0.1 
Total 37.5 ± 1.4" 35.3 ± 2.8" 42.6 ± 1.8' 39.2 ± 1.9' 
Data presented as described in Table 3. 
Table 8. (n - 3)PUFA composition of phospholipid classes from CHH-I cells cultured in medium supplemented with ~0:5(n - 3) 
n-3PUFA PC 
18:3 t 
18:4 0.1 ± 0.0 
20:3 t 
20:4 0.5 ± 0.1' 
20:5 11.0 ± 0.3· 
22:5 26.3 ± 0.3· 
22:6 0.5 ± 0.0· 
Total 38.4 ± 0.6' 
Data presented as described in Table 3. 
PS 
I 
0.1 ± 0.0 
I 
0.4 ± 0.1· 
1.6 ± 0.3· 
34.6 ± 0.2· 
1.3 ± 0.1· 
38.0 ± 0.2* 
PI 
0.1 ± 0.0 
0.3 ± 0.1' 
0.3 ± 0.1" 
14.8 ± 1.1. 
23.4 ± 1.0" 
1.0 ± 0.1" 
39.9 ± 0.3' 
PI' 
0.3 = n.n· 
9.7±O.I' 
30.7 :!: 0.7' 
~.9 ± 0.1' 
43.6 ± 0.-' 
Table 9. (n - 3)PUFA composition of phospholipid classes from CHH-I cells cultured in medium supplemented with ~2:6(n - 3) 
n-3PUFA 
18:3 
18:4 
20:3 
20:4 
20:5 
22:5 
22:6 
Total 
PC 
·0.1 ± 0.0 
"5.2 ± 1.0 
·1.9 ± 0.2 
·27.2 ± 5.4 
·34.4 ± 6.5 
Data presented as described in Table 3. 
PS 
*0.3 :t 0.1 
t 
·1.2 ± 0.0 
·1.8 ± 0.0 
·37.2 ± 2.6 
·40.5 ± 2.5 
PI 
0.1 ± 0.0 
·0.3 ± 0.1 
t 
·3.8 ± 0.2 
0\.8 ± 0.0 
·33.3 ± 1.1 
°40.2 ± 1.5 
PE 
·0.3 :!: 0.1 
·0.1 ± 0.0 
·2.0 ± 0.2 
"1.1 ± 0.1 
·44.0 ± 1.5 
°47.S ± 1.0 
PUF A similar to those with 20:5(n - 3). Incorpora-
tion of 22:6(n - 3) was particularly high in PE and 
PS (93 and 92010 of total (n - 3)PUF A respectively) 
while increased 20:5(n - 3) in all phospholipid class-
es suggested that significant retroconversion of 
22:6(n - 3) was occurring. 
Discussion 
A concentration of 25 IlM fatty acid was chosen 
since supplementation at this level produced con-
siderable alterations in PUF A content, without sig-
nificantly altering lipid class composition or induc-
ing intracellular lipid droplet formation in a num-
ber of previous studies utilising cultured cells 
(Stubbs and Smith 1984; Tocher 1990; Tocher and 
MacKinlay 1990). All CHH-l cells grew well at this 
concentration of fatty acid supplementation except 
those grown in 20:3(n - 6) which did not achieve 
confluence and began to detach from the flask after 
6-7 days. The experiment was repeated twice, us-
ing the same fatty acid concentration, with two 
different sources of 20:3(n - 6) and the same result 
was recorded. While the exact cause of the growth 
inhibition remains unclear, it seems unlikely that it 
was due to the presence of toxic oxidation products 
since measurement of TBA-reactive material in the 
PUF A-BSA complexes indicated greatest levels of 
oxidation products in the 20:5(n - 3) and 22:6 
(n - 3) supplements which demonstrated no growth 
inhibition (Results not shown). In a recent study 
with Atlantic salmon, we observed the development 
of pathophysiological lesions in heart of fish given 
diets containing elevated 18:2(n - 6) which caused a 
decreased (n - 3)1(n - 6)PUFA ratio in cardiac tis-
sue (Bell et al. 1991). While CHH-l cells sup-
plemented with 20:3(n - 6) also had a considerably 
reduced (n - 3)/(n - 6)PUFA ratio it is unlikely that 
this was solely to blame for the growth inhibition 
since supplementation with other (n - 6)PUF A at 
the same concentration did not affect growth. 
The long term culture of fish cells in FCS is 
known to cause a deficiency in essential fatty 
acids of the (n - 3) series (Tocher et 01. 1988). Al-
though the presence of considerable amounts of 
(n - 9)PUFA indicates that CHH-l cells grown in 
10070 FCS were deficient in (n - 3)pUFA, the distri-
bution of fatty acids between the phospholipid 
classes show many of the features occurring in 
whole fish. For example, PC contains high levels of 
16:0 and 18:1(n-9), PS and PI high 18:0 and PI 
high 20:4(n - 6). With all fatty acid supplements PI 
tended to accumulate 20-carbon PUF A which is 
consistent with a role as a precursor pool for eicosa-
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noid synthesis as postulated previously (Bell et al. 
1983). However, the extent of the (n - 3)PUF A 
deficiency is apparent when comparing the CHH-\ 
cells grown in 10070 FCS with cardiac tissue from 
Atlantic salmon (Bell et al. 1991). While CHH-l PE 
contained the highest levels of 20:5(n - 3) and 
22:6(n - 3) in any phospholipid class (1.4 and 4.2070 
respectively) the same fatty acids comprise 4 and 
421110 of the total in salmon heart. 
The increase in 18:3(n - 6) and 20:3(n - 6) on 
supplementation with 18:2(n - 6) and the increase 
in 18:4(n - 3) and 20:4(n - 3) on supplementation 
with 18:3(n - 3) clearly indicates the presence of 
..1-6-desaturase activity in CHH-l cells. The relative 
percentages of the ..1-6-desaturase products of 
18:2(n - 6) and 18:3(n - 3) indicated that there was 
no specificity for either substrate. This result is 
similar to that observed by Tocher el 01. (1989) with 
cells derived from rainbow trout gonad (RTG-2) 
and turbot fin (TF), but differed from Atlantic 
salmon cells (AS) which showed a preference 
towards the (n - 3) substrate (Tocher and Dick 
1990). However, the ..1-5-desaturase in CH H-I cells 
showed a preference towards the (n - 3) substrate 
since supplementation with 18:3(n - 3) resulted in 
increased 20:5(n - 3) incorporation while 18:2 
(n - 6) supplementation resulted in minimal 
20:4(11 - 6) production. This may not reflect a 
specific adaptation of fish cells since a similar sub-
strate preference has also been observed in mam-
mals (Stubbs and Smith 1984) and may be enhanced 
by the (n - 3)PUFA deficiency which exists in cells 
routinely cultured in FCS. In general, however, the 
accumulation of 20:3(n - 6) and 20:4(n - 3) on sup-
plementation with 18:2(n - 6) and 18:3(n - 3) is 
compatible with a low ..1-S-desaturase activity in 
CHH-l cdls which is considerably less than the ac-
tivity in both RTG-2 and AS cell lines (Tocher 1990; 
Tocher and Dick 1990). 
CHH-l cells like other salmonid derived cell lines 
appear to possess both ..1-6- and ..1-S-desaturase ac-
tivities, while ..1-4-desaturase is apparently absent. 
Whether the full desaturase complement was lost as 
a result of continuous culture or whether the origi-
nal cells were never capable of ..1-4-desaturation is 
not known. However, a number of cell lines are 
known to lose their ability to express desaturase ac-
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tivities after long term culture (Maeda et al. 1978; 
Robert et al. 1978). 
The considerable accumulation of 22C PUF A in 
comparison to other fish cell lines studied (Tocher 
1990; Tocher and MacKinlay 1990; Tocher and 
Dick 1990) suggests appreciable elongase activity is 
present in CHH-l cells. The large concentrations of 
elongation products arising from supplementation 
with both 20:4(n - 6) and 20:5(n - 3) may suggest 
some functional role for long-chain PUF A in these 
cells. 22:6(n - 3) is a major component of both rat 
cardiac phospholipids (Swanson and Kinsella 1986) 
and Atlantic salmon cardiac phospholipids (Bell et 
01. 1991). The concentration of 22:6(n - 3) in mem-
brane phospholipids of cardiomyocytes can pro-
foundly influence the activities in a number of 
membrane associated enzymes including Ca2 +-
Mg2 + ATPase and phospholipase A (Swanson et 
al. 1989; Nalbone et al. 1990). Culture of CHH-l 
cells in medium supplemented with 1 oro FCS and 25 
~M 22:6(n - 3) resulted in phospholipid fatty acid 
compositions similar to those in Atlantic salmon 
heart (Bell et al. 1991). The ability to return the"e 
cells to a lipid composition approaching that of the 
salmonid heart makes them a useful model system 
to study the effects of membrane fatty acid compo-
sition on a number of biochemical and physiologi-
cal functions. 
The ability of CHH-l cells to extensively elon-
gate both 20:4(n - 6) and 20:5(n - 3) is contrary to 
the situation in rat heart and isolated cardiomyo-
cytes which are unable to perform elongation (Mo-
hammed et al. 1990) or desaturation reactions 
(Hagve and Sprecher 1989). Future studies in this 
laboratory using isolated and primary cultures of 
salmonid cardiomyocytes would hope to elucidate 
whether the high levels of 22:6(n - 3) in heart are a 
result of the synthetic capacity of the cardiomyo-
cytes themselves, or are a result of hepatic modula-
tion of dietary fatty acids followed by release, and 
uptake by extrahepatic tissues. 
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ABSTRACT. Atlantic salmon (Salmo salar) post-smolls were fed practical-type diets in which the lipid was 
supplied either as fish oil (FO), sunflower oil (SFO) or linseed oil (LO) for 12 weeks. In general, the heart 
phospholipids from SFO-fed fish had increased 18:2n-6, 20:2n-6, 20:3n-6 and 20:4n-6 but decreased 20:5n-3 
compared to both other dietary treatments. This was reflected in a decreased n-3/n-6 polyunsaturated fatty 
acid (PUF A) ratio and an increased 20:4n-6/20:5n-3 or eicosanoid precursor ratio in SFO-fed fish. While heart 
phospholipids of fish fed LO had increased levels of 18:2n-6, 20:2n-6 and 20:3n-6 compared to fish fed FO, 
20:4n-6 levels were reduced, although only significantly in phosphatidylcholine (PC). Dietary-induced changes 
in phospholipid fatty acid compositions of blood leucocytes were similar to those in heart, although fish fed LO 
had increased 20:5n-3 compared to fish fed FO. Thromboxane Bz (TXB2) produced by stimulated blood cells 
was reduced in fish fed LO compared to those fed SFO. Prostaglandin Ez (PGEz) production was reduced in 
LO-fed fish compared to both other dietary treatments. Fish fed LO had reduced PC in heart membranes 
compared to the other two dietary treatments, resulting in a ratio of PC:PE (phosphatidylethanolamine) less 
than unity. Fish fed SFO developed a marked cardiac histopathology which, while present in FO-fed fish albeit 
in a less severe form, was virtually absent in fish fed LO. Fish fed SFO had increased heart phospholipase A 
activity compared to those given either FO or LO. 
INTRODUCTION 
Both essential fatty acids, linoleic acid [18:2n-6] and 
a-linolenic acid [18:3n-3] are metabolised by the same 
enzyme systems of sequential desaturation and elongation 
which result in the production of long chain polyunsatu-
rated fatty acids (PUF A) of the n-6 and n-3 series (1). 
Most freshwater fish are capable of A-6-desaturation 
of 18:3n-3 to 18:4n-3 followed by elongation and A-5-
desaturation to eicosapentaenoic acid [EPA. 20:5n-3] 
which finally undergoes elongation and A-4-desaturation 
to give docosahexaenoic acid [DHA. 22:6n-3] (2). 
Atlantic salmon (Salmo salar) are probably capable of 
metabolising 18:2n-6 similarly. since feeding diets con-
taining com oil resulted in increased arachidonic acid 
[AA. 20:4n-6] in membrane lipids (3). An important 
consideration in such experiments is that one type of 
fatty acid can influence the metabolism of the other (4). 
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Thus, an excess of n-6PUFA may inhibit metabolism of 
18:3n-3 although. in general. the n-3PUFA are more 
efficient in inhibiting the metabolism of n-6PUFA than 
vice versa (5). AA can be metabolised by both cyclooxy-
genase and Jipoxygenase to yield a wide range of highly 
bioactive eicosanoids (6). EPA can also give rise to 
eicosanoids although their biopotency is usually consid-
erabl) less than that of the AA homologues (7). In addi-
tion. both EPA and DHA. the major PUFA in fish tissues 
(2) and 18:3n-3 can directly inhibit cyclooxygenase 
activity. thereby reducing the production of AA-derived 
eicosanoids (8. 9). Evidence suggests that over production 
of AA-derived eicosanoids may be responsible for a 
number of pathophysiological conditions. including 
atherothrombotic and chronic inflammatory disorders in 
humans (10). 
Numerous mammalian studies have established that 
the PUF A composition of cardiac membrane phos-
pholipids can be directly influenced by dietary fat intake. 
In a previous study with Atlantic salmon, the phospholi-
pid fatty acid composition of heart tissue was consider-
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ably altered by feeding diets high in 18:2n-6 ( II). These 
fish also developed a severe cardiomyopathy which 
caused extensive thinning of the ventricular muscle and 
active necrosis in both the atrium and ventricle. Salmon 
given high levels of dietary 18:2n-6 showed increased 
levels of AA-derived eicosanoids in plasma and from 
stimulated blood leucocytes. compared to fish given low 
18:2n-6 (12). Prostaglandins (PGs) are important media-
tors of myocardial physiology ( 13) and are also involved 
in controlling muscle protein synthesis (14). 
In addition to their role in supplying precursors for 
eicosanoid metabolism. PUFA are vital components of 
membrane structure and as such can influence a number 
of membrane associated functions. In particular. mem-
brane phospholipid fatty acid composition can directly 
affect the activities of membrane-bound enzymes and 
receptors. For example. in rat ventricular myocytes the 
activities of both phospholipase A and lysophospholipase 
were affected by altering the membrane n-3/n-6PUF A 
ratio (15). 
The object of the present study was to explore essen-
tial fatty acid functions in cardiac physiology by feeding 
salmon diets in which the lipids were supplied either by 
sunflower (SFO). linseed (LO) or fish oil (FO). This was 
done by measuring phospholipid fatty acid compositions 
and PG production in both heart and blood leucocytes. 
and assessing the occurrence of cardiac lesions and 
measuring cardiac phospholipase A activity. 
MATERIALS AND METHODS 
Animals and diets 
330 Atlantic salmon S 1 smolts (initial mean weight ca. 
85 g) were obtained from the SOAFD Fish Cultivation 
Unit (Aultbea. Wester Ross. Scotland). The salmon were 
randomly distributed into three tanks of 2000 L capacity 
each. which were supplied with seawater at a rate of 
26 L/min. The tanks were subjected to natural photo-
period and the water temperature over the experimental 
period (August-November) was 15'-lOoC. The diets 
were supplied by automatic feeders which were acti-
vated for a few sec every 15 min during daylight hand 
adjusted initially to provide 28 g/kg biomass each day. 
When the average weight of the fish reached 120 g the 
ration was reduced to 20 g/kg each day. Fish were bulk 
weighed every 28 days and the ration adjusted accord-
ingly. The experiment was conducted in accordance with 
the British Home Office guidelines regarding research 
on experimental animals. 
The composition of the basal diet has been described 
in detail previously (11). The diet contained fishmeal 
(650 g/kg) (LT94. Ewos Ltd. Westfield, Lothian. 
Scotland). pre-cooked starch (150 g/kg). vitamin mix 
(10 g/kg). mineral mix (24 g/kg). a.-cellulose (65.5 g/kg) 
and choline chloride (4 g/kg). The lipid component 
(100 g/kg) was either FO (Fosol. Seven Seas Ltd. Hull, 
UK). SFO (Tesco. Cheshunt. UK), or LO (ICN Bio-
medical Ltd. High Wycombe. UK). An antioxidant mix 
(0.4 g/kg diet) was added to the oil before mixing with 
the other ingredients (II). The diets were formulated to 
satisfy the nutritional requirements of salmon (16) and 
contained 47Cft protein and 16Cft lipid. The fatty acid 
compositiol,,, of the three diets are given in Table I. 
Sampling procedure 
Samples of heart for lipid analysis and histology were 
collected after 12 weeks of the dietary treatment. Fish 
were killed by a blow to the head followed by decapitation 
and. after weighing. the heart was dissected. weighed 
and frozen in liquid N2. Samples were stored at -80°C 
prior to lipid analysis. Isolation of leucocytes and 
cardiomyocytes. and phospholipase A measurements were 
perfonned between 12-16 weeks of the dietary treatment. 
Lipid extraction and analysis 
Total lipid was extracted from hearts. leucocytes and 
diets by the method of Folch et al (17). The details 
of extraction. separation of phospholipid classes and 
preparation of fatty acid methyl esters have been de-
scribed previously (11). The fatty acid methyl esters 
were separated and quantified by gas-liquid chromatog-
raphy (Carlo Erba Vega 6000. Fisons Ltd, Crawley. UK) 
using a 50 m x 0.32 mm capillary column (CP-Wax 51. 
Chrompak Ltd. London. UK). Hydrogen was used as 
carrier gas and temperature programming was from 
50°C at 35°C/min to 150°C and then to 225°C at 2SC/ 
min. Individual methyl esters were identified by 
comparison with known standards and by reference to 
published data (18). 
The quantification of lipid class composition in heart 
was perfonned using high-performance thin-layer chro-
Table 1 Fatty acid composition of diets 
Fatty acid FOdiet SFO diet LOdiet 
mol'k 
14:0 7.4 2.0 2.0 
16:0 14.8 9.5 9.1 
18:0 2.2 3.9 3.2 
16:l(n-7) 5.1 2.0 2.0 
18:I(n-9) 8.9 16.2 15.9 
t8:\(n-7) 1.8 0.9 l.l 
20: Hn-9) 8.8 2.6 2.6 
22: I(n-II) 12.7 3.7 3.4 
24:1 0.7 0.4 0.4 
18:2(n·6) 1.3 37.0 11.2 
18:3(n-6) 0.2 0.1 I 
20:2(n-6) 0.3 0.1 0.1 
20:4(n-6) 0.5 0.4 0.4 
18:3(n-3) 1.2 0.5 29.4 
18:4(n-3) 2.9 0.9 0.8 
20:4(n-3) 0.6 0.2 0.2 
20:5(n-30 5.6 3.1 2.9 
22:5(n-3) 0.7 0.4 0.4 
22:6(n-3) 6.9 3.9 3.6 
Total (n-6) 2.3 37.6 11.7 
Total (n-3) 17.9 9.0 37.3 
(n-3)/(n-6) 7.8 0.2 3.2 
I = trace value < 0.05. 
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matography (HPTLC). 10 J..lg total lipid were applied to 
a lOx 10 cm HPTLC plate that had been pre-run in 
hexane:diethyl ether (l: 1 v/v) and activated at 110°C for 
30 min. The plates were developed to 6 cm in methyl 
acetate: isopropanol: chloroform: methanol: 0.25% (w/v) 
aqueous KCI (25:25:25:10:9 by volume) to separate 
phospholipid classes with neutral lipids running at the 
solvent front (19). After drying. the plates were developed 
fully in hexane:diethyl ether:acetic acid (80:20:2. v/v/v) 
to separate neutral lipids and cholesterol. Lipid classes 
were visualised by charring at 160°C for 15 min after 
spraying with 3% copper acetate (w/v) in 8% (v/v) 
phosphoric acid and identified by comparison with 
commercially available standards. Lipid classes were 
quantified by scanning densitometry using a Shimadzu 
CS-9000 dual wavelength TLC scanner and a DR-13 
recording integrator. 
Leucocyte isolation 
Blood collected from 6 fish per dietary treatment was 
diluted with 3 volumes of Hanks' balanced salt solution 
containing 20 Lu./ml heparin. 4 ml of diluted blood was 
layered on to 5 ml of lymphocyte separation medium 
and centrifuged at 400 x g for 45 min at 4°C. The 
leucocytes located around the interface of the separation 
medium and the salt solution were harvested and washed 
twice in phosphate buffered saline. If erythrocyte 
contamination was greater than 2% the gradient separation 
was repeated. The leucocytes obtained from 6 fish were 
pooled prior to lipid extraction. 
Cardiac myocyte isolation 
The enzymatic isolation procedure was based on the 
method of Powell et al (20). Hearts from 2 fish were 
cannulated via the bulbous arteriosus and perfused with 
modified Hanks' medium (concentrations in gIL; NaCI, 
10.29; KCI, 0.4; MgS04.7H20. 0.2; KH2P04, 0.06; 
Na2HP04.12H20, 0.13; NaHC03, 0.5; HEPES, 2.38) 
which was gassed continuously with 95% 02. 5% CO2, 
After 10 min the system was changed to recirculation 
and the medium changed to modified Hanks' plus 0.6% 
collagenase (w/v). After a further 45 min the hearts were 
removed and chopped finely in perfusion medium. This 
material was filtered through 190 J..lm nylon gauze and 
the myocytes collected by centrifugation (100 x g, 2 min). 
The myocytes were washed twice in collagenase-free 
Hanks' medium and finally resuspended in 1.0 ml of the 
same medium containing 2 mM CaCI2• The suspensions 
routinely contained 55-85% of the total cells present as 
rod-shaped cardiac myocytes. 100 J..lI of suspension was 
retained for protein determination. 
Challenge with calcium ionophore and eicosanoid 
extraction 
1 ml of whole blood was mixed with an equal volume of 
Hanks' medium containing 2 mM CaCI2. Both diluted 
blood (2 m\) and suspended cardiac myocytes (2 m!) 
were incubated in a shaking water bath at 18°C for 
10 min. Calcium ionophore A23187 was added in 2 III of 
dimethyl sulphoxide at a final concentration of 10 J..lM 
and the incubation continued for a further 20 min. The 
cells were then sedimented by centrifugation (12 000 x g. 
2 min) and the PGs extracted from the supernatant using 
CI8 'Sep-Pak' mini-columns (Millipore (UK) Ltd. 
Watford) as described by Powell (21). 
Measurement of PGEI and thromboxane BI (TXB1) 
PGE2 and TXB2• the stable metabolite of TXA2• were 
measured by enzyme immunoassay using kits supplied 
by Cascade Biochemicals Ltd. Reading. UK. 
Determination of phospholipase A activity 
Phospholipase A activity was assayed with endogenous 
substrate largely as described by Szymanska et al (22). 
One heart was homogenised in 2 ml of 50 mM Tris-HCl 
(pH8.5) containing 200 mM KCI and 5 mM CaCl l . I ml 
was removed and the lipid extracted immediately by 
the method of Fo\ch et al (17). 100 J..l1 was removed for 
protein determination and I ml was placed in a shaking 
water bath at 18°C. After 2 h the reaction was terminated 
by addition of 5 ml of chloroform:methanol (2: lv/v) 
containing 0.05% (w/v) butylated hydroxy toluene 
(BHT) and the lipids extracted as described above. 
Free fatty acids. phosphatidylcholine (PC) and phos-
phatidylethanolamine (PE) in 0 and 2 h samples were 
separated by HPTLC and quantified as described in the 
extraction of lipids section. 
Histology 
Samples of heart (approximately 50% of the ventricle) 
were fixed in 20% buffered formol saline at the time of 
the dissection within 2 min of killing the fish. embedded 
in paraffin wax and 5 11m sections were stained with 
haematoxylin and eosin. Pathological assessment was 
carried out on coded. randomised slides to eliminate bias 
in interpretation. 
Materials 
TLC plates (20 cm x 20 em x 0.25 mm) and HPTLC 
plates (10 em x 10 em x 0.25 mm). pre-coated with 
silica gel 60 were obtained from Merck (Darmstadt. 
Germany). All solvents were of HPLC grade and were 
obtained from Rathburn Chemicals Ltd (Walkerburn. 
UK). A23187 (Free acid) and collagenase (type IV) were 
obtained from Sigma Chemical Co. Ltd (Poole. UK). 
Lymphocyte separation medium, Hanks' balanced salt 
solution and phosphate buffered saline were obtained 
from Flow Ltd (Rickmansworth. UK). 
Statistical analysis 
Significance of difference (P < 0.05) between dietary 
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treatments was determined by analysis of variance 
CANOY A). Analyses were performed using a Statgraphics 
(system 3.0) computer package. Dala which were 
identified as non-homogeneous (using Bartletts' test) 
were subjected to either arcsine square root or log trans-
formation before analysis. Differences between means 
were determined by Tukeys' test. 
RESULTS 
No growth differences were observed over the 12 week 
experimental period and mortalities were low in all 
dietary treatments. There was no significant effect of 
dietary treatment on cardiosomatic index or heart total 
lipid content and no gross pathologies were evident. The 
only cardiac hi stopathological lesion ev ident was focal 
degeneration of the myocardium of the spongy layer of 
the ventricle with associated leucocyte accumulation 
(Figure). For assessment purposes the ventricle muscle 
ti ssue of each fi sh was categori sed into one of five 
groups ranging from no detectable degeneration through 
to severe lesion (Table 2). Similar lesions were also 
ev ident in the musc le of the auricle . The greatest in-
cidence and severity of lesion was in the SFO-fed fish 
although some ev idence of tissue damage was also ap-
parent in FO-fed fi sh. Feeding LO appeared to supress 
lesion occurrence to a greater extent than FO. 
The activities of cardiac phospholipase A, measured 
with endogenous substrate, are shown in Table 3. 
Results are calculated either as accumulation of free 
Table 2 Severit y or heart hi stopatholog y in salmon fed di ets 
contain ing FO. SFO o r LO 
Les ion severit y' FOd ie t SFO diet LO diet 
Num ber of fi sh 
0 7 6 II 
2 0 0 
2 2 J I 
3 0 2 0 
4 0 0 0 
Total sample II II 12 
' Lesion seve rity categori es; 0 = no changes evident. I = foca l increase 
of endocardial ce llul ari ty without ev idence o f myocardi al damage. 2 = 
focal lymphocyte accumu lation wi th myocardi al degenerati on. 1- 3 
les ions per vent ri cal section . 3 = as 2 but with 4- 10 les ions. 4 = as 2 
with 10 + les ions. 
Table 3 Phospho lipase A ac tivities in heart s of sa lmo n fed di ets 
con taining FO. SFO or LO 
Phospho lipase A ac tivit y FOdiet SFO die t LO diet 
nmol fa tty acid liberated/ 53. 1 ± 4 .9h 96.4 ± 6.9" 59.9 ± 1.'Ah 
h per mg prote in 
nmol PC and PE I 1.2 ± l .4h 26.3 ± 7 .0" 1.1.9 ± 3.4h 
hydrolysed/h per mg prote in 
Va lues are means ± SO for 4 fi sh per treatmen t. 
Values in the same row with differen t supersc ript letters are 
significantly different (P < 0.05) . 
fatty ac id or hydrolysis of PC and PE/h per mg protein . 
In both cases the phospholipase activity in fish given 
dietary SFO was sign ificantly increased compared to 
those g iven either FO or LO. 
Figure Areas of myotomal degeneration (arrowed) in the heart ventricle of a salmon fed on SFO containing diet. Scale bar = 
20 lim. 
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The levels of plasma PGE1 and TXB 2 and production 
of these PGs by stimulated whole blood and cardiac 
myocytes are given in Table 4. There were no significant 
dietary-induced changes in levels of either eicosanoid 
in circulating plasma. In stimulated blood cells TXB2 
was significantly increased in fish given SFO compared 
to those given LO. whereas PGE2 was significantly 
decreased in fish given LO compared to those given 
either FO or SFO. In stimulated cardiac myocytes TXB2 
production was not affected by dietary treatment 
whereas PGE1 was significantly increased in fish given 
both SFO and LO compared to those given FO. 
The lipid class composition of heart is shown in Table 
5. The amount of phosphatidylinositol (PI) was signifi-
cantly reduced in fish given SFO compared to those given 
FO and LO and PC was significantly reduced in fish given 
LO compared to both other dietary treatments. The latter 
observation significantly reduced the ratio PC:PE in LO-
fed fish compared to the other two dietary treatments so 
that in LO-fed fish PE was the major polar lipid class. 
Table" PGE~ and TXB~ concentrations in plasma and extracts from 
blood and cardiac myocytes stimulated with calcium-ionophl)re 
A23187 in salmon given diets containing FO. SFO or LO 
Eicosanoid 
Plasma TXB~ (ng/ml) 
Plasma PGE~ (pg/ml) 
Stimulated blood 
TXB~ (ng/ml) 
Stimulated blood 
PGE~(ng/ml)" 
Stimulated cardiac 
myocytes TXB~ 
FO diet 
1.2~ ± 0.35 
109.0 ± 15.5 
2.54 ± 2.0'" 
1.39 ± 0.33-' 
SFO diet LOdiet 
0.77 ± 0.55 1.02 ± 0.67 
125.3 ± ~6.1 165.7 ± 75.3 
12.27 ± 6.20' 2.20 ± 2.17" 
2.93 ± 0.8K·' 0.58 ± 0.21" 
(pg/mg protein) 112.2 ± ~8A Imu ± 27.1 98.0 ± 56.8 
Stimulated cardiac 268.0 ± 1~1.9" 857.0 ± 1~1.9' 706.3 ± 157.9J 
myocytes PGE~ 
(pg/mg protein) 
Values are mean ± SD for 4 fish per treatment. 
Values in the same row with different superscipt letters are 
significantly different. 
• Values were subjected to log transformation before ANOV A. 
Table 5 'k lipid class compositions of hearts from salmon fed diets 
containing either FO. SFO or lO 
Lipid FOdiet SFOdiet LOdiet 
g/IOO g lipid 
Total Phospholipids 60.1 ± 8.6 5~.5 t 8.3 53.5 t 3.5 
Total Neutral lipids 39.8 t 8.6 45.3 ± 8.3 ~6.3 ± 3.7 
SM 3.0 t 0.5 2.4 t 0.4 2.6 t 0.2 
PC· 22.2 t 3.1" 20.4 t 3.1' 16.1 ± 0.9h 
PS 3.3 t 0.6 2.7 t 0.4 3.1 t 0.2 
PI 3.5 t 0.6· 3.0 ± 0.5" 3.7 t 0.3· 
PA/Cl 8.7 t 1.4 7.9 t l.5 8.8 t 0.8 
PE 19.4 t 2.7 18.1 ± 2.7 19.3 t 1.6 
PC:PE ratio' 1.14 ± O.OY 1.13 ± 0.08· 0.84 ± 0.04" 
Triacylglycerol 27.8 t 9.8 32.8 t 8.8 33.6 t 5.1 
Free fatty acids 0.4 ± 0.1 0.5 ± 0.1 0.8 t 0.6 
Cholesterol 11.0 ± 1.8 12.3 ± 1.7 12.0 ± 1.6 
Values are means ± SD for 12 fish per treatment. 
Values in the same row with different superscript letters are 
significantly different. 
• Values subjected to arc sine square root transformation before 
ANOVA. 
• Value subjected to log transformation before ANOV A. 
PA: phosphatidic acid. Cl: cardiolipin. 
The fatty acid compositions of heart PC are shown 
in Table 6. Fish given SFO had significantly reduced 
total saturates compared to FO-fed fish. SFO-fed fish 
had significantly increased 18:2n-6; 18:3n-6, 20:2n-6. 
20:3n-6. AA and total n-6PUFA compared to both other 
dietary treatments. Fish given LO had increased 18:2n-6. 
20:2n-6. 20:3n-6 and total n-6PUFA compared to fish 
given FO but had significantly reduced AA compared to 
both other treatments. Fish given SFO had significantly 
decreased EPA. total n-3PUF A and n-3/n-6 ratio 
compared to both other treatments. The 20:4/20:5 ratio 
was also significantly increased compared to both other 
treatments while total PUFA was significantly increased 
compared to FO-fed fish. Fish given LO had significantly 
increased 18:3n-3 and 20:4n-3 but decreased EPA. DHA 
and n-3/n-6PUFA ratio compared to FO-fed fish. 
The fatty acid compositions of heart PE are shown in 
Table 7. Total monoenes were signiticantly different for 
each dietary treatment with the highest levels in FO-fed 
fish and the lowest in SFO-fed fish. SFO-fed fish had 
significantly increased 18:2n-6. 20:2n-6. 20:3n-6. AA 
and total n-6PUFA compared to the other two dietary 
tre.ltmcnts. Fish fed LO had sigllificantly greater 18:2n-6. 
20:2n-6 20:3n-6 and total n-6PUFA compared to FO-fed 
fish. 18:3n-3. 20:3n-3. 20:4n-3 and total n-3PUFA were 
significantly increased in LO-fed fish and significantly 
reduced in SFO-fed fish compared to fish fed FO. EPA 
was significantly reduced in fish fed SFO compared to 
the other two treatments. 22:5n-3 and the n-3/n-6PUFA 
ratio were significantly different in all dietary treatmcnts 
with the highest level in FO-fed fish and the lowest in 
SFO-fed fish. Total n-3 PUFA were also significantly 
different in each dietary treatment with the highest level 
in LO-fed fish and the lowest in SFO-fed fish. The 20:4/ 
20:5 eicosanoid precursor ratio was significantly increased 
in SFO-fed fish. Total PUFA were significantly increased 
Table 6 Fatty acid composition of PC from hearts of salmon fed 
diets containing dther FO. SFO or lO 
Fatty acid FOdiet SFO diet LOdiet 
mol'k 
Total saturates 33.1 ± 0.8' 31.3 ± O.lh 32.4 ± 0.3'" 
Total monoenes 12.9 t 0.8 11.6±0.9 12.4 ± 0.5 
11!:2(n-6) 0.5 t 0.1< 7.3 ± 0.1" 2.3±0.lh 
20:2(n-6) 0.1 t 0.0' 0.7 t 0.0" 0.2 to.D" 
20:3(n·6) 0.1 ± 0.0" \.3 t 0.1" 0.3 t O.lh 
20:4(n-6) 1.8 t 0.2h 2.6 t 0.2' 1.4 t O.lc 
Total (n-6)1 2.8 t 0.3< 12.2± 0.3" 4.4±0.lh 
18:3(n-3 ) 0.5 t 0.2b 0.2 ± O.()b 5.3 t 0.3· 
18:4(n-3) OJ t 0.1' 0.1 t O.()b 0.4 t 0.0" 
20:4(n-3) 0.4 t O.lb 0.3 ± O.lb 0.9 ± 0.0" 
20:5(n-3) 10.4 t 0.1" 6.6 t 0.1< 8.8 t 0.5h 
22:5(n-3) l.l ± 0.1 0.9tO.1 1.1 t 0.1 
22:6(n-3) 25.7 t 1.3' 24.0 ± 0.3,h 22.8 t 1.0h 
Total (n-3) 38.4 ± 1.0" 32.1 ± 0.2h 39.3 ± 0.8' 
(n-3)/(n-6)· 13.7 t 1.5' 2.6 t 0.1' 8.9 t O.4b 
20:4/20:5 0.2 t O.()b 0.4 t 0.0" 0.2 ± 0.(Jb 
Values are means ± SD for 3 fish per treatment. SD < 0.05 are 
tabulated as 0.0 . 
Values in the same row with different superscript letters are 
significantly different. 
IIndudes 18:3(n-6). 22:4(n-6) and 22:5(n-6). ·Values were subjected 
to log transformation before ANOV A. 
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Table 7 Fatty acid composition of PE from hearts of salmon fed 
diets containing either FO. SFO or LO 
Fatty acid FOdiet SFO diet LOdiet 
molCk 
. Total saturates 15.2 ± 0.2 14.9 ± 0.4 14.9 ± 0.6 
Total monoenes 11.3 ± 0.4' 7.0 ± 0.2" 8.3 ± 0.2h 
18:2(n-6) 1.0 ± 0.1' 7.5 ± O.Y 2.9 ± O.lh 
20:2(n-6) 0.2 ±O.I' 0.8 ± 0.0' 0.3 ± O.Oh 
20:3(n-6) 0.1 ± Doll' 0.9 ± 0.1' OJ ± O.lh 
20:4(n-6) 1.9 ± 0.3" 2.6 ± 0.2' 1.4 ± O.lh 
Total (n-6)1 3.9 ± 0.2' 12.7 ± 0.4" 5.6 ± 0.2h 
18:3(n-3) O.9±0.lh 0.4 ± 0.1' 5.2 ± 0.1" 
20:4(n-3) 0.6 ± O.lh 0.3 ± 0.0" 1.0 ± 0.0' 
20:5(n-3) 5.2±0.lb 4.0 ± 0.2' 5.6 ± 0.3" 
22:5(n-3) 3.1 ± 0.1" 2.6 ± O.lh 2.8 ± 0.1" 
22:6(n-3) 37.8 ± 0.5 36.7 ± 0.4 36.1 ± 1.3 
total (n-3) 47.6 ± 0.5b 44.0± 0.4' 50.7± l.O" 
Total PUFA 51.5 ± 0.3" 56.7 ± 0.3" 56.3± 1.1" 
(n-3)/(n-6) 12.2 ± 0.5" 3.5 ±O.I" 9.1 ± 0.2b 
20:4/20:5 0.4 ± O.lh 0.7±0.I' 0.3 ± 0.0" 
Total dimethyl 5.4 ± 0.5' 4.6±0.1" 4.7 ± 0.2·,h 
acetals 
Footnotes as described for Table 6. 
in SFO and LO-fed fish compared to those given FO. 
Total dimethyl acetals derived from plasmalogens were 
significantly reduced in SFO-fed fish compared to 
FO-fed fish. 
Heart phosphatidylserine (PS) fatty acid composition 
was less affected by dietary lipid than PC or PE. 18:2n-6 
and 18:3n-3 levels reflected dietary intake and 20:2n-6. 
20:3n-6 and total n-6PUFA levels were significantly 
increased in SFO-fed fish (data not shown). The n-3/ 
n-6PUFA ratio was significantly reduced in SFO-fed 
fish (data not shown). The fatty acid compositions of 
heart PI are shown in Table 8. Total monoenes were sig-
nificantly reduced in fish fed SFO and LO compared to 
those fed FO. 18:2n-6 was significantly different in each 
dietary treatment with highest levels in SFO and lowest 
levels in FO-fed fish. 20:2n-6. 20:3n-6. AA and total n-
6PUF A were significantly increased in SFO-fed fish 
compared to the other two treatments. 18:3n-3 was sig-
nificantly increased in fish fed the LO containing diet. 
Table 8 Fatty acid compositions of phosphatidylinositol from hearts 
of salmon fed diets containing either FO. SFO or LO 
Fatty acid FOdiet SFOdiet LOdiet 
molq. 
Total saturates 29.8 i 1.7 32.6 i 0.8 31.9 i 2.5 
Total monoenes 9.9 i 0.7' 7.8 ± 0.2" 7.5 i 0.2h 
18:2(n-6) 0.4 ± OJ} 3.3 ± 0.2' 1.0 ± O.lh 
20:2(n-6) 0.2 i O.lh 0.4 ±O,C}' 0.1 i 0.1" 
20:3(n-6) 0.2 ± 0.0" 1.0 ± 0.1' O.S ± 0.2" 
20:4(n-6) 16.6 ± 1.8" 19.6 ± 0.5' 15.9 ± 0.7" 
Total (n-6)1 17.4 ± 1.5" 2·U±0.6' 17.8 ± 0.6h 
18:3(n-3) 0.4 ± 0.2h 0.2 ± 0.0" 2.8 ± 0.2' 
20:4(n-3) 0.4 ± 0.1 0.3 iO.1 0.5 ± 0.1 
20:5(n-3) 8.8 ± 0.4' 5.6 ± 0.4" 8.8 ± 0.7" 
- 22:5(n-3) 1.0 i 0.1" 0.7 i 0.1" 0.9 i O.I'h 
22:6(n-3) 13.3 ± 2.2 10.6 ± 0.6 10.4 i 0.4 
Total (n-3) 23.9 ± 2.1" 17.4 ± 0.4" 23.4 i 1.3" 
Total PUFA 41.3± 1.0 41.7iO.3 -H.2 i 1.6 
(n-3)/(n-6) IAiO.2' 0.7iO.I" 1.3 i 0.1" 
20:4/20:5 1.9 ± 0.2" 3.5 ± 0.2' 1.8 ± 0.1" 
Foolnoles as described for Table 6. 
EPA, 22:5n-3. total n-3PUFA and n-3/n-6PUFA ratio 
were all significantly reduced in SFO-fed fish compared 
to fish fed the other two dietary treatments. The 20:4/ 
20:5 ratio was significantly increased in fish fed SFO. 
The fatty acid compositions of leucocyte PC and PE 
and shown in Table 9. The dietary induced changes 
in fatty acid compositions are largely similar for both 
phospholipid classes. In general feeding SFO increased 
18:2n-6 and all 20-carbon n-6PUFA while reducing the 
all n-3PUFA compared to FO-fed fish. This resulted in a 
decreased n-3/n-6PUF A ratio and an increased 20:4/20:5 
eicosanoid precursor ratio compared to FO-fed fish. 
Feeding LO also increased 18:2n-6. 20:2n-6 and 20:3n-6 
but decreased AA compared to FO-fed fish. EPA was 
increased in LO-fed fish compared to FO-fed fish and 
the resulting n-3/n-6PUFA ratio and 20:4/20:5 ratio were 
similar. The fatty acid compositions of leucocyte PS and 
PI are shown in Table 10. Dietary induced changes in PS 
were minimal although 18:2n-6 and 20-carbon n-6PUF A 
were increased in SFO-fed fish compared to the other 
two treatments. In LO-fed fish all n-3 PUFA were 
increased compared to the other two treatments. In PI. 
feeding LO did not reduce AA but did increase EPA 
such that the resulting 20:4/20:5 ratio was similar to that 
in FO-fed fish but was considerably less than SFO-fed 
fish. 
DISCUSSION 
Feeding both SFO and LO results in increased levels of 
18:2n-6 and 20:3n-6 (the product of Ll-6-desaturation 
and elongation) into phospholipids of heart and leucocytes. 
compared to fish fed fish FO. However. in most phos-
pholipid classes. the incorporation of AA (the product of 
Table 9 Fatty acid compositions of leucocyte PC and PE from 
salmon fed diels containing either FO. SFO or LO 
Fatty acid PC PE 
FO diel SFO diel LO diet FO diet SFO diel LO diet 
molq. 
Total saturates 33.0 35.4 34.5 21.5 14.6 14.2 
Total monoenes 27.4 23.~ ~5.4 14.4 9.4 13.7 
18:2(n-6) 1.6 8.8 204 1.8 10.4 4.0 
20:2(n-6) 0.2 1.4 0.3 0.2 1.3 0.4 
20:3(n-6) 0.3 104 004 0.2 0.8 0.3 
20:4/n-6) 1.8 2.6 104 2.5 4.0 2.2 
TOlal (n-6)1 4.3 14.4 4.9 4.9 16.9 7.2 
18:3(n-3) 0.5 O.~ 2.8 0.3 0.3 3.0 
20:4(n-3) 0.4 0.2 0.6 I I 0.3 
20:5(n-3) 7.6 5.2 7.9 3.4 2.7 4.2 
22:5(n-3) 1.2 0.6 0.7 0.9 0.8 0.9 
~2:6(n-3) 12.9 10.6 12.0 28.6 28.6 30.8 
Total (n-3)~ 22.8 20.6 24.6 33.2 32.4 39.6 
Total PUFA 27.1 35.0 29.5 38.1 49.3 46.8 
(n-3)/(n-6) 5.3 1.4 5.0 6.8 1.9 5.5 
20:4/20:5 0.2 0.5 0.2 0.7 1.5 0.5 
Total dimethyl 10.1 8.8 10.4 
acetals 
Results are obtained from pooled leucocYle samples from 6 fish per 
treatment. I = trace < 0.05q.. Ilnc1udes 22:4( n-6) and 22:5( n-6). 
:Includes 18:4( n-3) and 20:3/n-3). 
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Table 10 Fany acid compositions of leucocyte phosphatidylserine 
and phophatidylinositol from salmon fed diets containing either fbh 
oil. suntlower oil or linseed oil 
Fanyacid PS PI 
FO diet SFO diet LO diet FO diet SFO diet LO diet 
mol'K 
Total saturates 37.8 ~3.1 ~0.4 38.6 ~0.6 ~[).4 
Total monoenes 17.1 10.0 8.7 21.3 7.1 5.5 
18:2(n-6) 1.6 2.4 0.9 l.l 1.4 0.6 
20:2(n-6) 0.7 0.3 ().~ 0.1 
20:3(n-6) t 0.5 0.2 t 0.8 0.6 
20:4(n-6) 0.5 0.9 0.6 16.5 27.6 30.2 
Total (n-6)1 2.4 4.9 2.2 19.4 30.7 31.7 
18:3(n-3) 0.5 0.2 0.9 0.6 t 0.5 
20:4(n-3) t I 0.2 t t 0.4 
20:5(n-3) 1.3 l.l 1.7 1.0 0.8 1.5 
22:5(n-3) 1.3 1.3 1.7 0.5 0.9 1.0 
22:6(n-3) 24.3 24.9 29.9 6.5 5.3 ·U! 
Total (n_3)1 28.0 27.5 34.8 8.6 7.5 8.2 
Total PUFA 30.4 32.4 37.0 28.0 38.2 .W.9 
(n-3)/(n-6) 11.7 5.6 15.8 0.4 0.2 0.3 
20:4/20:5 0.4 0.9 0.4 16.2 36.1 19.8 
Footnotes as described for Table 9. 
.:l-5-desaturation) was increased when SFO was fed but 
was reduced when LO was the dietary lipid. Therefore. it 
appears that dietary LO, which is rich in 18:2n-6 but 
much richer in 18:3n-3, has an inhibitory effect on the.:l-
5-desaturase enzyme responsible for converting 20:3n-6 
to AA. Since there is more n-3PUF A than n-6PUF A in 
both 18 and 20-carbon fatty acids in LO-fed fish com-
pared to SFO-fed fish, it is inevitable that 18:2n-6 is me-
tabolized to AA in SFO-fed fish whereas the same does 
not occur in LO-fed fish to the same extent. That is. in 
LO-fed fish. there is competition at the .:l-6-desaturase 
between 18:2n-6 and 18:3n-3 and also at the .:l-S-
desaturase between 20:3n-6 and 20:4n-3 the net result of 
which is an apparent inhibition of ~-5-desaturation. 
The ability of 18:3n-3 to inhibit conversion of 18:2n-6 to 
AA has been observed previously in mammals (23). The 
SFO and LO containing diets both contained a similar 
concentration of EPA (as well as DHA) which was 
approximately half that provided by the FO diet. How-
ever. heart and leucocyte phospholipid fatty acid compo-
sitions indicated that. while SFO-fed fish had reduced 
levels of EPA. those fed LO had EPA values greater 
than or equal to those found in FO-fed fish. These results 
suggest appreciable conversion of 18:3n-3 to EPA via 
~-6- and ~-5-desaturation and elongation. The ability of 
post-smolt Atlantic salmon to elongate and desaturate 
18:2n-6 to AA has been identified previously (II). 
Except for leucocyte PS and PE. which showed small 
increases in DHA content. phospholipids from fish fed 
LO did not have increased DHA levels compared to fish 
fed FO. While parr of salmonid fish have been shown to 
desaturate and elongate 18:3n-3 to DHA (2). it is likely 
that the diets used in this experiment contained enough 
long-chain highly unsaturated fatty acids to satisfy the 
DHA requirement of salmon. 
While considerable data have been accumulated. from 
both mammals and fish. on the effects of different 
dietary lipids on tissue fatty acid compositions, the 
effects on lipid class composition are less well docu-
mented. In the present study salmon fed LO had reduced 
levels of PC compared to the other two dietary treat-
ments resulting in a PC:PE ratio less than unity. In the 
vast majority of fish species and tissues studied PC is the 
dominant phospholipid class (2). although. as in mam-
mals. some fish brain tissue has PE in excess of PC (24). 
Acclimation to low environmental temperature can alter 
the PC:PE ratio in fish tissues (25) which is accompa-
nied by increased incorporation of n-3PUFA. principally 
DHA. into membrane phospholipids. especially PE. In 
the present experiment DHA was not significantly in-
creased in heart membrane phospholipids although there 
was an overall increase in n-3PUFA in PE largely as a 
result of increased 18:3n-3. While the exact reason for 
the altered PC:PE ratio in fish fed LO is unclear. the 
consequences in terms of membrane physiology and 
biochemistry could be important. 
One aspect of membrane biochemistry which can be 
intluenced by fatty acid composition is the activities of 
membrane associated enzymes. including those involved 
in phospholipid metabolism. Nalbone et al (15) demon-
strated that cardiomyocytes grown in the presence of n-
6PUFA had higher phospholipase A activity and lower 
Iysophospholipase activity compared to those grown 
with n-3PUFA. In the present experiment the activity of 
phospholipase A was significantly increased in fish fed 
18:2n-6-rich SFO compared to fish fed either FO or LO. 
Increased phospholipase activity towards endogenous 
phospholipids could increase turnover of membrane 
fatty acids. provide increased substrate for eicosanoid 
synthesis and generally have a destabilising effect on 
membrane integrity. Although Iysophospholipase activ-
ity was not measured in this experiment, increased 
hydrolysis of PC could result in increased production of 
lysoPC which has potent cytolytic activity (26). 
In a previous study we identified an extensive cardio-
myopathy in salmon fed SFO which was largely absent 
in those fed FO (11). We speculated that the changes in 
membrane phospholipid fatty acid composition arising 
from feeding SFO could alter the species. concentration 
and thus the biological efficacy of resulting eicosanoids. 
Considerable evidence exists that EPA and DHA from 
dietary FO can modulate production of AA-derived 
eicosanoids either by inhibition of cyclooxygenase activ-
ity (27) or by production of EPA-derived eicosanoids 
of reduced biopotency relative to their AA homologue 
(10). Suppression of AA-derived eicosanoids by dietary 
18:3n-3 has also been observed in mammals (28). In the 
present study focal cardiac myopathy was observed in 
fish fed SFO and while some degeneration of cardiac 
tissue was also observed in fish fed FO these were much 
less severe. Cardiac myopathy was virtually absent in 
fish fed LO. 
The AA-derived PGs. TXB~ and PGE2 were measured 
in plasma. stimulated cardiac myocytes and stimulated 
blood cells. TX is an important mediator of platelet 
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aggregation. vascular tone and intracellular calcium 
concentration (10). while PGE~ is a mediator of inflam-
matory activity (29). is inhibitory to muscle fibre forma-
tion and can stimulate protein catabolism (14,30). 
Whole blood was chosen in preference to isolated 
leucocytes since this most closely resembles the in vivo 
situation where the eicosanoid spectrum is influenced by 
interactions between cell types. Studies with salmonid 
blood indicate that erythrocytes are not capable of 
eicosanoid synthesis (31). In stimulated blood cells. fish 
fed LO produced significantly less TXB~ than those fed 
SFO. and PGE2 production in the LO group was signifi-
cantly less than both the SFO and FO fed treatments. 
Thus, in general. production of AA-derived prostanoids 
by leucocytes was considerably reduced by feeding 
dietary LO. There was no difference in TXB2 production 
by stimulated cardiac myocytes between dietary treat-
ments but PGE2 production was increased in myocytes 
from fish fed SFO and LO compared to those fed FO. 
It would appear therefore that increased production of 
PGE2 by cardiac myocytes is not fundamental in the 
development of cardiac lesion. Feeding increased levels 
of purified 18:3n-3 similarly depressed AA-derived 
eicosanoid production in rats (32). The reasons for 
depressed AA-derived prostanoid production by 
leucocytes can be explained by the fatty acid composi-
tions of leucocyte phospholipids. In general, fish fed LO, 
had increased EPA in all leucocyte phospholipids and 
decreased AA in PC and PE compared to both other 
dietary treatments. Fish which developed the histopatho-
logical cardiac lesion showed extensive leucocyte infil-
tration at the lesion site. Thus increased production of 
highly bioactive AA-derived eicosanoids by leucocytes 
may be resposible for the severity of lesion develop-
ment. 
This experiment suggests that feeding diets high in 
18:2n-6 can result in undesirable pathophysiological 
conditions that may. in part. be due to alterations in fatty 
acid composition and metabolism. However feeding di-
ets high in 18:3n-3 may increase the anti-inflammatory 
activity to a greater degree than feeding FO alone and 
thus attenuate undesirable cardiac pathology. 
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Effect of Diets Rich in Linoleic or a-Linolenic Acid on Phospholipid 
Fatty Acid Composition and Eicosanoid Production in Atlantic 
Salmon (Sa/rno safar) 
J. Gordon Bell*, James R. Dick and John R. Sargent 
N.E.R.C. Unit of Aquatic Biochemistry. School of Natural Sciences, University of Stirling. Stirling FK9 4LA. Scotland. 
United Kingdom 
Atlantic salmon post-smolts were fed diets rich in linoleic 
acid (sunflower oil, SO), a-linolenic acid (linseed oil, LO) or 
long-chain polyunsaturated fatty acids (fish oil. FO) for a 
period of 12 wk. In the liver phospholipids of fish fed SO, 
the levels of 18:2n-6, 20:2n-6, 20:3n-6 and 20:4n-6 were sig-
nificantly elevated compared to both other treatments. In 
choline phospholipids (CPL), ethanolamine phospholipids 
(EPL) and phosphatidyIserine (PS) the levels of 22:40-6 and 
22:5n-6 were significantly elevated in fish fed SO. In liver 
phospholipids from fish fed LO. 18:2n-6. 2O:2n-6 and 2O:3n-6 
were significantly elevated but 20:40-6, 22:40-6 and 22:5n-6 
were similar or significantly decreased compared to fish 
fed FO. Liver phospholipids from fish fed LO had increased 
18:3n-3 and 20:4n-3 compared to both other treatments 
while EPL and phosphatidylinositol (PI) also had increased 
20:5n-3. In fish fed LO. 22:6n-3 was significantly reduced 
in CPL, PS and PI compared to fish fed FO. Broadly 
similar changes occurred in gill phospholipids. Production 
of 12-lipoxygenase metabolites in isolated gill cells stimu-
lated with the Ca2+ -ionophore A23187 were significantly 
reduced in fish fed either SO or LO compared to those fed 
FO. However, the ratio 12-hydroxy-S, 8,10, 14-eicosatetra-
enoic acid (12-HETE)/12-hydroxy-5. 8.10.14. 17-eicosapenta-
enoic acid (12-HEPE) was significantly elevated in 
stimulated gill cells from SO-fed fish. Although mean 
values of thromboxane B2 (TXB2) and prostaglandin E2 
(PG~) were increased in fish fed SO, they were not sig-
nificantly different from those of the other two treatmenls. 
Lipids 28. 819-826 (1993). 
The so-called essential fatty acids. linoleic acid (18:2n-6) and 
linolenic acid (18:3n-3), are the precursors of the long-chain 
n-6 and n-3 species which are important components of the 
phospholipid bilayer of cell membranes. It is generally ac-
cepted that both the n-6 and n-3 fatty acids are metabolized 
by the same sequence of desaturating and elongating en-
zymes (1). In these pathways the desaturation steps are 
generally rate-limiting while elongation is rapid (2). and thus 
competition between substrate fatty acids at desaturase 
binding sites will determine the' nature of the resulting 
polyunsaturated fatty acids (PUFA) and ultimately the com-
position of cellular membranes. In competitive terms. the 
n-3 PUFA are much more potent inhibitors of n-6 PUFA 
·To whom correspondence should be addressed. 
Abbreviations: AA. arachidonic acid; BHT. butylated hydroxytoluene; 
CPL. choline phospholipids; DHA. docosahexaenoic acid; EPA. 
eicosapentaenoic acid; EPL. ethanolamine phospholipids; FO. fish oil; 
HDHE. hydroxy-4. 7. 10. 13. 16. 19-docosahexaenoic acid; HEPE, 
hydroxy·5.8. 10.14. 17-eicosapentaenoic acid; HETE. hydroxy-5. B. 
10. 14-eicosatetraenoic acid; HPLC. high-performance liquid chro-
matography; LO. linseed oil; PGE 2• prostaglandin E2; Pl. 
phosphatidylinositol; PS. phosphatidylserine; PUF A. polyunsaturated 
fatty acid; SO. sunflower oil; TLC. thin-layer chromatography; TXB2• 
thromboxane B2; UV. ultraviolet. 
Copyright ~ 1993 by the American Oil Chemists' Society 
metabolism than vice versa although the relative concen-
trations of the two substrates will also determine the pro-
ducts that result (3,4). Many species of freshwater fish. in-
cluding Atlantic salmon (Salmo salad, possess the enzymes 
necessary to elongate and desaturate 18:3n-3 to docosahex-
aenoic acid (DHA. 22:6n-3) (5) and are capable of metaboliz-
ing 18:2n-6 similarly. resulting in increased arachidonic acid 
(AA; 20:4n-6) in membrane phospholipids (6). 
In mammals. AA is the major precursor for biologically 
active eicosanoids and in humans consuming a typical 
"Western-type" diet. overproduction of AA-derived eico-
sanoids may explain the prevalence of the many inflam-
matory conditions occurring in the developed world (7). Fish 
provide a useful model system for the study of eicosanoid 
metabolism since, although AA may be the preferred eico-
sanoid substrate (8.9). fish contain considerable amounts of 
eicosapentaenoic acid (EPA, 20:5n-3) and DHA. which can 
attenuate the production and efficacy of AA-derived 
eicosanoids (10). EPA can be metabolized by both cycloox· 
ygenase and lipoxygenase enzymes resulting in products of 
lower bioactivity when compared to their AA homologues 
(11.12). EPA can also competitively inhibit the prostaglan-
din synthetase enzyme complex. thereby reducing produc-
tion of AA-derived prostanoids (13). A number of recent 
studies have suggested that feeding oils rich in 18:3n-3 can 
reduce production of AA-derived eicosanoids by increasing 
levels of EPA in membrane phospholipids (14.15). In addi-
tion 18:3n·3 can directly inhibit cyclooxygenase activity (16). 
In previous studies with salmon we have shown that a high 
level of dietary 18:2n-6 can result in development of a severe 
cardiomyopathy involving active necrosis of both atrium and 
ventricle (17) and altered eicosanoid metabolism in blood 
leucocytes and gill cells (18). 
The objective of the present study was to investigate the 
metabolism of 18:2n-6 and 18:3n-3 in salmon fed diets con-
taining either sunflower oil (SO). linseed oil (LO) or fish oil 
(FO) by measuring phospholipid fatty acid compositions in 
liver and gill The 12-lipoxygenase products and the cycloox-
ygenase products prostaglandin E2 (PGE2) and thrombox-
ane B2 (TXB2) were measured in isolated gill cells stimu-
lated with the calcium ionophore A23187. 
MATERIALS AND METHODS 
Animals and diets. Three hundred and thirty Atlantic sal-
mon Sl smolts (salmon undergoing transition to seawater 
in one year) were obtained from the S.O.A.F.D. Fish Culti-
vation Unit (Aultbea. Wester Ross. Scotland) and distri-
buted randomly into three tanks of 2000 L capacity each. 
which were supplied with seawater at a rate of 26 Llmin. 
The fish (mean weight ca. 86 g) were subject to natural 
photoperiod, and the water temperature during the experi-
mental period (August-November) varied from 15-10cC. 
Diets were supplied by automatic feeders which were ad-
justed to provide 20 g/kg biomass per day. Fish were 
weighed every 28 d and the ration adjusted accordingly. 
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The diets were formulated to meet the nutritional re-
quirements of salmonid fish (19) and contained 47% pro-
tein and 16% lipid The composition of the basal diet has 
been described in detail previously (20) and contained 
fishmeal (650 g/kg) (LT94, Ewos Ltd., Westfield, Lothian, 
Scotland), pre-cooked starch (150 g/kg), vitamin mix (10 
g/kg), mineral mix (24 g/kg), o-cellulose (65.5 g/kg) and 
choline chloride (4 g/kg). The dietary lipid (100 g/kg) was 
supplied either as fish oil (Fosol, Seven Seas Ltd., Hull, 
United Kingdom), sunflower oil (Thsco, Cheshunt, United 
Kingdom) or linseed oil (lCN Biomedical Ltd., High 
Wycombe, United Kingdom). An antioxidant mix (0.4 
g/kg) was mixed with the oil before adding to the other 
diet components (20). The fatty acid compositions of the 
diets are shown in Table 1. 
Lipid extraction and fatty acid analysis. Samples were 
collected after 12 wk of the dietary trial and stored at 
-80°C until analyzed_ Lipids were extracted from liver 
and gill tissue by the method of Folch et aL (21). Thtallipid 
extracts were separated into choline phospholipids (CPL), 
ethanolamine phospholipids (EPL), phosphatidylserine 
(PS) and phosphatidylinositol (PI) fractions by thin-layer 
chromatography (TLC) as described by Vitiello and 
Zanetta (22). The plates were sprayed with 0.1% 2',7'-dich-
lorofluorescein in 97% methanol containing 0.05% buty-
lated hydroxy toluene (BHT), and the lipid bands were 
visualized under ultraviolet (UV) light. Acid-catalyzed 
transmethylation was carried out overnight at 50°C as 
TABLE 1 
Fatty Acid Composition or Diets 
Fatty acids Fish oil diet 
14:0 6.6 
16:0 14.8 
18:0 2.4 
Total saturatedD 24.6 
16:1n-7 5.1 
18:1n-9 9.7 
18:1n-7 2.0 
20:1n-9 10.5 
22:1n-11 16.6 
24:1 1.0 
Total monoenoicb 45.2 
1&2n~ 1.4 
18:3n-6 0.2 
20:2n-6 0.3 
20:3n-6 0.1 
20:4n-6 0.6 
Total n-6c 2.8 
1&3n~ 1~ 
1&4~3 ~1 
20:4n·3 0.7 
20:5n·3 6.5 
22:5n-3 0.9 
22:6n-3 8.8 
Total n-3 21.3 
Total PUFA· 25.0 
n-3/n-6 ratio 7.6 
Glncludes 15:0. 17:0. 20:0 and 22:0. 
blnc1udes 20:1n-11, 20:1n-7 and 22:1n-9. 
tIncludes 22:4n-6 and 22:5n-6. 
dt = Trace value <0.05%. 
·PUF A, polyunsaturated fatty acids. 
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described by Christie (23). The fatty acid methyl esters 
were separated and quantified by gas-liquid chroma-
tography (Carlo Erba Vega 6000, Fisons Ltd., Crawley. 
United Kingdom) on a 50 m X 0.32 mm capillary column 
(CP-Wax 51, Chrompak Ltd., London, United Kingdom). 
Hydrogen was used as carrier gas, and temperature pro-
gramming was from 50°C at 35°C/min to 150°C and then 
to 225°l" at 2.5°C'min. Individual methyl esters were iden-
tified by comparison with known standards and by 
reference to published data (24). 
Preparation of isolated gill cells. The procedure used for 
isolating gill cells has been described in detail previously 
(18). Minced gill filaments were incubated in a Hanks' 
medium specially formulated for use with salmonid fish 
(25) containing 0.1% collagenase (type IV, Sigma Chemical 
Co., Poole, United Kingdom) for 45 min at room temper-
ature with constant stirring. After filtering through nylon 
gauze, the cells were collected by centrifugation at 400 
X g for 2 min, washed twice in Hanks' medium and finallv 
resuspended in 1 mL of the same medium containing 'I 
mM CaCI2• 
lonophore challenge and eicosanoid extraction. Isolated 
gill cells prepared as described above were placed in glass 
tubes pre-coated with Sigmacote and incubated in a shak-
ing water bath at 18°C for 10 min. Calcium ionophore was 
added in 2 ilL of dimethyl sulfoxide at a final concentra-
tion of 10 ilM and the incubation continued for a further 
20 min. The cells were sedimented by centrifugation 
Sunflower oil diet 
(wt%) 
1.8 
9.5 
4.3 
15.9 
2.0 
17.8 
1.0 
3.1 
4.8 
0.6 
29.5 
40.3 
0.1 
0.1 
t 
0.5 
41.1 
0.5 
1.0 
0.2 
3.6 
0.5 
4.9 
10.7 
51.8 
0.3 
Linseed oil diet 
1.8 
9.1 
3.5 
14.9 
2.0 
17.4 
1.2 
3.1 
4.4 
0.5 
28.7 
12.2 
t d 
0.1 
t 
0.5 
12.9 
31.8 
0.9 
0.2 
3.4 
0.5 
4.5 
41.3 
54.2 
3.2 
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(12000 X g, 2 min) and the eicosanoids extracted from the 
supernatant using CI8 Sep-Pak minicolumns (Millipore 
Ltd., Watford, United Kingdom) according to Powell (26) 
High-performance liquid chromatography (HPLC). The 
hydroxy acids 12-hydroxy-5, 8,10, 14-eicosatetraenoic acid 
(12-HETE), 12-hydroxy-5, 8, 10, 14, 17-eicosapentaenoic 
acid (12-HEPE) and 14-hydroxy-4, 7, 10, 13, 16, 19-doco-
sahexaenoic acid (14-HDHE) were separated and quan-
tified by reverse-phase HPLC using a Spherisorb 5 ",m oc-
tadecyl silane (ODS 2) column (25 cm X 4.6 mm, Ana-
chern, Luton, United Kingdom). The chromatographic sys-
tem was equipped with Waters Model M-45 pumps 
(Waters Chromatography, Warford, United Kingdom) and 
the effluent was monitored at 235 nm using a Pye-Unicam 
LC-UV detector (Pye-Unicam, Cambridge, United King-
dom). An isocratic solvent system containing acetoni-
trile/methanol/water/acetic acid (40:29:30:0.5, by vol) was 
used at a flow rate of 1 mLlmin. Quantification was based 
on use of external standards of 12-HETE and 12-HEPE. 
Identification of 14-HDHE was done as described pre-
viously (18). 
Measurement of PGE2 and TXB2- PGE 2 and TXB2, 
the stable metabolite of thromboxane A2, were measured 
by enzyme immunoassay using kits supplied by Cascade 
Biochemicals Ltd. (Reading, United Kingdom). 
Materials. All solvents were of HPLC grade and were 
obtained from Rathburn Chemicals Ltd. (Walkerburn. 
Scotland, United Kingdom). TLC plates (20 cm X 20 cm 
X 0.25 mm), pre-coated with silica gel 60 were obtained 
from Merck (Darmstadt, Germany). 12(R,S)-HETE and 
12(S)-HEPE were obtained from Cascade Biochemicals 
Ltd. (Reading, United Kingdom). Sigmacote and A23187 
were obtained from Sigma Chemical Co. Ltd. (Poole. Dor-
set, United Kingdom). 
TABLE 2 
Statistical analysis. Significance of difference (P < 0.05) 
between dietary treatments was determined by analysis 
of variance using a Statgraphics (system 3.0) computer 
package. Data which were identified as nonhomogeneous 
were subjected to either arcsine square root or log trans-
formation before analysis. Differences between means 
were determined by Thkey's test. 
RESULTS 
The fatty acid compositions of liver CPL are shown in 
Table 2. Thtal monoenoic fatty acids were significantly 
reduced in SO-fed fish compared to FO-fed fish. In SO-
fed fish 18:2n-6, 18:3n-6, 20:2n-6, 20:3n-6, 20:4n-6, 22:4n·6 
and 22:5n-6 were all significantly increased compared to 
both other dietary treatments. Fish fed LO had 
significantly increased 18:2n-6, 18:3n-6, 20:2n-6. 20:3n·6 
and total n-6 PUFA but significantly reduced 22:5n-6 com-
pared to fish fed FO. LO fish had significantly increased 
18:3n-3, 18:4n-3. 20:3n-3 and 20:4n-3 compared to both 
other dietary treatments but had significantly reduced 
DHA compared to FO-fed fish. In fish fed SO 18:3n-3. 
20:4n-3, EPA. 22:5n-3 and total n-3 PUFA were significant-
ly reduced compared with both other dietary treatments 
while DHA was significantly reduced compared to Fa-
fed fish. The n·3/n-6 PUFA ratio was significantly different 
in the three dietary treatments with the highest value in 
FO-fed fish and the lowest in SO-fed fish. 
The fatty acid compositions of liver EPL are shown in 
Table 3. Thtal monoenoic fatty acids were significantly dif-
ferent for each dietary treatment with the highest levels 
in FO·fed fish and the lowest levels in SO-fed fish. Also. 
18:2n-6. 20:2n-6, 20:3n-6 and total n-6 PUFA were 
Fatty Acid Compositions of Choline Phospholipids rrom Salmon Liver· 
Sunflower oil diet 
Fatty acids Fish oil diet (wt%) Linseed oil diet 
Total saturated 29.3 ± 1.6 29.9 ± 3.5 31.7 ± 3.7 
Total monoenoic 16.0 ± 1.6b 13.2 ± 0.8< 14.6 ± l.lb.c 
18:2n·6 1.1 ± 0.3d 10.6 ± 1.7b 4.0 ± 0.5c 
18:3n·6 td 0.5 ± 0.3b 0.2 ± O.Oc 
20:2n·6 0.3 ± O.ld 1.7 ± 0.5b 0.6 ± O.lc 
20:3n·6 0.3 ± O.ld 6.4 ± LOb 2.0 ± 0.5c 
20:4n·6 0.7 ± O.lc 5.5 ± 2.2b 0.6 ± O.lc 
22:4n·6 0.1 ± O.Oc 0.7 ± 0.4b 0.1 ± O.Oc 
22:5n·6 0.3 ± 0.1< 0.7 ± 0.3b 0.1 ± 0.0· 
Total n·6 2.8 ± 0.3d 26.0 ± 0.4b 7.4 ± 0.4c 
18:3n·3 0.3 ± O.lc 0.1 ± O.Od 3.6 ± 1.2b 
18:4n-3 0.1 ± 0.0· 0.1 ± 0.0· 0.7 ± 0.2b 
20:3n·3 tC tC 0.4 ± O.lb 
20:4n·3 0.8 ± 0.2c 0.2 ± O.ld 2.9 ± O.Sb 
20:5n·3 9.8 ± LOb 3.8 ± 0.4c 9.5 ± 1.2b 
22:5n·3 3.0 ± 0.6b 2.0 ± 0.5c 3.3 ± 0.4b 
22:6n·3 35.9 ± 2.6b 23.8 ± 3.2e 25.5 ± 1.7' 
Total n-3 49.6 ± 1.8b 29.7 ± 3.1e 45.8 ± 2.2b 
Total PUFA 52.4 ± 1.8 55.7 ± 3.2 53.1 ± 2.1 
n-3/n·6 18.0 ± 1.6b 1.2 ± O.ld 6.2 ± 0.5c 
20:4/20:5 0.1 ± O.Oc 1.5 ± 0.6b 0.1 ± O.Oc 
°Results are % by weight ± SD from four fish per treatment; t = trace value <0.05%. 
SD <0.05 are recorded as 0.0. PUFA. polyunsaturated fatty acids. Values in the same 
row with different superscript letters b. c. d are significantly different (P < 0.051. 
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TABLE 3 
Fatty Acid Compositions of Ethanolamine Phospholipids from Salmon Liver" 
Sunflower oil diet 
Fatty acids Fish oil diet (wt%' Linseed oil diet 
Total saturated 12.6 ± 0.7 12.7 ± 0.6 13.6 ± 1.4 
Total monoenoic 25.2 ± 1.8b 15.5 ± 2.5d 21.1 ± 0.4< 
18:2n·6 1.7 ± O.4d 12.0 ± 2.1b 4.7 ± 1.1c 
18:3n·6 0.1 ± 0.0 0.2 ± 0.1 t 
20:2n·6 0.4 ± O.ld 2.3 ± 0.5b 0.7 ± O.lc 
20:3n·6 0.3 ± O.ld 5.1 ± 0.6b 1.5 ± 0.2c 
20:4n·6 1.3 ± O.4c 9.6 ± 2.7b 1.1 ± O.lc 
22:4n·6 tC 0.8 ± 0.4b tC 
22:5n·6 0.5 ± O.Oe 1.0 ± 0.3b 0.3 ± O.ld 
Total n·6 4.2 ± 0.4d 30.9 ± 2.5b 8.1 ± 1.1e 
18:3n·3 0.8 ± 0.2e 0.3 ± O.ld 3.0 ± 0.6b 
20:3n·3 tC te 0.7 ± O.lb 
20:4n·3 0.5 ± O.lc td 1.7 ± O.4b 
20:5n·3 8.8 ± 1.2c 3.6 ± 1.0 11.1 ± l.lb 
22:5n·3 2.1 ± O.4b.c 1.8 ± O.4c 2.8 ± 0.4b 
22:6n·3 41.9 ± 1.9b 32.5 ± 2.7< 36.0 ± 0.ge 
Total n·3 54.1 ± 0.8b 38.2 ± 2.2c 55.4 ± 0.3b 
Total PUFA 58.3 ± 1.2d 69.2 ± 2.7b 63.5 ± 1.4< 
n·3In·6 12.9 ± 1.2b 1.3 ± O.ld 6.9 ± 0.9" 
20:4120:5 0.2 ± O.le 2.9 ± l.4b 0.1 ± O.Oe 
aResults are % by weight ± SD from four fish per treatment; t = trace value <0.05%. 
SD <0.05 are recorded as 0.0. PUFA, polyunsaturated fatty acids. Values in the same 
row with different superscript letters b. c, d are significantly different IP < 0.051. 
significantly affected by dietary treatment with the 
highest levels in SO-fed fish and the lowest levels in FO-
fed fish. Levels of 22:5n-6 were also significantly different 
in each dietary group with highest values in SO· fed fish 
and lowest in LO-fed fish. AA and 22:4n-6 were signifi-
cantly increased in fish fed SO compared to both other 
dietary treatments. Also, 18:3n-3, 20:4n-3 and EPA were 
significantly different in each dietary treatment with 
highest levels in LO-fed fish and lowest in SO-fed fish. 
22:5n-3 was significantly increased in LO-fed fish com-
pared to SO-fed fish whereas DHA was significantly 
greater in FO-fed fish compared to both other treatments. 
Thtal n-3 PUFA were significantly lower in SO-fed fish 
while total PUFA were significantly different in each 
dietary treatment with the highest levels in SO-fed fish 
and the lowest in FO-fed fish. The ratio of n-3/n-6 PUFA 
was significantly different in each dietary treatment with 
the highest value in FO-fed fish and the lowest in SO-fed 
fish. The ANEPA ratio of eicosanoid precursors was sig-
nificantly increased in SO-fed fish compared to both other 
treatments. 
The fatty acid compositions of liver PS are shown in 
Table 4. Thtal saturated fatty acids were significantly in-
creased whereas total monoenoic fatty acids were sig-
nificantly decreased in fish fed SO and LO compared to 
those fed FO. The level of 20:3n-6 was significantly dif-
ferent in each dietary treatment with the highest levels 
in SO-fed fish and the lowest in FO-fed fish. AA and 
22:5n-6 were also significantly different in each treatment 
with the highest levels in SO-fed fish and the lowest in 
LO-fed fish. 18:2n-6, 20:2n-6, 22:4n-6 and total n-6 PUFA 
were all significantly increased in fish fed SO compared 
to the other dietary treatments. Levels of 18:3n-3 and 
20:4n-3 were significantly greater in fish fed LO than in 
LIPIDS, Vol. 28, no. 9 (1993) 
the two other treatments while EPA was significantly 
reduced in SO-fed fish compared to LO-fed fish. Thtal n-3 
PUFA were significantly reduced in SO-fed fish compared 
to both other treatments while DHA was reduced in fish 
fed SO compared to those fed FO. Thtal PUFA were 
significantly greater in SO-fed fish compared to LO-fed 
fish. The n-3/n-6 PUFA ratio was significantly lower and 
the AA/EPA ratio significantly greater in SO-fed fish com-
pared to both other treatments. 
The fatty acid compositions of liver PI are shown in 
Table 5. Thtal saturated fatty acids were significantly 
elevated in fish fed SO and LO compared with those fed 
FO. Thtal monoenoic fatty acids were significantly dif-
ferent in all treatments with the highest levels in fish fed 
FO and the lowest in those fed SO. Levels of 18:2n-6 and 
total n-6 PUFA were significantly increased in SO-fed fish 
compared to the other two treatments whereas 20:3n-6 
was significantly greater in LO-fed fish compared to the 
other treatments. AA was significantly different in all 
dietary treatments with the highest level in SO-fed fish 
and the lowest level in LO-fed fish. Also, 18:3n-3, 20:4n-3 
and total n-3 PUFA were significantly reduced in fish fed 
SO compared to the other two treatments. EPA was 
significantly different in all treatments with the highest 
level in LO-fed fish and the lowest in SO-fed fish. Levels 
of 22:5n-3 and DHA were significantly different in all 
treatments with the highest levels in FO-fed fish and the 
lowest in SO-fed fish. Thtal PUFA were significantly 
greater in SO-fed fish compared to LO-fed fish. The n-3/n-6 
PUFA ratio was significantly lower and the ANEPA ratio 
significantly greater in fish fed SO compared to both other 
treatments. 
The major PUFA in gill CPL and EPL are shown in 
Figure 1. in CPL 18:2n-6 and 20:3n-6 were significantly 
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TABLE 4 
Fatty Acid Compositions of Phosphatidylserine from Salmon Livera 
Sunflower oil diet 
Fatty acids Fish oil diet (wt%1 Linseed oil diet 
Total saturated 31.7 ± 1.5" 35.5 ± l.4b 35.8 ± 1.8b 
Total monoenes 10.3 ± 0.8b 6.2 ± 0.5" 6.7 ± 1.0c 
18:2n·6 0.5 ± O.le 1.5 ± 0.2b 0.6 ± O.lc 
18:3n·6 0.2 ± 0.2 0.2 ± 0.1 t 
20:2n·6 0.2 ± O.Oc 1.0 ± 0.3b 0.3 ± O.lc 
20:3n·6 0.2 ± O.ld 1.6 ± 0.5b 0.6 ± O.lc 
20:4n·6 0.5 ± O.lc 1.7 ± 0.3b 0.2 ± O.ld 
22:4n·6 tC 0.8 ± 0.5b tC 
22:5n·6 0.6 ± O.lc 1.1 ± O.4b 0.3 ± O.Od 
Total n·6 2.0 ± 0.2c 8.0 ± 0.7b 2.0 ± O.lc 
18:3n·3 0.4 ± 0.1 b.c 0.2 ± O.lc 0.6 ± 0.2b 
18:4n-3 0.4 ± 0.1 b tC tC 
20:4n-3 tC t C 0.5 ± O.lb 
20:5n-3 1.4 ± 0.5b .c 0.7 ± 0.3c 1.4 ± 0.3b 
22:5n-3 2.7 ± 0.4 3.2 ± 0.8 3.8 ± 0.6 
22:6n-3 47.3 ± l.6b 43.2 ± 2.3c 44.6 ± 0.7b.c 
Total n·3 52.3 ± 0.3b 47.2 ± 1.7c 50.9 ± 0.7b 
Total PUFA 54.3 ± 1.0b.e 55.2 ± 1.3b 52.9 ± 0.7" 
n-3/n-6 25.9 ± 2.l b 5.9 ± 0.6e 25.8 ± 1.3c 
20:4/20:5 0.4 ± 0.2c 3.1 ± 1.6b 0.2 ± O.le 
"Results are "'c by weight ± SD from four fish per treatment; t = trace value <0.05'·0. 
SD <0.05 are recorded as 0.0. PUFA. polyunsaturated fatty acids. Values in the same 
row with different superscript letters b. c. d are significantly different (P < 0.051. 
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different in all dietary treatments with the highest levels 
in SO-fed fish and the lowest in Fa-fed fish. AA was 
significantly increased and EPA significantly decreased 
in SO-fed fish compared to the other treatments. Conse-
quently, the AA/EPA ratio was significantly greater in 
SO fish compared to the other two treatments. DHA and 
total n-3 PUFA were significantly decreased in SO-fed fish 
compared to both other treatments. Largely similar ef-
fects occurred in gill EPL except that 20:3n-6 was signifi-
cantly greater in SO-fed fish compared to both other treat-
ments and DHA was significantly reduced in SO-fed fish 
compared to FO-fed fish. 
TABLE 5 
The major PUFA of gill PS and PI are shown in Figure 
2. In gill PS 18:2n-6 and 20:3n-6 were significantly 
Fatty Acid Compositions of Phosphatidylinositol from Salmon Liver· 
Sunflower oil diet 
Fatty acids Fish oil diet (wt%) Linseed oil diet 
Total saturated 33.3 ± 1.6c 38.1 ± 0.5b 38.4 ± l,lb 
Total monoenoic 12.5 ± l.4b 6.7 ± 0.7d 9.2 ± 0.6e 
18:2n-6 0.5 ± O.lc 1.4 ± 0.3b 0.6 ± O.lb 
20:2n-6 0.3 ± 0.1 0.5 ± 0.1 0.3 ± 0.1 
20:3n-6 2.0 ± 0.3c 1.8 ± 0.7c 5.8 ± 1.2b 
20:4n-6 28.4 ± 0.3e 41.8 ± 0.4b 21.0 ± 1.2d 
Total n-6 31.5 ± 0.2e 46.1 ± 0.5b 28.3 ± 1.7< 
18:3n-3 0.4 ± O.lb tC 0.5 ± O.lb 
20:4n-3 0.3 ± O.lb t C 0.5 ± O.lb 
20:5n-3 4.9 ± 0.ge 0.7 ± 0.3d 10.1 ± 2.5b 
22:5n-3 2.2 ± 0.3b 0.6 ± O.l d 1.7 ± 0.2e 
22:6n-3 12.4 ± 1.2b 4.7 ± 0.5d 8.1 ± 0.4< 
. Total n·3 19.7 ± O.4b 6.2 ± 0.6< 21.5 ± 2.9b 
Total PUFA 51.4 ± 0.7b.e 52.2 ± l,lb 49.7 ± l,lc 
n-3/n·6 0.6 ± O.Ob 0.1 ± 0.0< 0.7 ± 0.2b 
20:4/20:5 7.0 ± 2.2c 76.1 ± 28.2b 3.2 ± 2.2< 
"Results are % by weight ± SD from four fish per treatment; t = trace value <0.05%. 
SD <0.05 are recorded as 0.0. PUFA, polyunsaturated fatty acids. Values in the same 
row with different superscript letters b. c, d are significantly different (P < 0.05\. 
LIPIDS, Vol. 28, no. 9 (1993) 
824 
J .G . BELL ET At. 
30,---------------__________________ -, 
VI 25 
'" '(j 
~ 20 
!' 
~ 15 
'" '0 
~ 10 
o 
tfi. 
~ 5 
o 
A Gill C PL 
a 
..,. 
Fally Acid 
40.-----------------------------~--~ 
a 
B Gill EPL T ab 
III 30 
'" .c:; 
~ 
!' 
(;j 
~ 20 
-; 
'0 
t-
.... 
0 
tfi. 10 
~ 
o 
Fatty Acid 
FIG. I. The levels of the major polyunsaturated fatty acids of gill 
choline pbospbolipids (CPL) (A) and ethanolamine phospholipids 
(EPL) (B) from salmon fed diets containing either fish oil (dotted 
bars), sunflower oil (filled bars) or linseed oil (hatched bars). Values 
are means ± SD for four fish per treatment. Values for each fatty 
acid having a different column letter are significantly different 
(P < 0.05). 
different in all dietary treatments with the highest levels 
in SO-fed fish and the lowest levels in FO-fed fish. AA was 
significantly increased and EPA significantly reduced in 
SO-fed fish, resulting in an increased AA/EPA ratio when 
compared to fish fed either FO or LD. In gill PI the results 
were largely similar to PS except that DHA was signifi-
cantly greater in fish fed FO than in both other dietary 
treatments. 
The production of eicosanoids by isolated gill cells sti-
mulated by A23187 is shown in Table 6. The production 
of 12-HETE, 12-HEPE and 14-HDHE were all signifi-
cantly reduced in fish fed both LO and SO compared to 
those fed FO. However, the ratio of 12-HETEI12-HEPE 
was significantly increased in fish fed SO compared to 
both other treatments_ While mean values of both TXB2 
and PGE 2 were greatest in fish fed SO, they were not 
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FIG. 2. Levels of the major polyunsaturated fatty acids of gill 
ph08phatidylserine (PS) (A) and phosphatidylinositol (PI) (8) from 
salmon fed diets containing either fish oil (dotted bars), sunflower 
oil (filled bars) or linseed oil (hatched bars). Values are means ± SO 
for four fish per treatment. Values for each fatty acid having a dif· 
ferent column letter are significantly different (P < 0.05). ~ 
significantly different from either of the other dietary 
treatments. 
DISCUSSION 
Feeding SO results in increased levels of 18:2n-6. 20:2n-6. 
20:3n-6 and AA in all liver phospholipids while 22:4n-6 
and 22:5n-6 were increased in CPL, EPL and PS compared 
to both other treatments. 20:3n-6, the product of t.6 
desaturation and elongation of 18:2n-6, was also increased 
in fish fed LO, whereas AA, the product of t.5 desatura-
tion, was generally decreased in those fish compared to 
fish fed FO. Similarly 22:5n-6, the product of M desatura-
tion and elongation of AA was decreased in fish fed LO 
compared to those fed FD. Therefore it appears that 
feeding LO, which contains 18:2n-6 and 18:3n-3 in a ratio 
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TABLE 6 
Eicosanoids Crom Isolated Salmon Gill Cells Stimulated with the Ca2+ ·Ionophore A23187 
Eicosanoid" 
12·HETE 
12·HEPE 
12·HETEIl2·HEPE 
14·HDHE 
TXB 2 
PGE2 
Fish oil 
diet 
17.7 ± 9.6b 
45.2 ± 12.4h 
0.354 ± 0.094(' 
34.1 ± 11.86 
142.8 ± 80.4 
192.3 ± 54.0 
Sunflower oil 
diet 
5.7 ± 2.9" 
7.8 ± 3.2< 
0.791 ± 0.189h 
6.8 ± 3.8c 
229.0 ± 120.9 
807.3 ± 562.3 
Linseed oil 
diet 
5.8 ± 0.5< 
21.2 ± 8.2c 
0.327 ± 0.138< 
10.4 ± 1.9< 
172.0 ± 59.6 
510.3 ± 177.9 
"Values are mean ± SD from four fish per treatment. Values for 12·HETE. 12·HEPE 
and 14·HDHE are ng/mg protein. whereas those for TXB2 and PGE2 are pg/mg protein. 
b,cValues in the same row with different superscript letters are significantly different 
(P < O.05). HETE. hydroxy·5. 8. 10. 14·eicosatetraenoic acid: I HEPE. hydroxY·5. 8. 10. 
14. 17·eicosapentaenoic acid: HDHE. hydroxy·4. 7. 10. 13, 16. 19·docosahexaenoic acid: 
TXB2• thromboxane B2: PGE2• prostaglandin E2• 
of 1:3. has an inhibitory effect on lI5 (and possibly M) 
desaturase which is responsible for AA production. The 
ability of 18:3n-3 to reduce the conversion of 18:2n·6 to 
AA. by inhibition of 116 desaturase, has been recorded 
previously in mammals (27.28). The differences in 20:3n·6 
and AA production by fish fed either SO or LO can be 
explained by considering the competitive influences of the 
different dietary fatty acid compositions. In SO-fed fish 
the high 18:2n-6 level makes AA production inevitable 
whereas the presence of 18:3n-3 in LO·fed fish results in 
competition which reduces 20:3n-6 production from 
18:2n-6. At the same time 116 desaturation and elongation 
of 18:3n-3 results in increased 20:4n-3 in LO-fed fish, and 
this. coupled with reduced 20:3n-6. results in reduced AA 
production and an apparent inhibition of lI5 desaturase. 
Similar competitive effects presumably operate to increase 
or reduce 22:5n·6 levels in SO- and LO-fed fish. respect-
ively. 
In a previous study using the related salmonid. the rain-
bow trout. no increase in elongated and desaturated pro-
ducts of 18:3n-3 were observed in the polar lipid fraction 
of fish fed 18:3n-3 enriched diets (29). However. in the pre-
sent study with Atlantic salmon. although dietary EPA 
levels were similar in both SO and LO diets. the fatty acid 
compositions of phospholipid classes of both liver and gill 
showed decreased EPA in SO-fed fish. but LO-fed fish had 
EPA values greater than or equal to those of FO·fed fish. 
These results suggest that salmon are capable of EPA pro-
duction from 18:3n-3 utilizing the pathways of 116 and 115 
desaturation and elongation. Although some phospholipid 
classes from liver of La-fed fish had elevated 22:5n-3. there 
was no apparent increase in DHA compared to fish fed 
FO. Previous studies with Atlantic salmon parr have 
demonstrated that they are capable of converting 18:3n-3 
to DHA (5) but in the larger post-smolts used in the pre-
sent study M desaturation is either very low or. more like-
ly. the requirement for DHA is met by dietary input. 
Both AA and EPA can be metabolized by cycloox-
ygenase to yield prostaglandins of the 2 and 3 series and 
by lipoxygenase to yield leukotrienes of the 4 and 5 series 
and a number of HETE and HEPE isomers (14.30). It is 
generally regarded that EPA is a poorer substrate for 
cyclooxygenase than AA and thus acts as a competitive 
inhibitor (16). The biological activity of the EPA-derived 
prostanoids and leukotrienes is considerably less than 
that of their AA-derived equivalents (12.31) which ex-
plains the ability of so-called 'MaxEPA' preparations to at-
tenuate many of the pathophysiological conditions which 
occur in humans (7). In the present study feeding LO de-
creases AA and increases EPA in tissue phospholipids of 
Atlantic salmon and might therefore be expected to alter 
the spectrum of eicosanoids produced by these fish. 
Gill cells were chosen since they are known to possess 
a highly active 12-lipoxygenase (18.32) and also to con-
tain cyclooxygenase activity (5). While overall production 
of 12-lipoxygenase products was greatest in fish fed FO. 
the ratio of 12-HETEI12-HEPE was increased in SO-fed 
fish and was similar in both FO- and LO·fed fish. Al-
though no specific physiological role has been identified 
for products of 12-lipoxygenase, a number of recent stud-
ies have implicated 12-HETE as a modulator of ion chan-
nels (33.34). Clearly this activity would be particularly im-
portant in gills which. along with posterior kidney. are 
vital in controlling osmoregulation in fish. Diet·induced 
changes in gilllipoxygenase products might therefore af-
fect the ability of salmon to adapt to varying salinity. 
In a previous study Atlantic salmon given increasing 
dietary linoleic acid produced decreasing amounts of gill 
12-lipoxygenase products (18). In the present study sal-
mon fed LO also produced significantly less 12-lipoxygen-
ase products compared to fish fed FO. A similar decrease 
was also observed in platelet 12-lipoxygenase products 
from rats fed 18:3n-3 compared to those fed FO (14). One 
possible explanation is that changes in membrane phos-
pholipid fatty acid composition might affect the activity 
of phospholipase A2 which provides the precursors for 
eicosanoid production. Recent studies have established 
that phospholipase A2 activity can be either increased or 
decreased in different tissues as a result of decreasing the 
membrane n-3/n-6 PUFA ratio (35.36). 
The tendency for the PI fraction to accumulate 20-car-
bon fatty acids in fish has resulted in the hypothesis that 
this phospholipid might be the source of precursor fatty 
acids br eicosanoid production (5.37). However. the ratio 
of 12-HETE/12-HEPE produced by stimulated gill cells 
in the current experiment was most similar to the 
AA/EPA ratio present in gill CPL (0.20. 0.61 and 0.20 for 
Fa. SO and La diets, respectively). Comparison of the pre-
cursor fatty acid ratios of both CPL and PI would make 
the former class the more likely source of lipoxygenase 
substrate fatty acids. A similar result has been recorded in 
mammalian platelets (38) and cultured umbilical cells (39). 
The present study demonstrated that while diets rich 
in 18:2n-6 result in increased AA in membrane lipids of 
LIPIDS, Vol. 28. no. 9 (1993) 
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salmon, the fatty acid compositions can be 'normalized' 
to the position in fish fed FO, by feeding 18:3n-3. In this 
context linseed oil could be useful. when used in conjunc-
tion with marine oils, as an inhibitor of inflammatory 
activity in fish. 
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